domain	doc_id	annotator	adu1_pos	adu2_pos	adu1_aty	adu2_aty	adu1_afu	adu2_afu	adu1_main	adu2_main	rel_direction	relation	adu1_text	adu2_text	adu1_id	adu2_id	rel_id
BIO	10024363	mn	1	2	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	BIO_10024363_mn_1	BIO_10024363_mn_2	BIO_10024363_mn_1_2
BIO	10024363	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	BIO_10024363_mn_1	BIO_10024363_mn_3	BIO_10024363_mn_1_3
BIO	10024363	mn	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	BIO_10024363_mn_1	BIO_10024363_mn_4	BIO_10024363_mn_1_4
BIO	10024363	mn	1	5	motivation_background	result_means	info-required	support	secondary	secondary	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	BIO_10024363_mn_1	BIO_10024363_mn_5	BIO_10024363_mn_1_5
BIO	10024363	mn	1	6	motivation_background	observation	info-required	support	secondary	secondary	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	BIO_10024363_mn_1	BIO_10024363_mn_6	BIO_10024363_mn_1_6
BIO	10024363	mn	1	7	motivation_background	result_means	info-required	info-required	secondary	secondary	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	BIO_10024363_mn_1	BIO_10024363_mn_7	BIO_10024363_mn_1_7
BIO	10024363	mn	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_mn_1	BIO_10024363_mn_8	BIO_10024363_mn_1_8
BIO	10024363	mn	1	9	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_mn_1	BIO_10024363_mn_9	BIO_10024363_mn_1_9
BIO	10024363	mn	2	3	motivation_problem	proposal	support	none	secondary	main	forw	support	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	BIO_10024363_mn_2	BIO_10024363_mn_3	BIO_10024363_mn_2_3
BIO	10024363	mn	2	4	motivation_problem	proposal_implementation	support	elaboration	secondary	secondary	none	none	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	BIO_10024363_mn_2	BIO_10024363_mn_4	BIO_10024363_mn_2_4
BIO	10024363	mn	2	5	motivation_problem	result_means	support	support	secondary	secondary	none	none	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	BIO_10024363_mn_2	BIO_10024363_mn_5	BIO_10024363_mn_2_5
BIO	10024363	mn	2	6	motivation_problem	observation	support	support	secondary	secondary	none	none	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	BIO_10024363_mn_2	BIO_10024363_mn_6	BIO_10024363_mn_2_6
BIO	10024363	mn	2	7	motivation_problem	result_means	support	info-required	secondary	secondary	none	none	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	BIO_10024363_mn_2	BIO_10024363_mn_7	BIO_10024363_mn_2_7
BIO	10024363	mn	2	8	motivation_problem	observation	support	support	secondary	secondary	none	none	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_mn_2	BIO_10024363_mn_8	BIO_10024363_mn_2_8
BIO	10024363	mn	2	9	motivation_problem	conclusion	support	support	secondary	secondary	none	none	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_mn_2	BIO_10024363_mn_9	BIO_10024363_mn_2_9
BIO	10024363	mn	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	BIO_10024363_mn_3	BIO_10024363_mn_4	BIO_10024363_mn_3_4
BIO	10024363	mn	3	5	proposal	result_means	none	support	main	secondary	none	none	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	BIO_10024363_mn_3	BIO_10024363_mn_5	BIO_10024363_mn_3_5
BIO	10024363	mn	3	6	proposal	observation	none	support	main	secondary	none	none	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	BIO_10024363_mn_3	BIO_10024363_mn_6	BIO_10024363_mn_3_6
BIO	10024363	mn	3	7	proposal	result_means	none	info-required	main	secondary	none	none	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	BIO_10024363_mn_3	BIO_10024363_mn_7	BIO_10024363_mn_3_7
BIO	10024363	mn	3	8	proposal	observation	none	support	main	secondary	none	none	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_mn_3	BIO_10024363_mn_8	BIO_10024363_mn_3_8
BIO	10024363	mn	3	9	proposal	conclusion	none	support	main	secondary	back	support	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_mn_3	BIO_10024363_mn_9	BIO_10024363_mn_3_9
BIO	10024363	mn	4	5	proposal_implementation	result_means	elaboration	support	secondary	secondary	none	none	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	BIO_10024363_mn_4	BIO_10024363_mn_5	BIO_10024363_mn_4_5
BIO	10024363	mn	4	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	BIO_10024363_mn_4	BIO_10024363_mn_6	BIO_10024363_mn_4_6
BIO	10024363	mn	4	7	proposal_implementation	result_means	elaboration	info-required	secondary	secondary	none	none	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	BIO_10024363_mn_4	BIO_10024363_mn_7	BIO_10024363_mn_4_7
BIO	10024363	mn	4	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_mn_4	BIO_10024363_mn_8	BIO_10024363_mn_4_8
BIO	10024363	mn	4	9	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_mn_4	BIO_10024363_mn_9	BIO_10024363_mn_4_9
BIO	10024363	mn	5	6	result_means	observation	support	support	secondary	secondary	back	support	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	BIO_10024363_mn_5	BIO_10024363_mn_6	BIO_10024363_mn_5_6
BIO	10024363	mn	5	7	result_means	result_means	support	info-required	secondary	secondary	back	info-required	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	BIO_10024363_mn_5	BIO_10024363_mn_7	BIO_10024363_mn_5_7
BIO	10024363	mn	5	8	result_means	observation	support	support	secondary	secondary	none	none	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_mn_5	BIO_10024363_mn_8	BIO_10024363_mn_5_8
BIO	10024363	mn	5	9	result_means	conclusion	support	support	secondary	secondary	forw	support	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_mn_5	BIO_10024363_mn_9	BIO_10024363_mn_5_9
BIO	10024363	mn	6	7	observation	result_means	support	info-required	secondary	secondary	none	none	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	BIO_10024363_mn_6	BIO_10024363_mn_7	BIO_10024363_mn_6_7
BIO	10024363	mn	6	8	observation	observation	support	support	secondary	secondary	none	none	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_mn_6	BIO_10024363_mn_8	BIO_10024363_mn_6_8
BIO	10024363	mn	6	9	observation	conclusion	support	support	secondary	secondary	none	none	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_mn_6	BIO_10024363_mn_9	BIO_10024363_mn_6_9
BIO	10024363	mn	7	8	result_means	observation	info-required	support	secondary	secondary	back	support	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_mn_7	BIO_10024363_mn_8	BIO_10024363_mn_7_8
BIO	10024363	mn	7	9	result_means	conclusion	info-required	support	secondary	secondary	none	none	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_mn_7	BIO_10024363_mn_9	BIO_10024363_mn_7_9
BIO	10024363	mn	8	9	observation	conclusion	support	support	secondary	secondary	none	none	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_mn_8	BIO_10024363_mn_9	BIO_10024363_mn_8_9
BIO	10024363	mn	9	8	conclusion	observation	support	support	secondary	secondary	none	none	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_mn_9	BIO_10024363_mn_8	BIO_10024363_mn_8_9
BIO	10400678	mn	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	BIO_10400678_mn_1	BIO_10400678_mn_2	BIO_10400678_mn_1_2
BIO	10400678	mn	1	3	motivation_background	motivation_background	info-required	elaboration	secondary	secondary	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	It could be one protease with dual specificity or two distinct enzymes.	BIO_10400678_mn_1	BIO_10400678_mn_3	BIO_10400678_mn_1_3
BIO	10400678	mn	1	4	motivation_background	proposal	info-required	none	secondary	main	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	BIO_10400678_mn_1	BIO_10400678_mn_4	BIO_10400678_mn_1_4
BIO	10400678	mn	1	5	motivation_background	result	info-required	support	secondary	secondary	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	BIO_10400678_mn_1	BIO_10400678_mn_5	BIO_10400678_mn_1_5
BIO	10400678	mn	1	6	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	BIO_10400678_mn_1	BIO_10400678_mn_6	BIO_10400678_mn_1_6
BIO	10400678	mn	1	7	motivation_background	result	info-required	support	secondary	secondary	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	BIO_10400678_mn_1	BIO_10400678_mn_7	BIO_10400678_mn_1_7
BIO	10400678	mn	1	8	motivation_background	result	info-required	support	secondary	secondary	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_mn_1	BIO_10400678_mn_8	BIO_10400678_mn_1_8
BIO	10400678	mn	1	9	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_mn_1	BIO_10400678_mn_9	BIO_10400678_mn_1_9
BIO	10400678	mn	2	3	motivation_background	motivation_background	support	elaboration	secondary	secondary	back	elaboration	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	It could be one protease with dual specificity or two distinct enzymes.	BIO_10400678_mn_2	BIO_10400678_mn_3	BIO_10400678_mn_2_3
BIO	10400678	mn	2	4	motivation_background	proposal	support	none	secondary	main	forw	support	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	BIO_10400678_mn_2	BIO_10400678_mn_4	BIO_10400678_mn_2_4
BIO	10400678	mn	2	5	motivation_background	result	support	support	secondary	secondary	none	none	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	BIO_10400678_mn_2	BIO_10400678_mn_5	BIO_10400678_mn_2_5
BIO	10400678	mn	2	6	motivation_background	result	support	elaboration	secondary	secondary	none	none	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	BIO_10400678_mn_2	BIO_10400678_mn_6	BIO_10400678_mn_2_6
BIO	10400678	mn	2	7	motivation_background	result	support	support	secondary	secondary	none	none	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	BIO_10400678_mn_2	BIO_10400678_mn_7	BIO_10400678_mn_2_7
BIO	10400678	mn	2	8	motivation_background	result	support	support	secondary	secondary	none	none	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_mn_2	BIO_10400678_mn_8	BIO_10400678_mn_2_8
BIO	10400678	mn	2	9	motivation_background	conclusion	support	support	secondary	secondary	none	none	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_mn_2	BIO_10400678_mn_9	BIO_10400678_mn_2_9
BIO	10400678	mn	3	4	motivation_background	proposal	elaboration	none	secondary	main	none	none	It could be one protease with dual specificity or two distinct enzymes.	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	BIO_10400678_mn_3	BIO_10400678_mn_4	BIO_10400678_mn_3_4
BIO	10400678	mn	3	5	motivation_background	result	elaboration	support	secondary	secondary	none	none	It could be one protease with dual specificity or two distinct enzymes.	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	BIO_10400678_mn_3	BIO_10400678_mn_5	BIO_10400678_mn_3_5
BIO	10400678	mn	3	6	motivation_background	result	elaboration	elaboration	secondary	secondary	none	none	It could be one protease with dual specificity or two distinct enzymes.	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	BIO_10400678_mn_3	BIO_10400678_mn_6	BIO_10400678_mn_3_6
BIO	10400678	mn	3	7	motivation_background	result	elaboration	support	secondary	secondary	none	none	It could be one protease with dual specificity or two distinct enzymes.	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	BIO_10400678_mn_3	BIO_10400678_mn_7	BIO_10400678_mn_3_7
BIO	10400678	mn	3	8	motivation_background	result	elaboration	support	secondary	secondary	none	none	It could be one protease with dual specificity or two distinct enzymes.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_mn_3	BIO_10400678_mn_8	BIO_10400678_mn_3_8
BIO	10400678	mn	3	9	motivation_background	conclusion	elaboration	support	secondary	secondary	none	none	It could be one protease with dual specificity or two distinct enzymes.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_mn_3	BIO_10400678_mn_9	BIO_10400678_mn_3_9
BIO	10400678	mn	4	5	proposal	result	none	support	main	secondary	back	support	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	BIO_10400678_mn_4	BIO_10400678_mn_5	BIO_10400678_mn_4_5
BIO	10400678	mn	4	6	proposal	result	none	elaboration	main	secondary	none	none	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	BIO_10400678_mn_4	BIO_10400678_mn_6	BIO_10400678_mn_4_6
BIO	10400678	mn	4	7	proposal	result	none	support	main	secondary	back	support	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	BIO_10400678_mn_4	BIO_10400678_mn_7	BIO_10400678_mn_4_7
BIO	10400678	mn	4	8	proposal	result	none	support	main	secondary	back	support	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_mn_4	BIO_10400678_mn_8	BIO_10400678_mn_4_8
BIO	10400678	mn	4	9	proposal	conclusion	none	support	main	secondary	back	support	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_mn_4	BIO_10400678_mn_9	BIO_10400678_mn_4_9
BIO	10400678	mn	5	6	result	result	support	elaboration	secondary	secondary	back	elaboration	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	BIO_10400678_mn_5	BIO_10400678_mn_6	BIO_10400678_mn_5_6
BIO	10400678	mn	5	7	result	result	support	support	secondary	secondary	none	none	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	BIO_10400678_mn_5	BIO_10400678_mn_7	BIO_10400678_mn_5_7
BIO	10400678	mn	5	8	result	result	support	support	secondary	secondary	none	none	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_mn_5	BIO_10400678_mn_8	BIO_10400678_mn_5_8
BIO	10400678	mn	5	9	result	conclusion	support	support	secondary	secondary	none	none	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_mn_5	BIO_10400678_mn_9	BIO_10400678_mn_5_9
BIO	10400678	mn	6	7	result	result	elaboration	support	secondary	secondary	none	none	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	BIO_10400678_mn_6	BIO_10400678_mn_7	BIO_10400678_mn_6_7
BIO	10400678	mn	6	8	result	result	elaboration	support	secondary	secondary	none	none	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_mn_6	BIO_10400678_mn_8	BIO_10400678_mn_6_8
BIO	10400678	mn	6	9	result	conclusion	elaboration	support	secondary	secondary	none	none	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_mn_6	BIO_10400678_mn_9	BIO_10400678_mn_6_9
BIO	10400678	mn	7	8	result	result	support	support	secondary	secondary	none	none	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_mn_7	BIO_10400678_mn_8	BIO_10400678_mn_7_8
BIO	10400678	mn	7	9	result	conclusion	support	support	secondary	secondary	none	none	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_mn_7	BIO_10400678_mn_9	BIO_10400678_mn_7_9
BIO	10400678	mn	8	9	result	conclusion	support	support	secondary	secondary	none	none	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_mn_8	BIO_10400678_mn_9	BIO_10400678_mn_8_9
BIO	10400678	mn	9	8	conclusion	result	support	support	secondary	secondary	none	none	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_mn_9	BIO_10400678_mn_8	BIO_10400678_mn_8_9
BIO	10581038N	mn	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein.	The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats.	BIO_10581038N_mn_1	BIO_10581038N_mn_2	BIO_10581038N_mn_1_2
BIO	10581038N	mn	1	3	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein.	HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion.	BIO_10581038N_mn_1	BIO_10581038N_mn_3	BIO_10581038N_mn_1_3
BIO	10581038N	mn	1	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein.	For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10).	BIO_10581038N_mn_1	BIO_10581038N_mn_4	BIO_10581038N_mn_1_4
BIO	10581038N	mn	1	5	motivation_background	motivation_background	info-required	support	secondary	secondary	none	none	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein.	With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation, suggesting important functional correlations between repeat length and pathology.	BIO_10581038N_mn_1	BIO_10581038N_mn_5	BIO_10581038N_mn_1_5
BIO	10581038N	mn	1	6	motivation_background	proposal	info-required	none	secondary	main	none	none	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein.	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	BIO_10581038N_mn_1	BIO_10581038N_mn_6	BIO_10581038N_mn_1_6
BIO	10581038N	mn	1	7	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein.	Our results show that Msh2 is required for somatic instability of the CAG repeat.	BIO_10581038N_mn_1	BIO_10581038N_mn_7	BIO_10581038N_mn_1_7
BIO	10581038N	mn	2	3	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats.	HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion.	BIO_10581038N_mn_2	BIO_10581038N_mn_3	BIO_10581038N_mn_2_3
BIO	10581038N	mn	2	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats.	For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10).	BIO_10581038N_mn_2	BIO_10581038N_mn_4	BIO_10581038N_mn_2_4
BIO	10581038N	mn	2	5	motivation_background	motivation_background	info-required	support	secondary	secondary	none	none	The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats.	With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation, suggesting important functional correlations between repeat length and pathology.	BIO_10581038N_mn_2	BIO_10581038N_mn_5	BIO_10581038N_mn_2_5
BIO	10581038N	mn	2	6	motivation_background	proposal	info-required	none	secondary	main	none	none	The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats.	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	BIO_10581038N_mn_2	BIO_10581038N_mn_6	BIO_10581038N_mn_2_6
BIO	10581038N	mn	2	7	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats.	Our results show that Msh2 is required for somatic instability of the CAG repeat.	BIO_10581038N_mn_2	BIO_10581038N_mn_7	BIO_10581038N_mn_2_7
BIO	10581038N	mn	3	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion.	For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10).	BIO_10581038N_mn_3	BIO_10581038N_mn_4	BIO_10581038N_mn_3_4
BIO	10581038N	mn	3	5	motivation_background	motivation_background	info-required	support	secondary	secondary	none	none	HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion.	With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation, suggesting important functional correlations between repeat length and pathology.	BIO_10581038N_mn_3	BIO_10581038N_mn_5	BIO_10581038N_mn_3_5
BIO	10581038N	mn	3	6	motivation_background	proposal	info-required	none	secondary	main	none	none	HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion.	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	BIO_10581038N_mn_3	BIO_10581038N_mn_6	BIO_10581038N_mn_3_6
BIO	10581038N	mn	3	7	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion.	Our results show that Msh2 is required for somatic instability of the CAG repeat.	BIO_10581038N_mn_3	BIO_10581038N_mn_7	BIO_10581038N_mn_3_7
BIO	10581038N	mn	4	5	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10).	With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation, suggesting important functional correlations between repeat length and pathology.	BIO_10581038N_mn_4	BIO_10581038N_mn_5	BIO_10581038N_mn_4_5
BIO	10581038N	mn	4	6	motivation_background	proposal	info-required	none	secondary	main	none	none	For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10).	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	BIO_10581038N_mn_4	BIO_10581038N_mn_6	BIO_10581038N_mn_4_6
BIO	10581038N	mn	4	7	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10).	Our results show that Msh2 is required for somatic instability of the CAG repeat.	BIO_10581038N_mn_4	BIO_10581038N_mn_7	BIO_10581038N_mn_4_7
BIO	10581038N	mn	5	6	motivation_background	proposal	support	none	secondary	main	forw	support	With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation, suggesting important functional correlations between repeat length and pathology.	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	BIO_10581038N_mn_5	BIO_10581038N_mn_6	BIO_10581038N_mn_5_6
BIO	10581038N	mn	5	7	motivation_background	conclusion	support	support	secondary	secondary	none	none	With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation, suggesting important functional correlations between repeat length and pathology.	Our results show that Msh2 is required for somatic instability of the CAG repeat.	BIO_10581038N_mn_5	BIO_10581038N_mn_7	BIO_10581038N_mn_5_7
BIO	10581038N	mn	6	7	proposal	conclusion	none	support	main	secondary	back	support	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	Our results show that Msh2 is required for somatic instability of the CAG repeat.	BIO_10581038N_mn_6	BIO_10581038N_mn_7	BIO_10581038N_mn_6_7
BIO	10581038N	mn	7	6	conclusion	proposal	support	none	secondary	main	forw	support	Our results show that Msh2 is required for somatic instability of the CAG repeat.	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	BIO_10581038N_mn_7	BIO_10581038N_mn_6	BIO_10581038N_mn_6_7
BIO	10627141	mn	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	BIO_10627141_mn_1	BIO_10627141_mn_2	BIO_10627141_mn_1_2
BIO	10627141	mn	1	3	motivation_background	motivation_background	info-required	support	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	BIO_10627141_mn_1	BIO_10627141_mn_3	BIO_10627141_mn_1_3
BIO	10627141	mn	1	4	motivation_background	proposal	info-required	none	secondary	main	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	BIO_10627141_mn_1	BIO_10627141_mn_4	BIO_10627141_mn_1_4
BIO	10627141	mn	1	5	motivation_background	result	info-required	support	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	A total of 22 cancers were RER-positive.	BIO_10627141_mn_1	BIO_10627141_mn_5	BIO_10627141_mn_1_5
BIO	10627141	mn	1	6	motivation_background	means	info-required	by-means	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	BIO_10627141_mn_1	BIO_10627141_mn_6	BIO_10627141_mn_1_6
BIO	10627141	mn	1	7	motivation_background	result	info-required	support	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	We identified four previously undescribed mutations in four different samples.	BIO_10627141_mn_1	BIO_10627141_mn_7	BIO_10627141_mn_1_7
BIO	10627141	mn	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_mn_1	BIO_10627141_mn_8	BIO_10627141_mn_1_8
BIO	10627141	mn	1	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_mn_1	BIO_10627141_mn_9	BIO_10627141_mn_1_9
BIO	10627141	mn	1	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_mn_1	BIO_10627141_mn_10	BIO_10627141_mn_1_10
BIO	10627141	mn	1	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_mn_1	BIO_10627141_mn_11	BIO_10627141_mn_1_11
BIO	10627141	mn	1	12	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_mn_1	BIO_10627141_mn_12	BIO_10627141_mn_1_12
BIO	10627141	mn	2	3	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	BIO_10627141_mn_2	BIO_10627141_mn_3	BIO_10627141_mn_2_3
BIO	10627141	mn	2	4	motivation_background	proposal	info-required	none	secondary	main	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	BIO_10627141_mn_2	BIO_10627141_mn_4	BIO_10627141_mn_2_4
BIO	10627141	mn	2	5	motivation_background	result	info-required	support	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	A total of 22 cancers were RER-positive.	BIO_10627141_mn_2	BIO_10627141_mn_5	BIO_10627141_mn_2_5
BIO	10627141	mn	2	6	motivation_background	means	info-required	by-means	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	BIO_10627141_mn_2	BIO_10627141_mn_6	BIO_10627141_mn_2_6
BIO	10627141	mn	2	7	motivation_background	result	info-required	support	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	We identified four previously undescribed mutations in four different samples.	BIO_10627141_mn_2	BIO_10627141_mn_7	BIO_10627141_mn_2_7
BIO	10627141	mn	2	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_mn_2	BIO_10627141_mn_8	BIO_10627141_mn_2_8
BIO	10627141	mn	2	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_mn_2	BIO_10627141_mn_9	BIO_10627141_mn_2_9
BIO	10627141	mn	2	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_mn_2	BIO_10627141_mn_10	BIO_10627141_mn_2_10
BIO	10627141	mn	2	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_mn_2	BIO_10627141_mn_11	BIO_10627141_mn_2_11
BIO	10627141	mn	2	12	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_mn_2	BIO_10627141_mn_12	BIO_10627141_mn_2_12
BIO	10627141	mn	3	4	motivation_background	proposal	support	none	secondary	main	forw	support	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	BIO_10627141_mn_3	BIO_10627141_mn_4	BIO_10627141_mn_3_4
BIO	10627141	mn	3	5	motivation_background	result	support	support	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	A total of 22 cancers were RER-positive.	BIO_10627141_mn_3	BIO_10627141_mn_5	BIO_10627141_mn_3_5
BIO	10627141	mn	3	6	motivation_background	means	support	by-means	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	BIO_10627141_mn_3	BIO_10627141_mn_6	BIO_10627141_mn_3_6
BIO	10627141	mn	3	7	motivation_background	result	support	support	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	We identified four previously undescribed mutations in four different samples.	BIO_10627141_mn_3	BIO_10627141_mn_7	BIO_10627141_mn_3_7
BIO	10627141	mn	3	8	motivation_background	observation	support	support	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_mn_3	BIO_10627141_mn_8	BIO_10627141_mn_3_8
BIO	10627141	mn	3	9	motivation_background	observation	support	support	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_mn_3	BIO_10627141_mn_9	BIO_10627141_mn_3_9
BIO	10627141	mn	3	10	motivation_background	observation	support	support	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_mn_3	BIO_10627141_mn_10	BIO_10627141_mn_3_10
BIO	10627141	mn	3	11	motivation_background	observation	support	support	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_mn_3	BIO_10627141_mn_11	BIO_10627141_mn_3_11
BIO	10627141	mn	3	12	motivation_background	conclusion	support	support	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_mn_3	BIO_10627141_mn_12	BIO_10627141_mn_3_12
BIO	10627141	mn	4	5	proposal	result	none	support	main	secondary	back	support	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	A total of 22 cancers were RER-positive.	BIO_10627141_mn_4	BIO_10627141_mn_5	BIO_10627141_mn_4_5
BIO	10627141	mn	4	6	proposal	means	none	by-means	main	secondary	none	none	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	BIO_10627141_mn_4	BIO_10627141_mn_6	BIO_10627141_mn_4_6
BIO	10627141	mn	4	7	proposal	result	none	support	main	secondary	back	support	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	We identified four previously undescribed mutations in four different samples.	BIO_10627141_mn_4	BIO_10627141_mn_7	BIO_10627141_mn_4_7
BIO	10627141	mn	4	8	proposal	observation	none	support	main	secondary	none	none	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_mn_4	BIO_10627141_mn_8	BIO_10627141_mn_4_8
BIO	10627141	mn	4	9	proposal	observation	none	support	main	secondary	none	none	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_mn_4	BIO_10627141_mn_9	BIO_10627141_mn_4_9
BIO	10627141	mn	4	10	proposal	observation	none	support	main	secondary	none	none	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_mn_4	BIO_10627141_mn_10	BIO_10627141_mn_4_10
BIO	10627141	mn	4	11	proposal	observation	none	support	main	secondary	none	none	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_mn_4	BIO_10627141_mn_11	BIO_10627141_mn_4_11
BIO	10627141	mn	4	12	proposal	conclusion	none	support	main	secondary	back	support	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_mn_4	BIO_10627141_mn_12	BIO_10627141_mn_4_12
BIO	10627141	mn	5	6	result	means	support	by-means	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	BIO_10627141_mn_5	BIO_10627141_mn_6	BIO_10627141_mn_5_6
BIO	10627141	mn	5	7	result	result	support	support	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	We identified four previously undescribed mutations in four different samples.	BIO_10627141_mn_5	BIO_10627141_mn_7	BIO_10627141_mn_5_7
BIO	10627141	mn	5	8	result	observation	support	support	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_mn_5	BIO_10627141_mn_8	BIO_10627141_mn_5_8
BIO	10627141	mn	5	9	result	observation	support	support	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_mn_5	BIO_10627141_mn_9	BIO_10627141_mn_5_9
BIO	10627141	mn	5	10	result	observation	support	support	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_mn_5	BIO_10627141_mn_10	BIO_10627141_mn_5_10
BIO	10627141	mn	5	11	result	observation	support	support	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_mn_5	BIO_10627141_mn_11	BIO_10627141_mn_5_11
BIO	10627141	mn	5	12	result	conclusion	support	support	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_mn_5	BIO_10627141_mn_12	BIO_10627141_mn_5_12
BIO	10627141	mn	6	7	means	result	by-means	support	secondary	secondary	forw	by-means	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	We identified four previously undescribed mutations in four different samples.	BIO_10627141_mn_6	BIO_10627141_mn_7	BIO_10627141_mn_6_7
BIO	10627141	mn	6	8	means	observation	by-means	support	secondary	secondary	none	none	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_mn_6	BIO_10627141_mn_8	BIO_10627141_mn_6_8
BIO	10627141	mn	6	9	means	observation	by-means	support	secondary	secondary	none	none	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_mn_6	BIO_10627141_mn_9	BIO_10627141_mn_6_9
BIO	10627141	mn	6	10	means	observation	by-means	support	secondary	secondary	none	none	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_mn_6	BIO_10627141_mn_10	BIO_10627141_mn_6_10
BIO	10627141	mn	6	11	means	observation	by-means	support	secondary	secondary	none	none	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_mn_6	BIO_10627141_mn_11	BIO_10627141_mn_6_11
BIO	10627141	mn	6	12	means	conclusion	by-means	support	secondary	secondary	none	none	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_mn_6	BIO_10627141_mn_12	BIO_10627141_mn_6_12
BIO	10627141	mn	7	8	result	observation	support	support	secondary	secondary	back	support	We identified four previously undescribed mutations in four different samples.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_mn_7	BIO_10627141_mn_8	BIO_10627141_mn_7_8
BIO	10627141	mn	7	9	result	observation	support	support	secondary	secondary	back	support	We identified four previously undescribed mutations in four different samples.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_mn_7	BIO_10627141_mn_9	BIO_10627141_mn_7_9
BIO	10627141	mn	7	10	result	observation	support	support	secondary	secondary	back	support	We identified four previously undescribed mutations in four different samples.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_mn_7	BIO_10627141_mn_10	BIO_10627141_mn_7_10
BIO	10627141	mn	7	11	result	observation	support	support	secondary	secondary	back	support	We identified four previously undescribed mutations in four different samples.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_mn_7	BIO_10627141_mn_11	BIO_10627141_mn_7_11
BIO	10627141	mn	7	12	result	conclusion	support	support	secondary	secondary	none	none	We identified four previously undescribed mutations in four different samples.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_mn_7	BIO_10627141_mn_12	BIO_10627141_mn_7_12
BIO	10627141	mn	8	9	observation	observation	support	support	secondary	secondary	none	none	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_mn_8	BIO_10627141_mn_9	BIO_10627141_mn_8_9
BIO	10627141	mn	8	10	observation	observation	support	support	secondary	secondary	none	none	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_mn_8	BIO_10627141_mn_10	BIO_10627141_mn_8_10
BIO	10627141	mn	8	11	observation	observation	support	support	secondary	secondary	none	none	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_mn_8	BIO_10627141_mn_11	BIO_10627141_mn_8_11
BIO	10627141	mn	8	12	observation	conclusion	support	support	secondary	secondary	none	none	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_mn_8	BIO_10627141_mn_12	BIO_10627141_mn_8_12
BIO	10627141	mn	9	10	observation	observation	support	support	secondary	secondary	none	none	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_mn_9	BIO_10627141_mn_10	BIO_10627141_mn_9_10
BIO	10627141	mn	9	11	observation	observation	support	support	secondary	secondary	none	none	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_mn_9	BIO_10627141_mn_11	BIO_10627141_mn_9_11
BIO	10627141	mn	9	12	observation	conclusion	support	support	secondary	secondary	none	none	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_mn_9	BIO_10627141_mn_12	BIO_10627141_mn_9_12
BIO	10627141	mn	10	11	observation	observation	support	support	secondary	secondary	none	none	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_mn_10	BIO_10627141_mn_11	BIO_10627141_mn_10_11
BIO	10627141	mn	10	12	observation	conclusion	support	support	secondary	secondary	none	none	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_mn_10	BIO_10627141_mn_12	BIO_10627141_mn_10_12
BIO	10627141	mn	11	12	observation	conclusion	support	support	secondary	secondary	none	none	The mutations were not seen in the patients' constitutional DNA.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_mn_11	BIO_10627141_mn_12	BIO_10627141_mn_11_12
BIO	10627141	mn	12	11	conclusion	observation	support	support	secondary	secondary	none	none	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_mn_12	BIO_10627141_mn_11	BIO_10627141_mn_11_12
BIO	10762373	mn	1	2	proposal	motivation_hypothesis	none	support	main	secondary	back	support	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	BIO_10762373_mn_1	BIO_10762373_mn_2	BIO_10762373_mn_1_2
BIO	10762373	mn	1	3	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	BIO_10762373_mn_1	BIO_10762373_mn_3	BIO_10762373_mn_1_3
BIO	10762373	mn	1	4	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	BIO_10762373_mn_1	BIO_10762373_mn_4	BIO_10762373_mn_1_4
BIO	10762373	mn	1	5	proposal	result	none	support	main	secondary	back	support	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	BIO_10762373_mn_1	BIO_10762373_mn_5	BIO_10762373_mn_1_5
BIO	10762373	mn	1	6	proposal	observation	none	support	main	secondary	none	none	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	BIO_10762373_mn_1	BIO_10762373_mn_6	BIO_10762373_mn_1_6
BIO	10762373	mn	1	7	proposal	observation	none	support	main	secondary	none	none	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	BIO_10762373_mn_1	BIO_10762373_mn_7	BIO_10762373_mn_1_7
BIO	10762373	mn	1	8	proposal	result	none	support	main	secondary	back	support	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_mn_1	BIO_10762373_mn_8	BIO_10762373_mn_1_8
BIO	10762373	mn	1	9	proposal	conclusion	none	support	main	secondary	back	support	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_mn_1	BIO_10762373_mn_9	BIO_10762373_mn_1_9
BIO	10762373	mn	2	3	motivation_hypothesis	proposal_implementation	support	elaboration	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	BIO_10762373_mn_2	BIO_10762373_mn_3	BIO_10762373_mn_2_3
BIO	10762373	mn	2	4	motivation_hypothesis	proposal_implementation	support	elaboration	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	BIO_10762373_mn_2	BIO_10762373_mn_4	BIO_10762373_mn_2_4
BIO	10762373	mn	2	5	motivation_hypothesis	result	support	support	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	BIO_10762373_mn_2	BIO_10762373_mn_5	BIO_10762373_mn_2_5
BIO	10762373	mn	2	6	motivation_hypothesis	observation	support	support	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	BIO_10762373_mn_2	BIO_10762373_mn_6	BIO_10762373_mn_2_6
BIO	10762373	mn	2	7	motivation_hypothesis	observation	support	support	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	BIO_10762373_mn_2	BIO_10762373_mn_7	BIO_10762373_mn_2_7
BIO	10762373	mn	2	8	motivation_hypothesis	result	support	support	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_mn_2	BIO_10762373_mn_8	BIO_10762373_mn_2_8
BIO	10762373	mn	2	9	motivation_hypothesis	conclusion	support	support	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_mn_2	BIO_10762373_mn_9	BIO_10762373_mn_2_9
BIO	10762373	mn	3	4	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	BIO_10762373_mn_3	BIO_10762373_mn_4	BIO_10762373_mn_3_4
BIO	10762373	mn	3	5	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	BIO_10762373_mn_3	BIO_10762373_mn_5	BIO_10762373_mn_3_5
BIO	10762373	mn	3	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	BIO_10762373_mn_3	BIO_10762373_mn_6	BIO_10762373_mn_3_6
BIO	10762373	mn	3	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	BIO_10762373_mn_3	BIO_10762373_mn_7	BIO_10762373_mn_3_7
BIO	10762373	mn	3	8	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_mn_3	BIO_10762373_mn_8	BIO_10762373_mn_3_8
BIO	10762373	mn	3	9	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_mn_3	BIO_10762373_mn_9	BIO_10762373_mn_3_9
BIO	10762373	mn	4	5	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	BIO_10762373_mn_4	BIO_10762373_mn_5	BIO_10762373_mn_4_5
BIO	10762373	mn	4	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	BIO_10762373_mn_4	BIO_10762373_mn_6	BIO_10762373_mn_4_6
BIO	10762373	mn	4	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	BIO_10762373_mn_4	BIO_10762373_mn_7	BIO_10762373_mn_4_7
BIO	10762373	mn	4	8	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_mn_4	BIO_10762373_mn_8	BIO_10762373_mn_4_8
BIO	10762373	mn	4	9	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_mn_4	BIO_10762373_mn_9	BIO_10762373_mn_4_9
BIO	10762373	mn	5	6	result	observation	support	support	secondary	secondary	back	support	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	BIO_10762373_mn_5	BIO_10762373_mn_6	BIO_10762373_mn_5_6
BIO	10762373	mn	5	7	result	observation	support	support	secondary	secondary	back	support	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	BIO_10762373_mn_5	BIO_10762373_mn_7	BIO_10762373_mn_5_7
BIO	10762373	mn	5	8	result	result	support	support	secondary	secondary	none	none	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_mn_5	BIO_10762373_mn_8	BIO_10762373_mn_5_8
BIO	10762373	mn	5	9	result	conclusion	support	support	secondary	secondary	none	none	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_mn_5	BIO_10762373_mn_9	BIO_10762373_mn_5_9
BIO	10762373	mn	6	7	observation	observation	support	support	secondary	secondary	none	none	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	BIO_10762373_mn_6	BIO_10762373_mn_7	BIO_10762373_mn_6_7
BIO	10762373	mn	6	8	observation	result	support	support	secondary	secondary	none	none	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_mn_6	BIO_10762373_mn_8	BIO_10762373_mn_6_8
BIO	10762373	mn	6	9	observation	conclusion	support	support	secondary	secondary	none	none	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_mn_6	BIO_10762373_mn_9	BIO_10762373_mn_6_9
BIO	10762373	mn	7	8	observation	result	support	support	secondary	secondary	none	none	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_mn_7	BIO_10762373_mn_8	BIO_10762373_mn_7_8
BIO	10762373	mn	7	9	observation	conclusion	support	support	secondary	secondary	none	none	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_mn_7	BIO_10762373_mn_9	BIO_10762373_mn_7_9
BIO	10762373	mn	8	9	result	conclusion	support	support	secondary	secondary	none	none	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_mn_8	BIO_10762373_mn_9	BIO_10762373_mn_8_9
BIO	10762373	mn	9	8	conclusion	result	support	support	secondary	secondary	none	none	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_mn_9	BIO_10762373_mn_8	BIO_10762373_mn_8_9
BIO	10945643	mn	1	2	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	BIO_10945643_mn_1	BIO_10945643_mn_2	BIO_10945643_mn_1_2
BIO	10945643	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	BIO_10945643_mn_1	BIO_10945643_mn_3	BIO_10945643_mn_1_3
BIO	10945643	mn	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	BIO_10945643_mn_1	BIO_10945643_mn_4	BIO_10945643_mn_1_4
BIO	10945643	mn	1	5	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	Day 0 grafts underwent immunohistochemical assessment of ER status.	BIO_10945643_mn_1	BIO_10945643_mn_5	BIO_10945643_mn_1_5
BIO	10945643	mn	1	6	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	BIO_10945643_mn_1	BIO_10945643_mn_6	BIO_10945643_mn_1_6
BIO	10945643	mn	1	7	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	BIO_10945643_mn_1	BIO_10945643_mn_7	BIO_10945643_mn_1_7
BIO	10945643	mn	1	8	motivation_background	means	info-required	by-means	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_mn_1	BIO_10945643_mn_8	BIO_10945643_mn_1_8
BIO	10945643	mn	1	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_mn_1	BIO_10945643_mn_9	BIO_10945643_mn_1_9
BIO	10945643	mn	1	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_mn_1	BIO_10945643_mn_10	BIO_10945643_mn_1_10
BIO	10945643	mn	1	11	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_mn_1	BIO_10945643_mn_11	BIO_10945643_mn_1_11
BIO	10945643	mn	1	12	motivation_background	observation	info-required	support	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_mn_1	BIO_10945643_mn_12	BIO_10945643_mn_1_12
BIO	10945643	mn	1	13	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_mn_1	BIO_10945643_mn_13	BIO_10945643_mn_1_13
BIO	10945643	mn	2	3	motivation_problem	proposal	support	none	secondary	main	forw	support	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	BIO_10945643_mn_2	BIO_10945643_mn_3	BIO_10945643_mn_2_3
BIO	10945643	mn	2	4	motivation_problem	proposal_implementation	support	elaboration	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	BIO_10945643_mn_2	BIO_10945643_mn_4	BIO_10945643_mn_2_4
BIO	10945643	mn	2	5	motivation_problem	proposal_implementation	support	elaboration	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	Day 0 grafts underwent immunohistochemical assessment of ER status.	BIO_10945643_mn_2	BIO_10945643_mn_5	BIO_10945643_mn_2_5
BIO	10945643	mn	2	6	motivation_problem	proposal_implementation	support	elaboration	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	BIO_10945643_mn_2	BIO_10945643_mn_6	BIO_10945643_mn_2_6
BIO	10945643	mn	2	7	motivation_problem	proposal_implementation	support	elaboration	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	BIO_10945643_mn_2	BIO_10945643_mn_7	BIO_10945643_mn_2_7
BIO	10945643	mn	2	8	motivation_problem	means	support	by-means	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_mn_2	BIO_10945643_mn_8	BIO_10945643_mn_2_8
BIO	10945643	mn	2	9	motivation_problem	observation	support	support	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_mn_2	BIO_10945643_mn_9	BIO_10945643_mn_2_9
BIO	10945643	mn	2	10	motivation_problem	observation	support	support	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_mn_2	BIO_10945643_mn_10	BIO_10945643_mn_2_10
BIO	10945643	mn	2	11	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_mn_2	BIO_10945643_mn_11	BIO_10945643_mn_2_11
BIO	10945643	mn	2	12	motivation_problem	observation	support	support	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_mn_2	BIO_10945643_mn_12	BIO_10945643_mn_2_12
BIO	10945643	mn	2	13	motivation_problem	conclusion	support	support	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_mn_2	BIO_10945643_mn_13	BIO_10945643_mn_2_13
BIO	10945643	mn	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	BIO_10945643_mn_3	BIO_10945643_mn_4	BIO_10945643_mn_3_4
BIO	10945643	mn	3	5	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	Day 0 grafts underwent immunohistochemical assessment of ER status.	BIO_10945643_mn_3	BIO_10945643_mn_5	BIO_10945643_mn_3_5
BIO	10945643	mn	3	6	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	BIO_10945643_mn_3	BIO_10945643_mn_6	BIO_10945643_mn_3_6
BIO	10945643	mn	3	7	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	BIO_10945643_mn_3	BIO_10945643_mn_7	BIO_10945643_mn_3_7
BIO	10945643	mn	3	8	proposal	means	none	by-means	main	secondary	back	by-means	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_mn_3	BIO_10945643_mn_8	BIO_10945643_mn_3_8
BIO	10945643	mn	3	9	proposal	observation	none	support	main	secondary	back	support	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_mn_3	BIO_10945643_mn_9	BIO_10945643_mn_3_9
BIO	10945643	mn	3	10	proposal	observation	none	support	main	secondary	back	support	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_mn_3	BIO_10945643_mn_10	BIO_10945643_mn_3_10
BIO	10945643	mn	3	11	proposal	observation	none	elaboration	main	secondary	none	none	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_mn_3	BIO_10945643_mn_11	BIO_10945643_mn_3_11
BIO	10945643	mn	3	12	proposal	observation	none	support	main	secondary	back	support	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_mn_3	BIO_10945643_mn_12	BIO_10945643_mn_3_12
BIO	10945643	mn	3	13	proposal	conclusion	none	support	main	secondary	back	support	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_mn_3	BIO_10945643_mn_13	BIO_10945643_mn_3_13
BIO	10945643	mn	4	5	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	Day 0 grafts underwent immunohistochemical assessment of ER status.	BIO_10945643_mn_4	BIO_10945643_mn_5	BIO_10945643_mn_4_5
BIO	10945643	mn	4	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	BIO_10945643_mn_4	BIO_10945643_mn_6	BIO_10945643_mn_4_6
BIO	10945643	mn	4	7	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	BIO_10945643_mn_4	BIO_10945643_mn_7	BIO_10945643_mn_4_7
BIO	10945643	mn	4	8	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_mn_4	BIO_10945643_mn_8	BIO_10945643_mn_4_8
BIO	10945643	mn	4	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_mn_4	BIO_10945643_mn_9	BIO_10945643_mn_4_9
BIO	10945643	mn	4	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_mn_4	BIO_10945643_mn_10	BIO_10945643_mn_4_10
BIO	10945643	mn	4	11	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_mn_4	BIO_10945643_mn_11	BIO_10945643_mn_4_11
BIO	10945643	mn	4	12	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_mn_4	BIO_10945643_mn_12	BIO_10945643_mn_4_12
BIO	10945643	mn	4	13	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_mn_4	BIO_10945643_mn_13	BIO_10945643_mn_4_13
BIO	10945643	mn	5	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	Day 0 grafts underwent immunohistochemical assessment of ER status.	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	BIO_10945643_mn_5	BIO_10945643_mn_6	BIO_10945643_mn_5_6
BIO	10945643	mn	5	7	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	BIO_10945643_mn_5	BIO_10945643_mn_7	BIO_10945643_mn_5_7
BIO	10945643	mn	5	8	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_mn_5	BIO_10945643_mn_8	BIO_10945643_mn_5_8
BIO	10945643	mn	5	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_mn_5	BIO_10945643_mn_9	BIO_10945643_mn_5_9
BIO	10945643	mn	5	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_mn_5	BIO_10945643_mn_10	BIO_10945643_mn_5_10
BIO	10945643	mn	5	11	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_mn_5	BIO_10945643_mn_11	BIO_10945643_mn_5_11
BIO	10945643	mn	5	12	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_mn_5	BIO_10945643_mn_12	BIO_10945643_mn_5_12
BIO	10945643	mn	5	13	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_mn_5	BIO_10945643_mn_13	BIO_10945643_mn_5_13
BIO	10945643	mn	6	7	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	BIO_10945643_mn_6	BIO_10945643_mn_7	BIO_10945643_mn_6_7
BIO	10945643	mn	6	8	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_mn_6	BIO_10945643_mn_8	BIO_10945643_mn_6_8
BIO	10945643	mn	6	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_mn_6	BIO_10945643_mn_9	BIO_10945643_mn_6_9
BIO	10945643	mn	6	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_mn_6	BIO_10945643_mn_10	BIO_10945643_mn_6_10
BIO	10945643	mn	6	11	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_mn_6	BIO_10945643_mn_11	BIO_10945643_mn_6_11
BIO	10945643	mn	6	12	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_mn_6	BIO_10945643_mn_12	BIO_10945643_mn_6_12
BIO	10945643	mn	6	13	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_mn_6	BIO_10945643_mn_13	BIO_10945643_mn_6_13
BIO	10945643	mn	7	8	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_mn_7	BIO_10945643_mn_8	BIO_10945643_mn_7_8
BIO	10945643	mn	7	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_mn_7	BIO_10945643_mn_9	BIO_10945643_mn_7_9
BIO	10945643	mn	7	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_mn_7	BIO_10945643_mn_10	BIO_10945643_mn_7_10
BIO	10945643	mn	7	11	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_mn_7	BIO_10945643_mn_11	BIO_10945643_mn_7_11
BIO	10945643	mn	7	12	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_mn_7	BIO_10945643_mn_12	BIO_10945643_mn_7_12
BIO	10945643	mn	7	13	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_mn_7	BIO_10945643_mn_13	BIO_10945643_mn_7_13
BIO	10945643	mn	8	9	means	observation	by-means	support	secondary	secondary	none	none	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_mn_8	BIO_10945643_mn_9	BIO_10945643_mn_8_9
BIO	10945643	mn	8	10	means	observation	by-means	support	secondary	secondary	none	none	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_mn_8	BIO_10945643_mn_10	BIO_10945643_mn_8_10
BIO	10945643	mn	8	11	means	observation	by-means	elaboration	secondary	secondary	none	none	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_mn_8	BIO_10945643_mn_11	BIO_10945643_mn_8_11
BIO	10945643	mn	8	12	means	observation	by-means	support	secondary	secondary	none	none	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_mn_8	BIO_10945643_mn_12	BIO_10945643_mn_8_12
BIO	10945643	mn	8	13	means	conclusion	by-means	support	secondary	secondary	none	none	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_mn_8	BIO_10945643_mn_13	BIO_10945643_mn_8_13
BIO	10945643	mn	9	10	observation	observation	support	support	secondary	secondary	none	none	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_mn_9	BIO_10945643_mn_10	BIO_10945643_mn_9_10
BIO	10945643	mn	9	11	observation	observation	support	elaboration	secondary	secondary	none	none	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_mn_9	BIO_10945643_mn_11	BIO_10945643_mn_9_11
BIO	10945643	mn	9	12	observation	observation	support	support	secondary	secondary	none	none	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_mn_9	BIO_10945643_mn_12	BIO_10945643_mn_9_12
BIO	10945643	mn	9	13	observation	conclusion	support	support	secondary	secondary	none	none	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_mn_9	BIO_10945643_mn_13	BIO_10945643_mn_9_13
BIO	10945643	mn	10	11	observation	observation	support	elaboration	secondary	secondary	back	elaboration	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_mn_10	BIO_10945643_mn_11	BIO_10945643_mn_10_11
BIO	10945643	mn	10	12	observation	observation	support	support	secondary	secondary	none	none	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_mn_10	BIO_10945643_mn_12	BIO_10945643_mn_10_12
BIO	10945643	mn	10	13	observation	conclusion	support	support	secondary	secondary	none	none	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_mn_10	BIO_10945643_mn_13	BIO_10945643_mn_10_13
BIO	10945643	mn	11	12	observation	observation	elaboration	support	secondary	secondary	none	none	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_mn_11	BIO_10945643_mn_12	BIO_10945643_mn_11_12
BIO	10945643	mn	11	13	observation	conclusion	elaboration	support	secondary	secondary	none	none	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_mn_11	BIO_10945643_mn_13	BIO_10945643_mn_11_13
BIO	10945643	mn	12	13	observation	conclusion	support	support	secondary	secondary	none	none	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_mn_12	BIO_10945643_mn_13	BIO_10945643_mn_12_13
BIO	10945643	mn	13	12	conclusion	observation	support	support	secondary	secondary	none	none	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_mn_13	BIO_10945643_mn_12	BIO_10945643_mn_12_13
BIO	10978169	mn	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	BIO_10978169_mn_1	BIO_10978169_mn_2	BIO_10978169_mn_1_2
BIO	10978169	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	BIO_10978169_mn_1	BIO_10978169_mn_3	BIO_10978169_mn_1_3
BIO	10978169	mn	1	4	motivation_background	information_additional	info-required	info-optional	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	BIO_10978169_mn_1	BIO_10978169_mn_4	BIO_10978169_mn_1_4
BIO	10978169	mn	1	5	motivation_background	information_additional	info-required	info-optional	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	BIO_10978169_mn_1	BIO_10978169_mn_5	BIO_10978169_mn_1_5
BIO	10978169	mn	1	6	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	BIO_10978169_mn_1	BIO_10978169_mn_6	BIO_10978169_mn_1_6
BIO	10978169	mn	1	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	BIO_10978169_mn_1	BIO_10978169_mn_7	BIO_10978169_mn_1_7
BIO	10978169	mn	1	8	motivation_background	result	info-required	support	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_mn_1	BIO_10978169_mn_8	BIO_10978169_mn_1_8
BIO	10978169	mn	1	9	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_mn_1	BIO_10978169_mn_9	BIO_10978169_mn_1_9
BIO	10978169	mn	1	10	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_mn_1	BIO_10978169_mn_10	BIO_10978169_mn_1_10
BIO	10978169	mn	1	11	motivation_background	result	info-required	support	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_mn_1	BIO_10978169_mn_11	BIO_10978169_mn_1_11
BIO	10978169	mn	1	12	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_mn_1	BIO_10978169_mn_12	BIO_10978169_mn_1_12
BIO	10978169	mn	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	BIO_10978169_mn_2	BIO_10978169_mn_3	BIO_10978169_mn_2_3
BIO	10978169	mn	2	4	motivation_background	information_additional	support	info-optional	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	BIO_10978169_mn_2	BIO_10978169_mn_4	BIO_10978169_mn_2_4
BIO	10978169	mn	2	5	motivation_background	information_additional	support	info-optional	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	BIO_10978169_mn_2	BIO_10978169_mn_5	BIO_10978169_mn_2_5
BIO	10978169	mn	2	6	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	BIO_10978169_mn_2	BIO_10978169_mn_6	BIO_10978169_mn_2_6
BIO	10978169	mn	2	7	motivation_background	observation	support	support	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	BIO_10978169_mn_2	BIO_10978169_mn_7	BIO_10978169_mn_2_7
BIO	10978169	mn	2	8	motivation_background	result	support	support	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_mn_2	BIO_10978169_mn_8	BIO_10978169_mn_2_8
BIO	10978169	mn	2	9	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_mn_2	BIO_10978169_mn_9	BIO_10978169_mn_2_9
BIO	10978169	mn	2	10	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_mn_2	BIO_10978169_mn_10	BIO_10978169_mn_2_10
BIO	10978169	mn	2	11	motivation_background	result	support	support	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_mn_2	BIO_10978169_mn_11	BIO_10978169_mn_2_11
BIO	10978169	mn	2	12	motivation_background	conclusion	support	support	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_mn_2	BIO_10978169_mn_12	BIO_10978169_mn_2_12
BIO	10978169	mn	3	4	proposal	information_additional	none	info-optional	main	secondary	back	info-optional	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	BIO_10978169_mn_3	BIO_10978169_mn_4	BIO_10978169_mn_3_4
BIO	10978169	mn	3	5	proposal	information_additional	none	info-optional	main	secondary	back	info-optional	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	BIO_10978169_mn_3	BIO_10978169_mn_5	BIO_10978169_mn_3_5
BIO	10978169	mn	3	6	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	BIO_10978169_mn_3	BIO_10978169_mn_6	BIO_10978169_mn_3_6
BIO	10978169	mn	3	7	proposal	observation	none	support	main	secondary	none	none	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	BIO_10978169_mn_3	BIO_10978169_mn_7	BIO_10978169_mn_3_7
BIO	10978169	mn	3	8	proposal	result	none	support	main	secondary	back	support	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_mn_3	BIO_10978169_mn_8	BIO_10978169_mn_3_8
BIO	10978169	mn	3	9	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_mn_3	BIO_10978169_mn_9	BIO_10978169_mn_3_9
BIO	10978169	mn	3	10	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_mn_3	BIO_10978169_mn_10	BIO_10978169_mn_3_10
BIO	10978169	mn	3	11	proposal	result	none	support	main	secondary	back	support	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_mn_3	BIO_10978169_mn_11	BIO_10978169_mn_3_11
BIO	10978169	mn	3	12	proposal	conclusion	none	support	main	secondary	back	support	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_mn_3	BIO_10978169_mn_12	BIO_10978169_mn_3_12
BIO	10978169	mn	4	5	information_additional	information_additional	info-optional	info-optional	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	BIO_10978169_mn_4	BIO_10978169_mn_5	BIO_10978169_mn_4_5
BIO	10978169	mn	4	6	information_additional	proposal_implementation	info-optional	elaboration	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	BIO_10978169_mn_4	BIO_10978169_mn_6	BIO_10978169_mn_4_6
BIO	10978169	mn	4	7	information_additional	observation	info-optional	support	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	BIO_10978169_mn_4	BIO_10978169_mn_7	BIO_10978169_mn_4_7
BIO	10978169	mn	4	8	information_additional	result	info-optional	support	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_mn_4	BIO_10978169_mn_8	BIO_10978169_mn_4_8
BIO	10978169	mn	4	9	information_additional	proposal_implementation	info-optional	elaboration	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_mn_4	BIO_10978169_mn_9	BIO_10978169_mn_4_9
BIO	10978169	mn	4	10	information_additional	proposal_implementation	info-optional	elaboration	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_mn_4	BIO_10978169_mn_10	BIO_10978169_mn_4_10
BIO	10978169	mn	4	11	information_additional	result	info-optional	support	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_mn_4	BIO_10978169_mn_11	BIO_10978169_mn_4_11
BIO	10978169	mn	4	12	information_additional	conclusion	info-optional	support	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_mn_4	BIO_10978169_mn_12	BIO_10978169_mn_4_12
BIO	10978169	mn	5	6	information_additional	proposal_implementation	info-optional	elaboration	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	BIO_10978169_mn_5	BIO_10978169_mn_6	BIO_10978169_mn_5_6
BIO	10978169	mn	5	7	information_additional	observation	info-optional	support	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	BIO_10978169_mn_5	BIO_10978169_mn_7	BIO_10978169_mn_5_7
BIO	10978169	mn	5	8	information_additional	result	info-optional	support	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_mn_5	BIO_10978169_mn_8	BIO_10978169_mn_5_8
BIO	10978169	mn	5	9	information_additional	proposal_implementation	info-optional	elaboration	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_mn_5	BIO_10978169_mn_9	BIO_10978169_mn_5_9
BIO	10978169	mn	5	10	information_additional	proposal_implementation	info-optional	elaboration	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_mn_5	BIO_10978169_mn_10	BIO_10978169_mn_5_10
BIO	10978169	mn	5	11	information_additional	result	info-optional	support	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_mn_5	BIO_10978169_mn_11	BIO_10978169_mn_5_11
BIO	10978169	mn	5	12	information_additional	conclusion	info-optional	support	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_mn_5	BIO_10978169_mn_12	BIO_10978169_mn_5_12
BIO	10978169	mn	6	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	BIO_10978169_mn_6	BIO_10978169_mn_7	BIO_10978169_mn_6_7
BIO	10978169	mn	6	8	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_mn_6	BIO_10978169_mn_8	BIO_10978169_mn_6_8
BIO	10978169	mn	6	9	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_mn_6	BIO_10978169_mn_9	BIO_10978169_mn_6_9
BIO	10978169	mn	6	10	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_mn_6	BIO_10978169_mn_10	BIO_10978169_mn_6_10
BIO	10978169	mn	6	11	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_mn_6	BIO_10978169_mn_11	BIO_10978169_mn_6_11
BIO	10978169	mn	6	12	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_mn_6	BIO_10978169_mn_12	BIO_10978169_mn_6_12
BIO	10978169	mn	7	8	observation	result	support	support	secondary	secondary	forw	support	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_mn_7	BIO_10978169_mn_8	BIO_10978169_mn_7_8
BIO	10978169	mn	7	9	observation	proposal_implementation	support	elaboration	secondary	secondary	none	none	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_mn_7	BIO_10978169_mn_9	BIO_10978169_mn_7_9
BIO	10978169	mn	7	10	observation	proposal_implementation	support	elaboration	secondary	secondary	none	none	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_mn_7	BIO_10978169_mn_10	BIO_10978169_mn_7_10
BIO	10978169	mn	7	11	observation	result	support	support	secondary	secondary	none	none	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_mn_7	BIO_10978169_mn_11	BIO_10978169_mn_7_11
BIO	10978169	mn	7	12	observation	conclusion	support	support	secondary	secondary	none	none	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_mn_7	BIO_10978169_mn_12	BIO_10978169_mn_7_12
BIO	10978169	mn	8	9	result	proposal_implementation	support	elaboration	secondary	secondary	none	none	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_mn_8	BIO_10978169_mn_9	BIO_10978169_mn_8_9
BIO	10978169	mn	8	10	result	proposal_implementation	support	elaboration	secondary	secondary	none	none	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_mn_8	BIO_10978169_mn_10	BIO_10978169_mn_8_10
BIO	10978169	mn	8	11	result	result	support	support	secondary	secondary	none	none	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_mn_8	BIO_10978169_mn_11	BIO_10978169_mn_8_11
BIO	10978169	mn	8	12	result	conclusion	support	support	secondary	secondary	none	none	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_mn_8	BIO_10978169_mn_12	BIO_10978169_mn_8_12
BIO	10978169	mn	9	10	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_mn_9	BIO_10978169_mn_10	BIO_10978169_mn_9_10
BIO	10978169	mn	9	11	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_mn_9	BIO_10978169_mn_11	BIO_10978169_mn_9_11
BIO	10978169	mn	9	12	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_mn_9	BIO_10978169_mn_12	BIO_10978169_mn_9_12
BIO	10978169	mn	10	11	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	These dimers arose intracellularly rather than being derived from the medium by reuptake.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_mn_10	BIO_10978169_mn_11	BIO_10978169_mn_10_11
BIO	10978169	mn	10	12	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	These dimers arose intracellularly rather than being derived from the medium by reuptake.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_mn_10	BIO_10978169_mn_12	BIO_10978169_mn_10_12
BIO	10978169	mn	11	12	result	conclusion	support	support	secondary	secondary	none	none	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_mn_11	BIO_10978169_mn_12	BIO_10978169_mn_11_12
BIO	10978169	mn	12	11	conclusion	result	support	support	secondary	secondary	none	none	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_mn_12	BIO_10978169_mn_11	BIO_10978169_mn_11_12
BIO	11044594	mn	1	2	motivation_background	proposal	support	none	secondary	main	forw	support	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	BIO_11044594_mn_1	BIO_11044594_mn_2	BIO_11044594_mn_1_2
BIO	11044594	mn	1	3	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	BIO_11044594_mn_1	BIO_11044594_mn_3	BIO_11044594_mn_1_3
BIO	11044594	mn	1	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	BIO_11044594_mn_1	BIO_11044594_mn_4	BIO_11044594_mn_1_4
BIO	11044594	mn	1	5	motivation_background	means	support	by-means	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	BIO_11044594_mn_1	BIO_11044594_mn_5	BIO_11044594_mn_1_5
BIO	11044594	mn	1	6	motivation_background	result	support	support	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	BIO_11044594_mn_1	BIO_11044594_mn_6	BIO_11044594_mn_1_6
BIO	11044594	mn	1	7	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	BIO_11044594_mn_1	BIO_11044594_mn_7	BIO_11044594_mn_1_7
BIO	11044594	mn	1	8	motivation_background	result	support	support	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_mn_1	BIO_11044594_mn_8	BIO_11044594_mn_1_8
BIO	11044594	mn	1	9	motivation_background	result	support	support	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_mn_1	BIO_11044594_mn_9	BIO_11044594_mn_1_9
BIO	11044594	mn	1	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_mn_1	BIO_11044594_mn_10	BIO_11044594_mn_1_10
BIO	11044594	mn	2	3	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	BIO_11044594_mn_2	BIO_11044594_mn_3	BIO_11044594_mn_2_3
BIO	11044594	mn	2	4	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	BIO_11044594_mn_2	BIO_11044594_mn_4	BIO_11044594_mn_2_4
BIO	11044594	mn	2	5	proposal	means	none	by-means	main	secondary	none	none	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	BIO_11044594_mn_2	BIO_11044594_mn_5	BIO_11044594_mn_2_5
BIO	11044594	mn	2	6	proposal	result	none	support	main	secondary	back	support	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	BIO_11044594_mn_2	BIO_11044594_mn_6	BIO_11044594_mn_2_6
BIO	11044594	mn	2	7	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	BIO_11044594_mn_2	BIO_11044594_mn_7	BIO_11044594_mn_2_7
BIO	11044594	mn	2	8	proposal	result	none	support	main	secondary	back	support	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_mn_2	BIO_11044594_mn_8	BIO_11044594_mn_2_8
BIO	11044594	mn	2	9	proposal	result	none	support	main	secondary	back	support	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_mn_2	BIO_11044594_mn_9	BIO_11044594_mn_2_9
BIO	11044594	mn	2	10	proposal	conclusion	none	support	main	secondary	back	support	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_mn_2	BIO_11044594_mn_10	BIO_11044594_mn_2_10
BIO	11044594	mn	3	4	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	BIO_11044594_mn_3	BIO_11044594_mn_4	BIO_11044594_mn_3_4
BIO	11044594	mn	3	5	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	BIO_11044594_mn_3	BIO_11044594_mn_5	BIO_11044594_mn_3_5
BIO	11044594	mn	3	6	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	BIO_11044594_mn_3	BIO_11044594_mn_6	BIO_11044594_mn_3_6
BIO	11044594	mn	3	7	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	BIO_11044594_mn_3	BIO_11044594_mn_7	BIO_11044594_mn_3_7
BIO	11044594	mn	3	8	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_mn_3	BIO_11044594_mn_8	BIO_11044594_mn_3_8
BIO	11044594	mn	3	9	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_mn_3	BIO_11044594_mn_9	BIO_11044594_mn_3_9
BIO	11044594	mn	3	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_mn_3	BIO_11044594_mn_10	BIO_11044594_mn_3_10
BIO	11044594	mn	4	5	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	BIO_11044594_mn_4	BIO_11044594_mn_5	BIO_11044594_mn_4_5
BIO	11044594	mn	4	6	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	BIO_11044594_mn_4	BIO_11044594_mn_6	BIO_11044594_mn_4_6
BIO	11044594	mn	4	7	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	BIO_11044594_mn_4	BIO_11044594_mn_7	BIO_11044594_mn_4_7
BIO	11044594	mn	4	8	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_mn_4	BIO_11044594_mn_8	BIO_11044594_mn_4_8
BIO	11044594	mn	4	9	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_mn_4	BIO_11044594_mn_9	BIO_11044594_mn_4_9
BIO	11044594	mn	4	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_mn_4	BIO_11044594_mn_10	BIO_11044594_mn_4_10
BIO	11044594	mn	5	6	means	result	by-means	support	secondary	secondary	forw	by-means	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	BIO_11044594_mn_5	BIO_11044594_mn_6	BIO_11044594_mn_5_6
BIO	11044594	mn	5	7	means	proposal_implementation	by-means	elaboration	secondary	secondary	none	none	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	BIO_11044594_mn_5	BIO_11044594_mn_7	BIO_11044594_mn_5_7
BIO	11044594	mn	5	8	means	result	by-means	support	secondary	secondary	none	none	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_mn_5	BIO_11044594_mn_8	BIO_11044594_mn_5_8
BIO	11044594	mn	5	9	means	result	by-means	support	secondary	secondary	none	none	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_mn_5	BIO_11044594_mn_9	BIO_11044594_mn_5_9
BIO	11044594	mn	5	10	means	conclusion	by-means	support	secondary	secondary	none	none	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_mn_5	BIO_11044594_mn_10	BIO_11044594_mn_5_10
BIO	11044594	mn	6	7	result	proposal_implementation	support	elaboration	secondary	secondary	none	none	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	BIO_11044594_mn_6	BIO_11044594_mn_7	BIO_11044594_mn_6_7
BIO	11044594	mn	6	8	result	result	support	support	secondary	secondary	none	none	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_mn_6	BIO_11044594_mn_8	BIO_11044594_mn_6_8
BIO	11044594	mn	6	9	result	result	support	support	secondary	secondary	none	none	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_mn_6	BIO_11044594_mn_9	BIO_11044594_mn_6_9
BIO	11044594	mn	6	10	result	conclusion	support	support	secondary	secondary	none	none	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_mn_6	BIO_11044594_mn_10	BIO_11044594_mn_6_10
BIO	11044594	mn	7	8	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_mn_7	BIO_11044594_mn_8	BIO_11044594_mn_7_8
BIO	11044594	mn	7	9	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_mn_7	BIO_11044594_mn_9	BIO_11044594_mn_7_9
BIO	11044594	mn	7	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_mn_7	BIO_11044594_mn_10	BIO_11044594_mn_7_10
BIO	11044594	mn	8	9	result	result	support	support	secondary	secondary	none	none	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_mn_8	BIO_11044594_mn_9	BIO_11044594_mn_8_9
BIO	11044594	mn	8	10	result	conclusion	support	support	secondary	secondary	none	none	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_mn_8	BIO_11044594_mn_10	BIO_11044594_mn_8_10
BIO	11044594	mn	9	10	result	conclusion	support	support	secondary	secondary	none	none	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_mn_9	BIO_11044594_mn_10	BIO_11044594_mn_9_10
BIO	11044594	mn	10	9	conclusion	result	support	support	secondary	secondary	none	none	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_mn_10	BIO_11044594_mn_9	BIO_11044594_mn_9_10
BIO	11063736	mn	1	2	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Gender is known to influence the transmission of trinucleotide repeats in human disease.	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	BIO_11063736_mn_1	BIO_11063736_mn_2	BIO_11063736_mn_1_2
BIO	11063736	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	BIO_11063736_mn_1	BIO_11063736_mn_3	BIO_11063736_mn_1_3
BIO	11063736	mn	1	4	motivation_background	information_additional	info-required	info-optional	secondary	secondary	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	BIO_11063736_mn_1	BIO_11063736_mn_4	BIO_11063736_mn_1_4
BIO	11063736	mn	1	5	motivation_background	result	info-required	support	secondary	secondary	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	BIO_11063736_mn_1	BIO_11063736_mn_5	BIO_11063736_mn_1_5
BIO	11063736	mn	1	6	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	Males predominantly expand the repeat whereas females predominantly contract the repeat.	BIO_11063736_mn_1	BIO_11063736_mn_6	BIO_11063736_mn_1_6
BIO	11063736	mn	1	7	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	BIO_11063736_mn_1	BIO_11063736_mn_7	BIO_11063736_mn_1_7
BIO	11063736	mn	1	8	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_mn_1	BIO_11063736_mn_8	BIO_11063736_mn_1_8
BIO	11063736	mn	1	9	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_mn_1	BIO_11063736_mn_9	BIO_11063736_mn_1_9
BIO	11063736	mn	2	3	motivation_problem	proposal	support	none	secondary	main	forw	support	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	BIO_11063736_mn_2	BIO_11063736_mn_3	BIO_11063736_mn_2_3
BIO	11063736	mn	2	4	motivation_problem	information_additional	support	info-optional	secondary	secondary	none	none	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	BIO_11063736_mn_2	BIO_11063736_mn_4	BIO_11063736_mn_2_4
BIO	11063736	mn	2	5	motivation_problem	result	support	support	secondary	secondary	none	none	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	BIO_11063736_mn_2	BIO_11063736_mn_5	BIO_11063736_mn_2_5
BIO	11063736	mn	2	6	motivation_problem	result	support	elaboration	secondary	secondary	none	none	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	Males predominantly expand the repeat whereas females predominantly contract the repeat.	BIO_11063736_mn_2	BIO_11063736_mn_6	BIO_11063736_mn_2_6
BIO	11063736	mn	2	7	motivation_problem	result	support	elaboration	secondary	secondary	none	none	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	BIO_11063736_mn_2	BIO_11063736_mn_7	BIO_11063736_mn_2_7
BIO	11063736	mn	2	8	motivation_problem	conclusion	support	support	secondary	secondary	none	none	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_mn_2	BIO_11063736_mn_8	BIO_11063736_mn_2_8
BIO	11063736	mn	2	9	motivation_problem	conclusion	support	support	secondary	secondary	none	none	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_mn_2	BIO_11063736_mn_9	BIO_11063736_mn_2_9
BIO	11063736	mn	3	4	proposal	information_additional	none	info-optional	main	secondary	back	info-optional	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	BIO_11063736_mn_3	BIO_11063736_mn_4	BIO_11063736_mn_3_4
BIO	11063736	mn	3	5	proposal	result	none	support	main	secondary	back	support	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	BIO_11063736_mn_3	BIO_11063736_mn_5	BIO_11063736_mn_3_5
BIO	11063736	mn	3	6	proposal	result	none	elaboration	main	secondary	none	none	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	Males predominantly expand the repeat whereas females predominantly contract the repeat.	BIO_11063736_mn_3	BIO_11063736_mn_6	BIO_11063736_mn_3_6
BIO	11063736	mn	3	7	proposal	result	none	elaboration	main	secondary	none	none	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	BIO_11063736_mn_3	BIO_11063736_mn_7	BIO_11063736_mn_3_7
BIO	11063736	mn	3	8	proposal	conclusion	none	support	main	secondary	back	support	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_mn_3	BIO_11063736_mn_8	BIO_11063736_mn_3_8
BIO	11063736	mn	3	9	proposal	conclusion	none	support	main	secondary	back	support	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_mn_3	BIO_11063736_mn_9	BIO_11063736_mn_3_9
BIO	11063736	mn	4	5	information_additional	result	info-optional	support	secondary	secondary	none	none	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	BIO_11063736_mn_4	BIO_11063736_mn_5	BIO_11063736_mn_4_5
BIO	11063736	mn	4	6	information_additional	result	info-optional	elaboration	secondary	secondary	none	none	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	Males predominantly expand the repeat whereas females predominantly contract the repeat.	BIO_11063736_mn_4	BIO_11063736_mn_6	BIO_11063736_mn_4_6
BIO	11063736	mn	4	7	information_additional	result	info-optional	elaboration	secondary	secondary	none	none	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	BIO_11063736_mn_4	BIO_11063736_mn_7	BIO_11063736_mn_4_7
BIO	11063736	mn	4	8	information_additional	conclusion	info-optional	support	secondary	secondary	none	none	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_mn_4	BIO_11063736_mn_8	BIO_11063736_mn_4_8
BIO	11063736	mn	4	9	information_additional	conclusion	info-optional	support	secondary	secondary	none	none	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_mn_4	BIO_11063736_mn_9	BIO_11063736_mn_4_9
BIO	11063736	mn	5	6	result	result	support	elaboration	secondary	secondary	back	elaboration	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	Males predominantly expand the repeat whereas females predominantly contract the repeat.	BIO_11063736_mn_5	BIO_11063736_mn_6	BIO_11063736_mn_5_6
BIO	11063736	mn	5	7	result	result	support	elaboration	secondary	secondary	back	elaboration	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	BIO_11063736_mn_5	BIO_11063736_mn_7	BIO_11063736_mn_5_7
BIO	11063736	mn	5	8	result	conclusion	support	support	secondary	secondary	none	none	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_mn_5	BIO_11063736_mn_8	BIO_11063736_mn_5_8
BIO	11063736	mn	5	9	result	conclusion	support	support	secondary	secondary	none	none	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_mn_5	BIO_11063736_mn_9	BIO_11063736_mn_5_9
BIO	11063736	mn	6	7	result	result	elaboration	elaboration	secondary	secondary	none	none	Males predominantly expand the repeat whereas females predominantly contract the repeat.	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	BIO_11063736_mn_6	BIO_11063736_mn_7	BIO_11063736_mn_6_7
BIO	11063736	mn	6	8	result	conclusion	elaboration	support	secondary	secondary	none	none	Males predominantly expand the repeat whereas females predominantly contract the repeat.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_mn_6	BIO_11063736_mn_8	BIO_11063736_mn_6_8
BIO	11063736	mn	6	9	result	conclusion	elaboration	support	secondary	secondary	none	none	Males predominantly expand the repeat whereas females predominantly contract the repeat.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_mn_6	BIO_11063736_mn_9	BIO_11063736_mn_6_9
BIO	11063736	mn	7	8	result	conclusion	elaboration	support	secondary	secondary	none	none	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_mn_7	BIO_11063736_mn_8	BIO_11063736_mn_7_8
BIO	11063736	mn	7	9	result	conclusion	elaboration	support	secondary	secondary	none	none	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_mn_7	BIO_11063736_mn_9	BIO_11063736_mn_7_9
BIO	11063736	mn	8	9	conclusion	conclusion	support	support	secondary	secondary	none	none	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_mn_8	BIO_11063736_mn_9	BIO_11063736_mn_8_9
BIO	11063736	mn	9	8	conclusion	conclusion	support	support	secondary	secondary	none	none	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_mn_9	BIO_11063736_mn_8	BIO_11063736_mn_8_9
BIO	11129784	mn	1	2	motivation_background	proposal	support	none	secondary	main	forw	support	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	BIO_11129784_mn_1	BIO_11129784_mn_2	BIO_11129784_mn_1_2
BIO	11129784	mn	1	3	motivation_background	result_means	support	support	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	BIO_11129784_mn_1	BIO_11129784_mn_3	BIO_11129784_mn_1_3
BIO	11129784	mn	1	4	motivation_background	observation	support	support	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	BIO_11129784_mn_1	BIO_11129784_mn_4	BIO_11129784_mn_1_4
BIO	11129784	mn	1	5	motivation_background	observation	support	support	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	BIO_11129784_mn_1	BIO_11129784_mn_5	BIO_11129784_mn_1_5
BIO	11129784	mn	1	6	motivation_background	observation	support	elaboration	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	BIO_11129784_mn_1	BIO_11129784_mn_6	BIO_11129784_mn_1_6
BIO	11129784	mn	1	7	motivation_background	observation	support	support	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	BIO_11129784_mn_1	BIO_11129784_mn_7	BIO_11129784_mn_1_7
BIO	11129784	mn	1	8	motivation_background	observation	support	elaboration	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_mn_1	BIO_11129784_mn_8	BIO_11129784_mn_1_8
BIO	11129784	mn	1	9	motivation_background	observation	support	elaboration	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_mn_1	BIO_11129784_mn_9	BIO_11129784_mn_1_9
BIO	11129784	mn	1	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_mn_1	BIO_11129784_mn_10	BIO_11129784_mn_1_10
BIO	11129784	mn	2	3	proposal	result_means	none	support	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	BIO_11129784_mn_2	BIO_11129784_mn_3	BIO_11129784_mn_2_3
BIO	11129784	mn	2	4	proposal	observation	none	support	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	BIO_11129784_mn_2	BIO_11129784_mn_4	BIO_11129784_mn_2_4
BIO	11129784	mn	2	5	proposal	observation	none	support	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	BIO_11129784_mn_2	BIO_11129784_mn_5	BIO_11129784_mn_2_5
BIO	11129784	mn	2	6	proposal	observation	none	elaboration	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	BIO_11129784_mn_2	BIO_11129784_mn_6	BIO_11129784_mn_2_6
BIO	11129784	mn	2	7	proposal	observation	none	support	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	BIO_11129784_mn_2	BIO_11129784_mn_7	BIO_11129784_mn_2_7
BIO	11129784	mn	2	8	proposal	observation	none	elaboration	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_mn_2	BIO_11129784_mn_8	BIO_11129784_mn_2_8
BIO	11129784	mn	2	9	proposal	observation	none	elaboration	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_mn_2	BIO_11129784_mn_9	BIO_11129784_mn_2_9
BIO	11129784	mn	2	10	proposal	conclusion	none	support	main	secondary	back	support	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_mn_2	BIO_11129784_mn_10	BIO_11129784_mn_2_10
BIO	11129784	mn	3	4	result_means	observation	support	support	secondary	secondary	none	none	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	BIO_11129784_mn_3	BIO_11129784_mn_4	BIO_11129784_mn_3_4
BIO	11129784	mn	3	5	result_means	observation	support	support	secondary	secondary	none	none	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	BIO_11129784_mn_3	BIO_11129784_mn_5	BIO_11129784_mn_3_5
BIO	11129784	mn	3	6	result_means	observation	support	elaboration	secondary	secondary	none	none	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	BIO_11129784_mn_3	BIO_11129784_mn_6	BIO_11129784_mn_3_6
BIO	11129784	mn	3	7	result_means	observation	support	support	secondary	secondary	none	none	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	BIO_11129784_mn_3	BIO_11129784_mn_7	BIO_11129784_mn_3_7
BIO	11129784	mn	3	8	result_means	observation	support	elaboration	secondary	secondary	none	none	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_mn_3	BIO_11129784_mn_8	BIO_11129784_mn_3_8
BIO	11129784	mn	3	9	result_means	observation	support	elaboration	secondary	secondary	none	none	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_mn_3	BIO_11129784_mn_9	BIO_11129784_mn_3_9
BIO	11129784	mn	3	10	result_means	conclusion	support	support	secondary	secondary	forw	support	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_mn_3	BIO_11129784_mn_10	BIO_11129784_mn_3_10
BIO	11129784	mn	4	5	observation	observation	support	support	secondary	secondary	none	none	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	BIO_11129784_mn_4	BIO_11129784_mn_5	BIO_11129784_mn_4_5
BIO	11129784	mn	4	6	observation	observation	support	elaboration	secondary	secondary	none	none	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	BIO_11129784_mn_4	BIO_11129784_mn_6	BIO_11129784_mn_4_6
BIO	11129784	mn	4	7	observation	observation	support	support	secondary	secondary	none	none	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	BIO_11129784_mn_4	BIO_11129784_mn_7	BIO_11129784_mn_4_7
BIO	11129784	mn	4	8	observation	observation	support	elaboration	secondary	secondary	none	none	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_mn_4	BIO_11129784_mn_8	BIO_11129784_mn_4_8
BIO	11129784	mn	4	9	observation	observation	support	elaboration	secondary	secondary	none	none	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_mn_4	BIO_11129784_mn_9	BIO_11129784_mn_4_9
BIO	11129784	mn	4	10	observation	conclusion	support	support	secondary	secondary	forw	support	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_mn_4	BIO_11129784_mn_10	BIO_11129784_mn_4_10
BIO	11129784	mn	5	6	observation	observation	support	elaboration	secondary	secondary	back	elaboration	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	BIO_11129784_mn_5	BIO_11129784_mn_6	BIO_11129784_mn_5_6
BIO	11129784	mn	5	7	observation	observation	support	support	secondary	secondary	none	none	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	BIO_11129784_mn_5	BIO_11129784_mn_7	BIO_11129784_mn_5_7
BIO	11129784	mn	5	8	observation	observation	support	elaboration	secondary	secondary	none	none	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_mn_5	BIO_11129784_mn_8	BIO_11129784_mn_5_8
BIO	11129784	mn	5	9	observation	observation	support	elaboration	secondary	secondary	none	none	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_mn_5	BIO_11129784_mn_9	BIO_11129784_mn_5_9
BIO	11129784	mn	5	10	observation	conclusion	support	support	secondary	secondary	forw	support	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_mn_5	BIO_11129784_mn_10	BIO_11129784_mn_5_10
BIO	11129784	mn	6	7	observation	observation	elaboration	support	secondary	secondary	none	none	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	BIO_11129784_mn_6	BIO_11129784_mn_7	BIO_11129784_mn_6_7
BIO	11129784	mn	6	8	observation	observation	elaboration	elaboration	secondary	secondary	none	none	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_mn_6	BIO_11129784_mn_8	BIO_11129784_mn_6_8
BIO	11129784	mn	6	9	observation	observation	elaboration	elaboration	secondary	secondary	none	none	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_mn_6	BIO_11129784_mn_9	BIO_11129784_mn_6_9
BIO	11129784	mn	6	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_mn_6	BIO_11129784_mn_10	BIO_11129784_mn_6_10
BIO	11129784	mn	7	8	observation	observation	support	elaboration	secondary	secondary	back	elaboration	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_mn_7	BIO_11129784_mn_8	BIO_11129784_mn_7_8
BIO	11129784	mn	7	9	observation	observation	support	elaboration	secondary	secondary	none	none	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_mn_7	BIO_11129784_mn_9	BIO_11129784_mn_7_9
BIO	11129784	mn	7	10	observation	conclusion	support	support	secondary	secondary	forw	support	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_mn_7	BIO_11129784_mn_10	BIO_11129784_mn_7_10
BIO	11129784	mn	8	9	observation	observation	elaboration	elaboration	secondary	secondary	back	elaboration	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_mn_8	BIO_11129784_mn_9	BIO_11129784_mn_8_9
BIO	11129784	mn	8	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_mn_8	BIO_11129784_mn_10	BIO_11129784_mn_8_10
BIO	11129784	mn	9	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_mn_9	BIO_11129784_mn_10	BIO_11129784_mn_9_10
BIO	11129784	mn	10	9	conclusion	observation	support	elaboration	secondary	secondary	none	none	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_mn_10	BIO_11129784_mn_9	BIO_11129784_mn_9_10
BIO	11154280	mn	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	BIO_11154280_mn_1	BIO_11154280_mn_2	BIO_11154280_mn_1_2
BIO	11154280	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	Here we investigate the mechanism of this mutator effect.	BIO_11154280_mn_1	BIO_11154280_mn_3	BIO_11154280_mn_1_3
BIO	11154280	mn	1	4	motivation_background	result	info-required	support	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	BIO_11154280_mn_1	BIO_11154280_mn_4	BIO_11154280_mn_1_4
BIO	11154280	mn	1	5	motivation_background	observation	info-required	support	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	BIO_11154280_mn_1	BIO_11154280_mn_5	BIO_11154280_mn_1_5
BIO	11154280	mn	1	6	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	BIO_11154280_mn_1	BIO_11154280_mn_6	BIO_11154280_mn_1_6
BIO	11154280	mn	1	7	motivation_background	result	info-required	support	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	BIO_11154280_mn_1	BIO_11154280_mn_7	BIO_11154280_mn_1_7
BIO	11154280	mn	1	8	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_mn_1	BIO_11154280_mn_8	BIO_11154280_mn_1_8
BIO	11154280	mn	1	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_mn_1	BIO_11154280_mn_9	BIO_11154280_mn_1_9
BIO	11154280	mn	1	10	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_mn_1	BIO_11154280_mn_10	BIO_11154280_mn_1_10
BIO	11154280	mn	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	Here we investigate the mechanism of this mutator effect.	BIO_11154280_mn_2	BIO_11154280_mn_3	BIO_11154280_mn_2_3
BIO	11154280	mn	2	4	motivation_background	result	support	support	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	BIO_11154280_mn_2	BIO_11154280_mn_4	BIO_11154280_mn_2_4
BIO	11154280	mn	2	5	motivation_background	observation	support	support	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	BIO_11154280_mn_2	BIO_11154280_mn_5	BIO_11154280_mn_2_5
BIO	11154280	mn	2	6	motivation_background	conclusion	support	support	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	BIO_11154280_mn_2	BIO_11154280_mn_6	BIO_11154280_mn_2_6
BIO	11154280	mn	2	7	motivation_background	result	support	support	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	BIO_11154280_mn_2	BIO_11154280_mn_7	BIO_11154280_mn_2_7
BIO	11154280	mn	2	8	motivation_background	result	support	elaboration	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_mn_2	BIO_11154280_mn_8	BIO_11154280_mn_2_8
BIO	11154280	mn	2	9	motivation_background	observation	support	support	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_mn_2	BIO_11154280_mn_9	BIO_11154280_mn_2_9
BIO	11154280	mn	2	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_mn_2	BIO_11154280_mn_10	BIO_11154280_mn_2_10
BIO	11154280	mn	3	4	proposal	result	none	support	main	secondary	back	support	Here we investigate the mechanism of this mutator effect.	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	BIO_11154280_mn_3	BIO_11154280_mn_4	BIO_11154280_mn_3_4
BIO	11154280	mn	3	5	proposal	observation	none	support	main	secondary	none	none	Here we investigate the mechanism of this mutator effect.	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	BIO_11154280_mn_3	BIO_11154280_mn_5	BIO_11154280_mn_3_5
BIO	11154280	mn	3	6	proposal	conclusion	none	support	main	secondary	back	support	Here we investigate the mechanism of this mutator effect.	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	BIO_11154280_mn_3	BIO_11154280_mn_6	BIO_11154280_mn_3_6
BIO	11154280	mn	3	7	proposal	result	none	support	main	secondary	back	support	Here we investigate the mechanism of this mutator effect.	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	BIO_11154280_mn_3	BIO_11154280_mn_7	BIO_11154280_mn_3_7
BIO	11154280	mn	3	8	proposal	result	none	elaboration	main	secondary	none	none	Here we investigate the mechanism of this mutator effect.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_mn_3	BIO_11154280_mn_8	BIO_11154280_mn_3_8
BIO	11154280	mn	3	9	proposal	observation	none	support	main	secondary	none	none	Here we investigate the mechanism of this mutator effect.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_mn_3	BIO_11154280_mn_9	BIO_11154280_mn_3_9
BIO	11154280	mn	3	10	proposal	conclusion	none	support	main	secondary	back	support	Here we investigate the mechanism of this mutator effect.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_mn_3	BIO_11154280_mn_10	BIO_11154280_mn_3_10
BIO	11154280	mn	4	5	result	observation	support	support	secondary	secondary	none	none	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	BIO_11154280_mn_4	BIO_11154280_mn_5	BIO_11154280_mn_4_5
BIO	11154280	mn	4	6	result	conclusion	support	support	secondary	secondary	none	none	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	BIO_11154280_mn_4	BIO_11154280_mn_6	BIO_11154280_mn_4_6
BIO	11154280	mn	4	7	result	result	support	support	secondary	secondary	none	none	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	BIO_11154280_mn_4	BIO_11154280_mn_7	BIO_11154280_mn_4_7
BIO	11154280	mn	4	8	result	result	support	elaboration	secondary	secondary	none	none	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_mn_4	BIO_11154280_mn_8	BIO_11154280_mn_4_8
BIO	11154280	mn	4	9	result	observation	support	support	secondary	secondary	none	none	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_mn_4	BIO_11154280_mn_9	BIO_11154280_mn_4_9
BIO	11154280	mn	4	10	result	conclusion	support	support	secondary	secondary	none	none	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_mn_4	BIO_11154280_mn_10	BIO_11154280_mn_4_10
BIO	11154280	mn	5	6	observation	conclusion	support	support	secondary	secondary	forw	support	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	BIO_11154280_mn_5	BIO_11154280_mn_6	BIO_11154280_mn_5_6
BIO	11154280	mn	5	7	observation	result	support	support	secondary	secondary	none	none	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	BIO_11154280_mn_5	BIO_11154280_mn_7	BIO_11154280_mn_5_7
BIO	11154280	mn	5	8	observation	result	support	elaboration	secondary	secondary	none	none	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_mn_5	BIO_11154280_mn_8	BIO_11154280_mn_5_8
BIO	11154280	mn	5	9	observation	observation	support	support	secondary	secondary	none	none	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_mn_5	BIO_11154280_mn_9	BIO_11154280_mn_5_9
BIO	11154280	mn	5	10	observation	conclusion	support	support	secondary	secondary	none	none	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_mn_5	BIO_11154280_mn_10	BIO_11154280_mn_5_10
BIO	11154280	mn	6	7	conclusion	result	support	support	secondary	secondary	none	none	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	BIO_11154280_mn_6	BIO_11154280_mn_7	BIO_11154280_mn_6_7
BIO	11154280	mn	6	8	conclusion	result	support	elaboration	secondary	secondary	none	none	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_mn_6	BIO_11154280_mn_8	BIO_11154280_mn_6_8
BIO	11154280	mn	6	9	conclusion	observation	support	support	secondary	secondary	none	none	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_mn_6	BIO_11154280_mn_9	BIO_11154280_mn_6_9
BIO	11154280	mn	6	10	conclusion	conclusion	support	support	secondary	secondary	none	none	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_mn_6	BIO_11154280_mn_10	BIO_11154280_mn_6_10
BIO	11154280	mn	7	8	result	result	support	elaboration	secondary	secondary	back	elaboration	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_mn_7	BIO_11154280_mn_8	BIO_11154280_mn_7_8
BIO	11154280	mn	7	9	result	observation	support	support	secondary	secondary	none	none	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_mn_7	BIO_11154280_mn_9	BIO_11154280_mn_7_9
BIO	11154280	mn	7	10	result	conclusion	support	support	secondary	secondary	none	none	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_mn_7	BIO_11154280_mn_10	BIO_11154280_mn_7_10
BIO	11154280	mn	8	9	result	observation	elaboration	support	secondary	secondary	back	support	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_mn_8	BIO_11154280_mn_9	BIO_11154280_mn_8_9
BIO	11154280	mn	8	10	result	conclusion	elaboration	support	secondary	secondary	none	none	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_mn_8	BIO_11154280_mn_10	BIO_11154280_mn_8_10
BIO	11154280	mn	9	10	observation	conclusion	support	support	secondary	secondary	none	none	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_mn_9	BIO_11154280_mn_10	BIO_11154280_mn_9_10
BIO	11154280	mn	10	9	conclusion	observation	support	support	secondary	secondary	none	none	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_mn_10	BIO_11154280_mn_9	BIO_11154280_mn_9_10
BIO	11226671	mn	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	BIO_11226671_mn_1	BIO_11226671_mn_2	BIO_11226671_mn_1_2
BIO	11226671	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	BIO_11226671_mn_1	BIO_11226671_mn_3	BIO_11226671_mn_1_3
BIO	11226671	mn	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	BIO_11226671_mn_1	BIO_11226671_mn_4	BIO_11226671_mn_1_4
BIO	11226671	mn	1	5	motivation_background	observation	info-required	support	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	BIO_11226671_mn_1	BIO_11226671_mn_5	BIO_11226671_mn_1_5
BIO	11226671	mn	1	6	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	BIO_11226671_mn_1	BIO_11226671_mn_6	BIO_11226671_mn_1_6
BIO	11226671	mn	1	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	BIO_11226671_mn_1	BIO_11226671_mn_7	BIO_11226671_mn_1_7
BIO	11226671	mn	1	8	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_mn_1	BIO_11226671_mn_8	BIO_11226671_mn_1_8
BIO	11226671	mn	1	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_mn_1	BIO_11226671_mn_9	BIO_11226671_mn_1_9
BIO	11226671	mn	1	10	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_mn_1	BIO_11226671_mn_10	BIO_11226671_mn_1_10
BIO	11226671	mn	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	BIO_11226671_mn_2	BIO_11226671_mn_3	BIO_11226671_mn_2_3
BIO	11226671	mn	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	BIO_11226671_mn_2	BIO_11226671_mn_4	BIO_11226671_mn_2_4
BIO	11226671	mn	2	5	motivation_background	observation	support	support	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	BIO_11226671_mn_2	BIO_11226671_mn_5	BIO_11226671_mn_2_5
BIO	11226671	mn	2	6	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	BIO_11226671_mn_2	BIO_11226671_mn_6	BIO_11226671_mn_2_6
BIO	11226671	mn	2	7	motivation_background	observation	support	support	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	BIO_11226671_mn_2	BIO_11226671_mn_7	BIO_11226671_mn_2_7
BIO	11226671	mn	2	8	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_mn_2	BIO_11226671_mn_8	BIO_11226671_mn_2_8
BIO	11226671	mn	2	9	motivation_background	observation	support	support	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_mn_2	BIO_11226671_mn_9	BIO_11226671_mn_2_9
BIO	11226671	mn	2	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_mn_2	BIO_11226671_mn_10	BIO_11226671_mn_2_10
BIO	11226671	mn	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	BIO_11226671_mn_3	BIO_11226671_mn_4	BIO_11226671_mn_3_4
BIO	11226671	mn	3	5	proposal	observation	none	support	main	secondary	none	none	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	BIO_11226671_mn_3	BIO_11226671_mn_5	BIO_11226671_mn_3_5
BIO	11226671	mn	3	6	proposal	observation	none	elaboration	main	secondary	none	none	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	BIO_11226671_mn_3	BIO_11226671_mn_6	BIO_11226671_mn_3_6
BIO	11226671	mn	3	7	proposal	observation	none	support	main	secondary	none	none	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	BIO_11226671_mn_3	BIO_11226671_mn_7	BIO_11226671_mn_3_7
BIO	11226671	mn	3	8	proposal	observation	none	elaboration	main	secondary	none	none	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_mn_3	BIO_11226671_mn_8	BIO_11226671_mn_3_8
BIO	11226671	mn	3	9	proposal	observation	none	support	main	secondary	none	none	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_mn_3	BIO_11226671_mn_9	BIO_11226671_mn_3_9
BIO	11226671	mn	3	10	proposal	conclusion	none	support	main	secondary	back	support	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_mn_3	BIO_11226671_mn_10	BIO_11226671_mn_3_10
BIO	11226671	mn	4	5	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	BIO_11226671_mn_4	BIO_11226671_mn_5	BIO_11226671_mn_4_5
BIO	11226671	mn	4	6	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	BIO_11226671_mn_4	BIO_11226671_mn_6	BIO_11226671_mn_4_6
BIO	11226671	mn	4	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	BIO_11226671_mn_4	BIO_11226671_mn_7	BIO_11226671_mn_4_7
BIO	11226671	mn	4	8	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_mn_4	BIO_11226671_mn_8	BIO_11226671_mn_4_8
BIO	11226671	mn	4	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_mn_4	BIO_11226671_mn_9	BIO_11226671_mn_4_9
BIO	11226671	mn	4	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_mn_4	BIO_11226671_mn_10	BIO_11226671_mn_4_10
BIO	11226671	mn	5	6	observation	observation	support	elaboration	secondary	secondary	back	elaboration	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	BIO_11226671_mn_5	BIO_11226671_mn_6	BIO_11226671_mn_5_6
BIO	11226671	mn	5	7	observation	observation	support	support	secondary	secondary	none	none	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	BIO_11226671_mn_5	BIO_11226671_mn_7	BIO_11226671_mn_5_7
BIO	11226671	mn	5	8	observation	observation	support	elaboration	secondary	secondary	none	none	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_mn_5	BIO_11226671_mn_8	BIO_11226671_mn_5_8
BIO	11226671	mn	5	9	observation	observation	support	support	secondary	secondary	none	none	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_mn_5	BIO_11226671_mn_9	BIO_11226671_mn_5_9
BIO	11226671	mn	5	10	observation	conclusion	support	support	secondary	secondary	forw	support	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_mn_5	BIO_11226671_mn_10	BIO_11226671_mn_5_10
BIO	11226671	mn	6	7	observation	observation	elaboration	support	secondary	secondary	none	none	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	BIO_11226671_mn_6	BIO_11226671_mn_7	BIO_11226671_mn_6_7
BIO	11226671	mn	6	8	observation	observation	elaboration	elaboration	secondary	secondary	none	none	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_mn_6	BIO_11226671_mn_8	BIO_11226671_mn_6_8
BIO	11226671	mn	6	9	observation	observation	elaboration	support	secondary	secondary	none	none	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_mn_6	BIO_11226671_mn_9	BIO_11226671_mn_6_9
BIO	11226671	mn	6	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_mn_6	BIO_11226671_mn_10	BIO_11226671_mn_6_10
BIO	11226671	mn	7	8	observation	observation	support	elaboration	secondary	secondary	back	elaboration	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_mn_7	BIO_11226671_mn_8	BIO_11226671_mn_7_8
BIO	11226671	mn	7	9	observation	observation	support	support	secondary	secondary	none	none	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_mn_7	BIO_11226671_mn_9	BIO_11226671_mn_7_9
BIO	11226671	mn	7	10	observation	conclusion	support	support	secondary	secondary	forw	support	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_mn_7	BIO_11226671_mn_10	BIO_11226671_mn_7_10
BIO	11226671	mn	8	9	observation	observation	elaboration	support	secondary	secondary	none	none	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_mn_8	BIO_11226671_mn_9	BIO_11226671_mn_8_9
BIO	11226671	mn	8	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_mn_8	BIO_11226671_mn_10	BIO_11226671_mn_8_10
BIO	11226671	mn	9	10	observation	conclusion	support	support	secondary	secondary	forw	support	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_mn_9	BIO_11226671_mn_10	BIO_11226671_mn_9_10
BIO	11226671	mn	10	9	conclusion	observation	support	support	secondary	secondary	back	support	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_mn_10	BIO_11226671_mn_9	BIO_11226671_mn_9_10
BIO	11494364	mn	1	2	motivation_background	proposal	support	none	secondary	main	forw	support	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	BIO_11494364_mn_1	BIO_11494364_mn_2	BIO_11494364_mn_1_2
BIO	11494364	mn	1	3	motivation_background	observation	support	support	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	BIO_11494364_mn_1	BIO_11494364_mn_3	BIO_11494364_mn_1_3
BIO	11494364	mn	1	4	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	BIO_11494364_mn_1	BIO_11494364_mn_4	BIO_11494364_mn_1_4
BIO	11494364	mn	1	5	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	BIO_11494364_mn_1	BIO_11494364_mn_5	BIO_11494364_mn_1_5
BIO	11494364	mn	1	6	motivation_background	observation	support	support	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	BIO_11494364_mn_1	BIO_11494364_mn_6	BIO_11494364_mn_1_6
BIO	11494364	mn	1	7	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	BIO_11494364_mn_1	BIO_11494364_mn_7	BIO_11494364_mn_1_7
BIO	11494364	mn	1	8	motivation_background	observation	support	support	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_mn_1	BIO_11494364_mn_8	BIO_11494364_mn_1_8
BIO	11494364	mn	1	9	motivation_background	result	support	support	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_mn_1	BIO_11494364_mn_9	BIO_11494364_mn_1_9
BIO	11494364	mn	1	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_mn_1	BIO_11494364_mn_10	BIO_11494364_mn_1_10
BIO	11494364	mn	2	3	proposal	observation	none	support	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	BIO_11494364_mn_2	BIO_11494364_mn_3	BIO_11494364_mn_2_3
BIO	11494364	mn	2	4	proposal	observation	none	elaboration	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	BIO_11494364_mn_2	BIO_11494364_mn_4	BIO_11494364_mn_2_4
BIO	11494364	mn	2	5	proposal	observation	none	elaboration	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	BIO_11494364_mn_2	BIO_11494364_mn_5	BIO_11494364_mn_2_5
BIO	11494364	mn	2	6	proposal	observation	none	support	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	BIO_11494364_mn_2	BIO_11494364_mn_6	BIO_11494364_mn_2_6
BIO	11494364	mn	2	7	proposal	observation	none	elaboration	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	BIO_11494364_mn_2	BIO_11494364_mn_7	BIO_11494364_mn_2_7
BIO	11494364	mn	2	8	proposal	observation	none	support	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_mn_2	BIO_11494364_mn_8	BIO_11494364_mn_2_8
BIO	11494364	mn	2	9	proposal	result	none	support	main	secondary	back	support	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_mn_2	BIO_11494364_mn_9	BIO_11494364_mn_2_9
BIO	11494364	mn	2	10	proposal	conclusion	none	support	main	secondary	back	support	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_mn_2	BIO_11494364_mn_10	BIO_11494364_mn_2_10
BIO	11494364	mn	3	4	observation	observation	support	elaboration	secondary	secondary	back	elaboration	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	BIO_11494364_mn_3	BIO_11494364_mn_4	BIO_11494364_mn_3_4
BIO	11494364	mn	3	5	observation	observation	support	elaboration	secondary	secondary	none	none	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	BIO_11494364_mn_3	BIO_11494364_mn_5	BIO_11494364_mn_3_5
BIO	11494364	mn	3	6	observation	observation	support	support	secondary	secondary	none	none	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	BIO_11494364_mn_3	BIO_11494364_mn_6	BIO_11494364_mn_3_6
BIO	11494364	mn	3	7	observation	observation	support	elaboration	secondary	secondary	none	none	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	BIO_11494364_mn_3	BIO_11494364_mn_7	BIO_11494364_mn_3_7
BIO	11494364	mn	3	8	observation	observation	support	support	secondary	secondary	none	none	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_mn_3	BIO_11494364_mn_8	BIO_11494364_mn_3_8
BIO	11494364	mn	3	9	observation	result	support	support	secondary	secondary	forw	support	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_mn_3	BIO_11494364_mn_9	BIO_11494364_mn_3_9
BIO	11494364	mn	3	10	observation	conclusion	support	support	secondary	secondary	none	none	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_mn_3	BIO_11494364_mn_10	BIO_11494364_mn_3_10
BIO	11494364	mn	4	5	observation	observation	elaboration	elaboration	secondary	secondary	back	elaboration	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	BIO_11494364_mn_4	BIO_11494364_mn_5	BIO_11494364_mn_4_5
BIO	11494364	mn	4	6	observation	observation	elaboration	support	secondary	secondary	none	none	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	BIO_11494364_mn_4	BIO_11494364_mn_6	BIO_11494364_mn_4_6
BIO	11494364	mn	4	7	observation	observation	elaboration	elaboration	secondary	secondary	none	none	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	BIO_11494364_mn_4	BIO_11494364_mn_7	BIO_11494364_mn_4_7
BIO	11494364	mn	4	8	observation	observation	elaboration	support	secondary	secondary	none	none	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_mn_4	BIO_11494364_mn_8	BIO_11494364_mn_4_8
BIO	11494364	mn	4	9	observation	result	elaboration	support	secondary	secondary	none	none	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_mn_4	BIO_11494364_mn_9	BIO_11494364_mn_4_9
BIO	11494364	mn	4	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_mn_4	BIO_11494364_mn_10	BIO_11494364_mn_4_10
BIO	11494364	mn	5	6	observation	observation	elaboration	support	secondary	secondary	none	none	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	BIO_11494364_mn_5	BIO_11494364_mn_6	BIO_11494364_mn_5_6
BIO	11494364	mn	5	7	observation	observation	elaboration	elaboration	secondary	secondary	none	none	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	BIO_11494364_mn_5	BIO_11494364_mn_7	BIO_11494364_mn_5_7
BIO	11494364	mn	5	8	observation	observation	elaboration	support	secondary	secondary	none	none	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_mn_5	BIO_11494364_mn_8	BIO_11494364_mn_5_8
BIO	11494364	mn	5	9	observation	result	elaboration	support	secondary	secondary	none	none	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_mn_5	BIO_11494364_mn_9	BIO_11494364_mn_5_9
BIO	11494364	mn	5	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_mn_5	BIO_11494364_mn_10	BIO_11494364_mn_5_10
BIO	11494364	mn	6	7	observation	observation	support	elaboration	secondary	secondary	back	elaboration	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	BIO_11494364_mn_6	BIO_11494364_mn_7	BIO_11494364_mn_6_7
BIO	11494364	mn	6	8	observation	observation	support	support	secondary	secondary	none	none	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_mn_6	BIO_11494364_mn_8	BIO_11494364_mn_6_8
BIO	11494364	mn	6	9	observation	result	support	support	secondary	secondary	forw	support	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_mn_6	BIO_11494364_mn_9	BIO_11494364_mn_6_9
BIO	11494364	mn	6	10	observation	conclusion	support	support	secondary	secondary	none	none	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_mn_6	BIO_11494364_mn_10	BIO_11494364_mn_6_10
BIO	11494364	mn	7	8	observation	observation	elaboration	support	secondary	secondary	none	none	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_mn_7	BIO_11494364_mn_8	BIO_11494364_mn_7_8
BIO	11494364	mn	7	9	observation	result	elaboration	support	secondary	secondary	none	none	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_mn_7	BIO_11494364_mn_9	BIO_11494364_mn_7_9
BIO	11494364	mn	7	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_mn_7	BIO_11494364_mn_10	BIO_11494364_mn_7_10
BIO	11494364	mn	8	9	observation	result	support	support	secondary	secondary	forw	support	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_mn_8	BIO_11494364_mn_9	BIO_11494364_mn_8_9
BIO	11494364	mn	8	10	observation	conclusion	support	support	secondary	secondary	none	none	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_mn_8	BIO_11494364_mn_10	BIO_11494364_mn_8_10
BIO	11494364	mn	9	10	result	conclusion	support	support	secondary	secondary	none	none	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_mn_9	BIO_11494364_mn_10	BIO_11494364_mn_9_10
BIO	11494364	mn	10	9	conclusion	result	support	support	secondary	secondary	none	none	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_mn_10	BIO_11494364_mn_9	BIO_11494364_mn_9_10
BIO	11567062	mn	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	BIO_11567062_mn_1	BIO_11567062_mn_2	BIO_11567062_mn_1_2
BIO	11567062	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	BIO_11567062_mn_1	BIO_11567062_mn_3	BIO_11567062_mn_1_3
BIO	11567062	mn	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	BIO_11567062_mn_1	BIO_11567062_mn_4	BIO_11567062_mn_1_4
BIO	11567062	mn	1	5	motivation_background	observation	info-required	support	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	BIO_11567062_mn_1	BIO_11567062_mn_5	BIO_11567062_mn_1_5
BIO	11567062	mn	1	6	motivation_background	observation	info-required	support	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	BIO_11567062_mn_1	BIO_11567062_mn_6	BIO_11567062_mn_1_6
BIO	11567062	mn	1	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	BIO_11567062_mn_1	BIO_11567062_mn_7	BIO_11567062_mn_1_7
BIO	11567062	mn	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_mn_1	BIO_11567062_mn_8	BIO_11567062_mn_1_8
BIO	11567062	mn	1	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_mn_1	BIO_11567062_mn_9	BIO_11567062_mn_1_9
BIO	11567062	mn	1	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_mn_1	BIO_11567062_mn_10	BIO_11567062_mn_1_10
BIO	11567062	mn	1	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_mn_1	BIO_11567062_mn_11	BIO_11567062_mn_1_11
BIO	11567062	mn	1	12	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_mn_1	BIO_11567062_mn_12	BIO_11567062_mn_1_12
BIO	11567062	mn	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	BIO_11567062_mn_2	BIO_11567062_mn_3	BIO_11567062_mn_2_3
BIO	11567062	mn	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	BIO_11567062_mn_2	BIO_11567062_mn_4	BIO_11567062_mn_2_4
BIO	11567062	mn	2	5	motivation_background	observation	support	support	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	BIO_11567062_mn_2	BIO_11567062_mn_5	BIO_11567062_mn_2_5
BIO	11567062	mn	2	6	motivation_background	observation	support	support	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	BIO_11567062_mn_2	BIO_11567062_mn_6	BIO_11567062_mn_2_6
BIO	11567062	mn	2	7	motivation_background	observation	support	support	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	BIO_11567062_mn_2	BIO_11567062_mn_7	BIO_11567062_mn_2_7
BIO	11567062	mn	2	8	motivation_background	observation	support	support	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_mn_2	BIO_11567062_mn_8	BIO_11567062_mn_2_8
BIO	11567062	mn	2	9	motivation_background	observation	support	support	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_mn_2	BIO_11567062_mn_9	BIO_11567062_mn_2_9
BIO	11567062	mn	2	10	motivation_background	observation	support	support	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_mn_2	BIO_11567062_mn_10	BIO_11567062_mn_2_10
BIO	11567062	mn	2	11	motivation_background	observation	support	support	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_mn_2	BIO_11567062_mn_11	BIO_11567062_mn_2_11
BIO	11567062	mn	2	12	motivation_background	conclusion	support	support	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_mn_2	BIO_11567062_mn_12	BIO_11567062_mn_2_12
BIO	11567062	mn	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	BIO_11567062_mn_3	BIO_11567062_mn_4	BIO_11567062_mn_3_4
BIO	11567062	mn	3	5	proposal	observation	none	support	main	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	BIO_11567062_mn_3	BIO_11567062_mn_5	BIO_11567062_mn_3_5
BIO	11567062	mn	3	6	proposal	observation	none	support	main	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	BIO_11567062_mn_3	BIO_11567062_mn_6	BIO_11567062_mn_3_6
BIO	11567062	mn	3	7	proposal	observation	none	support	main	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	BIO_11567062_mn_3	BIO_11567062_mn_7	BIO_11567062_mn_3_7
BIO	11567062	mn	3	8	proposal	observation	none	support	main	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_mn_3	BIO_11567062_mn_8	BIO_11567062_mn_3_8
BIO	11567062	mn	3	9	proposal	observation	none	support	main	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_mn_3	BIO_11567062_mn_9	BIO_11567062_mn_3_9
BIO	11567062	mn	3	10	proposal	observation	none	support	main	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_mn_3	BIO_11567062_mn_10	BIO_11567062_mn_3_10
BIO	11567062	mn	3	11	proposal	observation	none	support	main	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_mn_3	BIO_11567062_mn_11	BIO_11567062_mn_3_11
BIO	11567062	mn	3	12	proposal	conclusion	none	support	main	secondary	back	support	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_mn_3	BIO_11567062_mn_12	BIO_11567062_mn_3_12
BIO	11567062	mn	4	5	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	BIO_11567062_mn_4	BIO_11567062_mn_5	BIO_11567062_mn_4_5
BIO	11567062	mn	4	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	BIO_11567062_mn_4	BIO_11567062_mn_6	BIO_11567062_mn_4_6
BIO	11567062	mn	4	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	BIO_11567062_mn_4	BIO_11567062_mn_7	BIO_11567062_mn_4_7
BIO	11567062	mn	4	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_mn_4	BIO_11567062_mn_8	BIO_11567062_mn_4_8
BIO	11567062	mn	4	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_mn_4	BIO_11567062_mn_9	BIO_11567062_mn_4_9
BIO	11567062	mn	4	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_mn_4	BIO_11567062_mn_10	BIO_11567062_mn_4_10
BIO	11567062	mn	4	11	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_mn_4	BIO_11567062_mn_11	BIO_11567062_mn_4_11
BIO	11567062	mn	4	12	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_mn_4	BIO_11567062_mn_12	BIO_11567062_mn_4_12
BIO	11567062	mn	5	6	observation	observation	support	support	secondary	secondary	none	none	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	BIO_11567062_mn_5	BIO_11567062_mn_6	BIO_11567062_mn_5_6
BIO	11567062	mn	5	7	observation	observation	support	support	secondary	secondary	none	none	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	BIO_11567062_mn_5	BIO_11567062_mn_7	BIO_11567062_mn_5_7
BIO	11567062	mn	5	8	observation	observation	support	support	secondary	secondary	none	none	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_mn_5	BIO_11567062_mn_8	BIO_11567062_mn_5_8
BIO	11567062	mn	5	9	observation	observation	support	support	secondary	secondary	none	none	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_mn_5	BIO_11567062_mn_9	BIO_11567062_mn_5_9
BIO	11567062	mn	5	10	observation	observation	support	support	secondary	secondary	none	none	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_mn_5	BIO_11567062_mn_10	BIO_11567062_mn_5_10
BIO	11567062	mn	5	11	observation	observation	support	support	secondary	secondary	none	none	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_mn_5	BIO_11567062_mn_11	BIO_11567062_mn_5_11
BIO	11567062	mn	5	12	observation	conclusion	support	support	secondary	secondary	forw	support	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_mn_5	BIO_11567062_mn_12	BIO_11567062_mn_5_12
BIO	11567062	mn	6	7	observation	observation	support	support	secondary	secondary	none	none	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	BIO_11567062_mn_6	BIO_11567062_mn_7	BIO_11567062_mn_6_7
BIO	11567062	mn	6	8	observation	observation	support	support	secondary	secondary	none	none	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_mn_6	BIO_11567062_mn_8	BIO_11567062_mn_6_8
BIO	11567062	mn	6	9	observation	observation	support	support	secondary	secondary	none	none	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_mn_6	BIO_11567062_mn_9	BIO_11567062_mn_6_9
BIO	11567062	mn	6	10	observation	observation	support	support	secondary	secondary	none	none	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_mn_6	BIO_11567062_mn_10	BIO_11567062_mn_6_10
BIO	11567062	mn	6	11	observation	observation	support	support	secondary	secondary	none	none	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_mn_6	BIO_11567062_mn_11	BIO_11567062_mn_6_11
BIO	11567062	mn	6	12	observation	conclusion	support	support	secondary	secondary	forw	support	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_mn_6	BIO_11567062_mn_12	BIO_11567062_mn_6_12
BIO	11567062	mn	7	8	observation	observation	support	support	secondary	secondary	back	support	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_mn_7	BIO_11567062_mn_8	BIO_11567062_mn_7_8
BIO	11567062	mn	7	9	observation	observation	support	support	secondary	secondary	none	none	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_mn_7	BIO_11567062_mn_9	BIO_11567062_mn_7_9
BIO	11567062	mn	7	10	observation	observation	support	support	secondary	secondary	none	none	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_mn_7	BIO_11567062_mn_10	BIO_11567062_mn_7_10
BIO	11567062	mn	7	11	observation	observation	support	support	secondary	secondary	none	none	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_mn_7	BIO_11567062_mn_11	BIO_11567062_mn_7_11
BIO	11567062	mn	7	12	observation	conclusion	support	support	secondary	secondary	forw	support	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_mn_7	BIO_11567062_mn_12	BIO_11567062_mn_7_12
BIO	11567062	mn	8	9	observation	observation	support	support	secondary	secondary	none	none	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_mn_8	BIO_11567062_mn_9	BIO_11567062_mn_8_9
BIO	11567062	mn	8	10	observation	observation	support	support	secondary	secondary	none	none	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_mn_8	BIO_11567062_mn_10	BIO_11567062_mn_8_10
BIO	11567062	mn	8	11	observation	observation	support	support	secondary	secondary	none	none	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_mn_8	BIO_11567062_mn_11	BIO_11567062_mn_8_11
BIO	11567062	mn	8	12	observation	conclusion	support	support	secondary	secondary	none	none	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_mn_8	BIO_11567062_mn_12	BIO_11567062_mn_8_12
BIO	11567062	mn	9	10	observation	observation	support	support	secondary	secondary	none	none	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_mn_9	BIO_11567062_mn_10	BIO_11567062_mn_9_10
BIO	11567062	mn	9	11	observation	observation	support	support	secondary	secondary	none	none	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_mn_9	BIO_11567062_mn_11	BIO_11567062_mn_9_11
BIO	11567062	mn	9	12	observation	conclusion	support	support	secondary	secondary	forw	support	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_mn_9	BIO_11567062_mn_12	BIO_11567062_mn_9_12
BIO	11567062	mn	10	11	observation	observation	support	support	secondary	secondary	none	none	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_mn_10	BIO_11567062_mn_11	BIO_11567062_mn_10_11
BIO	11567062	mn	10	12	observation	conclusion	support	support	secondary	secondary	forw	support	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_mn_10	BIO_11567062_mn_12	BIO_11567062_mn_10_12
BIO	11567062	mn	11	12	observation	conclusion	support	support	secondary	secondary	forw	support	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_mn_11	BIO_11567062_mn_12	BIO_11567062_mn_11_12
BIO	11567062	mn	12	11	conclusion	observation	support	support	secondary	secondary	back	support	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_mn_12	BIO_11567062_mn_11	BIO_11567062_mn_11_12
BIO	11591455	mn	1	2	motivation_background	proposal	support	none	secondary	main	forw	support	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	BIO_11591455_mn_1	BIO_11591455_mn_2	BIO_11591455_mn_1_2
BIO	11591455	mn	1	3	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	BIO_11591455_mn_1	BIO_11591455_mn_3	BIO_11591455_mn_1_3
BIO	11591455	mn	1	4	motivation_background	result	support	support	secondary	secondary	none	none	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	BIO_11591455_mn_1	BIO_11591455_mn_4	BIO_11591455_mn_1_4
BIO	11591455	mn	1	5	motivation_background	observation	support	support	secondary	secondary	none	none	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	BIO_11591455_mn_1	BIO_11591455_mn_5	BIO_11591455_mn_1_5
BIO	11591455	mn	1	6	motivation_background	observation	support	support	secondary	secondary	none	none	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	BIO_11591455_mn_1	BIO_11591455_mn_6	BIO_11591455_mn_1_6
BIO	11591455	mn	1	7	motivation_background	result	support	support	secondary	secondary	none	none	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_mn_1	BIO_11591455_mn_7	BIO_11591455_mn_1_7
BIO	11591455	mn	1	8	motivation_background	conclusion	support	support	secondary	secondary	none	none	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_mn_1	BIO_11591455_mn_8	BIO_11591455_mn_1_8
BIO	11591455	mn	2	3	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	BIO_11591455_mn_2	BIO_11591455_mn_3	BIO_11591455_mn_2_3
BIO	11591455	mn	2	4	proposal	result	none	support	main	secondary	back	support	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	BIO_11591455_mn_2	BIO_11591455_mn_4	BIO_11591455_mn_2_4
BIO	11591455	mn	2	5	proposal	observation	none	support	main	secondary	none	none	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	BIO_11591455_mn_2	BIO_11591455_mn_5	BIO_11591455_mn_2_5
BIO	11591455	mn	2	6	proposal	observation	none	support	main	secondary	none	none	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	BIO_11591455_mn_2	BIO_11591455_mn_6	BIO_11591455_mn_2_6
BIO	11591455	mn	2	7	proposal	result	none	support	main	secondary	back	support	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_mn_2	BIO_11591455_mn_7	BIO_11591455_mn_2_7
BIO	11591455	mn	2	8	proposal	conclusion	none	support	main	secondary	back	support	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_mn_2	BIO_11591455_mn_8	BIO_11591455_mn_2_8
BIO	11591455	mn	3	4	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	BIO_11591455_mn_3	BIO_11591455_mn_4	BIO_11591455_mn_3_4
BIO	11591455	mn	3	5	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	BIO_11591455_mn_3	BIO_11591455_mn_5	BIO_11591455_mn_3_5
BIO	11591455	mn	3	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	BIO_11591455_mn_3	BIO_11591455_mn_6	BIO_11591455_mn_3_6
BIO	11591455	mn	3	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_mn_3	BIO_11591455_mn_7	BIO_11591455_mn_3_7
BIO	11591455	mn	3	8	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_mn_3	BIO_11591455_mn_8	BIO_11591455_mn_3_8
BIO	11591455	mn	4	5	result	observation	support	support	secondary	secondary	back	support	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	BIO_11591455_mn_4	BIO_11591455_mn_5	BIO_11591455_mn_4_5
BIO	11591455	mn	4	6	result	observation	support	support	secondary	secondary	none	none	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	BIO_11591455_mn_4	BIO_11591455_mn_6	BIO_11591455_mn_4_6
BIO	11591455	mn	4	7	result	result	support	support	secondary	secondary	none	none	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_mn_4	BIO_11591455_mn_7	BIO_11591455_mn_4_7
BIO	11591455	mn	4	8	result	conclusion	support	support	secondary	secondary	none	none	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_mn_4	BIO_11591455_mn_8	BIO_11591455_mn_4_8
BIO	11591455	mn	5	6	observation	observation	support	support	secondary	secondary	none	none	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	BIO_11591455_mn_5	BIO_11591455_mn_6	BIO_11591455_mn_5_6
BIO	11591455	mn	5	7	observation	result	support	support	secondary	secondary	none	none	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_mn_5	BIO_11591455_mn_7	BIO_11591455_mn_5_7
BIO	11591455	mn	5	8	observation	conclusion	support	support	secondary	secondary	none	none	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_mn_5	BIO_11591455_mn_8	BIO_11591455_mn_5_8
BIO	11591455	mn	6	7	observation	result	support	support	secondary	secondary	forw	support	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_mn_6	BIO_11591455_mn_7	BIO_11591455_mn_6_7
BIO	11591455	mn	6	8	observation	conclusion	support	support	secondary	secondary	none	none	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_mn_6	BIO_11591455_mn_8	BIO_11591455_mn_6_8
BIO	11591455	mn	7	8	result	conclusion	support	support	secondary	secondary	none	none	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_mn_7	BIO_11591455_mn_8	BIO_11591455_mn_7_8
BIO	11591455	mn	8	7	conclusion	result	support	support	secondary	secondary	none	none	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_mn_8	BIO_11591455_mn_7	BIO_11591455_mn_7_8
BIO	11850540	mn	1	2	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	BIO_11850540_mn_1	BIO_11850540_mn_2	BIO_11850540_mn_1_2
BIO	11850540	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	BIO_11850540_mn_1	BIO_11850540_mn_3	BIO_11850540_mn_1_3
BIO	11850540	mn	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	BIO_11850540_mn_1	BIO_11850540_mn_4	BIO_11850540_mn_1_4
BIO	11850540	mn	1	5	motivation_background	result_means	info-required	elaboration	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	BIO_11850540_mn_1	BIO_11850540_mn_5	BIO_11850540_mn_1_5
BIO	11850540	mn	1	6	motivation_background	observation	info-required	support	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	BIO_11850540_mn_1	BIO_11850540_mn_6	BIO_11850540_mn_1_6
BIO	11850540	mn	1	7	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	There was no amplification in DH or normal ductal epithelium.	BIO_11850540_mn_1	BIO_11850540_mn_7	BIO_11850540_mn_1_7
BIO	11850540	mn	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_mn_1	BIO_11850540_mn_8	BIO_11850540_mn_1_8
BIO	11850540	mn	1	9	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_mn_1	BIO_11850540_mn_9	BIO_11850540_mn_1_9
BIO	11850540	mn	1	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_mn_1	BIO_11850540_mn_10	BIO_11850540_mn_1_10
BIO	11850540	mn	1	11	motivation_background	means	info-required	by-means	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_mn_1	BIO_11850540_mn_11	BIO_11850540_mn_1_11
BIO	11850540	mn	1	12	motivation_background	observation	info-required	support	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_mn_1	BIO_11850540_mn_12	BIO_11850540_mn_1_12
BIO	11850540	mn	1	13	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_mn_1	BIO_11850540_mn_13	BIO_11850540_mn_1_13
BIO	11850540	mn	1	14	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_1	BIO_11850540_mn_14	BIO_11850540_mn_1_14
BIO	11850540	mn	1	15	motivation_background	result	info-required	support	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_1	BIO_11850540_mn_15	BIO_11850540_mn_1_15
BIO	11850540	mn	1	16	motivation_background	result	info-required	support	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_1	BIO_11850540_mn_16	BIO_11850540_mn_1_16
BIO	11850540	mn	1	17	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_1	BIO_11850540_mn_17	BIO_11850540_mn_1_17
BIO	11850540	mn	2	3	motivation_problem	proposal	support	none	secondary	main	forw	support	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	BIO_11850540_mn_2	BIO_11850540_mn_3	BIO_11850540_mn_2_3
BIO	11850540	mn	2	4	motivation_problem	proposal_implementation	support	elaboration	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	BIO_11850540_mn_2	BIO_11850540_mn_4	BIO_11850540_mn_2_4
BIO	11850540	mn	2	5	motivation_problem	result_means	support	elaboration	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	BIO_11850540_mn_2	BIO_11850540_mn_5	BIO_11850540_mn_2_5
BIO	11850540	mn	2	6	motivation_problem	observation	support	support	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	BIO_11850540_mn_2	BIO_11850540_mn_6	BIO_11850540_mn_2_6
BIO	11850540	mn	2	7	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	There was no amplification in DH or normal ductal epithelium.	BIO_11850540_mn_2	BIO_11850540_mn_7	BIO_11850540_mn_2_7
BIO	11850540	mn	2	8	motivation_problem	observation	support	support	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_mn_2	BIO_11850540_mn_8	BIO_11850540_mn_2_8
BIO	11850540	mn	2	9	motivation_problem	result	support	elaboration	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_mn_2	BIO_11850540_mn_9	BIO_11850540_mn_2_9
BIO	11850540	mn	2	10	motivation_problem	observation	support	support	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_mn_2	BIO_11850540_mn_10	BIO_11850540_mn_2_10
BIO	11850540	mn	2	11	motivation_problem	means	support	by-means	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_mn_2	BIO_11850540_mn_11	BIO_11850540_mn_2_11
BIO	11850540	mn	2	12	motivation_problem	observation	support	support	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_mn_2	BIO_11850540_mn_12	BIO_11850540_mn_2_12
BIO	11850540	mn	2	13	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_mn_2	BIO_11850540_mn_13	BIO_11850540_mn_2_13
BIO	11850540	mn	2	14	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_2	BIO_11850540_mn_14	BIO_11850540_mn_2_14
BIO	11850540	mn	2	15	motivation_problem	result	support	support	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_2	BIO_11850540_mn_15	BIO_11850540_mn_2_15
BIO	11850540	mn	2	16	motivation_problem	result	support	support	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_2	BIO_11850540_mn_16	BIO_11850540_mn_2_16
BIO	11850540	mn	2	17	motivation_problem	conclusion	support	support	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_2	BIO_11850540_mn_17	BIO_11850540_mn_2_17
BIO	11850540	mn	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	BIO_11850540_mn_3	BIO_11850540_mn_4	BIO_11850540_mn_3_4
BIO	11850540	mn	3	5	proposal	result_means	none	elaboration	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	BIO_11850540_mn_3	BIO_11850540_mn_5	BIO_11850540_mn_3_5
BIO	11850540	mn	3	6	proposal	observation	none	support	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	BIO_11850540_mn_3	BIO_11850540_mn_6	BIO_11850540_mn_3_6
BIO	11850540	mn	3	7	proposal	observation	none	elaboration	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	There was no amplification in DH or normal ductal epithelium.	BIO_11850540_mn_3	BIO_11850540_mn_7	BIO_11850540_mn_3_7
BIO	11850540	mn	3	8	proposal	observation	none	support	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_mn_3	BIO_11850540_mn_8	BIO_11850540_mn_3_8
BIO	11850540	mn	3	9	proposal	result	none	elaboration	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_mn_3	BIO_11850540_mn_9	BIO_11850540_mn_3_9
BIO	11850540	mn	3	10	proposal	observation	none	support	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_mn_3	BIO_11850540_mn_10	BIO_11850540_mn_3_10
BIO	11850540	mn	3	11	proposal	means	none	by-means	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_mn_3	BIO_11850540_mn_11	BIO_11850540_mn_3_11
BIO	11850540	mn	3	12	proposal	observation	none	support	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_mn_3	BIO_11850540_mn_12	BIO_11850540_mn_3_12
BIO	11850540	mn	3	13	proposal	observation	none	elaboration	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_mn_3	BIO_11850540_mn_13	BIO_11850540_mn_3_13
BIO	11850540	mn	3	14	proposal	observation	none	elaboration	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_3	BIO_11850540_mn_14	BIO_11850540_mn_3_14
BIO	11850540	mn	3	15	proposal	result	none	support	main	secondary	back	support	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_3	BIO_11850540_mn_15	BIO_11850540_mn_3_15
BIO	11850540	mn	3	16	proposal	result	none	support	main	secondary	back	support	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_3	BIO_11850540_mn_16	BIO_11850540_mn_3_16
BIO	11850540	mn	3	17	proposal	conclusion	none	support	main	secondary	back	support	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_3	BIO_11850540_mn_17	BIO_11850540_mn_3_17
BIO	11850540	mn	4	5	proposal_implementation	result_means	elaboration	elaboration	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	BIO_11850540_mn_4	BIO_11850540_mn_5	BIO_11850540_mn_4_5
BIO	11850540	mn	4	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	BIO_11850540_mn_4	BIO_11850540_mn_6	BIO_11850540_mn_4_6
BIO	11850540	mn	4	7	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	There was no amplification in DH or normal ductal epithelium.	BIO_11850540_mn_4	BIO_11850540_mn_7	BIO_11850540_mn_4_7
BIO	11850540	mn	4	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_mn_4	BIO_11850540_mn_8	BIO_11850540_mn_4_8
BIO	11850540	mn	4	9	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_mn_4	BIO_11850540_mn_9	BIO_11850540_mn_4_9
BIO	11850540	mn	4	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_mn_4	BIO_11850540_mn_10	BIO_11850540_mn_4_10
BIO	11850540	mn	4	11	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_mn_4	BIO_11850540_mn_11	BIO_11850540_mn_4_11
BIO	11850540	mn	4	12	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_mn_4	BIO_11850540_mn_12	BIO_11850540_mn_4_12
BIO	11850540	mn	4	13	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_mn_4	BIO_11850540_mn_13	BIO_11850540_mn_4_13
BIO	11850540	mn	4	14	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_4	BIO_11850540_mn_14	BIO_11850540_mn_4_14
BIO	11850540	mn	4	15	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_4	BIO_11850540_mn_15	BIO_11850540_mn_4_15
BIO	11850540	mn	4	16	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_4	BIO_11850540_mn_16	BIO_11850540_mn_4_16
BIO	11850540	mn	4	17	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_4	BIO_11850540_mn_17	BIO_11850540_mn_4_17
BIO	11850540	mn	5	6	result_means	observation	elaboration	support	secondary	secondary	back	support	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	BIO_11850540_mn_5	BIO_11850540_mn_6	BIO_11850540_mn_5_6
BIO	11850540	mn	5	7	result_means	observation	elaboration	elaboration	secondary	secondary	back	elaboration	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	There was no amplification in DH or normal ductal epithelium.	BIO_11850540_mn_5	BIO_11850540_mn_7	BIO_11850540_mn_5_7
BIO	11850540	mn	5	8	result_means	observation	elaboration	support	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_mn_5	BIO_11850540_mn_8	BIO_11850540_mn_5_8
BIO	11850540	mn	5	9	result_means	result	elaboration	elaboration	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_mn_5	BIO_11850540_mn_9	BIO_11850540_mn_5_9
BIO	11850540	mn	5	10	result_means	observation	elaboration	support	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_mn_5	BIO_11850540_mn_10	BIO_11850540_mn_5_10
BIO	11850540	mn	5	11	result_means	means	elaboration	by-means	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_mn_5	BIO_11850540_mn_11	BIO_11850540_mn_5_11
BIO	11850540	mn	5	12	result_means	observation	elaboration	support	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_mn_5	BIO_11850540_mn_12	BIO_11850540_mn_5_12
BIO	11850540	mn	5	13	result_means	observation	elaboration	elaboration	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_mn_5	BIO_11850540_mn_13	BIO_11850540_mn_5_13
BIO	11850540	mn	5	14	result_means	observation	elaboration	elaboration	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_5	BIO_11850540_mn_14	BIO_11850540_mn_5_14
BIO	11850540	mn	5	15	result_means	result	elaboration	support	secondary	secondary	forw	elaboration	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_5	BIO_11850540_mn_15	BIO_11850540_mn_5_15
BIO	11850540	mn	5	16	result_means	result	elaboration	support	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_5	BIO_11850540_mn_16	BIO_11850540_mn_5_16
BIO	11850540	mn	5	17	result_means	conclusion	elaboration	support	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_5	BIO_11850540_mn_17	BIO_11850540_mn_5_17
BIO	11850540	mn	6	7	observation	observation	support	elaboration	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	There was no amplification in DH or normal ductal epithelium.	BIO_11850540_mn_6	BIO_11850540_mn_7	BIO_11850540_mn_6_7
BIO	11850540	mn	6	8	observation	observation	support	support	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_mn_6	BIO_11850540_mn_8	BIO_11850540_mn_6_8
BIO	11850540	mn	6	9	observation	result	support	elaboration	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_mn_6	BIO_11850540_mn_9	BIO_11850540_mn_6_9
BIO	11850540	mn	6	10	observation	observation	support	support	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_mn_6	BIO_11850540_mn_10	BIO_11850540_mn_6_10
BIO	11850540	mn	6	11	observation	means	support	by-means	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_mn_6	BIO_11850540_mn_11	BIO_11850540_mn_6_11
BIO	11850540	mn	6	12	observation	observation	support	support	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_mn_6	BIO_11850540_mn_12	BIO_11850540_mn_6_12
BIO	11850540	mn	6	13	observation	observation	support	elaboration	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_mn_6	BIO_11850540_mn_13	BIO_11850540_mn_6_13
BIO	11850540	mn	6	14	observation	observation	support	elaboration	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_6	BIO_11850540_mn_14	BIO_11850540_mn_6_14
BIO	11850540	mn	6	15	observation	result	support	support	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_6	BIO_11850540_mn_15	BIO_11850540_mn_6_15
BIO	11850540	mn	6	16	observation	result	support	support	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_6	BIO_11850540_mn_16	BIO_11850540_mn_6_16
BIO	11850540	mn	6	17	observation	conclusion	support	support	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_6	BIO_11850540_mn_17	BIO_11850540_mn_6_17
BIO	11850540	mn	7	8	observation	observation	elaboration	support	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_mn_7	BIO_11850540_mn_8	BIO_11850540_mn_7_8
BIO	11850540	mn	7	9	observation	result	elaboration	elaboration	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_mn_7	BIO_11850540_mn_9	BIO_11850540_mn_7_9
BIO	11850540	mn	7	10	observation	observation	elaboration	support	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_mn_7	BIO_11850540_mn_10	BIO_11850540_mn_7_10
BIO	11850540	mn	7	11	observation	means	elaboration	by-means	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_mn_7	BIO_11850540_mn_11	BIO_11850540_mn_7_11
BIO	11850540	mn	7	12	observation	observation	elaboration	support	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_mn_7	BIO_11850540_mn_12	BIO_11850540_mn_7_12
BIO	11850540	mn	7	13	observation	observation	elaboration	elaboration	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_mn_7	BIO_11850540_mn_13	BIO_11850540_mn_7_13
BIO	11850540	mn	7	14	observation	observation	elaboration	elaboration	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_7	BIO_11850540_mn_14	BIO_11850540_mn_7_14
BIO	11850540	mn	7	15	observation	result	elaboration	support	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_7	BIO_11850540_mn_15	BIO_11850540_mn_7_15
BIO	11850540	mn	7	16	observation	result	elaboration	support	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_7	BIO_11850540_mn_16	BIO_11850540_mn_7_16
BIO	11850540	mn	7	17	observation	conclusion	elaboration	support	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_7	BIO_11850540_mn_17	BIO_11850540_mn_7_17
BIO	11850540	mn	8	9	observation	result	support	elaboration	secondary	secondary	forw	support	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_mn_8	BIO_11850540_mn_9	BIO_11850540_mn_8_9
BIO	11850540	mn	8	10	observation	observation	support	support	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_mn_8	BIO_11850540_mn_10	BIO_11850540_mn_8_10
BIO	11850540	mn	8	11	observation	means	support	by-means	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_mn_8	BIO_11850540_mn_11	BIO_11850540_mn_8_11
BIO	11850540	mn	8	12	observation	observation	support	support	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_mn_8	BIO_11850540_mn_12	BIO_11850540_mn_8_12
BIO	11850540	mn	8	13	observation	observation	support	elaboration	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_mn_8	BIO_11850540_mn_13	BIO_11850540_mn_8_13
BIO	11850540	mn	8	14	observation	observation	support	elaboration	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_8	BIO_11850540_mn_14	BIO_11850540_mn_8_14
BIO	11850540	mn	8	15	observation	result	support	support	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_8	BIO_11850540_mn_15	BIO_11850540_mn_8_15
BIO	11850540	mn	8	16	observation	result	support	support	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_8	BIO_11850540_mn_16	BIO_11850540_mn_8_16
BIO	11850540	mn	8	17	observation	conclusion	support	support	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_8	BIO_11850540_mn_17	BIO_11850540_mn_8_17
BIO	11850540	mn	9	10	result	observation	elaboration	support	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_mn_9	BIO_11850540_mn_10	BIO_11850540_mn_9_10
BIO	11850540	mn	9	11	result	means	elaboration	by-means	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_mn_9	BIO_11850540_mn_11	BIO_11850540_mn_9_11
BIO	11850540	mn	9	12	result	observation	elaboration	support	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_mn_9	BIO_11850540_mn_12	BIO_11850540_mn_9_12
BIO	11850540	mn	9	13	result	observation	elaboration	elaboration	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_mn_9	BIO_11850540_mn_13	BIO_11850540_mn_9_13
BIO	11850540	mn	9	14	result	observation	elaboration	elaboration	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_9	BIO_11850540_mn_14	BIO_11850540_mn_9_14
BIO	11850540	mn	9	15	result	result	elaboration	support	secondary	secondary	forw	elaboration	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_9	BIO_11850540_mn_15	BIO_11850540_mn_9_15
BIO	11850540	mn	9	16	result	result	elaboration	support	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_9	BIO_11850540_mn_16	BIO_11850540_mn_9_16
BIO	11850540	mn	9	17	result	conclusion	elaboration	support	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_9	BIO_11850540_mn_17	BIO_11850540_mn_9_17
BIO	11850540	mn	10	11	observation	means	support	by-means	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_mn_10	BIO_11850540_mn_11	BIO_11850540_mn_10_11
BIO	11850540	mn	10	12	observation	observation	support	support	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_mn_10	BIO_11850540_mn_12	BIO_11850540_mn_10_12
BIO	11850540	mn	10	13	observation	observation	support	elaboration	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_mn_10	BIO_11850540_mn_13	BIO_11850540_mn_10_13
BIO	11850540	mn	10	14	observation	observation	support	elaboration	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_10	BIO_11850540_mn_14	BIO_11850540_mn_10_14
BIO	11850540	mn	10	15	observation	result	support	support	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_10	BIO_11850540_mn_15	BIO_11850540_mn_10_15
BIO	11850540	mn	10	16	observation	result	support	support	secondary	secondary	forw	support	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_10	BIO_11850540_mn_16	BIO_11850540_mn_10_16
BIO	11850540	mn	10	17	observation	conclusion	support	support	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_10	BIO_11850540_mn_17	BIO_11850540_mn_10_17
BIO	11850540	mn	11	12	means	observation	by-means	support	secondary	secondary	none	none	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_mn_11	BIO_11850540_mn_12	BIO_11850540_mn_11_12
BIO	11850540	mn	11	13	means	observation	by-means	elaboration	secondary	secondary	none	none	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_mn_11	BIO_11850540_mn_13	BIO_11850540_mn_11_13
BIO	11850540	mn	11	14	means	observation	by-means	elaboration	secondary	secondary	none	none	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_11	BIO_11850540_mn_14	BIO_11850540_mn_11_14
BIO	11850540	mn	11	15	means	result	by-means	support	secondary	secondary	forw	by-means	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_11	BIO_11850540_mn_15	BIO_11850540_mn_11_15
BIO	11850540	mn	11	16	means	result	by-means	support	secondary	secondary	none	none	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_11	BIO_11850540_mn_16	BIO_11850540_mn_11_16
BIO	11850540	mn	11	17	means	conclusion	by-means	support	secondary	secondary	none	none	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_11	BIO_11850540_mn_17	BIO_11850540_mn_11_17
BIO	11850540	mn	12	13	observation	observation	support	elaboration	secondary	secondary	back	elaboration	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_mn_12	BIO_11850540_mn_13	BIO_11850540_mn_12_13
BIO	11850540	mn	12	14	observation	observation	support	elaboration	secondary	secondary	back	elaboration	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_12	BIO_11850540_mn_14	BIO_11850540_mn_12_14
BIO	11850540	mn	12	15	observation	result	support	support	secondary	secondary	forw	support	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_12	BIO_11850540_mn_15	BIO_11850540_mn_12_15
BIO	11850540	mn	12	16	observation	result	support	support	secondary	secondary	none	none	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_12	BIO_11850540_mn_16	BIO_11850540_mn_12_16
BIO	11850540	mn	12	17	observation	conclusion	support	support	secondary	secondary	none	none	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_12	BIO_11850540_mn_17	BIO_11850540_mn_12_17
BIO	11850540	mn	13	14	observation	observation	elaboration	elaboration	secondary	secondary	none	none	One patient had amplification in the primary tumor but not in an axillary metastasis.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_mn_13	BIO_11850540_mn_14	BIO_11850540_mn_13_14
BIO	11850540	mn	13	15	observation	result	elaboration	support	secondary	secondary	none	none	One patient had amplification in the primary tumor but not in an axillary metastasis.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_13	BIO_11850540_mn_15	BIO_11850540_mn_13_15
BIO	11850540	mn	13	16	observation	result	elaboration	support	secondary	secondary	none	none	One patient had amplification in the primary tumor but not in an axillary metastasis.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_13	BIO_11850540_mn_16	BIO_11850540_mn_13_16
BIO	11850540	mn	13	17	observation	conclusion	elaboration	support	secondary	secondary	none	none	One patient had amplification in the primary tumor but not in an axillary metastasis.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_13	BIO_11850540_mn_17	BIO_11850540_mn_13_17
BIO	11850540	mn	14	15	observation	result	elaboration	support	secondary	secondary	none	none	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_mn_14	BIO_11850540_mn_15	BIO_11850540_mn_14_15
BIO	11850540	mn	14	16	observation	result	elaboration	support	secondary	secondary	none	none	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_14	BIO_11850540_mn_16	BIO_11850540_mn_14_16
BIO	11850540	mn	14	17	observation	conclusion	elaboration	support	secondary	secondary	none	none	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_14	BIO_11850540_mn_17	BIO_11850540_mn_14_17
BIO	11850540	mn	15	16	result	result	support	support	secondary	secondary	none	none	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_15	BIO_11850540_mn_16	BIO_11850540_mn_15_16
BIO	11850540	mn	15	17	result	conclusion	support	support	secondary	secondary	none	none	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_15	BIO_11850540_mn_17	BIO_11850540_mn_15_17
BIO	11850540	mn	16	17	result	conclusion	support	support	secondary	secondary	none	none	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_mn_16	BIO_11850540_mn_17	BIO_11850540_mn_16_17
BIO	11850540	mn	17	16	conclusion	result	support	support	secondary	secondary	none	none	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_mn_17	BIO_11850540_mn_16	BIO_11850540_mn_16_17
BIO	11860483	mn	1	2	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	BIO_11860483_mn_1	BIO_11860483_mn_2	BIO_11860483_mn_1_2
BIO	11860483	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	BIO_11860483_mn_1	BIO_11860483_mn_3	BIO_11860483_mn_1_3
BIO	11860483	mn	1	4	motivation_background	result_means	info-required	support	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	BIO_11860483_mn_1	BIO_11860483_mn_4	BIO_11860483_mn_1_4
BIO	11860483	mn	1	5	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	BIO_11860483_mn_1	BIO_11860483_mn_5	BIO_11860483_mn_1_5
BIO	11860483	mn	1	6	motivation_background	information_additional	info-required	info-optional	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	As in previous EEG studies, we found that, on average, correlation decreased during movements.	BIO_11860483_mn_1	BIO_11860483_mn_6	BIO_11860483_mn_1_6
BIO	11860483	mn	1	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	BIO_11860483_mn_1	BIO_11860483_mn_7	BIO_11860483_mn_1_7
BIO	11860483	mn	1	8	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_mn_1	BIO_11860483_mn_8	BIO_11860483_mn_1_8
BIO	11860483	mn	1	9	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_mn_1	BIO_11860483_mn_9	BIO_11860483_mn_1_9
BIO	11860483	mn	1	10	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_mn_1	BIO_11860483_mn_10	BIO_11860483_mn_1_10
BIO	11860483	mn	1	11	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_mn_1	BIO_11860483_mn_11	BIO_11860483_mn_1_11
BIO	11860483	mn	2	3	motivation_problem	proposal	support	none	secondary	main	forw	support	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	BIO_11860483_mn_2	BIO_11860483_mn_3	BIO_11860483_mn_2_3
BIO	11860483	mn	2	4	motivation_problem	result_means	support	support	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	BIO_11860483_mn_2	BIO_11860483_mn_4	BIO_11860483_mn_2_4
BIO	11860483	mn	2	5	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	BIO_11860483_mn_2	BIO_11860483_mn_5	BIO_11860483_mn_2_5
BIO	11860483	mn	2	6	motivation_problem	information_additional	support	info-optional	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	As in previous EEG studies, we found that, on average, correlation decreased during movements.	BIO_11860483_mn_2	BIO_11860483_mn_6	BIO_11860483_mn_2_6
BIO	11860483	mn	2	7	motivation_problem	observation	support	support	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	BIO_11860483_mn_2	BIO_11860483_mn_7	BIO_11860483_mn_2_7
BIO	11860483	mn	2	8	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_mn_2	BIO_11860483_mn_8	BIO_11860483_mn_2_8
BIO	11860483	mn	2	9	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_mn_2	BIO_11860483_mn_9	BIO_11860483_mn_2_9
BIO	11860483	mn	2	10	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_mn_2	BIO_11860483_mn_10	BIO_11860483_mn_2_10
BIO	11860483	mn	2	11	motivation_problem	result	support	elaboration	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_mn_2	BIO_11860483_mn_11	BIO_11860483_mn_2_11
BIO	11860483	mn	3	4	proposal	result_means	none	support	main	secondary	back	support	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	BIO_11860483_mn_3	BIO_11860483_mn_4	BIO_11860483_mn_3_4
BIO	11860483	mn	3	5	proposal	observation	none	elaboration	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	BIO_11860483_mn_3	BIO_11860483_mn_5	BIO_11860483_mn_3_5
BIO	11860483	mn	3	6	proposal	information_additional	none	info-optional	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	As in previous EEG studies, we found that, on average, correlation decreased during movements.	BIO_11860483_mn_3	BIO_11860483_mn_6	BIO_11860483_mn_3_6
BIO	11860483	mn	3	7	proposal	observation	none	support	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	BIO_11860483_mn_3	BIO_11860483_mn_7	BIO_11860483_mn_3_7
BIO	11860483	mn	3	8	proposal	observation	none	elaboration	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_mn_3	BIO_11860483_mn_8	BIO_11860483_mn_3_8
BIO	11860483	mn	3	9	proposal	observation	none	elaboration	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_mn_3	BIO_11860483_mn_9	BIO_11860483_mn_3_9
BIO	11860483	mn	3	10	proposal	observation	none	elaboration	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_mn_3	BIO_11860483_mn_10	BIO_11860483_mn_3_10
BIO	11860483	mn	3	11	proposal	result	none	elaboration	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_mn_3	BIO_11860483_mn_11	BIO_11860483_mn_3_11
BIO	11860483	mn	4	5	result_means	observation	support	elaboration	secondary	secondary	back	elaboration	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	BIO_11860483_mn_4	BIO_11860483_mn_5	BIO_11860483_mn_4_5
BIO	11860483	mn	4	6	result_means	information_additional	support	info-optional	secondary	secondary	none	none	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	As in previous EEG studies, we found that, on average, correlation decreased during movements.	BIO_11860483_mn_4	BIO_11860483_mn_6	BIO_11860483_mn_4_6
BIO	11860483	mn	4	7	result_means	observation	support	support	secondary	secondary	back	support	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	BIO_11860483_mn_4	BIO_11860483_mn_7	BIO_11860483_mn_4_7
BIO	11860483	mn	4	8	result_means	observation	support	elaboration	secondary	secondary	none	none	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_mn_4	BIO_11860483_mn_8	BIO_11860483_mn_4_8
BIO	11860483	mn	4	9	result_means	observation	support	elaboration	secondary	secondary	back	elaboration	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_mn_4	BIO_11860483_mn_9	BIO_11860483_mn_4_9
BIO	11860483	mn	4	10	result_means	observation	support	elaboration	secondary	secondary	none	none	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_mn_4	BIO_11860483_mn_10	BIO_11860483_mn_4_10
BIO	11860483	mn	4	11	result_means	result	support	elaboration	secondary	secondary	back	elaboration	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_mn_4	BIO_11860483_mn_11	BIO_11860483_mn_4_11
BIO	11860483	mn	5	6	observation	information_additional	elaboration	info-optional	secondary	secondary	none	none	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	As in previous EEG studies, we found that, on average, correlation decreased during movements.	BIO_11860483_mn_5	BIO_11860483_mn_6	BIO_11860483_mn_5_6
BIO	11860483	mn	5	7	observation	observation	elaboration	support	secondary	secondary	none	none	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	BIO_11860483_mn_5	BIO_11860483_mn_7	BIO_11860483_mn_5_7
BIO	11860483	mn	5	8	observation	observation	elaboration	elaboration	secondary	secondary	none	none	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_mn_5	BIO_11860483_mn_8	BIO_11860483_mn_5_8
BIO	11860483	mn	5	9	observation	observation	elaboration	elaboration	secondary	secondary	none	none	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_mn_5	BIO_11860483_mn_9	BIO_11860483_mn_5_9
BIO	11860483	mn	5	10	observation	observation	elaboration	elaboration	secondary	secondary	none	none	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_mn_5	BIO_11860483_mn_10	BIO_11860483_mn_5_10
BIO	11860483	mn	5	11	observation	result	elaboration	elaboration	secondary	secondary	none	none	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_mn_5	BIO_11860483_mn_11	BIO_11860483_mn_5_11
BIO	11860483	mn	6	7	information_additional	observation	info-optional	support	secondary	secondary	forw	info-optional	As in previous EEG studies, we found that, on average, correlation decreased during movements.	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	BIO_11860483_mn_6	BIO_11860483_mn_7	BIO_11860483_mn_6_7
BIO	11860483	mn	6	8	information_additional	observation	info-optional	elaboration	secondary	secondary	none	none	As in previous EEG studies, we found that, on average, correlation decreased during movements.	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_mn_6	BIO_11860483_mn_8	BIO_11860483_mn_6_8
BIO	11860483	mn	6	9	information_additional	observation	info-optional	elaboration	secondary	secondary	none	none	As in previous EEG studies, we found that, on average, correlation decreased during movements.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_mn_6	BIO_11860483_mn_9	BIO_11860483_mn_6_9
BIO	11860483	mn	6	10	information_additional	observation	info-optional	elaboration	secondary	secondary	none	none	As in previous EEG studies, we found that, on average, correlation decreased during movements.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_mn_6	BIO_11860483_mn_10	BIO_11860483_mn_6_10
BIO	11860483	mn	6	11	information_additional	result	info-optional	elaboration	secondary	secondary	none	none	As in previous EEG studies, we found that, on average, correlation decreased during movements.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_mn_6	BIO_11860483_mn_11	BIO_11860483_mn_6_11
BIO	11860483	mn	7	8	observation	observation	support	elaboration	secondary	secondary	back	elaboration	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_mn_7	BIO_11860483_mn_8	BIO_11860483_mn_7_8
BIO	11860483	mn	7	9	observation	observation	support	elaboration	secondary	secondary	none	none	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_mn_7	BIO_11860483_mn_9	BIO_11860483_mn_7_9
BIO	11860483	mn	7	10	observation	observation	support	elaboration	secondary	secondary	none	none	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_mn_7	BIO_11860483_mn_10	BIO_11860483_mn_7_10
BIO	11860483	mn	7	11	observation	result	support	elaboration	secondary	secondary	none	none	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_mn_7	BIO_11860483_mn_11	BIO_11860483_mn_7_11
BIO	11860483	mn	8	9	observation	observation	elaboration	elaboration	secondary	secondary	none	none	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_mn_8	BIO_11860483_mn_9	BIO_11860483_mn_8_9
BIO	11860483	mn	8	10	observation	observation	elaboration	elaboration	secondary	secondary	none	none	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_mn_8	BIO_11860483_mn_10	BIO_11860483_mn_8_10
BIO	11860483	mn	8	11	observation	result	elaboration	elaboration	secondary	secondary	none	none	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_mn_8	BIO_11860483_mn_11	BIO_11860483_mn_8_11
BIO	11860483	mn	9	10	observation	observation	elaboration	elaboration	secondary	secondary	back	elaboration	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_mn_9	BIO_11860483_mn_10	BIO_11860483_mn_9_10
BIO	11860483	mn	9	11	observation	result	elaboration	elaboration	secondary	secondary	none	none	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_mn_9	BIO_11860483_mn_11	BIO_11860483_mn_9_11
BIO	11860483	mn	10	11	observation	result	elaboration	elaboration	secondary	secondary	none	none	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_mn_10	BIO_11860483_mn_11	BIO_11860483_mn_10_11
BIO	11860483	mn	11	10	result	observation	elaboration	elaboration	secondary	secondary	none	none	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_mn_11	BIO_11860483_mn_10	BIO_11860483_mn_10_11
BIO	11978821	mn	1	2	motivation_background	proposal	support	none	secondary	main	forw	support	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	BIO_11978821_mn_1	BIO_11978821_mn_2	BIO_11978821_mn_1_2
BIO	11978821	mn	1	3	motivation_background	information_additional	support	info-optional	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	BIO_11978821_mn_1	BIO_11978821_mn_3	BIO_11978821_mn_1_3
BIO	11978821	mn	1	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	BIO_11978821_mn_1	BIO_11978821_mn_4	BIO_11978821_mn_1_4
BIO	11978821	mn	1	5	motivation_background	result	support	support	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	BIO_11978821_mn_1	BIO_11978821_mn_5	BIO_11978821_mn_1_5
BIO	11978821	mn	1	6	motivation_background	observation	support	support	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	BIO_11978821_mn_1	BIO_11978821_mn_6	BIO_11978821_mn_1_6
BIO	11978821	mn	1	7	motivation_background	observation	support	elaboration	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	BIO_11978821_mn_1	BIO_11978821_mn_7	BIO_11978821_mn_1_7
BIO	11978821	mn	1	8	motivation_background	observation	support	support	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_mn_1	BIO_11978821_mn_8	BIO_11978821_mn_1_8
BIO	11978821	mn	1	9	motivation_background	conclusion	support	support	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_mn_1	BIO_11978821_mn_9	BIO_11978821_mn_1_9
BIO	11978821	mn	1	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_mn_1	BIO_11978821_mn_10	BIO_11978821_mn_1_10
BIO	11978821	mn	1	11	motivation_background	conclusion	support	support	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_mn_1	BIO_11978821_mn_11	BIO_11978821_mn_1_11
BIO	11978821	mn	1	12	motivation_background	conclusion	support	support	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_mn_1	BIO_11978821_mn_12	BIO_11978821_mn_1_12
BIO	11978821	mn	2	3	proposal	information_additional	none	info-optional	main	secondary	back	info-optional	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	BIO_11978821_mn_2	BIO_11978821_mn_3	BIO_11978821_mn_2_3
BIO	11978821	mn	2	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	BIO_11978821_mn_2	BIO_11978821_mn_4	BIO_11978821_mn_2_4
BIO	11978821	mn	2	5	proposal	result	none	support	main	secondary	back	support	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	BIO_11978821_mn_2	BIO_11978821_mn_5	BIO_11978821_mn_2_5
BIO	11978821	mn	2	6	proposal	observation	none	support	main	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	BIO_11978821_mn_2	BIO_11978821_mn_6	BIO_11978821_mn_2_6
BIO	11978821	mn	2	7	proposal	observation	none	elaboration	main	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	BIO_11978821_mn_2	BIO_11978821_mn_7	BIO_11978821_mn_2_7
BIO	11978821	mn	2	8	proposal	observation	none	support	main	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_mn_2	BIO_11978821_mn_8	BIO_11978821_mn_2_8
BIO	11978821	mn	2	9	proposal	conclusion	none	support	main	secondary	back	support	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_mn_2	BIO_11978821_mn_9	BIO_11978821_mn_2_9
BIO	11978821	mn	2	10	proposal	conclusion	none	support	main	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_mn_2	BIO_11978821_mn_10	BIO_11978821_mn_2_10
BIO	11978821	mn	2	11	proposal	conclusion	none	support	main	secondary	back	support	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_mn_2	BIO_11978821_mn_11	BIO_11978821_mn_2_11
BIO	11978821	mn	2	12	proposal	conclusion	none	support	main	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_mn_2	BIO_11978821_mn_12	BIO_11978821_mn_2_12
BIO	11978821	mn	3	4	information_additional	proposal_implementation	info-optional	elaboration	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	BIO_11978821_mn_3	BIO_11978821_mn_4	BIO_11978821_mn_3_4
BIO	11978821	mn	3	5	information_additional	result	info-optional	support	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	BIO_11978821_mn_3	BIO_11978821_mn_5	BIO_11978821_mn_3_5
BIO	11978821	mn	3	6	information_additional	observation	info-optional	support	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	BIO_11978821_mn_3	BIO_11978821_mn_6	BIO_11978821_mn_3_6
BIO	11978821	mn	3	7	information_additional	observation	info-optional	elaboration	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	BIO_11978821_mn_3	BIO_11978821_mn_7	BIO_11978821_mn_3_7
BIO	11978821	mn	3	8	information_additional	observation	info-optional	support	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_mn_3	BIO_11978821_mn_8	BIO_11978821_mn_3_8
BIO	11978821	mn	3	9	information_additional	conclusion	info-optional	support	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_mn_3	BIO_11978821_mn_9	BIO_11978821_mn_3_9
BIO	11978821	mn	3	10	information_additional	conclusion	info-optional	support	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_mn_3	BIO_11978821_mn_10	BIO_11978821_mn_3_10
BIO	11978821	mn	3	11	information_additional	conclusion	info-optional	support	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_mn_3	BIO_11978821_mn_11	BIO_11978821_mn_3_11
BIO	11978821	mn	3	12	information_additional	conclusion	info-optional	support	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_mn_3	BIO_11978821_mn_12	BIO_11978821_mn_3_12
BIO	11978821	mn	4	5	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	BIO_11978821_mn_4	BIO_11978821_mn_5	BIO_11978821_mn_4_5
BIO	11978821	mn	4	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	BIO_11978821_mn_4	BIO_11978821_mn_6	BIO_11978821_mn_4_6
BIO	11978821	mn	4	7	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	BIO_11978821_mn_4	BIO_11978821_mn_7	BIO_11978821_mn_4_7
BIO	11978821	mn	4	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_mn_4	BIO_11978821_mn_8	BIO_11978821_mn_4_8
BIO	11978821	mn	4	9	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_mn_4	BIO_11978821_mn_9	BIO_11978821_mn_4_9
BIO	11978821	mn	4	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_mn_4	BIO_11978821_mn_10	BIO_11978821_mn_4_10
BIO	11978821	mn	4	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_mn_4	BIO_11978821_mn_11	BIO_11978821_mn_4_11
BIO	11978821	mn	4	12	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_mn_4	BIO_11978821_mn_12	BIO_11978821_mn_4_12
BIO	11978821	mn	5	6	result	observation	support	support	secondary	secondary	back	support	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	BIO_11978821_mn_5	BIO_11978821_mn_6	BIO_11978821_mn_5_6
BIO	11978821	mn	5	7	result	observation	support	elaboration	secondary	secondary	none	none	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	BIO_11978821_mn_5	BIO_11978821_mn_7	BIO_11978821_mn_5_7
BIO	11978821	mn	5	8	result	observation	support	support	secondary	secondary	back	support	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_mn_5	BIO_11978821_mn_8	BIO_11978821_mn_5_8
BIO	11978821	mn	5	9	result	conclusion	support	support	secondary	secondary	none	none	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_mn_5	BIO_11978821_mn_9	BIO_11978821_mn_5_9
BIO	11978821	mn	5	10	result	conclusion	support	support	secondary	secondary	none	none	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_mn_5	BIO_11978821_mn_10	BIO_11978821_mn_5_10
BIO	11978821	mn	5	11	result	conclusion	support	support	secondary	secondary	none	none	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_mn_5	BIO_11978821_mn_11	BIO_11978821_mn_5_11
BIO	11978821	mn	5	12	result	conclusion	support	support	secondary	secondary	none	none	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_mn_5	BIO_11978821_mn_12	BIO_11978821_mn_5_12
BIO	11978821	mn	6	7	observation	observation	support	elaboration	secondary	secondary	back	elaboration	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	BIO_11978821_mn_6	BIO_11978821_mn_7	BIO_11978821_mn_6_7
BIO	11978821	mn	6	8	observation	observation	support	support	secondary	secondary	none	none	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_mn_6	BIO_11978821_mn_8	BIO_11978821_mn_6_8
BIO	11978821	mn	6	9	observation	conclusion	support	support	secondary	secondary	none	none	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_mn_6	BIO_11978821_mn_9	BIO_11978821_mn_6_9
BIO	11978821	mn	6	10	observation	conclusion	support	support	secondary	secondary	none	none	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_mn_6	BIO_11978821_mn_10	BIO_11978821_mn_6_10
BIO	11978821	mn	6	11	observation	conclusion	support	support	secondary	secondary	none	none	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_mn_6	BIO_11978821_mn_11	BIO_11978821_mn_6_11
BIO	11978821	mn	6	12	observation	conclusion	support	support	secondary	secondary	none	none	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_mn_6	BIO_11978821_mn_12	BIO_11978821_mn_6_12
BIO	11978821	mn	7	8	observation	observation	elaboration	support	secondary	secondary	none	none	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_mn_7	BIO_11978821_mn_8	BIO_11978821_mn_7_8
BIO	11978821	mn	7	9	observation	conclusion	elaboration	support	secondary	secondary	none	none	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_mn_7	BIO_11978821_mn_9	BIO_11978821_mn_7_9
BIO	11978821	mn	7	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_mn_7	BIO_11978821_mn_10	BIO_11978821_mn_7_10
BIO	11978821	mn	7	11	observation	conclusion	elaboration	support	secondary	secondary	none	none	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_mn_7	BIO_11978821_mn_11	BIO_11978821_mn_7_11
BIO	11978821	mn	7	12	observation	conclusion	elaboration	support	secondary	secondary	none	none	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_mn_7	BIO_11978821_mn_12	BIO_11978821_mn_7_12
BIO	11978821	mn	8	9	observation	conclusion	support	support	secondary	secondary	none	none	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_mn_8	BIO_11978821_mn_9	BIO_11978821_mn_8_9
BIO	11978821	mn	8	10	observation	conclusion	support	support	secondary	secondary	none	none	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_mn_8	BIO_11978821_mn_10	BIO_11978821_mn_8_10
BIO	11978821	mn	8	11	observation	conclusion	support	support	secondary	secondary	none	none	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_mn_8	BIO_11978821_mn_11	BIO_11978821_mn_8_11
BIO	11978821	mn	8	12	observation	conclusion	support	support	secondary	secondary	none	none	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_mn_8	BIO_11978821_mn_12	BIO_11978821_mn_8_12
BIO	11978821	mn	9	10	conclusion	conclusion	support	support	secondary	secondary	back	support	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_mn_9	BIO_11978821_mn_10	BIO_11978821_mn_9_10
BIO	11978821	mn	9	11	conclusion	conclusion	support	support	secondary	secondary	none	none	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_mn_9	BIO_11978821_mn_11	BIO_11978821_mn_9_11
BIO	11978821	mn	9	12	conclusion	conclusion	support	support	secondary	secondary	none	none	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_mn_9	BIO_11978821_mn_12	BIO_11978821_mn_9_12
BIO	11978821	mn	10	11	conclusion	conclusion	support	support	secondary	secondary	none	none	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_mn_10	BIO_11978821_mn_11	BIO_11978821_mn_10_11
BIO	11978821	mn	10	12	conclusion	conclusion	support	support	secondary	secondary	none	none	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_mn_10	BIO_11978821_mn_12	BIO_11978821_mn_10_12
BIO	11978821	mn	11	12	conclusion	conclusion	support	support	secondary	secondary	back	support	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_mn_11	BIO_11978821_mn_12	BIO_11978821_mn_11_12
BIO	11978821	mn	12	11	conclusion	conclusion	support	support	secondary	secondary	forw	support	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_mn_12	BIO_11978821_mn_11	BIO_11978821_mn_11_12
BIO	12044662	mn	1	2	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	BIO_12044662_mn_1	BIO_12044662_mn_2	BIO_12044662_mn_1_2
BIO	12044662	mn	1	3	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	BIO_12044662_mn_1	BIO_12044662_mn_3	BIO_12044662_mn_1_3
BIO	12044662	mn	1	4	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	BIO_12044662_mn_1	BIO_12044662_mn_4	BIO_12044662_mn_1_4
BIO	12044662	mn	1	5	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	BIO_12044662_mn_1	BIO_12044662_mn_5	BIO_12044662_mn_1_5
BIO	12044662	mn	1	6	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	BIO_12044662_mn_1	BIO_12044662_mn_6	BIO_12044662_mn_1_6
BIO	12044662	mn	1	7	proposal	result	none	support	main	secondary	back	support	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	BIO_12044662_mn_1	BIO_12044662_mn_7	BIO_12044662_mn_1_7
BIO	12044662	mn	1	8	proposal	observation	none	support	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_mn_1	BIO_12044662_mn_8	BIO_12044662_mn_1_8
BIO	12044662	mn	1	9	proposal	result	none	elaboration	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_mn_1	BIO_12044662_mn_9	BIO_12044662_mn_1_9
BIO	12044662	mn	1	10	proposal	observation	none	support	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_mn_1	BIO_12044662_mn_10	BIO_12044662_mn_1_10
BIO	12044662	mn	1	11	proposal	result_means	none	support	main	secondary	back	support	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_mn_1	BIO_12044662_mn_11	BIO_12044662_mn_1_11
BIO	12044662	mn	1	12	proposal	result	none	support	main	secondary	back	support	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_mn_1	BIO_12044662_mn_12	BIO_12044662_mn_1_12
BIO	12044662	mn	1	13	proposal	conclusion	none	support	main	secondary	back	support	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_mn_1	BIO_12044662_mn_13	BIO_12044662_mn_1_13
BIO	12044662	mn	2	3	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	BIO_12044662_mn_2	BIO_12044662_mn_3	BIO_12044662_mn_2_3
BIO	12044662	mn	2	4	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	BIO_12044662_mn_2	BIO_12044662_mn_4	BIO_12044662_mn_2_4
BIO	12044662	mn	2	5	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	BIO_12044662_mn_2	BIO_12044662_mn_5	BIO_12044662_mn_2_5
BIO	12044662	mn	2	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	BIO_12044662_mn_2	BIO_12044662_mn_6	BIO_12044662_mn_2_6
BIO	12044662	mn	2	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	BIO_12044662_mn_2	BIO_12044662_mn_7	BIO_12044662_mn_2_7
BIO	12044662	mn	2	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_mn_2	BIO_12044662_mn_8	BIO_12044662_mn_2_8
BIO	12044662	mn	2	9	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_mn_2	BIO_12044662_mn_9	BIO_12044662_mn_2_9
BIO	12044662	mn	2	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_mn_2	BIO_12044662_mn_10	BIO_12044662_mn_2_10
BIO	12044662	mn	2	11	proposal_implementation	result_means	elaboration	support	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_mn_2	BIO_12044662_mn_11	BIO_12044662_mn_2_11
BIO	12044662	mn	2	12	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_mn_2	BIO_12044662_mn_12	BIO_12044662_mn_2_12
BIO	12044662	mn	2	13	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_mn_2	BIO_12044662_mn_13	BIO_12044662_mn_2_13
BIO	12044662	mn	3	4	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	BIO_12044662_mn_3	BIO_12044662_mn_4	BIO_12044662_mn_3_4
BIO	12044662	mn	3	5	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	BIO_12044662_mn_3	BIO_12044662_mn_5	BIO_12044662_mn_3_5
BIO	12044662	mn	3	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	BIO_12044662_mn_3	BIO_12044662_mn_6	BIO_12044662_mn_3_6
BIO	12044662	mn	3	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	BIO_12044662_mn_3	BIO_12044662_mn_7	BIO_12044662_mn_3_7
BIO	12044662	mn	3	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_mn_3	BIO_12044662_mn_8	BIO_12044662_mn_3_8
BIO	12044662	mn	3	9	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_mn_3	BIO_12044662_mn_9	BIO_12044662_mn_3_9
BIO	12044662	mn	3	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_mn_3	BIO_12044662_mn_10	BIO_12044662_mn_3_10
BIO	12044662	mn	3	11	proposal_implementation	result_means	elaboration	support	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_mn_3	BIO_12044662_mn_11	BIO_12044662_mn_3_11
BIO	12044662	mn	3	12	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_mn_3	BIO_12044662_mn_12	BIO_12044662_mn_3_12
BIO	12044662	mn	3	13	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_mn_3	BIO_12044662_mn_13	BIO_12044662_mn_3_13
BIO	12044662	mn	4	5	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	BIO_12044662_mn_4	BIO_12044662_mn_5	BIO_12044662_mn_4_5
BIO	12044662	mn	4	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	BIO_12044662_mn_4	BIO_12044662_mn_6	BIO_12044662_mn_4_6
BIO	12044662	mn	4	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	BIO_12044662_mn_4	BIO_12044662_mn_7	BIO_12044662_mn_4_7
BIO	12044662	mn	4	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_mn_4	BIO_12044662_mn_8	BIO_12044662_mn_4_8
BIO	12044662	mn	4	9	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_mn_4	BIO_12044662_mn_9	BIO_12044662_mn_4_9
BIO	12044662	mn	4	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_mn_4	BIO_12044662_mn_10	BIO_12044662_mn_4_10
BIO	12044662	mn	4	11	proposal_implementation	result_means	elaboration	support	secondary	secondary	none	none	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_mn_4	BIO_12044662_mn_11	BIO_12044662_mn_4_11
BIO	12044662	mn	4	12	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_mn_4	BIO_12044662_mn_12	BIO_12044662_mn_4_12
BIO	12044662	mn	4	13	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_mn_4	BIO_12044662_mn_13	BIO_12044662_mn_4_13
BIO	12044662	mn	5	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	BIO_12044662_mn_5	BIO_12044662_mn_6	BIO_12044662_mn_5_6
BIO	12044662	mn	5	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	BIO_12044662_mn_5	BIO_12044662_mn_7	BIO_12044662_mn_5_7
BIO	12044662	mn	5	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_mn_5	BIO_12044662_mn_8	BIO_12044662_mn_5_8
BIO	12044662	mn	5	9	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_mn_5	BIO_12044662_mn_9	BIO_12044662_mn_5_9
BIO	12044662	mn	5	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_mn_5	BIO_12044662_mn_10	BIO_12044662_mn_5_10
BIO	12044662	mn	5	11	proposal_implementation	result_means	elaboration	support	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_mn_5	BIO_12044662_mn_11	BIO_12044662_mn_5_11
BIO	12044662	mn	5	12	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_mn_5	BIO_12044662_mn_12	BIO_12044662_mn_5_12
BIO	12044662	mn	5	13	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_mn_5	BIO_12044662_mn_13	BIO_12044662_mn_5_13
BIO	12044662	mn	6	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	BIO_12044662_mn_6	BIO_12044662_mn_7	BIO_12044662_mn_6_7
BIO	12044662	mn	6	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_mn_6	BIO_12044662_mn_8	BIO_12044662_mn_6_8
BIO	12044662	mn	6	9	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_mn_6	BIO_12044662_mn_9	BIO_12044662_mn_6_9
BIO	12044662	mn	6	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_mn_6	BIO_12044662_mn_10	BIO_12044662_mn_6_10
BIO	12044662	mn	6	11	proposal_implementation	result_means	elaboration	support	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_mn_6	BIO_12044662_mn_11	BIO_12044662_mn_6_11
BIO	12044662	mn	6	12	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_mn_6	BIO_12044662_mn_12	BIO_12044662_mn_6_12
BIO	12044662	mn	6	13	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_mn_6	BIO_12044662_mn_13	BIO_12044662_mn_6_13
BIO	12044662	mn	7	8	result	observation	support	support	secondary	secondary	back	support	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_mn_7	BIO_12044662_mn_8	BIO_12044662_mn_7_8
BIO	12044662	mn	7	9	result	result	support	elaboration	secondary	secondary	back	elaboration	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_mn_7	BIO_12044662_mn_9	BIO_12044662_mn_7_9
BIO	12044662	mn	7	10	result	observation	support	support	secondary	secondary	none	none	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_mn_7	BIO_12044662_mn_10	BIO_12044662_mn_7_10
BIO	12044662	mn	7	11	result	result_means	support	support	secondary	secondary	none	none	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_mn_7	BIO_12044662_mn_11	BIO_12044662_mn_7_11
BIO	12044662	mn	7	12	result	result	support	support	secondary	secondary	none	none	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_mn_7	BIO_12044662_mn_12	BIO_12044662_mn_7_12
BIO	12044662	mn	7	13	result	conclusion	support	support	secondary	secondary	none	none	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_mn_7	BIO_12044662_mn_13	BIO_12044662_mn_7_13
BIO	12044662	mn	8	9	observation	result	support	elaboration	secondary	secondary	none	none	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_mn_8	BIO_12044662_mn_9	BIO_12044662_mn_8_9
BIO	12044662	mn	8	10	observation	observation	support	support	secondary	secondary	none	none	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_mn_8	BIO_12044662_mn_10	BIO_12044662_mn_8_10
BIO	12044662	mn	8	11	observation	result_means	support	support	secondary	secondary	none	none	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_mn_8	BIO_12044662_mn_11	BIO_12044662_mn_8_11
BIO	12044662	mn	8	12	observation	result	support	support	secondary	secondary	none	none	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_mn_8	BIO_12044662_mn_12	BIO_12044662_mn_8_12
BIO	12044662	mn	8	13	observation	conclusion	support	support	secondary	secondary	none	none	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_mn_8	BIO_12044662_mn_13	BIO_12044662_mn_8_13
BIO	12044662	mn	9	10	result	observation	elaboration	support	secondary	secondary	back	support	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_mn_9	BIO_12044662_mn_10	BIO_12044662_mn_9_10
BIO	12044662	mn	9	11	result	result_means	elaboration	support	secondary	secondary	none	none	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_mn_9	BIO_12044662_mn_11	BIO_12044662_mn_9_11
BIO	12044662	mn	9	12	result	result	elaboration	support	secondary	secondary	none	none	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_mn_9	BIO_12044662_mn_12	BIO_12044662_mn_9_12
BIO	12044662	mn	9	13	result	conclusion	elaboration	support	secondary	secondary	none	none	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_mn_9	BIO_12044662_mn_13	BIO_12044662_mn_9_13
BIO	12044662	mn	10	11	observation	result_means	support	support	secondary	secondary	none	none	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_mn_10	BIO_12044662_mn_11	BIO_12044662_mn_10_11
BIO	12044662	mn	10	12	observation	result	support	support	secondary	secondary	none	none	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_mn_10	BIO_12044662_mn_12	BIO_12044662_mn_10_12
BIO	12044662	mn	10	13	observation	conclusion	support	support	secondary	secondary	none	none	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_mn_10	BIO_12044662_mn_13	BIO_12044662_mn_10_13
BIO	12044662	mn	11	12	result_means	result	support	support	secondary	secondary	none	none	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_mn_11	BIO_12044662_mn_12	BIO_12044662_mn_11_12
BIO	12044662	mn	11	13	result_means	conclusion	support	support	secondary	secondary	none	none	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_mn_11	BIO_12044662_mn_13	BIO_12044662_mn_11_13
BIO	12044662	mn	12	13	result	conclusion	support	support	secondary	secondary	none	none	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_mn_12	BIO_12044662_mn_13	BIO_12044662_mn_12_13
BIO	12044662	mn	13	12	conclusion	result	support	support	secondary	secondary	none	none	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_mn_13	BIO_12044662_mn_12	BIO_12044662_mn_12_13
BIO	12064471	mn	1	2	motivation_background	proposal	support	none	secondary	main	forw	support	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	BIO_12064471_mn_1	BIO_12064471_mn_2	BIO_12064471_mn_1_2
BIO	12064471	mn	1	3	motivation_background	result_means	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	BIO_12064471_mn_1	BIO_12064471_mn_3	BIO_12064471_mn_1_3
BIO	12064471	mn	1	4	motivation_background	result_means	support	elaboration	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	These vesicles also contain Abeta(1-42), measured by RIA.	BIO_12064471_mn_1	BIO_12064471_mn_4	BIO_12064471_mn_1_4
BIO	12064471	mn	1	5	motivation_background	observation	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	BIO_12064471_mn_1	BIO_12064471_mn_5	BIO_12064471_mn_1_5
BIO	12064471	mn	1	6	motivation_background	conclusion	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	BIO_12064471_mn_1	BIO_12064471_mn_6	BIO_12064471_mn_1_6
BIO	12064471	mn	1	7	motivation_background	result_means	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	BIO_12064471_mn_1	BIO_12064471_mn_7	BIO_12064471_mn_1_7
BIO	12064471	mn	1	8	motivation_background	result	support	elaboration	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_mn_1	BIO_12064471_mn_8	BIO_12064471_mn_1_8
BIO	12064471	mn	1	9	motivation_background	observation	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_mn_1	BIO_12064471_mn_9	BIO_12064471_mn_1_9
BIO	12064471	mn	1	10	motivation_background	result	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_mn_1	BIO_12064471_mn_10	BIO_12064471_mn_1_10
BIO	12064471	mn	1	11	motivation_background	result	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_mn_1	BIO_12064471_mn_11	BIO_12064471_mn_1_11
BIO	12064471	mn	1	12	motivation_background	observation	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_mn_1	BIO_12064471_mn_12	BIO_12064471_mn_1_12
BIO	12064471	mn	1	13	motivation_background	conclusion	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_mn_1	BIO_12064471_mn_13	BIO_12064471_mn_1_13
BIO	12064471	mn	1	14	motivation_background	conclusion	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_1	BIO_12064471_mn_14	BIO_12064471_mn_1_14
BIO	12064471	mn	1	15	motivation_background	conclusion	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_1	BIO_12064471_mn_15	BIO_12064471_mn_1_15
BIO	12064471	mn	2	3	proposal	result_means	none	support	main	secondary	back	support	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	BIO_12064471_mn_2	BIO_12064471_mn_3	BIO_12064471_mn_2_3
BIO	12064471	mn	2	4	proposal	result_means	none	elaboration	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	These vesicles also contain Abeta(1-42), measured by RIA.	BIO_12064471_mn_2	BIO_12064471_mn_4	BIO_12064471_mn_2_4
BIO	12064471	mn	2	5	proposal	observation	none	support	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	BIO_12064471_mn_2	BIO_12064471_mn_5	BIO_12064471_mn_2_5
BIO	12064471	mn	2	6	proposal	conclusion	none	support	main	secondary	back	support	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	BIO_12064471_mn_2	BIO_12064471_mn_6	BIO_12064471_mn_2_6
BIO	12064471	mn	2	7	proposal	result_means	none	support	main	secondary	back	support	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	BIO_12064471_mn_2	BIO_12064471_mn_7	BIO_12064471_mn_2_7
BIO	12064471	mn	2	8	proposal	result	none	elaboration	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_mn_2	BIO_12064471_mn_8	BIO_12064471_mn_2_8
BIO	12064471	mn	2	9	proposal	observation	none	support	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_mn_2	BIO_12064471_mn_9	BIO_12064471_mn_2_9
BIO	12064471	mn	2	10	proposal	result	none	support	main	secondary	back	support	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_mn_2	BIO_12064471_mn_10	BIO_12064471_mn_2_10
BIO	12064471	mn	2	11	proposal	result	none	support	main	secondary	back	support	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_mn_2	BIO_12064471_mn_11	BIO_12064471_mn_2_11
BIO	12064471	mn	2	12	proposal	observation	none	support	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_mn_2	BIO_12064471_mn_12	BIO_12064471_mn_2_12
BIO	12064471	mn	2	13	proposal	conclusion	none	support	main	secondary	back	support	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_mn_2	BIO_12064471_mn_13	BIO_12064471_mn_2_13
BIO	12064471	mn	2	14	proposal	conclusion	none	support	main	secondary	back	support	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_2	BIO_12064471_mn_14	BIO_12064471_mn_2_14
BIO	12064471	mn	2	15	proposal	conclusion	none	support	main	secondary	back	support	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_2	BIO_12064471_mn_15	BIO_12064471_mn_2_15
BIO	12064471	mn	3	4	result_means	result_means	support	elaboration	secondary	secondary	back	elaboration	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	These vesicles also contain Abeta(1-42), measured by RIA.	BIO_12064471_mn_3	BIO_12064471_mn_4	BIO_12064471_mn_3_4
BIO	12064471	mn	3	5	result_means	observation	support	support	secondary	secondary	back	support	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	BIO_12064471_mn_3	BIO_12064471_mn_5	BIO_12064471_mn_3_5
BIO	12064471	mn	3	6	result_means	conclusion	support	support	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	BIO_12064471_mn_3	BIO_12064471_mn_6	BIO_12064471_mn_3_6
BIO	12064471	mn	3	7	result_means	result_means	support	support	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	BIO_12064471_mn_3	BIO_12064471_mn_7	BIO_12064471_mn_3_7
BIO	12064471	mn	3	8	result_means	result	support	elaboration	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_mn_3	BIO_12064471_mn_8	BIO_12064471_mn_3_8
BIO	12064471	mn	3	9	result_means	observation	support	support	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_mn_3	BIO_12064471_mn_9	BIO_12064471_mn_3_9
BIO	12064471	mn	3	10	result_means	result	support	support	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_mn_3	BIO_12064471_mn_10	BIO_12064471_mn_3_10
BIO	12064471	mn	3	11	result_means	result	support	support	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_mn_3	BIO_12064471_mn_11	BIO_12064471_mn_3_11
BIO	12064471	mn	3	12	result_means	observation	support	support	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_mn_3	BIO_12064471_mn_12	BIO_12064471_mn_3_12
BIO	12064471	mn	3	13	result_means	conclusion	support	support	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_mn_3	BIO_12064471_mn_13	BIO_12064471_mn_3_13
BIO	12064471	mn	3	14	result_means	conclusion	support	support	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_3	BIO_12064471_mn_14	BIO_12064471_mn_3_14
BIO	12064471	mn	3	15	result_means	conclusion	support	support	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_3	BIO_12064471_mn_15	BIO_12064471_mn_3_15
BIO	12064471	mn	4	5	result_means	observation	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	BIO_12064471_mn_4	BIO_12064471_mn_5	BIO_12064471_mn_4_5
BIO	12064471	mn	4	6	result_means	conclusion	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	BIO_12064471_mn_4	BIO_12064471_mn_6	BIO_12064471_mn_4_6
BIO	12064471	mn	4	7	result_means	result_means	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	BIO_12064471_mn_4	BIO_12064471_mn_7	BIO_12064471_mn_4_7
BIO	12064471	mn	4	8	result_means	result	elaboration	elaboration	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_mn_4	BIO_12064471_mn_8	BIO_12064471_mn_4_8
BIO	12064471	mn	4	9	result_means	observation	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_mn_4	BIO_12064471_mn_9	BIO_12064471_mn_4_9
BIO	12064471	mn	4	10	result_means	result	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_mn_4	BIO_12064471_mn_10	BIO_12064471_mn_4_10
BIO	12064471	mn	4	11	result_means	result	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_mn_4	BIO_12064471_mn_11	BIO_12064471_mn_4_11
BIO	12064471	mn	4	12	result_means	observation	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_mn_4	BIO_12064471_mn_12	BIO_12064471_mn_4_12
BIO	12064471	mn	4	13	result_means	conclusion	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_mn_4	BIO_12064471_mn_13	BIO_12064471_mn_4_13
BIO	12064471	mn	4	14	result_means	conclusion	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_4	BIO_12064471_mn_14	BIO_12064471_mn_4_14
BIO	12064471	mn	4	15	result_means	conclusion	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_4	BIO_12064471_mn_15	BIO_12064471_mn_4_15
BIO	12064471	mn	5	6	observation	conclusion	support	support	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	BIO_12064471_mn_5	BIO_12064471_mn_6	BIO_12064471_mn_5_6
BIO	12064471	mn	5	7	observation	result_means	support	support	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	BIO_12064471_mn_5	BIO_12064471_mn_7	BIO_12064471_mn_5_7
BIO	12064471	mn	5	8	observation	result	support	elaboration	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_mn_5	BIO_12064471_mn_8	BIO_12064471_mn_5_8
BIO	12064471	mn	5	9	observation	observation	support	support	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_mn_5	BIO_12064471_mn_9	BIO_12064471_mn_5_9
BIO	12064471	mn	5	10	observation	result	support	support	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_mn_5	BIO_12064471_mn_10	BIO_12064471_mn_5_10
BIO	12064471	mn	5	11	observation	result	support	support	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_mn_5	BIO_12064471_mn_11	BIO_12064471_mn_5_11
BIO	12064471	mn	5	12	observation	observation	support	support	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_mn_5	BIO_12064471_mn_12	BIO_12064471_mn_5_12
BIO	12064471	mn	5	13	observation	conclusion	support	support	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_mn_5	BIO_12064471_mn_13	BIO_12064471_mn_5_13
BIO	12064471	mn	5	14	observation	conclusion	support	support	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_5	BIO_12064471_mn_14	BIO_12064471_mn_5_14
BIO	12064471	mn	5	15	observation	conclusion	support	support	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_5	BIO_12064471_mn_15	BIO_12064471_mn_5_15
BIO	12064471	mn	6	7	conclusion	result_means	support	support	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	BIO_12064471_mn_6	BIO_12064471_mn_7	BIO_12064471_mn_6_7
BIO	12064471	mn	6	8	conclusion	result	support	elaboration	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_mn_6	BIO_12064471_mn_8	BIO_12064471_mn_6_8
BIO	12064471	mn	6	9	conclusion	observation	support	support	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_mn_6	BIO_12064471_mn_9	BIO_12064471_mn_6_9
BIO	12064471	mn	6	10	conclusion	result	support	support	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_mn_6	BIO_12064471_mn_10	BIO_12064471_mn_6_10
BIO	12064471	mn	6	11	conclusion	result	support	support	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_mn_6	BIO_12064471_mn_11	BIO_12064471_mn_6_11
BIO	12064471	mn	6	12	conclusion	observation	support	support	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_mn_6	BIO_12064471_mn_12	BIO_12064471_mn_6_12
BIO	12064471	mn	6	13	conclusion	conclusion	support	support	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_mn_6	BIO_12064471_mn_13	BIO_12064471_mn_6_13
BIO	12064471	mn	6	14	conclusion	conclusion	support	support	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_6	BIO_12064471_mn_14	BIO_12064471_mn_6_14
BIO	12064471	mn	6	15	conclusion	conclusion	support	support	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_6	BIO_12064471_mn_15	BIO_12064471_mn_6_15
BIO	12064471	mn	7	8	result_means	result	support	elaboration	secondary	secondary	back	elaboration	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_mn_7	BIO_12064471_mn_8	BIO_12064471_mn_7_8
BIO	12064471	mn	7	9	result_means	observation	support	support	secondary	secondary	back	support	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_mn_7	BIO_12064471_mn_9	BIO_12064471_mn_7_9
BIO	12064471	mn	7	10	result_means	result	support	support	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_mn_7	BIO_12064471_mn_10	BIO_12064471_mn_7_10
BIO	12064471	mn	7	11	result_means	result	support	support	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_mn_7	BIO_12064471_mn_11	BIO_12064471_mn_7_11
BIO	12064471	mn	7	12	result_means	observation	support	support	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_mn_7	BIO_12064471_mn_12	BIO_12064471_mn_7_12
BIO	12064471	mn	7	13	result_means	conclusion	support	support	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_mn_7	BIO_12064471_mn_13	BIO_12064471_mn_7_13
BIO	12064471	mn	7	14	result_means	conclusion	support	support	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_7	BIO_12064471_mn_14	BIO_12064471_mn_7_14
BIO	12064471	mn	7	15	result_means	conclusion	support	support	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_7	BIO_12064471_mn_15	BIO_12064471_mn_7_15
BIO	12064471	mn	8	9	result	observation	elaboration	support	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_mn_8	BIO_12064471_mn_9	BIO_12064471_mn_8_9
BIO	12064471	mn	8	10	result	result	elaboration	support	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_mn_8	BIO_12064471_mn_10	BIO_12064471_mn_8_10
BIO	12064471	mn	8	11	result	result	elaboration	support	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_mn_8	BIO_12064471_mn_11	BIO_12064471_mn_8_11
BIO	12064471	mn	8	12	result	observation	elaboration	support	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_mn_8	BIO_12064471_mn_12	BIO_12064471_mn_8_12
BIO	12064471	mn	8	13	result	conclusion	elaboration	support	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_mn_8	BIO_12064471_mn_13	BIO_12064471_mn_8_13
BIO	12064471	mn	8	14	result	conclusion	elaboration	support	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_8	BIO_12064471_mn_14	BIO_12064471_mn_8_14
BIO	12064471	mn	8	15	result	conclusion	elaboration	support	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_8	BIO_12064471_mn_15	BIO_12064471_mn_8_15
BIO	12064471	mn	9	10	observation	result	support	support	secondary	secondary	none	none	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_mn_9	BIO_12064471_mn_10	BIO_12064471_mn_9_10
BIO	12064471	mn	9	11	observation	result	support	support	secondary	secondary	none	none	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_mn_9	BIO_12064471_mn_11	BIO_12064471_mn_9_11
BIO	12064471	mn	9	12	observation	observation	support	support	secondary	secondary	none	none	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_mn_9	BIO_12064471_mn_12	BIO_12064471_mn_9_12
BIO	12064471	mn	9	13	observation	conclusion	support	support	secondary	secondary	none	none	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_mn_9	BIO_12064471_mn_13	BIO_12064471_mn_9_13
BIO	12064471	mn	9	14	observation	conclusion	support	support	secondary	secondary	none	none	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_9	BIO_12064471_mn_14	BIO_12064471_mn_9_14
BIO	12064471	mn	9	15	observation	conclusion	support	support	secondary	secondary	none	none	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_9	BIO_12064471_mn_15	BIO_12064471_mn_9_15
BIO	12064471	mn	10	11	result	result	support	support	secondary	secondary	none	none	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_mn_10	BIO_12064471_mn_11	BIO_12064471_mn_10_11
BIO	12064471	mn	10	12	result	observation	support	support	secondary	secondary	none	none	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_mn_10	BIO_12064471_mn_12	BIO_12064471_mn_10_12
BIO	12064471	mn	10	13	result	conclusion	support	support	secondary	secondary	none	none	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_mn_10	BIO_12064471_mn_13	BIO_12064471_mn_10_13
BIO	12064471	mn	10	14	result	conclusion	support	support	secondary	secondary	none	none	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_10	BIO_12064471_mn_14	BIO_12064471_mn_10_14
BIO	12064471	mn	10	15	result	conclusion	support	support	secondary	secondary	none	none	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_10	BIO_12064471_mn_15	BIO_12064471_mn_10_15
BIO	12064471	mn	11	12	result	observation	support	support	secondary	secondary	back	support	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_mn_11	BIO_12064471_mn_12	BIO_12064471_mn_11_12
BIO	12064471	mn	11	13	result	conclusion	support	support	secondary	secondary	none	none	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_mn_11	BIO_12064471_mn_13	BIO_12064471_mn_11_13
BIO	12064471	mn	11	14	result	conclusion	support	support	secondary	secondary	none	none	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_11	BIO_12064471_mn_14	BIO_12064471_mn_11_14
BIO	12064471	mn	11	15	result	conclusion	support	support	secondary	secondary	none	none	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_11	BIO_12064471_mn_15	BIO_12064471_mn_11_15
BIO	12064471	mn	12	13	observation	conclusion	support	support	secondary	secondary	none	none	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_mn_12	BIO_12064471_mn_13	BIO_12064471_mn_12_13
BIO	12064471	mn	12	14	observation	conclusion	support	support	secondary	secondary	none	none	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_12	BIO_12064471_mn_14	BIO_12064471_mn_12_14
BIO	12064471	mn	12	15	observation	conclusion	support	support	secondary	secondary	none	none	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_12	BIO_12064471_mn_15	BIO_12064471_mn_12_15
BIO	12064471	mn	13	14	conclusion	conclusion	support	support	secondary	secondary	none	none	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_13	BIO_12064471_mn_14	BIO_12064471_mn_13_14
BIO	12064471	mn	13	15	conclusion	conclusion	support	support	secondary	secondary	none	none	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_13	BIO_12064471_mn_15	BIO_12064471_mn_13_15
BIO	12064471	mn	14	15	conclusion	conclusion	support	support	secondary	secondary	none	none	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_mn_14	BIO_12064471_mn_15	BIO_12064471_mn_14_15
BIO	12064471	mn	15	14	conclusion	conclusion	support	support	secondary	secondary	none	none	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_mn_15	BIO_12064471_mn_14	BIO_12064471_mn_14_15
BIO	12091911	mn	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	BIO_12091911_mn_1	BIO_12091911_mn_2	BIO_12091911_mn_1_2
BIO	12091911	mn	1	3	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	BIO_12091911_mn_1	BIO_12091911_mn_3	BIO_12091911_mn_1_3
BIO	12091911	mn	1	4	motivation_background	motivation_background	info-required	support	secondary	secondary	none	none	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	BIO_12091911_mn_1	BIO_12091911_mn_4	BIO_12091911_mn_1_4
BIO	12091911	mn	1	5	motivation_background	proposal	info-required	none	secondary	main	none	none	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	BIO_12091911_mn_1	BIO_12091911_mn_5	BIO_12091911_mn_1_5
BIO	12091911	mn	1	6	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	Here we show that Mlh3(-/-) mice are viable but sterile.	BIO_12091911_mn_1	BIO_12091911_mn_6	BIO_12091911_mn_1_6
BIO	12091911	mn	1	7	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_mn_1	BIO_12091911_mn_7	BIO_12091911_mn_1_7
BIO	12091911	mn	1	8	motivation_background	result	info-required	support	secondary	secondary	none	none	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_mn_1	BIO_12091911_mn_8	BIO_12091911_mn_1_8
BIO	12091911	mn	2	3	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	BIO_12091911_mn_2	BIO_12091911_mn_3	BIO_12091911_mn_2_3
BIO	12091911	mn	2	4	motivation_background	motivation_background	info-required	support	secondary	secondary	none	none	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	BIO_12091911_mn_2	BIO_12091911_mn_4	BIO_12091911_mn_2_4
BIO	12091911	mn	2	5	motivation_background	proposal	info-required	none	secondary	main	none	none	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	BIO_12091911_mn_2	BIO_12091911_mn_5	BIO_12091911_mn_2_5
BIO	12091911	mn	2	6	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	Here we show that Mlh3(-/-) mice are viable but sterile.	BIO_12091911_mn_2	BIO_12091911_mn_6	BIO_12091911_mn_2_6
BIO	12091911	mn	2	7	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_mn_2	BIO_12091911_mn_7	BIO_12091911_mn_2_7
BIO	12091911	mn	2	8	motivation_background	result	info-required	support	secondary	secondary	none	none	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_mn_2	BIO_12091911_mn_8	BIO_12091911_mn_2_8
BIO	12091911	mn	3	4	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	BIO_12091911_mn_3	BIO_12091911_mn_4	BIO_12091911_mn_3_4
BIO	12091911	mn	3	5	motivation_background	proposal	info-required	none	secondary	main	none	none	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	BIO_12091911_mn_3	BIO_12091911_mn_5	BIO_12091911_mn_3_5
BIO	12091911	mn	3	6	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	Here we show that Mlh3(-/-) mice are viable but sterile.	BIO_12091911_mn_3	BIO_12091911_mn_6	BIO_12091911_mn_3_6
BIO	12091911	mn	3	7	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_mn_3	BIO_12091911_mn_7	BIO_12091911_mn_3_7
BIO	12091911	mn	3	8	motivation_background	result	info-required	support	secondary	secondary	none	none	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_mn_3	BIO_12091911_mn_8	BIO_12091911_mn_3_8
BIO	12091911	mn	4	5	motivation_background	proposal	support	none	secondary	main	forw	support	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	BIO_12091911_mn_4	BIO_12091911_mn_5	BIO_12091911_mn_4_5
BIO	12091911	mn	4	6	motivation_background	conclusion	support	support	secondary	secondary	none	none	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	Here we show that Mlh3(-/-) mice are viable but sterile.	BIO_12091911_mn_4	BIO_12091911_mn_6	BIO_12091911_mn_4_6
BIO	12091911	mn	4	7	motivation_background	result	support	elaboration	secondary	secondary	none	none	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_mn_4	BIO_12091911_mn_7	BIO_12091911_mn_4_7
BIO	12091911	mn	4	8	motivation_background	result	support	support	secondary	secondary	none	none	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_mn_4	BIO_12091911_mn_8	BIO_12091911_mn_4_8
BIO	12091911	mn	5	6	proposal	conclusion	none	support	main	secondary	back	support	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	Here we show that Mlh3(-/-) mice are viable but sterile.	BIO_12091911_mn_5	BIO_12091911_mn_6	BIO_12091911_mn_5_6
BIO	12091911	mn	5	7	proposal	result	none	elaboration	main	secondary	none	none	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_mn_5	BIO_12091911_mn_7	BIO_12091911_mn_5_7
BIO	12091911	mn	5	8	proposal	result	none	support	main	secondary	back	support	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_mn_5	BIO_12091911_mn_8	BIO_12091911_mn_5_8
BIO	12091911	mn	6	7	conclusion	result	support	elaboration	secondary	secondary	none	none	Here we show that Mlh3(-/-) mice are viable but sterile.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_mn_6	BIO_12091911_mn_7	BIO_12091911_mn_6_7
BIO	12091911	mn	6	8	conclusion	result	support	support	secondary	secondary	none	none	Here we show that Mlh3(-/-) mice are viable but sterile.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_mn_6	BIO_12091911_mn_8	BIO_12091911_mn_6_8
BIO	12091911	mn	7	8	result	result	elaboration	support	secondary	secondary	forw	elaboration	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_mn_7	BIO_12091911_mn_8	BIO_12091911_mn_7_8
BIO	12091911	mn	8	7	result	result	support	elaboration	secondary	secondary	back	elaboration	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_mn_8	BIO_12091911_mn_7	BIO_12091911_mn_7_8
BIO	12217951	mn	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size.	Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in Hdh(Q111) mice, although these abnormalities are not manifest in Hdh(Q50) mice, with 50-glutamine mutant protein.	BIO_12217951_mn_1	BIO_12217951_mn_2	BIO_12217951_mn_1_2
BIO	12217951	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size.	Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins.	BIO_12217951_mn_1	BIO_12217951_mn_3	BIO_12217951_mn_1_3
BIO	12217951	mn	1	4	motivation_background	observation	info-required	support	secondary	secondary	none	none	The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size.	Probes generated from Hdh(Q111) homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein.	BIO_12217951_mn_1	BIO_12217951_mn_4	BIO_12217951_mn_1_4
BIO	12217951	mn	1	5	motivation_background	observation	info-required	support	secondary	secondary	none	none	The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size.	Subsequent, quantitative RT-PCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous Hdh(Q111) striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in Hdh(Q50) striatum.	BIO_12217951_mn_1	BIO_12217951_mn_5	BIO_12217951_mn_1_5
BIO	12217951	mn	1	6	motivation_background	observation	info-required	support	secondary	secondary	none	none	The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size.	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	BIO_12217951_mn_1	BIO_12217951_mn_6	BIO_12217951_mn_1_6
BIO	12217951	mn	1	7	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size.	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	BIO_12217951_mn_1	BIO_12217951_mn_7	BIO_12217951_mn_1_7
BIO	12217951	mn	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in Hdh(Q111) mice, although these abnormalities are not manifest in Hdh(Q50) mice, with 50-glutamine mutant protein.	Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins.	BIO_12217951_mn_2	BIO_12217951_mn_3	BIO_12217951_mn_2_3
BIO	12217951	mn	2	4	motivation_background	observation	support	support	secondary	secondary	none	none	Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in Hdh(Q111) mice, although these abnormalities are not manifest in Hdh(Q50) mice, with 50-glutamine mutant protein.	Probes generated from Hdh(Q111) homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein.	BIO_12217951_mn_2	BIO_12217951_mn_4	BIO_12217951_mn_2_4
BIO	12217951	mn	2	5	motivation_background	observation	support	support	secondary	secondary	none	none	Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in Hdh(Q111) mice, although these abnormalities are not manifest in Hdh(Q50) mice, with 50-glutamine mutant protein.	Subsequent, quantitative RT-PCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous Hdh(Q111) striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in Hdh(Q50) striatum.	BIO_12217951_mn_2	BIO_12217951_mn_5	BIO_12217951_mn_2_5
BIO	12217951	mn	2	6	motivation_background	observation	support	support	secondary	secondary	none	none	Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in Hdh(Q111) mice, although these abnormalities are not manifest in Hdh(Q50) mice, with 50-glutamine mutant protein.	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	BIO_12217951_mn_2	BIO_12217951_mn_6	BIO_12217951_mn_2_6
BIO	12217951	mn	2	7	motivation_background	conclusion	support	support	secondary	secondary	none	none	Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in Hdh(Q111) mice, although these abnormalities are not manifest in Hdh(Q50) mice, with 50-glutamine mutant protein.	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	BIO_12217951_mn_2	BIO_12217951_mn_7	BIO_12217951_mn_2_7
BIO	12217951	mn	3	4	proposal	observation	none	support	main	secondary	none	none	Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins.	Probes generated from Hdh(Q111) homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein.	BIO_12217951_mn_3	BIO_12217951_mn_4	BIO_12217951_mn_3_4
BIO	12217951	mn	3	5	proposal	observation	none	support	main	secondary	none	none	Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins.	Subsequent, quantitative RT-PCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous Hdh(Q111) striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in Hdh(Q50) striatum.	BIO_12217951_mn_3	BIO_12217951_mn_5	BIO_12217951_mn_3_5
BIO	12217951	mn	3	6	proposal	observation	none	support	main	secondary	none	none	Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins.	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	BIO_12217951_mn_3	BIO_12217951_mn_6	BIO_12217951_mn_3_6
BIO	12217951	mn	3	7	proposal	conclusion	none	support	main	secondary	back	support	Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins.	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	BIO_12217951_mn_3	BIO_12217951_mn_7	BIO_12217951_mn_3_7
BIO	12217951	mn	4	5	observation	observation	support	support	secondary	secondary	none	none	Probes generated from Hdh(Q111) homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein.	Subsequent, quantitative RT-PCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous Hdh(Q111) striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in Hdh(Q50) striatum.	BIO_12217951_mn_4	BIO_12217951_mn_5	BIO_12217951_mn_4_5
BIO	12217951	mn	4	6	observation	observation	support	support	secondary	secondary	none	none	Probes generated from Hdh(Q111) homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein.	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	BIO_12217951_mn_4	BIO_12217951_mn_6	BIO_12217951_mn_4_6
BIO	12217951	mn	4	7	observation	conclusion	support	support	secondary	secondary	forw	support	Probes generated from Hdh(Q111) homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein.	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	BIO_12217951_mn_4	BIO_12217951_mn_7	BIO_12217951_mn_4_7
BIO	12217951	mn	5	6	observation	observation	support	support	secondary	secondary	none	none	Subsequent, quantitative RT-PCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous Hdh(Q111) striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in Hdh(Q50) striatum.	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	BIO_12217951_mn_5	BIO_12217951_mn_6	BIO_12217951_mn_5_6
BIO	12217951	mn	5	7	observation	conclusion	support	support	secondary	secondary	forw	support	Subsequent, quantitative RT-PCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous Hdh(Q111) striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in Hdh(Q50) striatum.	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	BIO_12217951_mn_5	BIO_12217951_mn_7	BIO_12217951_mn_5_7
BIO	12217951	mn	6	7	observation	conclusion	support	support	secondary	secondary	forw	support	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	BIO_12217951_mn_6	BIO_12217951_mn_7	BIO_12217951_mn_6_7
BIO	12217951	mn	7	6	conclusion	observation	support	support	secondary	secondary	back	support	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	BIO_12217951_mn_7	BIO_12217951_mn_6	BIO_12217951_mn_6_7
BIO	12423249	mn	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	BIO_12423249_mn_1	BIO_12423249_mn_2	BIO_12423249_mn_1_2
BIO	12423249	mn	1	3	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	BIO_12423249_mn_1	BIO_12423249_mn_3	BIO_12423249_mn_1_3
BIO	12423249	mn	1	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	BIO_12423249_mn_1	BIO_12423249_mn_4	BIO_12423249_mn_1_4
BIO	12423249	mn	1	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	However, the proteolytic activity of PS1 remains a matter of debate.	BIO_12423249_mn_1	BIO_12423249_mn_5	BIO_12423249_mn_1_5
BIO	12423249	mn	1	6	motivation_background	proposal	info-required	none	secondary	main	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	BIO_12423249_mn_1	BIO_12423249_mn_6	BIO_12423249_mn_1_6
BIO	12423249	mn	1	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	BIO_12423249_mn_1	BIO_12423249_mn_7	BIO_12423249_mn_1_7
BIO	12423249	mn	1	8	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_mn_1	BIO_12423249_mn_8	BIO_12423249_mn_1_8
BIO	12423249	mn	1	9	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_mn_1	BIO_12423249_mn_9	BIO_12423249_mn_1_9
BIO	12423249	mn	1	10	motivation_background	result	info-required	support	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_mn_1	BIO_12423249_mn_10	BIO_12423249_mn_1_10
BIO	12423249	mn	2	3	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	BIO_12423249_mn_2	BIO_12423249_mn_3	BIO_12423249_mn_2_3
BIO	12423249	mn	2	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	BIO_12423249_mn_2	BIO_12423249_mn_4	BIO_12423249_mn_2_4
BIO	12423249	mn	2	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	However, the proteolytic activity of PS1 remains a matter of debate.	BIO_12423249_mn_2	BIO_12423249_mn_5	BIO_12423249_mn_2_5
BIO	12423249	mn	2	6	motivation_background	proposal	info-required	none	secondary	main	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	BIO_12423249_mn_2	BIO_12423249_mn_6	BIO_12423249_mn_2_6
BIO	12423249	mn	2	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	BIO_12423249_mn_2	BIO_12423249_mn_7	BIO_12423249_mn_2_7
BIO	12423249	mn	2	8	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_mn_2	BIO_12423249_mn_8	BIO_12423249_mn_2_8
BIO	12423249	mn	2	9	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_mn_2	BIO_12423249_mn_9	BIO_12423249_mn_2_9
BIO	12423249	mn	2	10	motivation_background	result	info-required	support	secondary	secondary	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_mn_2	BIO_12423249_mn_10	BIO_12423249_mn_2_10
BIO	12423249	mn	3	4	motivation_problem	motivation_background	support	info-required	secondary	secondary	forw	support	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	BIO_12423249_mn_3	BIO_12423249_mn_4	BIO_12423249_mn_3_4
BIO	12423249	mn	3	5	motivation_problem	motivation_problem	support	support	secondary	secondary	none	none	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	However, the proteolytic activity of PS1 remains a matter of debate.	BIO_12423249_mn_3	BIO_12423249_mn_5	BIO_12423249_mn_3_5
BIO	12423249	mn	3	6	motivation_problem	proposal	support	none	secondary	main	none	none	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	BIO_12423249_mn_3	BIO_12423249_mn_6	BIO_12423249_mn_3_6
BIO	12423249	mn	3	7	motivation_problem	observation	support	support	secondary	secondary	none	none	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	BIO_12423249_mn_3	BIO_12423249_mn_7	BIO_12423249_mn_3_7
BIO	12423249	mn	3	8	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_mn_3	BIO_12423249_mn_8	BIO_12423249_mn_3_8
BIO	12423249	mn	3	9	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_mn_3	BIO_12423249_mn_9	BIO_12423249_mn_3_9
BIO	12423249	mn	3	10	motivation_problem	result	support	support	secondary	secondary	none	none	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_mn_3	BIO_12423249_mn_10	BIO_12423249_mn_3_10
BIO	12423249	mn	4	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	However, the proteolytic activity of PS1 remains a matter of debate.	BIO_12423249_mn_4	BIO_12423249_mn_5	BIO_12423249_mn_4_5
BIO	12423249	mn	4	6	motivation_background	proposal	info-required	none	secondary	main	none	none	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	BIO_12423249_mn_4	BIO_12423249_mn_6	BIO_12423249_mn_4_6
BIO	12423249	mn	4	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	BIO_12423249_mn_4	BIO_12423249_mn_7	BIO_12423249_mn_4_7
BIO	12423249	mn	4	8	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_mn_4	BIO_12423249_mn_8	BIO_12423249_mn_4_8
BIO	12423249	mn	4	9	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_mn_4	BIO_12423249_mn_9	BIO_12423249_mn_4_9
BIO	12423249	mn	4	10	motivation_background	result	info-required	support	secondary	secondary	none	none	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_mn_4	BIO_12423249_mn_10	BIO_12423249_mn_4_10
BIO	12423249	mn	5	6	motivation_problem	proposal	support	none	secondary	main	forw	support	However, the proteolytic activity of PS1 remains a matter of debate.	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	BIO_12423249_mn_5	BIO_12423249_mn_6	BIO_12423249_mn_5_6
BIO	12423249	mn	5	7	motivation_problem	observation	support	support	secondary	secondary	none	none	However, the proteolytic activity of PS1 remains a matter of debate.	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	BIO_12423249_mn_5	BIO_12423249_mn_7	BIO_12423249_mn_5_7
BIO	12423249	mn	5	8	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	However, the proteolytic activity of PS1 remains a matter of debate.	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_mn_5	BIO_12423249_mn_8	BIO_12423249_mn_5_8
BIO	12423249	mn	5	9	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	However, the proteolytic activity of PS1 remains a matter of debate.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_mn_5	BIO_12423249_mn_9	BIO_12423249_mn_5_9
BIO	12423249	mn	5	10	motivation_problem	result	support	support	secondary	secondary	none	none	However, the proteolytic activity of PS1 remains a matter of debate.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_mn_5	BIO_12423249_mn_10	BIO_12423249_mn_5_10
BIO	12423249	mn	6	7	proposal	observation	none	support	main	secondary	none	none	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	BIO_12423249_mn_6	BIO_12423249_mn_7	BIO_12423249_mn_6_7
BIO	12423249	mn	6	8	proposal	observation	none	elaboration	main	secondary	none	none	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_mn_6	BIO_12423249_mn_8	BIO_12423249_mn_6_8
BIO	12423249	mn	6	9	proposal	observation	none	elaboration	main	secondary	none	none	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_mn_6	BIO_12423249_mn_9	BIO_12423249_mn_6_9
BIO	12423249	mn	6	10	proposal	result	none	support	main	secondary	back	support	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_mn_6	BIO_12423249_mn_10	BIO_12423249_mn_6_10
BIO	12423249	mn	7	8	observation	observation	support	elaboration	secondary	secondary	back	elaboration	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_mn_7	BIO_12423249_mn_8	BIO_12423249_mn_7_8
BIO	12423249	mn	7	9	observation	observation	support	elaboration	secondary	secondary	none	none	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_mn_7	BIO_12423249_mn_9	BIO_12423249_mn_7_9
BIO	12423249	mn	7	10	observation	result	support	support	secondary	secondary	forw	support	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_mn_7	BIO_12423249_mn_10	BIO_12423249_mn_7_10
BIO	12423249	mn	8	9	observation	observation	elaboration	elaboration	secondary	secondary	back	elaboration	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_mn_8	BIO_12423249_mn_9	BIO_12423249_mn_8_9
BIO	12423249	mn	8	10	observation	result	elaboration	support	secondary	secondary	none	none	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_mn_8	BIO_12423249_mn_10	BIO_12423249_mn_8_10
BIO	12423249	mn	9	10	observation	result	elaboration	support	secondary	secondary	none	none	Despite this interaction, Sf9 cells still do not produce Abeta.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_mn_9	BIO_12423249_mn_10	BIO_12423249_mn_9_10
BIO	12423249	mn	10	9	result	observation	support	elaboration	secondary	secondary	none	none	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_mn_10	BIO_12423249_mn_9	BIO_12423249_mn_9_10
BIO	12468047	mn	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	BIO_12468047_mn_1	BIO_12468047_mn_2	BIO_12468047_mn_1_2
BIO	12468047	mn	1	3	motivation_background	motivation_background	info-required	support	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	Memantine has neuroprotective actions in several in vitro and in vivo models.	BIO_12468047_mn_1	BIO_12468047_mn_3	BIO_12468047_mn_1_3
BIO	12468047	mn	1	4	motivation_background	proposal	info-required	none	secondary	main	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	BIO_12468047_mn_1	BIO_12468047_mn_4	BIO_12468047_mn_1_4
BIO	12468047	mn	1	5	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	BIO_12468047_mn_1	BIO_12468047_mn_5	BIO_12468047_mn_1_5
BIO	12468047	mn	1	6	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	BIO_12468047_mn_1	BIO_12468047_mn_6	BIO_12468047_mn_1_6
BIO	12468047	mn	1	7	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	BIO_12468047_mn_1	BIO_12468047_mn_7	BIO_12468047_mn_1_7
BIO	12468047	mn	1	8	motivation_background	means	info-required	by-means	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_mn_1	BIO_12468047_mn_8	BIO_12468047_mn_1_8
BIO	12468047	mn	1	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_mn_1	BIO_12468047_mn_9	BIO_12468047_mn_1_9
BIO	12468047	mn	1	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_mn_1	BIO_12468047_mn_10	BIO_12468047_mn_1_10
BIO	12468047	mn	1	11	motivation_background	result	info-required	support	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_mn_1	BIO_12468047_mn_11	BIO_12468047_mn_1_11
BIO	12468047	mn	2	3	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	Memantine has neuroprotective actions in several in vitro and in vivo models.	BIO_12468047_mn_2	BIO_12468047_mn_3	BIO_12468047_mn_2_3
BIO	12468047	mn	2	4	motivation_background	proposal	info-required	none	secondary	main	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	BIO_12468047_mn_2	BIO_12468047_mn_4	BIO_12468047_mn_2_4
BIO	12468047	mn	2	5	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	BIO_12468047_mn_2	BIO_12468047_mn_5	BIO_12468047_mn_2_5
BIO	12468047	mn	2	6	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	BIO_12468047_mn_2	BIO_12468047_mn_6	BIO_12468047_mn_2_6
BIO	12468047	mn	2	7	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	BIO_12468047_mn_2	BIO_12468047_mn_7	BIO_12468047_mn_2_7
BIO	12468047	mn	2	8	motivation_background	means	info-required	by-means	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_mn_2	BIO_12468047_mn_8	BIO_12468047_mn_2_8
BIO	12468047	mn	2	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_mn_2	BIO_12468047_mn_9	BIO_12468047_mn_2_9
BIO	12468047	mn	2	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_mn_2	BIO_12468047_mn_10	BIO_12468047_mn_2_10
BIO	12468047	mn	2	11	motivation_background	result	info-required	support	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_mn_2	BIO_12468047_mn_11	BIO_12468047_mn_2_11
BIO	12468047	mn	3	4	motivation_background	proposal	support	none	secondary	main	forw	support	Memantine has neuroprotective actions in several in vitro and in vivo models.	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	BIO_12468047_mn_3	BIO_12468047_mn_4	BIO_12468047_mn_3_4
BIO	12468047	mn	3	5	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	BIO_12468047_mn_3	BIO_12468047_mn_5	BIO_12468047_mn_3_5
BIO	12468047	mn	3	6	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	BIO_12468047_mn_3	BIO_12468047_mn_6	BIO_12468047_mn_3_6
BIO	12468047	mn	3	7	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	BIO_12468047_mn_3	BIO_12468047_mn_7	BIO_12468047_mn_3_7
BIO	12468047	mn	3	8	motivation_background	means	support	by-means	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_mn_3	BIO_12468047_mn_8	BIO_12468047_mn_3_8
BIO	12468047	mn	3	9	motivation_background	observation	support	support	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_mn_3	BIO_12468047_mn_9	BIO_12468047_mn_3_9
BIO	12468047	mn	3	10	motivation_background	observation	support	support	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_mn_3	BIO_12468047_mn_10	BIO_12468047_mn_3_10
BIO	12468047	mn	3	11	motivation_background	result	support	support	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_mn_3	BIO_12468047_mn_11	BIO_12468047_mn_3_11
BIO	12468047	mn	4	5	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	BIO_12468047_mn_4	BIO_12468047_mn_5	BIO_12468047_mn_4_5
BIO	12468047	mn	4	6	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	BIO_12468047_mn_4	BIO_12468047_mn_6	BIO_12468047_mn_4_6
BIO	12468047	mn	4	7	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	BIO_12468047_mn_4	BIO_12468047_mn_7	BIO_12468047_mn_4_7
BIO	12468047	mn	4	8	proposal	means	none	by-means	main	secondary	none	none	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_mn_4	BIO_12468047_mn_8	BIO_12468047_mn_4_8
BIO	12468047	mn	4	9	proposal	observation	none	support	main	secondary	none	none	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_mn_4	BIO_12468047_mn_9	BIO_12468047_mn_4_9
BIO	12468047	mn	4	10	proposal	observation	none	support	main	secondary	none	none	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_mn_4	BIO_12468047_mn_10	BIO_12468047_mn_4_10
BIO	12468047	mn	4	11	proposal	result	none	support	main	secondary	back	support	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_mn_4	BIO_12468047_mn_11	BIO_12468047_mn_4_11
BIO	12468047	mn	5	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	BIO_12468047_mn_5	BIO_12468047_mn_6	BIO_12468047_mn_5_6
BIO	12468047	mn	5	7	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	BIO_12468047_mn_5	BIO_12468047_mn_7	BIO_12468047_mn_5_7
BIO	12468047	mn	5	8	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_mn_5	BIO_12468047_mn_8	BIO_12468047_mn_5_8
BIO	12468047	mn	5	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_mn_5	BIO_12468047_mn_9	BIO_12468047_mn_5_9
BIO	12468047	mn	5	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_mn_5	BIO_12468047_mn_10	BIO_12468047_mn_5_10
BIO	12468047	mn	5	11	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_mn_5	BIO_12468047_mn_11	BIO_12468047_mn_5_11
BIO	12468047	mn	6	7	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	BIO_12468047_mn_6	BIO_12468047_mn_7	BIO_12468047_mn_6_7
BIO	12468047	mn	6	8	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_mn_6	BIO_12468047_mn_8	BIO_12468047_mn_6_8
BIO	12468047	mn	6	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_mn_6	BIO_12468047_mn_9	BIO_12468047_mn_6_9
BIO	12468047	mn	6	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_mn_6	BIO_12468047_mn_10	BIO_12468047_mn_6_10
BIO	12468047	mn	6	11	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_mn_6	BIO_12468047_mn_11	BIO_12468047_mn_6_11
BIO	12468047	mn	7	8	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_mn_7	BIO_12468047_mn_8	BIO_12468047_mn_7_8
BIO	12468047	mn	7	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_mn_7	BIO_12468047_mn_9	BIO_12468047_mn_7_9
BIO	12468047	mn	7	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_mn_7	BIO_12468047_mn_10	BIO_12468047_mn_7_10
BIO	12468047	mn	7	11	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_mn_7	BIO_12468047_mn_11	BIO_12468047_mn_7_11
BIO	12468047	mn	8	9	means	observation	by-means	support	secondary	secondary	none	none	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_mn_8	BIO_12468047_mn_9	BIO_12468047_mn_8_9
BIO	12468047	mn	8	10	means	observation	by-means	support	secondary	secondary	none	none	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_mn_8	BIO_12468047_mn_10	BIO_12468047_mn_8_10
BIO	12468047	mn	8	11	means	result	by-means	support	secondary	secondary	forw	by-means	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_mn_8	BIO_12468047_mn_11	BIO_12468047_mn_8_11
BIO	12468047	mn	9	10	observation	observation	support	support	secondary	secondary	none	none	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_mn_9	BIO_12468047_mn_10	BIO_12468047_mn_9_10
BIO	12468047	mn	9	11	observation	result	support	support	secondary	secondary	forw	support	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_mn_9	BIO_12468047_mn_11	BIO_12468047_mn_9_11
BIO	12468047	mn	10	11	observation	result	support	support	secondary	secondary	forw	support	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_mn_10	BIO_12468047_mn_11	BIO_12468047_mn_10_11
BIO	12468047	mn	11	10	result	observation	support	support	secondary	secondary	back	support	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_mn_11	BIO_12468047_mn_10	BIO_12468047_mn_10_11
BIO	12483089	mn	1	2	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	BIO_12483089_mn_1	BIO_12483089_mn_2	BIO_12483089_mn_1_2
BIO	12483089	mn	1	3	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	BIO_12483089_mn_1	BIO_12483089_mn_3	BIO_12483089_mn_1_3
BIO	12483089	mn	1	4	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	BIO_12483089_mn_1	BIO_12483089_mn_4	BIO_12483089_mn_1_4
BIO	12483089	mn	1	5	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	BIO_12483089_mn_1	BIO_12483089_mn_5	BIO_12483089_mn_1_5
BIO	12483089	mn	1	6	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	BIO_12483089_mn_1	BIO_12483089_mn_6	BIO_12483089_mn_1_6
BIO	12483089	mn	1	7	proposal	result	none	support	main	secondary	back	support	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	BIO_12483089_mn_1	BIO_12483089_mn_7	BIO_12483089_mn_1_7
BIO	12483089	mn	1	8	proposal	observation	none	support	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_mn_1	BIO_12483089_mn_8	BIO_12483089_mn_1_8
BIO	12483089	mn	1	9	proposal	observation	none	support	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_mn_1	BIO_12483089_mn_9	BIO_12483089_mn_1_9
BIO	12483089	mn	1	10	proposal	observation	none	support	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_mn_1	BIO_12483089_mn_10	BIO_12483089_mn_1_10
BIO	12483089	mn	1	11	proposal	conclusion	none	support	main	secondary	back	support	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_mn_1	BIO_12483089_mn_11	BIO_12483089_mn_1_11
BIO	12483089	mn	2	3	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	BIO_12483089_mn_2	BIO_12483089_mn_3	BIO_12483089_mn_2_3
BIO	12483089	mn	2	4	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	BIO_12483089_mn_2	BIO_12483089_mn_4	BIO_12483089_mn_2_4
BIO	12483089	mn	2	5	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	BIO_12483089_mn_2	BIO_12483089_mn_5	BIO_12483089_mn_2_5
BIO	12483089	mn	2	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	BIO_12483089_mn_2	BIO_12483089_mn_6	BIO_12483089_mn_2_6
BIO	12483089	mn	2	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	BIO_12483089_mn_2	BIO_12483089_mn_7	BIO_12483089_mn_2_7
BIO	12483089	mn	2	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_mn_2	BIO_12483089_mn_8	BIO_12483089_mn_2_8
BIO	12483089	mn	2	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_mn_2	BIO_12483089_mn_9	BIO_12483089_mn_2_9
BIO	12483089	mn	2	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_mn_2	BIO_12483089_mn_10	BIO_12483089_mn_2_10
BIO	12483089	mn	2	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_mn_2	BIO_12483089_mn_11	BIO_12483089_mn_2_11
BIO	12483089	mn	3	4	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	BIO_12483089_mn_3	BIO_12483089_mn_4	BIO_12483089_mn_3_4
BIO	12483089	mn	3	5	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	BIO_12483089_mn_3	BIO_12483089_mn_5	BIO_12483089_mn_3_5
BIO	12483089	mn	3	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	BIO_12483089_mn_3	BIO_12483089_mn_6	BIO_12483089_mn_3_6
BIO	12483089	mn	3	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	BIO_12483089_mn_3	BIO_12483089_mn_7	BIO_12483089_mn_3_7
BIO	12483089	mn	3	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_mn_3	BIO_12483089_mn_8	BIO_12483089_mn_3_8
BIO	12483089	mn	3	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_mn_3	BIO_12483089_mn_9	BIO_12483089_mn_3_9
BIO	12483089	mn	3	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_mn_3	BIO_12483089_mn_10	BIO_12483089_mn_3_10
BIO	12483089	mn	3	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_mn_3	BIO_12483089_mn_11	BIO_12483089_mn_3_11
BIO	12483089	mn	4	5	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	BIO_12483089_mn_4	BIO_12483089_mn_5	BIO_12483089_mn_4_5
BIO	12483089	mn	4	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	BIO_12483089_mn_4	BIO_12483089_mn_6	BIO_12483089_mn_4_6
BIO	12483089	mn	4	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	BIO_12483089_mn_4	BIO_12483089_mn_7	BIO_12483089_mn_4_7
BIO	12483089	mn	4	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_mn_4	BIO_12483089_mn_8	BIO_12483089_mn_4_8
BIO	12483089	mn	4	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_mn_4	BIO_12483089_mn_9	BIO_12483089_mn_4_9
BIO	12483089	mn	4	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_mn_4	BIO_12483089_mn_10	BIO_12483089_mn_4_10
BIO	12483089	mn	4	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_mn_4	BIO_12483089_mn_11	BIO_12483089_mn_4_11
BIO	12483089	mn	5	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	BIO_12483089_mn_5	BIO_12483089_mn_6	BIO_12483089_mn_5_6
BIO	12483089	mn	5	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	BIO_12483089_mn_5	BIO_12483089_mn_7	BIO_12483089_mn_5_7
BIO	12483089	mn	5	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_mn_5	BIO_12483089_mn_8	BIO_12483089_mn_5_8
BIO	12483089	mn	5	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_mn_5	BIO_12483089_mn_9	BIO_12483089_mn_5_9
BIO	12483089	mn	5	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_mn_5	BIO_12483089_mn_10	BIO_12483089_mn_5_10
BIO	12483089	mn	5	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_mn_5	BIO_12483089_mn_11	BIO_12483089_mn_5_11
BIO	12483089	mn	6	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	BIO_12483089_mn_6	BIO_12483089_mn_7	BIO_12483089_mn_6_7
BIO	12483089	mn	6	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_mn_6	BIO_12483089_mn_8	BIO_12483089_mn_6_8
BIO	12483089	mn	6	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_mn_6	BIO_12483089_mn_9	BIO_12483089_mn_6_9
BIO	12483089	mn	6	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_mn_6	BIO_12483089_mn_10	BIO_12483089_mn_6_10
BIO	12483089	mn	6	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_mn_6	BIO_12483089_mn_11	BIO_12483089_mn_6_11
BIO	12483089	mn	7	8	result	observation	support	support	secondary	secondary	back	support	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_mn_7	BIO_12483089_mn_8	BIO_12483089_mn_7_8
BIO	12483089	mn	7	9	result	observation	support	support	secondary	secondary	back	support	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_mn_7	BIO_12483089_mn_9	BIO_12483089_mn_7_9
BIO	12483089	mn	7	10	result	observation	support	support	secondary	secondary	back	support	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_mn_7	BIO_12483089_mn_10	BIO_12483089_mn_7_10
BIO	12483089	mn	7	11	result	conclusion	support	support	secondary	secondary	none	none	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_mn_7	BIO_12483089_mn_11	BIO_12483089_mn_7_11
BIO	12483089	mn	8	9	observation	observation	support	support	secondary	secondary	none	none	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_mn_8	BIO_12483089_mn_9	BIO_12483089_mn_8_9
BIO	12483089	mn	8	10	observation	observation	support	support	secondary	secondary	none	none	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_mn_8	BIO_12483089_mn_10	BIO_12483089_mn_8_10
BIO	12483089	mn	8	11	observation	conclusion	support	support	secondary	secondary	none	none	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_mn_8	BIO_12483089_mn_11	BIO_12483089_mn_8_11
BIO	12483089	mn	9	10	observation	observation	support	support	secondary	secondary	none	none	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_mn_9	BIO_12483089_mn_10	BIO_12483089_mn_9_10
BIO	12483089	mn	9	11	observation	conclusion	support	support	secondary	secondary	none	none	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_mn_9	BIO_12483089_mn_11	BIO_12483089_mn_9_11
BIO	12483089	mn	10	11	observation	conclusion	support	support	secondary	secondary	none	none	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_mn_10	BIO_12483089_mn_11	BIO_12483089_mn_10_11
BIO	12483089	mn	11	10	conclusion	observation	support	support	secondary	secondary	none	none	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_mn_11	BIO_12483089_mn_10	BIO_12483089_mn_10_11
BIO	12573519	mn	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	Recent clinical trials have found that few neuroprotectants are effective.	BIO_12573519_mn_1	BIO_12573519_mn_2	BIO_12573519_mn_1_2
BIO	12573519	mn	1	3	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	BIO_12573519_mn_1	BIO_12573519_mn_3	BIO_12573519_mn_1_3
BIO	12573519	mn	1	4	motivation_background	proposal	info-required	none	secondary	main	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	BIO_12573519_mn_1	BIO_12573519_mn_4	BIO_12573519_mn_1_4
BIO	12573519	mn	1	5	motivation_background	observation	info-required	support	secondary	secondary	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	BIO_12573519_mn_1	BIO_12573519_mn_5	BIO_12573519_mn_1_5
BIO	12573519	mn	1	6	motivation_background	means	info-required	by-means	secondary	secondary	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	BIO_12573519_mn_1	BIO_12573519_mn_6	BIO_12573519_mn_1_6
BIO	12573519	mn	1	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	BIO_12573519_mn_1	BIO_12573519_mn_7	BIO_12573519_mn_1_7
BIO	12573519	mn	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_mn_1	BIO_12573519_mn_8	BIO_12573519_mn_1_8
BIO	12573519	mn	1	9	motivation_background	result	info-required	support	secondary	secondary	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_mn_1	BIO_12573519_mn_9	BIO_12573519_mn_1_9
BIO	12573519	mn	2	3	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Recent clinical trials have found that few neuroprotectants are effective.	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	BIO_12573519_mn_2	BIO_12573519_mn_3	BIO_12573519_mn_2_3
BIO	12573519	mn	2	4	motivation_background	proposal	info-required	none	secondary	main	none	none	Recent clinical trials have found that few neuroprotectants are effective.	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	BIO_12573519_mn_2	BIO_12573519_mn_4	BIO_12573519_mn_2_4
BIO	12573519	mn	2	5	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recent clinical trials have found that few neuroprotectants are effective.	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	BIO_12573519_mn_2	BIO_12573519_mn_5	BIO_12573519_mn_2_5
BIO	12573519	mn	2	6	motivation_background	means	info-required	by-means	secondary	secondary	none	none	Recent clinical trials have found that few neuroprotectants are effective.	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	BIO_12573519_mn_2	BIO_12573519_mn_6	BIO_12573519_mn_2_6
BIO	12573519	mn	2	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recent clinical trials have found that few neuroprotectants are effective.	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	BIO_12573519_mn_2	BIO_12573519_mn_7	BIO_12573519_mn_2_7
BIO	12573519	mn	2	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recent clinical trials have found that few neuroprotectants are effective.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_mn_2	BIO_12573519_mn_8	BIO_12573519_mn_2_8
BIO	12573519	mn	2	9	motivation_background	result	info-required	support	secondary	secondary	none	none	Recent clinical trials have found that few neuroprotectants are effective.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_mn_2	BIO_12573519_mn_9	BIO_12573519_mn_2_9
BIO	12573519	mn	3	4	motivation_problem	proposal	support	none	secondary	main	forw	support	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	BIO_12573519_mn_3	BIO_12573519_mn_4	BIO_12573519_mn_3_4
BIO	12573519	mn	3	5	motivation_problem	observation	support	support	secondary	secondary	none	none	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	BIO_12573519_mn_3	BIO_12573519_mn_5	BIO_12573519_mn_3_5
BIO	12573519	mn	3	6	motivation_problem	means	support	by-means	secondary	secondary	none	none	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	BIO_12573519_mn_3	BIO_12573519_mn_6	BIO_12573519_mn_3_6
BIO	12573519	mn	3	7	motivation_problem	observation	support	support	secondary	secondary	none	none	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	BIO_12573519_mn_3	BIO_12573519_mn_7	BIO_12573519_mn_3_7
BIO	12573519	mn	3	8	motivation_problem	observation	support	support	secondary	secondary	none	none	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_mn_3	BIO_12573519_mn_8	BIO_12573519_mn_3_8
BIO	12573519	mn	3	9	motivation_problem	result	support	support	secondary	secondary	none	none	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_mn_3	BIO_12573519_mn_9	BIO_12573519_mn_3_9
BIO	12573519	mn	4	5	proposal	observation	none	support	main	secondary	none	none	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	BIO_12573519_mn_4	BIO_12573519_mn_5	BIO_12573519_mn_4_5
BIO	12573519	mn	4	6	proposal	means	none	by-means	main	secondary	none	none	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	BIO_12573519_mn_4	BIO_12573519_mn_6	BIO_12573519_mn_4_6
BIO	12573519	mn	4	7	proposal	observation	none	support	main	secondary	none	none	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	BIO_12573519_mn_4	BIO_12573519_mn_7	BIO_12573519_mn_4_7
BIO	12573519	mn	4	8	proposal	observation	none	support	main	secondary	none	none	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_mn_4	BIO_12573519_mn_8	BIO_12573519_mn_4_8
BIO	12573519	mn	4	9	proposal	result	none	support	main	secondary	back	support	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_mn_4	BIO_12573519_mn_9	BIO_12573519_mn_4_9
BIO	12573519	mn	5	6	observation	means	support	by-means	secondary	secondary	none	none	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	BIO_12573519_mn_5	BIO_12573519_mn_6	BIO_12573519_mn_5_6
BIO	12573519	mn	5	7	observation	observation	support	support	secondary	secondary	none	none	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	BIO_12573519_mn_5	BIO_12573519_mn_7	BIO_12573519_mn_5_7
BIO	12573519	mn	5	8	observation	observation	support	support	secondary	secondary	none	none	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_mn_5	BIO_12573519_mn_8	BIO_12573519_mn_5_8
BIO	12573519	mn	5	9	observation	result	support	support	secondary	secondary	forw	support	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_mn_5	BIO_12573519_mn_9	BIO_12573519_mn_5_9
BIO	12573519	mn	6	7	means	observation	by-means	support	secondary	secondary	forw	by-means	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	BIO_12573519_mn_6	BIO_12573519_mn_7	BIO_12573519_mn_6_7
BIO	12573519	mn	6	8	means	observation	by-means	support	secondary	secondary	none	none	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_mn_6	BIO_12573519_mn_8	BIO_12573519_mn_6_8
BIO	12573519	mn	6	9	means	result	by-means	support	secondary	secondary	none	none	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_mn_6	BIO_12573519_mn_9	BIO_12573519_mn_6_9
BIO	12573519	mn	7	8	observation	observation	support	support	secondary	secondary	forw	support	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_mn_7	BIO_12573519_mn_8	BIO_12573519_mn_7_8
BIO	12573519	mn	7	9	observation	result	support	support	secondary	secondary	none	none	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_mn_7	BIO_12573519_mn_9	BIO_12573519_mn_7_9
BIO	12573519	mn	8	9	observation	result	support	support	secondary	secondary	forw	support	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_mn_8	BIO_12573519_mn_9	BIO_12573519_mn_8_9
BIO	12573519	mn	9	8	result	observation	support	support	secondary	secondary	back	support	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_mn_9	BIO_12573519_mn_8	BIO_12573519_mn_8_9
BIO	12609492	mn	1	2	motivation_background	proposal	support	none	secondary	main	forw	support	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	BIO_12609492_mn_1	BIO_12609492_mn_2	BIO_12609492_mn_1_2
BIO	12609492	mn	1	3	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	BIO_12609492_mn_1	BIO_12609492_mn_3	BIO_12609492_mn_1_3
BIO	12609492	mn	1	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	BIO_12609492_mn_1	BIO_12609492_mn_4	BIO_12609492_mn_1_4
BIO	12609492	mn	1	5	motivation_background	observation	support	support	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	BIO_12609492_mn_1	BIO_12609492_mn_5	BIO_12609492_mn_1_5
BIO	12609492	mn	1	6	motivation_background	observation	support	support	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	BIO_12609492_mn_1	BIO_12609492_mn_6	BIO_12609492_mn_1_6
BIO	12609492	mn	1	7	motivation_background	observation	support	support	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	BIO_12609492_mn_1	BIO_12609492_mn_7	BIO_12609492_mn_1_7
BIO	12609492	mn	1	8	motivation_background	observation	support	support	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_mn_1	BIO_12609492_mn_8	BIO_12609492_mn_1_8
BIO	12609492	mn	1	9	motivation_background	result	support	support	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_mn_1	BIO_12609492_mn_9	BIO_12609492_mn_1_9
BIO	12609492	mn	1	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_mn_1	BIO_12609492_mn_10	BIO_12609492_mn_1_10
BIO	12609492	mn	1	11	motivation_background	result	support	support	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_mn_1	BIO_12609492_mn_11	BIO_12609492_mn_1_11
BIO	12609492	mn	1	12	motivation_background	result	support	elaboration	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_mn_1	BIO_12609492_mn_12	BIO_12609492_mn_1_12
BIO	12609492	mn	2	3	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	BIO_12609492_mn_2	BIO_12609492_mn_3	BIO_12609492_mn_2_3
BIO	12609492	mn	2	4	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	BIO_12609492_mn_2	BIO_12609492_mn_4	BIO_12609492_mn_2_4
BIO	12609492	mn	2	5	proposal	observation	none	support	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	BIO_12609492_mn_2	BIO_12609492_mn_5	BIO_12609492_mn_2_5
BIO	12609492	mn	2	6	proposal	observation	none	support	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	BIO_12609492_mn_2	BIO_12609492_mn_6	BIO_12609492_mn_2_6
BIO	12609492	mn	2	7	proposal	observation	none	support	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	BIO_12609492_mn_2	BIO_12609492_mn_7	BIO_12609492_mn_2_7
BIO	12609492	mn	2	8	proposal	observation	none	support	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_mn_2	BIO_12609492_mn_8	BIO_12609492_mn_2_8
BIO	12609492	mn	2	9	proposal	result	none	support	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_mn_2	BIO_12609492_mn_9	BIO_12609492_mn_2_9
BIO	12609492	mn	2	10	proposal	conclusion	none	support	main	secondary	back	support	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_mn_2	BIO_12609492_mn_10	BIO_12609492_mn_2_10
BIO	12609492	mn	2	11	proposal	result	none	support	main	secondary	back	support	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_mn_2	BIO_12609492_mn_11	BIO_12609492_mn_2_11
BIO	12609492	mn	2	12	proposal	result	none	elaboration	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_mn_2	BIO_12609492_mn_12	BIO_12609492_mn_2_12
BIO	12609492	mn	3	4	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	BIO_12609492_mn_3	BIO_12609492_mn_4	BIO_12609492_mn_3_4
BIO	12609492	mn	3	5	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	BIO_12609492_mn_3	BIO_12609492_mn_5	BIO_12609492_mn_3_5
BIO	12609492	mn	3	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	BIO_12609492_mn_3	BIO_12609492_mn_6	BIO_12609492_mn_3_6
BIO	12609492	mn	3	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	BIO_12609492_mn_3	BIO_12609492_mn_7	BIO_12609492_mn_3_7
BIO	12609492	mn	3	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_mn_3	BIO_12609492_mn_8	BIO_12609492_mn_3_8
BIO	12609492	mn	3	9	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_mn_3	BIO_12609492_mn_9	BIO_12609492_mn_3_9
BIO	12609492	mn	3	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_mn_3	BIO_12609492_mn_10	BIO_12609492_mn_3_10
BIO	12609492	mn	3	11	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_mn_3	BIO_12609492_mn_11	BIO_12609492_mn_3_11
BIO	12609492	mn	3	12	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_mn_3	BIO_12609492_mn_12	BIO_12609492_mn_3_12
BIO	12609492	mn	4	5	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	BIO_12609492_mn_4	BIO_12609492_mn_5	BIO_12609492_mn_4_5
BIO	12609492	mn	4	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	BIO_12609492_mn_4	BIO_12609492_mn_6	BIO_12609492_mn_4_6
BIO	12609492	mn	4	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	BIO_12609492_mn_4	BIO_12609492_mn_7	BIO_12609492_mn_4_7
BIO	12609492	mn	4	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_mn_4	BIO_12609492_mn_8	BIO_12609492_mn_4_8
BIO	12609492	mn	4	9	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_mn_4	BIO_12609492_mn_9	BIO_12609492_mn_4_9
BIO	12609492	mn	4	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_mn_4	BIO_12609492_mn_10	BIO_12609492_mn_4_10
BIO	12609492	mn	4	11	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_mn_4	BIO_12609492_mn_11	BIO_12609492_mn_4_11
BIO	12609492	mn	4	12	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_mn_4	BIO_12609492_mn_12	BIO_12609492_mn_4_12
BIO	12609492	mn	5	6	observation	observation	support	support	secondary	secondary	back	support	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	BIO_12609492_mn_5	BIO_12609492_mn_6	BIO_12609492_mn_5_6
BIO	12609492	mn	5	7	observation	observation	support	support	secondary	secondary	none	none	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	BIO_12609492_mn_5	BIO_12609492_mn_7	BIO_12609492_mn_5_7
BIO	12609492	mn	5	8	observation	observation	support	support	secondary	secondary	none	none	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_mn_5	BIO_12609492_mn_8	BIO_12609492_mn_5_8
BIO	12609492	mn	5	9	observation	result	support	support	secondary	secondary	none	none	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_mn_5	BIO_12609492_mn_9	BIO_12609492_mn_5_9
BIO	12609492	mn	5	10	observation	conclusion	support	support	secondary	secondary	none	none	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_mn_5	BIO_12609492_mn_10	BIO_12609492_mn_5_10
BIO	12609492	mn	5	11	observation	result	support	support	secondary	secondary	forw	support	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_mn_5	BIO_12609492_mn_11	BIO_12609492_mn_5_11
BIO	12609492	mn	5	12	observation	result	support	elaboration	secondary	secondary	none	none	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_mn_5	BIO_12609492_mn_12	BIO_12609492_mn_5_12
BIO	12609492	mn	6	7	observation	observation	support	support	secondary	secondary	none	none	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	BIO_12609492_mn_6	BIO_12609492_mn_7	BIO_12609492_mn_6_7
BIO	12609492	mn	6	8	observation	observation	support	support	secondary	secondary	none	none	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_mn_6	BIO_12609492_mn_8	BIO_12609492_mn_6_8
BIO	12609492	mn	6	9	observation	result	support	support	secondary	secondary	none	none	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_mn_6	BIO_12609492_mn_9	BIO_12609492_mn_6_9
BIO	12609492	mn	6	10	observation	conclusion	support	support	secondary	secondary	none	none	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_mn_6	BIO_12609492_mn_10	BIO_12609492_mn_6_10
BIO	12609492	mn	6	11	observation	result	support	support	secondary	secondary	none	none	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_mn_6	BIO_12609492_mn_11	BIO_12609492_mn_6_11
BIO	12609492	mn	6	12	observation	result	support	elaboration	secondary	secondary	none	none	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_mn_6	BIO_12609492_mn_12	BIO_12609492_mn_6_12
BIO	12609492	mn	7	8	observation	observation	support	support	secondary	secondary	none	none	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_mn_7	BIO_12609492_mn_8	BIO_12609492_mn_7_8
BIO	12609492	mn	7	9	observation	result	support	support	secondary	secondary	none	none	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_mn_7	BIO_12609492_mn_9	BIO_12609492_mn_7_9
BIO	12609492	mn	7	10	observation	conclusion	support	support	secondary	secondary	none	none	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_mn_7	BIO_12609492_mn_10	BIO_12609492_mn_7_10
BIO	12609492	mn	7	11	observation	result	support	support	secondary	secondary	forw	support	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_mn_7	BIO_12609492_mn_11	BIO_12609492_mn_7_11
BIO	12609492	mn	7	12	observation	result	support	elaboration	secondary	secondary	none	none	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_mn_7	BIO_12609492_mn_12	BIO_12609492_mn_7_12
BIO	12609492	mn	8	9	observation	result	support	support	secondary	secondary	forw	support	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_mn_8	BIO_12609492_mn_9	BIO_12609492_mn_8_9
BIO	12609492	mn	8	10	observation	conclusion	support	support	secondary	secondary	none	none	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_mn_8	BIO_12609492_mn_10	BIO_12609492_mn_8_10
BIO	12609492	mn	8	11	observation	result	support	support	secondary	secondary	none	none	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_mn_8	BIO_12609492_mn_11	BIO_12609492_mn_8_11
BIO	12609492	mn	8	12	observation	result	support	elaboration	secondary	secondary	none	none	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_mn_8	BIO_12609492_mn_12	BIO_12609492_mn_8_12
BIO	12609492	mn	9	10	result	conclusion	support	support	secondary	secondary	forw	support	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_mn_9	BIO_12609492_mn_10	BIO_12609492_mn_9_10
BIO	12609492	mn	9	11	result	result	support	support	secondary	secondary	none	none	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_mn_9	BIO_12609492_mn_11	BIO_12609492_mn_9_11
BIO	12609492	mn	9	12	result	result	support	elaboration	secondary	secondary	none	none	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_mn_9	BIO_12609492_mn_12	BIO_12609492_mn_9_12
BIO	12609492	mn	10	11	conclusion	result	support	support	secondary	secondary	none	none	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_mn_10	BIO_12609492_mn_11	BIO_12609492_mn_10_11
BIO	12609492	mn	10	12	conclusion	result	support	elaboration	secondary	secondary	none	none	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_mn_10	BIO_12609492_mn_12	BIO_12609492_mn_10_12
BIO	12609492	mn	11	12	result	result	support	elaboration	secondary	secondary	back	elaboration	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_mn_11	BIO_12609492_mn_12	BIO_12609492_mn_11_12
BIO	12609492	mn	12	11	result	result	elaboration	support	secondary	secondary	forw	elaboration	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_mn_12	BIO_12609492_mn_11	BIO_12609492_mn_11_12
BIO	12612044	mn	1	2	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	A virtual target and cursor image were viewed co-planar with the manipulandum.	BIO_12612044_mn_1	BIO_12612044_mn_2	BIO_12612044_mn_1_2
BIO	12612044	mn	1	3	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	BIO_12612044_mn_1	BIO_12612044_mn_3	BIO_12612044_mn_1_3
BIO	12612044	mn	1	4	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	BIO_12612044_mn_1	BIO_12612044_mn_4	BIO_12612044_mn_1_4
BIO	12612044	mn	1	5	proposal	observation	none	support	main	secondary	back	support	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	BIO_12612044_mn_1	BIO_12612044_mn_5	BIO_12612044_mn_1_5
BIO	12612044	mn	1	6	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	BIO_12612044_mn_1	BIO_12612044_mn_6	BIO_12612044_mn_1_6
BIO	12612044	mn	1	7	proposal	observation	none	elaboration	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	Most task-related neurons (68%) showed no significant directional modulation.	BIO_12612044_mn_1	BIO_12612044_mn_7	BIO_12612044_mn_1_7
BIO	12612044	mn	1	8	proposal	observation	none	support	main	secondary	back	support	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_mn_1	BIO_12612044_mn_8	BIO_12612044_mn_1_8
BIO	12612044	mn	1	9	proposal	result	none	support	main	secondary	back	support	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_mn_1	BIO_12612044_mn_9	BIO_12612044_mn_1_9
BIO	12612044	mn	1	10	proposal	result	none	elaboration	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_mn_1	BIO_12612044_mn_10	BIO_12612044_mn_1_10
BIO	12612044	mn	1	11	proposal	conclusion	none	support	main	secondary	back	support	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_mn_1	BIO_12612044_mn_11	BIO_12612044_mn_1_11
BIO	12612044	mn	1	12	proposal	conclusion	none	support	main	secondary	back	support	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_mn_1	BIO_12612044_mn_12	BIO_12612044_mn_1_12
BIO	12612044	mn	2	3	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	A virtual target and cursor image were viewed co-planar with the manipulandum.	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	BIO_12612044_mn_2	BIO_12612044_mn_3	BIO_12612044_mn_2_3
BIO	12612044	mn	2	4	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	BIO_12612044_mn_2	BIO_12612044_mn_4	BIO_12612044_mn_2_4
BIO	12612044	mn	2	5	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	BIO_12612044_mn_2	BIO_12612044_mn_5	BIO_12612044_mn_2_5
BIO	12612044	mn	2	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	BIO_12612044_mn_2	BIO_12612044_mn_6	BIO_12612044_mn_2_6
BIO	12612044	mn	2	7	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	Most task-related neurons (68%) showed no significant directional modulation.	BIO_12612044_mn_2	BIO_12612044_mn_7	BIO_12612044_mn_2_7
BIO	12612044	mn	2	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_mn_2	BIO_12612044_mn_8	BIO_12612044_mn_2_8
BIO	12612044	mn	2	9	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_mn_2	BIO_12612044_mn_9	BIO_12612044_mn_2_9
BIO	12612044	mn	2	10	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_mn_2	BIO_12612044_mn_10	BIO_12612044_mn_2_10
BIO	12612044	mn	2	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_mn_2	BIO_12612044_mn_11	BIO_12612044_mn_2_11
BIO	12612044	mn	2	12	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_mn_2	BIO_12612044_mn_12	BIO_12612044_mn_2_12
BIO	12612044	mn	3	4	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	BIO_12612044_mn_3	BIO_12612044_mn_4	BIO_12612044_mn_3_4
BIO	12612044	mn	3	5	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	BIO_12612044_mn_3	BIO_12612044_mn_5	BIO_12612044_mn_3_5
BIO	12612044	mn	3	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	BIO_12612044_mn_3	BIO_12612044_mn_6	BIO_12612044_mn_3_6
BIO	12612044	mn	3	7	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	Most task-related neurons (68%) showed no significant directional modulation.	BIO_12612044_mn_3	BIO_12612044_mn_7	BIO_12612044_mn_3_7
BIO	12612044	mn	3	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_mn_3	BIO_12612044_mn_8	BIO_12612044_mn_3_8
BIO	12612044	mn	3	9	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_mn_3	BIO_12612044_mn_9	BIO_12612044_mn_3_9
BIO	12612044	mn	3	10	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_mn_3	BIO_12612044_mn_10	BIO_12612044_mn_3_10
BIO	12612044	mn	3	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_mn_3	BIO_12612044_mn_11	BIO_12612044_mn_3_11
BIO	12612044	mn	3	12	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_mn_3	BIO_12612044_mn_12	BIO_12612044_mn_3_12
BIO	12612044	mn	4	5	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	BIO_12612044_mn_4	BIO_12612044_mn_5	BIO_12612044_mn_4_5
BIO	12612044	mn	4	6	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	BIO_12612044_mn_4	BIO_12612044_mn_6	BIO_12612044_mn_4_6
BIO	12612044	mn	4	7	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	Most task-related neurons (68%) showed no significant directional modulation.	BIO_12612044_mn_4	BIO_12612044_mn_7	BIO_12612044_mn_4_7
BIO	12612044	mn	4	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_mn_4	BIO_12612044_mn_8	BIO_12612044_mn_4_8
BIO	12612044	mn	4	9	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_mn_4	BIO_12612044_mn_9	BIO_12612044_mn_4_9
BIO	12612044	mn	4	10	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_mn_4	BIO_12612044_mn_10	BIO_12612044_mn_4_10
BIO	12612044	mn	4	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_mn_4	BIO_12612044_mn_11	BIO_12612044_mn_4_11
BIO	12612044	mn	4	12	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_mn_4	BIO_12612044_mn_12	BIO_12612044_mn_4_12
BIO	12612044	mn	5	6	observation	proposal_implementation	support	elaboration	secondary	secondary	none	none	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	BIO_12612044_mn_5	BIO_12612044_mn_6	BIO_12612044_mn_5_6
BIO	12612044	mn	5	7	observation	observation	support	elaboration	secondary	secondary	back	elaboration	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	Most task-related neurons (68%) showed no significant directional modulation.	BIO_12612044_mn_5	BIO_12612044_mn_7	BIO_12612044_mn_5_7
BIO	12612044	mn	5	8	observation	observation	support	support	secondary	secondary	none	none	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_mn_5	BIO_12612044_mn_8	BIO_12612044_mn_5_8
BIO	12612044	mn	5	9	observation	result	support	support	secondary	secondary	none	none	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_mn_5	BIO_12612044_mn_9	BIO_12612044_mn_5_9
BIO	12612044	mn	5	10	observation	result	support	elaboration	secondary	secondary	none	none	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_mn_5	BIO_12612044_mn_10	BIO_12612044_mn_5_10
BIO	12612044	mn	5	11	observation	conclusion	support	support	secondary	secondary	none	none	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_mn_5	BIO_12612044_mn_11	BIO_12612044_mn_5_11
BIO	12612044	mn	5	12	observation	conclusion	support	support	secondary	secondary	none	none	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_mn_5	BIO_12612044_mn_12	BIO_12612044_mn_5_12
BIO	12612044	mn	6	7	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	Most task-related neurons (68%) showed no significant directional modulation.	BIO_12612044_mn_6	BIO_12612044_mn_7	BIO_12612044_mn_6_7
BIO	12612044	mn	6	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_mn_6	BIO_12612044_mn_8	BIO_12612044_mn_6_8
BIO	12612044	mn	6	9	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_mn_6	BIO_12612044_mn_9	BIO_12612044_mn_6_9
BIO	12612044	mn	6	10	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_mn_6	BIO_12612044_mn_10	BIO_12612044_mn_6_10
BIO	12612044	mn	6	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_mn_6	BIO_12612044_mn_11	BIO_12612044_mn_6_11
BIO	12612044	mn	6	12	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_mn_6	BIO_12612044_mn_12	BIO_12612044_mn_6_12
BIO	12612044	mn	7	8	observation	observation	elaboration	support	secondary	secondary	none	none	Most task-related neurons (68%) showed no significant directional modulation.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_mn_7	BIO_12612044_mn_8	BIO_12612044_mn_7_8
BIO	12612044	mn	7	9	observation	result	elaboration	support	secondary	secondary	none	none	Most task-related neurons (68%) showed no significant directional modulation.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_mn_7	BIO_12612044_mn_9	BIO_12612044_mn_7_9
BIO	12612044	mn	7	10	observation	result	elaboration	elaboration	secondary	secondary	none	none	Most task-related neurons (68%) showed no significant directional modulation.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_mn_7	BIO_12612044_mn_10	BIO_12612044_mn_7_10
BIO	12612044	mn	7	11	observation	conclusion	elaboration	support	secondary	secondary	none	none	Most task-related neurons (68%) showed no significant directional modulation.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_mn_7	BIO_12612044_mn_11	BIO_12612044_mn_7_11
BIO	12612044	mn	7	12	observation	conclusion	elaboration	support	secondary	secondary	none	none	Most task-related neurons (68%) showed no significant directional modulation.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_mn_7	BIO_12612044_mn_12	BIO_12612044_mn_7_12
BIO	12612044	mn	8	9	observation	result	support	support	secondary	secondary	none	none	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_mn_8	BIO_12612044_mn_9	BIO_12612044_mn_8_9
BIO	12612044	mn	8	10	observation	result	support	elaboration	secondary	secondary	none	none	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_mn_8	BIO_12612044_mn_10	BIO_12612044_mn_8_10
BIO	12612044	mn	8	11	observation	conclusion	support	support	secondary	secondary	none	none	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_mn_8	BIO_12612044_mn_11	BIO_12612044_mn_8_11
BIO	12612044	mn	8	12	observation	conclusion	support	support	secondary	secondary	none	none	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_mn_8	BIO_12612044_mn_12	BIO_12612044_mn_8_12
BIO	12612044	mn	9	10	result	result	support	elaboration	secondary	secondary	back	elaboration	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_mn_9	BIO_12612044_mn_10	BIO_12612044_mn_9_10
BIO	12612044	mn	9	11	result	conclusion	support	support	secondary	secondary	none	none	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_mn_9	BIO_12612044_mn_11	BIO_12612044_mn_9_11
BIO	12612044	mn	9	12	result	conclusion	support	support	secondary	secondary	none	none	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_mn_9	BIO_12612044_mn_12	BIO_12612044_mn_9_12
BIO	12612044	mn	10	11	result	conclusion	elaboration	support	secondary	secondary	none	none	Hence, activity returned to baseline about when the delayed cursor reached the target.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_mn_10	BIO_12612044_mn_11	BIO_12612044_mn_10_11
BIO	12612044	mn	10	12	result	conclusion	elaboration	support	secondary	secondary	none	none	Hence, activity returned to baseline about when the delayed cursor reached the target.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_mn_10	BIO_12612044_mn_12	BIO_12612044_mn_10_12
BIO	12612044	mn	11	12	conclusion	conclusion	support	support	secondary	secondary	none	none	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_mn_11	BIO_12612044_mn_12	BIO_12612044_mn_11_12
BIO	12612044	mn	12	11	conclusion	conclusion	support	support	secondary	secondary	none	none	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_mn_12	BIO_12612044_mn_11	BIO_12612044_mn_11_12
BIO	12622405	mn	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	BIO_12622405_mn_1	BIO_12622405_mn_2	BIO_12622405_mn_1_2
BIO	12622405	mn	1	3	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	BIO_12622405_mn_1	BIO_12622405_mn_3	BIO_12622405_mn_1_3
BIO	12622405	mn	1	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	BIO_12622405_mn_1	BIO_12622405_mn_4	BIO_12622405_mn_1_4
BIO	12622405	mn	1	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Their neuroprotective activity against excitotoxic insults remains elusive.	BIO_12622405_mn_1	BIO_12622405_mn_5	BIO_12622405_mn_1_5
BIO	12622405	mn	1	6	motivation_background	proposal	info-required	none	secondary	main	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	BIO_12622405_mn_1	BIO_12622405_mn_6	BIO_12622405_mn_1_6
BIO	12622405	mn	1	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	BIO_12622405_mn_1	BIO_12622405_mn_7	BIO_12622405_mn_1_7
BIO	12622405	mn	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_mn_1	BIO_12622405_mn_8	BIO_12622405_mn_1_8
BIO	12622405	mn	1	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_mn_1	BIO_12622405_mn_9	BIO_12622405_mn_1_9
BIO	12622405	mn	1	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_mn_1	BIO_12622405_mn_10	BIO_12622405_mn_1_10
BIO	12622405	mn	1	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_mn_1	BIO_12622405_mn_11	BIO_12622405_mn_1_11
BIO	12622405	mn	1	12	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_mn_1	BIO_12622405_mn_12	BIO_12622405_mn_1_12
BIO	12622405	mn	1	13	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_1	BIO_12622405_mn_13	BIO_12622405_mn_1_13
BIO	12622405	mn	1	14	motivation_background	result	info-required	support	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_1	BIO_12622405_mn_14	BIO_12622405_mn_1_14
BIO	12622405	mn	2	3	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	BIO_12622405_mn_2	BIO_12622405_mn_3	BIO_12622405_mn_2_3
BIO	12622405	mn	2	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	BIO_12622405_mn_2	BIO_12622405_mn_4	BIO_12622405_mn_2_4
BIO	12622405	mn	2	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Their neuroprotective activity against excitotoxic insults remains elusive.	BIO_12622405_mn_2	BIO_12622405_mn_5	BIO_12622405_mn_2_5
BIO	12622405	mn	2	6	motivation_background	proposal	info-required	none	secondary	main	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	BIO_12622405_mn_2	BIO_12622405_mn_6	BIO_12622405_mn_2_6
BIO	12622405	mn	2	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	BIO_12622405_mn_2	BIO_12622405_mn_7	BIO_12622405_mn_2_7
BIO	12622405	mn	2	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_mn_2	BIO_12622405_mn_8	BIO_12622405_mn_2_8
BIO	12622405	mn	2	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_mn_2	BIO_12622405_mn_9	BIO_12622405_mn_2_9
BIO	12622405	mn	2	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_mn_2	BIO_12622405_mn_10	BIO_12622405_mn_2_10
BIO	12622405	mn	2	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_mn_2	BIO_12622405_mn_11	BIO_12622405_mn_2_11
BIO	12622405	mn	2	12	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_mn_2	BIO_12622405_mn_12	BIO_12622405_mn_2_12
BIO	12622405	mn	2	13	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_2	BIO_12622405_mn_13	BIO_12622405_mn_2_13
BIO	12622405	mn	2	14	motivation_background	result	info-required	support	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_2	BIO_12622405_mn_14	BIO_12622405_mn_2_14
BIO	12622405	mn	3	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	BIO_12622405_mn_3	BIO_12622405_mn_4	BIO_12622405_mn_3_4
BIO	12622405	mn	3	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	Their neuroprotective activity against excitotoxic insults remains elusive.	BIO_12622405_mn_3	BIO_12622405_mn_5	BIO_12622405_mn_3_5
BIO	12622405	mn	3	6	motivation_background	proposal	info-required	none	secondary	main	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	BIO_12622405_mn_3	BIO_12622405_mn_6	BIO_12622405_mn_3_6
BIO	12622405	mn	3	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	BIO_12622405_mn_3	BIO_12622405_mn_7	BIO_12622405_mn_3_7
BIO	12622405	mn	3	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_mn_3	BIO_12622405_mn_8	BIO_12622405_mn_3_8
BIO	12622405	mn	3	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_mn_3	BIO_12622405_mn_9	BIO_12622405_mn_3_9
BIO	12622405	mn	3	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_mn_3	BIO_12622405_mn_10	BIO_12622405_mn_3_10
BIO	12622405	mn	3	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_mn_3	BIO_12622405_mn_11	BIO_12622405_mn_3_11
BIO	12622405	mn	3	12	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_mn_3	BIO_12622405_mn_12	BIO_12622405_mn_3_12
BIO	12622405	mn	3	13	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_3	BIO_12622405_mn_13	BIO_12622405_mn_3_13
BIO	12622405	mn	3	14	motivation_background	result	info-required	support	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_3	BIO_12622405_mn_14	BIO_12622405_mn_3_14
BIO	12622405	mn	4	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	Their neuroprotective activity against excitotoxic insults remains elusive.	BIO_12622405_mn_4	BIO_12622405_mn_5	BIO_12622405_mn_4_5
BIO	12622405	mn	4	6	motivation_background	proposal	info-required	none	secondary	main	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	BIO_12622405_mn_4	BIO_12622405_mn_6	BIO_12622405_mn_4_6
BIO	12622405	mn	4	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	BIO_12622405_mn_4	BIO_12622405_mn_7	BIO_12622405_mn_4_7
BIO	12622405	mn	4	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_mn_4	BIO_12622405_mn_8	BIO_12622405_mn_4_8
BIO	12622405	mn	4	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_mn_4	BIO_12622405_mn_9	BIO_12622405_mn_4_9
BIO	12622405	mn	4	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_mn_4	BIO_12622405_mn_10	BIO_12622405_mn_4_10
BIO	12622405	mn	4	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_mn_4	BIO_12622405_mn_11	BIO_12622405_mn_4_11
BIO	12622405	mn	4	12	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_mn_4	BIO_12622405_mn_12	BIO_12622405_mn_4_12
BIO	12622405	mn	4	13	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_4	BIO_12622405_mn_13	BIO_12622405_mn_4_13
BIO	12622405	mn	4	14	motivation_background	result	info-required	support	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_4	BIO_12622405_mn_14	BIO_12622405_mn_4_14
BIO	12622405	mn	5	6	motivation_problem	proposal	support	none	secondary	main	forw	support	Their neuroprotective activity against excitotoxic insults remains elusive.	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	BIO_12622405_mn_5	BIO_12622405_mn_6	BIO_12622405_mn_5_6
BIO	12622405	mn	5	7	motivation_problem	observation	support	support	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	BIO_12622405_mn_5	BIO_12622405_mn_7	BIO_12622405_mn_5_7
BIO	12622405	mn	5	8	motivation_problem	observation	support	support	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_mn_5	BIO_12622405_mn_8	BIO_12622405_mn_5_8
BIO	12622405	mn	5	9	motivation_problem	observation	support	support	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_mn_5	BIO_12622405_mn_9	BIO_12622405_mn_5_9
BIO	12622405	mn	5	10	motivation_problem	observation	support	support	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_mn_5	BIO_12622405_mn_10	BIO_12622405_mn_5_10
BIO	12622405	mn	5	11	motivation_problem	observation	support	support	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_mn_5	BIO_12622405_mn_11	BIO_12622405_mn_5_11
BIO	12622405	mn	5	12	motivation_problem	result	support	elaboration	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_mn_5	BIO_12622405_mn_12	BIO_12622405_mn_5_12
BIO	12622405	mn	5	13	motivation_problem	result	support	elaboration	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_5	BIO_12622405_mn_13	BIO_12622405_mn_5_13
BIO	12622405	mn	5	14	motivation_problem	result	support	support	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_5	BIO_12622405_mn_14	BIO_12622405_mn_5_14
BIO	12622405	mn	6	7	proposal	observation	none	support	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	BIO_12622405_mn_6	BIO_12622405_mn_7	BIO_12622405_mn_6_7
BIO	12622405	mn	6	8	proposal	observation	none	support	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_mn_6	BIO_12622405_mn_8	BIO_12622405_mn_6_8
BIO	12622405	mn	6	9	proposal	observation	none	support	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_mn_6	BIO_12622405_mn_9	BIO_12622405_mn_6_9
BIO	12622405	mn	6	10	proposal	observation	none	support	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_mn_6	BIO_12622405_mn_10	BIO_12622405_mn_6_10
BIO	12622405	mn	6	11	proposal	observation	none	support	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_mn_6	BIO_12622405_mn_11	BIO_12622405_mn_6_11
BIO	12622405	mn	6	12	proposal	result	none	elaboration	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_mn_6	BIO_12622405_mn_12	BIO_12622405_mn_6_12
BIO	12622405	mn	6	13	proposal	result	none	elaboration	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_6	BIO_12622405_mn_13	BIO_12622405_mn_6_13
BIO	12622405	mn	6	14	proposal	result	none	support	main	secondary	back	support	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_6	BIO_12622405_mn_14	BIO_12622405_mn_6_14
BIO	12622405	mn	7	8	observation	observation	support	support	secondary	secondary	back	support	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_mn_7	BIO_12622405_mn_8	BIO_12622405_mn_7_8
BIO	12622405	mn	7	9	observation	observation	support	support	secondary	secondary	back	support	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_mn_7	BIO_12622405_mn_9	BIO_12622405_mn_7_9
BIO	12622405	mn	7	10	observation	observation	support	support	secondary	secondary	none	none	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_mn_7	BIO_12622405_mn_10	BIO_12622405_mn_7_10
BIO	12622405	mn	7	11	observation	observation	support	support	secondary	secondary	none	none	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_mn_7	BIO_12622405_mn_11	BIO_12622405_mn_7_11
BIO	12622405	mn	7	12	observation	result	support	elaboration	secondary	secondary	forw	support	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_mn_7	BIO_12622405_mn_12	BIO_12622405_mn_7_12
BIO	12622405	mn	7	13	observation	result	support	elaboration	secondary	secondary	none	none	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_7	BIO_12622405_mn_13	BIO_12622405_mn_7_13
BIO	12622405	mn	7	14	observation	result	support	support	secondary	secondary	none	none	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_7	BIO_12622405_mn_14	BIO_12622405_mn_7_14
BIO	12622405	mn	8	9	observation	observation	support	support	secondary	secondary	none	none	Similar results were obtained for L-glutamate at 14 DIV.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_mn_8	BIO_12622405_mn_9	BIO_12622405_mn_8_9
BIO	12622405	mn	8	10	observation	observation	support	support	secondary	secondary	none	none	Similar results were obtained for L-glutamate at 14 DIV.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_mn_8	BIO_12622405_mn_10	BIO_12622405_mn_8_10
BIO	12622405	mn	8	11	observation	observation	support	support	secondary	secondary	none	none	Similar results were obtained for L-glutamate at 14 DIV.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_mn_8	BIO_12622405_mn_11	BIO_12622405_mn_8_11
BIO	12622405	mn	8	12	observation	result	support	elaboration	secondary	secondary	none	none	Similar results were obtained for L-glutamate at 14 DIV.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_mn_8	BIO_12622405_mn_12	BIO_12622405_mn_8_12
BIO	12622405	mn	8	13	observation	result	support	elaboration	secondary	secondary	none	none	Similar results were obtained for L-glutamate at 14 DIV.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_8	BIO_12622405_mn_13	BIO_12622405_mn_8_13
BIO	12622405	mn	8	14	observation	result	support	support	secondary	secondary	none	none	Similar results were obtained for L-glutamate at 14 DIV.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_8	BIO_12622405_mn_14	BIO_12622405_mn_8_14
BIO	12622405	mn	9	10	observation	observation	support	support	secondary	secondary	back	support	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_mn_9	BIO_12622405_mn_10	BIO_12622405_mn_9_10
BIO	12622405	mn	9	11	observation	observation	support	support	secondary	secondary	none	none	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_mn_9	BIO_12622405_mn_11	BIO_12622405_mn_9_11
BIO	12622405	mn	9	12	observation	result	support	elaboration	secondary	secondary	none	none	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_mn_9	BIO_12622405_mn_12	BIO_12622405_mn_9_12
BIO	12622405	mn	9	13	observation	result	support	elaboration	secondary	secondary	none	none	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_9	BIO_12622405_mn_13	BIO_12622405_mn_9_13
BIO	12622405	mn	9	14	observation	result	support	support	secondary	secondary	none	none	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_9	BIO_12622405_mn_14	BIO_12622405_mn_9_14
BIO	12622405	mn	10	11	observation	observation	support	support	secondary	secondary	none	none	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_mn_10	BIO_12622405_mn_11	BIO_12622405_mn_10_11
BIO	12622405	mn	10	12	observation	result	support	elaboration	secondary	secondary	none	none	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_mn_10	BIO_12622405_mn_12	BIO_12622405_mn_10_12
BIO	12622405	mn	10	13	observation	result	support	elaboration	secondary	secondary	none	none	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_10	BIO_12622405_mn_13	BIO_12622405_mn_10_13
BIO	12622405	mn	10	14	observation	result	support	support	secondary	secondary	none	none	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_10	BIO_12622405_mn_14	BIO_12622405_mn_10_14
BIO	12622405	mn	11	12	observation	result	support	elaboration	secondary	secondary	forw	support	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_mn_11	BIO_12622405_mn_12	BIO_12622405_mn_11_12
BIO	12622405	mn	11	13	observation	result	support	elaboration	secondary	secondary	none	none	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_11	BIO_12622405_mn_13	BIO_12622405_mn_11_13
BIO	12622405	mn	11	14	observation	result	support	support	secondary	secondary	none	none	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_11	BIO_12622405_mn_14	BIO_12622405_mn_11_14
BIO	12622405	mn	12	13	result	result	elaboration	elaboration	secondary	secondary	back	elaboration	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_12	BIO_12622405_mn_13	BIO_12622405_mn_12_13
BIO	12622405	mn	12	14	result	result	elaboration	support	secondary	secondary	forw	elaboration	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_12	BIO_12622405_mn_14	BIO_12622405_mn_12_14
BIO	12622405	mn	13	14	result	result	elaboration	support	secondary	secondary	none	none	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_mn_13	BIO_12622405_mn_14	BIO_12622405_mn_13_14
BIO	12622405	mn	14	13	result	result	support	elaboration	secondary	secondary	none	none	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_mn_14	BIO_12622405_mn_13	BIO_12622405_mn_13_14
BIO	12663096	mn	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	BIO_12663096_mn_1	BIO_12663096_mn_2	BIO_12663096_mn_1_2
BIO	12663096	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	BIO_12663096_mn_1	BIO_12663096_mn_3	BIO_12663096_mn_1_3
BIO	12663096	mn	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	BIO_12663096_mn_1	BIO_12663096_mn_4	BIO_12663096_mn_1_4
BIO	12663096	mn	1	5	motivation_background	result	info-required	support	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	BIO_12663096_mn_1	BIO_12663096_mn_5	BIO_12663096_mn_1_5
BIO	12663096	mn	1	6	motivation_background	observation	info-required	support	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	BIO_12663096_mn_1	BIO_12663096_mn_6	BIO_12663096_mn_1_6
BIO	12663096	mn	1	7	motivation_background	result	info-required	support	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	BIO_12663096_mn_1	BIO_12663096_mn_7	BIO_12663096_mn_1_7
BIO	12663096	mn	1	8	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_mn_1	BIO_12663096_mn_8	BIO_12663096_mn_1_8
BIO	12663096	mn	1	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_mn_1	BIO_12663096_mn_9	BIO_12663096_mn_1_9
BIO	12663096	mn	1	10	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_mn_1	BIO_12663096_mn_10	BIO_12663096_mn_1_10
BIO	12663096	mn	1	11	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_mn_1	BIO_12663096_mn_11	BIO_12663096_mn_1_11
BIO	12663096	mn	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	BIO_12663096_mn_2	BIO_12663096_mn_3	BIO_12663096_mn_2_3
BIO	12663096	mn	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	BIO_12663096_mn_2	BIO_12663096_mn_4	BIO_12663096_mn_2_4
BIO	12663096	mn	2	5	motivation_background	result	support	support	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	BIO_12663096_mn_2	BIO_12663096_mn_5	BIO_12663096_mn_2_5
BIO	12663096	mn	2	6	motivation_background	observation	support	support	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	BIO_12663096_mn_2	BIO_12663096_mn_6	BIO_12663096_mn_2_6
BIO	12663096	mn	2	7	motivation_background	result	support	support	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	BIO_12663096_mn_2	BIO_12663096_mn_7	BIO_12663096_mn_2_7
BIO	12663096	mn	2	8	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_mn_2	BIO_12663096_mn_8	BIO_12663096_mn_2_8
BIO	12663096	mn	2	9	motivation_background	observation	support	support	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_mn_2	BIO_12663096_mn_9	BIO_12663096_mn_2_9
BIO	12663096	mn	2	10	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_mn_2	BIO_12663096_mn_10	BIO_12663096_mn_2_10
BIO	12663096	mn	2	11	motivation_background	conclusion	support	support	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_mn_2	BIO_12663096_mn_11	BIO_12663096_mn_2_11
BIO	12663096	mn	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	BIO_12663096_mn_3	BIO_12663096_mn_4	BIO_12663096_mn_3_4
BIO	12663096	mn	3	5	proposal	result	none	support	main	secondary	back	support	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	BIO_12663096_mn_3	BIO_12663096_mn_5	BIO_12663096_mn_3_5
BIO	12663096	mn	3	6	proposal	observation	none	support	main	secondary	none	none	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	BIO_12663096_mn_3	BIO_12663096_mn_6	BIO_12663096_mn_3_6
BIO	12663096	mn	3	7	proposal	result	none	support	main	secondary	back	support	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	BIO_12663096_mn_3	BIO_12663096_mn_7	BIO_12663096_mn_3_7
BIO	12663096	mn	3	8	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_mn_3	BIO_12663096_mn_8	BIO_12663096_mn_3_8
BIO	12663096	mn	3	9	proposal	observation	none	support	main	secondary	back	support	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_mn_3	BIO_12663096_mn_9	BIO_12663096_mn_3_9
BIO	12663096	mn	3	10	proposal	observation	none	elaboration	main	secondary	none	none	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_mn_3	BIO_12663096_mn_10	BIO_12663096_mn_3_10
BIO	12663096	mn	3	11	proposal	conclusion	none	support	main	secondary	back	support	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_mn_3	BIO_12663096_mn_11	BIO_12663096_mn_3_11
BIO	12663096	mn	4	5	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	BIO_12663096_mn_4	BIO_12663096_mn_5	BIO_12663096_mn_4_5
BIO	12663096	mn	4	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	BIO_12663096_mn_4	BIO_12663096_mn_6	BIO_12663096_mn_4_6
BIO	12663096	mn	4	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	BIO_12663096_mn_4	BIO_12663096_mn_7	BIO_12663096_mn_4_7
BIO	12663096	mn	4	8	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_mn_4	BIO_12663096_mn_8	BIO_12663096_mn_4_8
BIO	12663096	mn	4	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_mn_4	BIO_12663096_mn_9	BIO_12663096_mn_4_9
BIO	12663096	mn	4	10	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_mn_4	BIO_12663096_mn_10	BIO_12663096_mn_4_10
BIO	12663096	mn	4	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_mn_4	BIO_12663096_mn_11	BIO_12663096_mn_4_11
BIO	12663096	mn	5	6	result	observation	support	support	secondary	secondary	back	support	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	BIO_12663096_mn_5	BIO_12663096_mn_6	BIO_12663096_mn_5_6
BIO	12663096	mn	5	7	result	result	support	support	secondary	secondary	none	none	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	BIO_12663096_mn_5	BIO_12663096_mn_7	BIO_12663096_mn_5_7
BIO	12663096	mn	5	8	result	proposal_implementation	support	elaboration	secondary	secondary	none	none	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_mn_5	BIO_12663096_mn_8	BIO_12663096_mn_5_8
BIO	12663096	mn	5	9	result	observation	support	support	secondary	secondary	none	none	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_mn_5	BIO_12663096_mn_9	BIO_12663096_mn_5_9
BIO	12663096	mn	5	10	result	observation	support	elaboration	secondary	secondary	none	none	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_mn_5	BIO_12663096_mn_10	BIO_12663096_mn_5_10
BIO	12663096	mn	5	11	result	conclusion	support	support	secondary	secondary	none	none	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_mn_5	BIO_12663096_mn_11	BIO_12663096_mn_5_11
BIO	12663096	mn	6	7	observation	result	support	support	secondary	secondary	none	none	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	BIO_12663096_mn_6	BIO_12663096_mn_7	BIO_12663096_mn_6_7
BIO	12663096	mn	6	8	observation	proposal_implementation	support	elaboration	secondary	secondary	none	none	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_mn_6	BIO_12663096_mn_8	BIO_12663096_mn_6_8
BIO	12663096	mn	6	9	observation	observation	support	support	secondary	secondary	none	none	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_mn_6	BIO_12663096_mn_9	BIO_12663096_mn_6_9
BIO	12663096	mn	6	10	observation	observation	support	elaboration	secondary	secondary	none	none	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_mn_6	BIO_12663096_mn_10	BIO_12663096_mn_6_10
BIO	12663096	mn	6	11	observation	conclusion	support	support	secondary	secondary	none	none	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_mn_6	BIO_12663096_mn_11	BIO_12663096_mn_6_11
BIO	12663096	mn	7	8	result	proposal_implementation	support	elaboration	secondary	secondary	none	none	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_mn_7	BIO_12663096_mn_8	BIO_12663096_mn_7_8
BIO	12663096	mn	7	9	result	observation	support	support	secondary	secondary	none	none	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_mn_7	BIO_12663096_mn_9	BIO_12663096_mn_7_9
BIO	12663096	mn	7	10	result	observation	support	elaboration	secondary	secondary	none	none	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_mn_7	BIO_12663096_mn_10	BIO_12663096_mn_7_10
BIO	12663096	mn	7	11	result	conclusion	support	support	secondary	secondary	none	none	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_mn_7	BIO_12663096_mn_11	BIO_12663096_mn_7_11
BIO	12663096	mn	8	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_mn_8	BIO_12663096_mn_9	BIO_12663096_mn_8_9
BIO	12663096	mn	8	10	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_mn_8	BIO_12663096_mn_10	BIO_12663096_mn_8_10
BIO	12663096	mn	8	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_mn_8	BIO_12663096_mn_11	BIO_12663096_mn_8_11
BIO	12663096	mn	9	10	observation	observation	support	elaboration	secondary	secondary	back	elaboration	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_mn_9	BIO_12663096_mn_10	BIO_12663096_mn_9_10
BIO	12663096	mn	9	11	observation	conclusion	support	support	secondary	secondary	none	none	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_mn_9	BIO_12663096_mn_11	BIO_12663096_mn_9_11
BIO	12663096	mn	10	11	observation	conclusion	elaboration	support	secondary	secondary	none	none	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_mn_10	BIO_12663096_mn_11	BIO_12663096_mn_10_11
BIO	12663096	mn	11	10	conclusion	observation	support	elaboration	secondary	secondary	none	none	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_mn_11	BIO_12663096_mn_10	BIO_12663096_mn_10_11
BIO	12710980	mn	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	BIO_12710980_mn_1	BIO_12710980_mn_2	BIO_12710980_mn_1_2
BIO	12710980	mn	1	3	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	BIO_12710980_mn_1	BIO_12710980_mn_3	BIO_12710980_mn_1_3
BIO	12710980	mn	1	4	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	At present, pharmacological prevention of limbic sclerosis is not available.	BIO_12710980_mn_1	BIO_12710980_mn_4	BIO_12710980_mn_1_4
BIO	12710980	mn	1	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	BIO_12710980_mn_1	BIO_12710980_mn_5	BIO_12710980_mn_1_5
BIO	12710980	mn	1	6	motivation_background	motivation_hypothesis	info-required	support	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	BIO_12710980_mn_1	BIO_12710980_mn_6	BIO_12710980_mn_1_6
BIO	12710980	mn	1	7	motivation_background	proposal	info-required	none	secondary	main	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	BIO_12710980_mn_1	BIO_12710980_mn_7	BIO_12710980_mn_1_7
BIO	12710980	mn	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_mn_1	BIO_12710980_mn_8	BIO_12710980_mn_1_8
BIO	12710980	mn	1	9	motivation_background	result	info-required	support	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_mn_1	BIO_12710980_mn_9	BIO_12710980_mn_1_9
BIO	12710980	mn	1	10	motivation_background	result	info-required	support	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_mn_1	BIO_12710980_mn_10	BIO_12710980_mn_1_10
BIO	12710980	mn	1	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_mn_1	BIO_12710980_mn_11	BIO_12710980_mn_1_11
BIO	12710980	mn	1	12	motivation_background	result	info-required	support	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_mn_1	BIO_12710980_mn_12	BIO_12710980_mn_1_12
BIO	12710980	mn	2	3	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	BIO_12710980_mn_2	BIO_12710980_mn_3	BIO_12710980_mn_2_3
BIO	12710980	mn	2	4	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	At present, pharmacological prevention of limbic sclerosis is not available.	BIO_12710980_mn_2	BIO_12710980_mn_4	BIO_12710980_mn_2_4
BIO	12710980	mn	2	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	BIO_12710980_mn_2	BIO_12710980_mn_5	BIO_12710980_mn_2_5
BIO	12710980	mn	2	6	motivation_background	motivation_hypothesis	info-required	support	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	BIO_12710980_mn_2	BIO_12710980_mn_6	BIO_12710980_mn_2_6
BIO	12710980	mn	2	7	motivation_background	proposal	info-required	none	secondary	main	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	BIO_12710980_mn_2	BIO_12710980_mn_7	BIO_12710980_mn_2_7
BIO	12710980	mn	2	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_mn_2	BIO_12710980_mn_8	BIO_12710980_mn_2_8
BIO	12710980	mn	2	9	motivation_background	result	info-required	support	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_mn_2	BIO_12710980_mn_9	BIO_12710980_mn_2_9
BIO	12710980	mn	2	10	motivation_background	result	info-required	support	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_mn_2	BIO_12710980_mn_10	BIO_12710980_mn_2_10
BIO	12710980	mn	2	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_mn_2	BIO_12710980_mn_11	BIO_12710980_mn_2_11
BIO	12710980	mn	2	12	motivation_background	result	info-required	support	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_mn_2	BIO_12710980_mn_12	BIO_12710980_mn_2_12
BIO	12710980	mn	3	4	motivation_problem	motivation_problem	support	support	secondary	secondary	forw	support	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	At present, pharmacological prevention of limbic sclerosis is not available.	BIO_12710980_mn_3	BIO_12710980_mn_4	BIO_12710980_mn_3_4
BIO	12710980	mn	3	5	motivation_problem	motivation_problem	support	support	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	BIO_12710980_mn_3	BIO_12710980_mn_5	BIO_12710980_mn_3_5
BIO	12710980	mn	3	6	motivation_problem	motivation_hypothesis	support	support	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	BIO_12710980_mn_3	BIO_12710980_mn_6	BIO_12710980_mn_3_6
BIO	12710980	mn	3	7	motivation_problem	proposal	support	none	secondary	main	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	BIO_12710980_mn_3	BIO_12710980_mn_7	BIO_12710980_mn_3_7
BIO	12710980	mn	3	8	motivation_problem	observation	support	support	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_mn_3	BIO_12710980_mn_8	BIO_12710980_mn_3_8
BIO	12710980	mn	3	9	motivation_problem	result	support	support	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_mn_3	BIO_12710980_mn_9	BIO_12710980_mn_3_9
BIO	12710980	mn	3	10	motivation_problem	result	support	support	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_mn_3	BIO_12710980_mn_10	BIO_12710980_mn_3_10
BIO	12710980	mn	3	11	motivation_problem	observation	support	support	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_mn_3	BIO_12710980_mn_11	BIO_12710980_mn_3_11
BIO	12710980	mn	3	12	motivation_problem	result	support	support	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_mn_3	BIO_12710980_mn_12	BIO_12710980_mn_3_12
BIO	12710980	mn	4	5	motivation_problem	motivation_problem	support	support	secondary	secondary	forw	support	At present, pharmacological prevention of limbic sclerosis is not available.	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	BIO_12710980_mn_4	BIO_12710980_mn_5	BIO_12710980_mn_4_5
BIO	12710980	mn	4	6	motivation_problem	motivation_hypothesis	support	support	secondary	secondary	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	BIO_12710980_mn_4	BIO_12710980_mn_6	BIO_12710980_mn_4_6
BIO	12710980	mn	4	7	motivation_problem	proposal	support	none	secondary	main	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	BIO_12710980_mn_4	BIO_12710980_mn_7	BIO_12710980_mn_4_7
BIO	12710980	mn	4	8	motivation_problem	observation	support	support	secondary	secondary	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_mn_4	BIO_12710980_mn_8	BIO_12710980_mn_4_8
BIO	12710980	mn	4	9	motivation_problem	result	support	support	secondary	secondary	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_mn_4	BIO_12710980_mn_9	BIO_12710980_mn_4_9
BIO	12710980	mn	4	10	motivation_problem	result	support	support	secondary	secondary	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_mn_4	BIO_12710980_mn_10	BIO_12710980_mn_4_10
BIO	12710980	mn	4	11	motivation_problem	observation	support	support	secondary	secondary	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_mn_4	BIO_12710980_mn_11	BIO_12710980_mn_4_11
BIO	12710980	mn	4	12	motivation_problem	result	support	support	secondary	secondary	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_mn_4	BIO_12710980_mn_12	BIO_12710980_mn_4_12
BIO	12710980	mn	5	6	motivation_problem	motivation_hypothesis	support	support	secondary	secondary	forw	support	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	BIO_12710980_mn_5	BIO_12710980_mn_6	BIO_12710980_mn_5_6
BIO	12710980	mn	5	7	motivation_problem	proposal	support	none	secondary	main	none	none	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	BIO_12710980_mn_5	BIO_12710980_mn_7	BIO_12710980_mn_5_7
BIO	12710980	mn	5	8	motivation_problem	observation	support	support	secondary	secondary	none	none	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_mn_5	BIO_12710980_mn_8	BIO_12710980_mn_5_8
BIO	12710980	mn	5	9	motivation_problem	result	support	support	secondary	secondary	none	none	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_mn_5	BIO_12710980_mn_9	BIO_12710980_mn_5_9
BIO	12710980	mn	5	10	motivation_problem	result	support	support	secondary	secondary	none	none	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_mn_5	BIO_12710980_mn_10	BIO_12710980_mn_5_10
BIO	12710980	mn	5	11	motivation_problem	observation	support	support	secondary	secondary	none	none	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_mn_5	BIO_12710980_mn_11	BIO_12710980_mn_5_11
BIO	12710980	mn	5	12	motivation_problem	result	support	support	secondary	secondary	none	none	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_mn_5	BIO_12710980_mn_12	BIO_12710980_mn_5_12
BIO	12710980	mn	6	7	motivation_hypothesis	proposal	support	none	secondary	main	forw	support	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	BIO_12710980_mn_6	BIO_12710980_mn_7	BIO_12710980_mn_6_7
BIO	12710980	mn	6	8	motivation_hypothesis	observation	support	support	secondary	secondary	none	none	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_mn_6	BIO_12710980_mn_8	BIO_12710980_mn_6_8
BIO	12710980	mn	6	9	motivation_hypothesis	result	support	support	secondary	secondary	none	none	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_mn_6	BIO_12710980_mn_9	BIO_12710980_mn_6_9
BIO	12710980	mn	6	10	motivation_hypothesis	result	support	support	secondary	secondary	none	none	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_mn_6	BIO_12710980_mn_10	BIO_12710980_mn_6_10
BIO	12710980	mn	6	11	motivation_hypothesis	observation	support	support	secondary	secondary	none	none	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_mn_6	BIO_12710980_mn_11	BIO_12710980_mn_6_11
BIO	12710980	mn	6	12	motivation_hypothesis	result	support	support	secondary	secondary	none	none	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_mn_6	BIO_12710980_mn_12	BIO_12710980_mn_6_12
BIO	12710980	mn	7	8	proposal	observation	none	support	main	secondary	none	none	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_mn_7	BIO_12710980_mn_8	BIO_12710980_mn_7_8
BIO	12710980	mn	7	9	proposal	result	none	support	main	secondary	none	none	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_mn_7	BIO_12710980_mn_9	BIO_12710980_mn_7_9
BIO	12710980	mn	7	10	proposal	result	none	support	main	secondary	back	support	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_mn_7	BIO_12710980_mn_10	BIO_12710980_mn_7_10
BIO	12710980	mn	7	11	proposal	observation	none	support	main	secondary	none	none	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_mn_7	BIO_12710980_mn_11	BIO_12710980_mn_7_11
BIO	12710980	mn	7	12	proposal	result	none	support	main	secondary	back	support	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_mn_7	BIO_12710980_mn_12	BIO_12710980_mn_7_12
BIO	12710980	mn	8	9	observation	result	support	support	secondary	secondary	back	support	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_mn_8	BIO_12710980_mn_9	BIO_12710980_mn_8_9
BIO	12710980	mn	8	10	observation	result	support	support	secondary	secondary	forw	support	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_mn_8	BIO_12710980_mn_10	BIO_12710980_mn_8_10
BIO	12710980	mn	8	11	observation	observation	support	support	secondary	secondary	none	none	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_mn_8	BIO_12710980_mn_11	BIO_12710980_mn_8_11
BIO	12710980	mn	8	12	observation	result	support	support	secondary	secondary	none	none	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_mn_8	BIO_12710980_mn_12	BIO_12710980_mn_8_12
BIO	12710980	mn	9	10	result	result	support	support	secondary	secondary	none	none	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_mn_9	BIO_12710980_mn_10	BIO_12710980_mn_9_10
BIO	12710980	mn	9	11	result	observation	support	support	secondary	secondary	none	none	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_mn_9	BIO_12710980_mn_11	BIO_12710980_mn_9_11
BIO	12710980	mn	9	12	result	result	support	support	secondary	secondary	none	none	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_mn_9	BIO_12710980_mn_12	BIO_12710980_mn_9_12
BIO	12710980	mn	10	11	result	observation	support	support	secondary	secondary	none	none	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_mn_10	BIO_12710980_mn_11	BIO_12710980_mn_10_11
BIO	12710980	mn	10	12	result	result	support	support	secondary	secondary	none	none	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_mn_10	BIO_12710980_mn_12	BIO_12710980_mn_10_12
BIO	12710980	mn	11	12	observation	result	support	support	secondary	secondary	forw	support	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_mn_11	BIO_12710980_mn_12	BIO_12710980_mn_11_12
BIO	12710980	mn	12	11	result	observation	support	support	secondary	secondary	back	support	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_mn_12	BIO_12710980_mn_11	BIO_12710980_mn_11_12
BIO	14523085	mn	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	BIO_14523085_mn_1	BIO_14523085_mn_2	BIO_14523085_mn_1_2
BIO	14523085	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	BIO_14523085_mn_1	BIO_14523085_mn_3	BIO_14523085_mn_1_3
BIO	14523085	mn	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	BIO_14523085_mn_1	BIO_14523085_mn_4	BIO_14523085_mn_1_4
BIO	14523085	mn	1	5	motivation_background	result	info-required	support	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	BIO_14523085_mn_1	BIO_14523085_mn_5	BIO_14523085_mn_1_5
BIO	14523085	mn	1	6	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	BIO_14523085_mn_1	BIO_14523085_mn_6	BIO_14523085_mn_1_6
BIO	14523085	mn	1	7	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	These changes differed from changes seen in tissue lysates from the same animals.	BIO_14523085_mn_1	BIO_14523085_mn_7	BIO_14523085_mn_1_7
BIO	14523085	mn	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_mn_1	BIO_14523085_mn_8	BIO_14523085_mn_1_8
BIO	14523085	mn	1	9	motivation_background	result	info-required	support	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_mn_1	BIO_14523085_mn_9	BIO_14523085_mn_1_9
BIO	14523085	mn	1	10	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_mn_1	BIO_14523085_mn_10	BIO_14523085_mn_1_10
BIO	14523085	mn	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	BIO_14523085_mn_2	BIO_14523085_mn_3	BIO_14523085_mn_2_3
BIO	14523085	mn	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	BIO_14523085_mn_2	BIO_14523085_mn_4	BIO_14523085_mn_2_4
BIO	14523085	mn	2	5	motivation_background	result	support	support	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	BIO_14523085_mn_2	BIO_14523085_mn_5	BIO_14523085_mn_2_5
BIO	14523085	mn	2	6	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	BIO_14523085_mn_2	BIO_14523085_mn_6	BIO_14523085_mn_2_6
BIO	14523085	mn	2	7	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	These changes differed from changes seen in tissue lysates from the same animals.	BIO_14523085_mn_2	BIO_14523085_mn_7	BIO_14523085_mn_2_7
BIO	14523085	mn	2	8	motivation_background	observation	support	support	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_mn_2	BIO_14523085_mn_8	BIO_14523085_mn_2_8
BIO	14523085	mn	2	9	motivation_background	result	support	support	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_mn_2	BIO_14523085_mn_9	BIO_14523085_mn_2_9
BIO	14523085	mn	2	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_mn_2	BIO_14523085_mn_10	BIO_14523085_mn_2_10
BIO	14523085	mn	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	BIO_14523085_mn_3	BIO_14523085_mn_4	BIO_14523085_mn_3_4
BIO	14523085	mn	3	5	proposal	result	none	support	main	secondary	back	support	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	BIO_14523085_mn_3	BIO_14523085_mn_5	BIO_14523085_mn_3_5
BIO	14523085	mn	3	6	proposal	observation	none	elaboration	main	secondary	none	none	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	BIO_14523085_mn_3	BIO_14523085_mn_6	BIO_14523085_mn_3_6
BIO	14523085	mn	3	7	proposal	observation	none	elaboration	main	secondary	none	none	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	These changes differed from changes seen in tissue lysates from the same animals.	BIO_14523085_mn_3	BIO_14523085_mn_7	BIO_14523085_mn_3_7
BIO	14523085	mn	3	8	proposal	observation	none	support	main	secondary	none	none	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_mn_3	BIO_14523085_mn_8	BIO_14523085_mn_3_8
BIO	14523085	mn	3	9	proposal	result	none	support	main	secondary	back	support	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_mn_3	BIO_14523085_mn_9	BIO_14523085_mn_3_9
BIO	14523085	mn	3	10	proposal	conclusion	none	support	main	secondary	back	support	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_mn_3	BIO_14523085_mn_10	BIO_14523085_mn_3_10
BIO	14523085	mn	4	5	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	BIO_14523085_mn_4	BIO_14523085_mn_5	BIO_14523085_mn_4_5
BIO	14523085	mn	4	6	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	BIO_14523085_mn_4	BIO_14523085_mn_6	BIO_14523085_mn_4_6
BIO	14523085	mn	4	7	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	These changes differed from changes seen in tissue lysates from the same animals.	BIO_14523085_mn_4	BIO_14523085_mn_7	BIO_14523085_mn_4_7
BIO	14523085	mn	4	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_mn_4	BIO_14523085_mn_8	BIO_14523085_mn_4_8
BIO	14523085	mn	4	9	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_mn_4	BIO_14523085_mn_9	BIO_14523085_mn_4_9
BIO	14523085	mn	4	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_mn_4	BIO_14523085_mn_10	BIO_14523085_mn_4_10
BIO	14523085	mn	5	6	result	observation	support	elaboration	secondary	secondary	back	elaboration	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	BIO_14523085_mn_5	BIO_14523085_mn_6	BIO_14523085_mn_5_6
BIO	14523085	mn	5	7	result	observation	support	elaboration	secondary	secondary	none	none	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	These changes differed from changes seen in tissue lysates from the same animals.	BIO_14523085_mn_5	BIO_14523085_mn_7	BIO_14523085_mn_5_7
BIO	14523085	mn	5	8	result	observation	support	support	secondary	secondary	none	none	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_mn_5	BIO_14523085_mn_8	BIO_14523085_mn_5_8
BIO	14523085	mn	5	9	result	result	support	support	secondary	secondary	none	none	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_mn_5	BIO_14523085_mn_9	BIO_14523085_mn_5_9
BIO	14523085	mn	5	10	result	conclusion	support	support	secondary	secondary	none	none	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_mn_5	BIO_14523085_mn_10	BIO_14523085_mn_5_10
BIO	14523085	mn	6	7	observation	observation	elaboration	elaboration	secondary	secondary	back	elaboration	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	These changes differed from changes seen in tissue lysates from the same animals.	BIO_14523085_mn_6	BIO_14523085_mn_7	BIO_14523085_mn_6_7
BIO	14523085	mn	6	8	observation	observation	elaboration	support	secondary	secondary	none	none	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_mn_6	BIO_14523085_mn_8	BIO_14523085_mn_6_8
BIO	14523085	mn	6	9	observation	result	elaboration	support	secondary	secondary	none	none	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_mn_6	BIO_14523085_mn_9	BIO_14523085_mn_6_9
BIO	14523085	mn	6	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_mn_6	BIO_14523085_mn_10	BIO_14523085_mn_6_10
BIO	14523085	mn	7	8	observation	observation	elaboration	support	secondary	secondary	none	none	These changes differed from changes seen in tissue lysates from the same animals.	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_mn_7	BIO_14523085_mn_8	BIO_14523085_mn_7_8
BIO	14523085	mn	7	9	observation	result	elaboration	support	secondary	secondary	none	none	These changes differed from changes seen in tissue lysates from the same animals.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_mn_7	BIO_14523085_mn_9	BIO_14523085_mn_7_9
BIO	14523085	mn	7	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	These changes differed from changes seen in tissue lysates from the same animals.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_mn_7	BIO_14523085_mn_10	BIO_14523085_mn_7_10
BIO	14523085	mn	8	9	observation	result	support	support	secondary	secondary	forw	support	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_mn_8	BIO_14523085_mn_9	BIO_14523085_mn_8_9
BIO	14523085	mn	8	10	observation	conclusion	support	support	secondary	secondary	none	none	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_mn_8	BIO_14523085_mn_10	BIO_14523085_mn_8_10
BIO	14523085	mn	9	10	result	conclusion	support	support	secondary	secondary	none	none	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_mn_9	BIO_14523085_mn_10	BIO_14523085_mn_9_10
BIO	14523085	mn	10	9	conclusion	result	support	support	secondary	secondary	none	none	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_mn_10	BIO_14523085_mn_9	BIO_14523085_mn_9_10
BIO	14663338	mn	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	BIO_14663338_mn_1	BIO_14663338_mn_2	BIO_14663338_mn_1_2
BIO	14663338	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	BIO_14663338_mn_1	BIO_14663338_mn_3	BIO_14663338_mn_1_3
BIO	14663338	mn	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	BIO_14663338_mn_1	BIO_14663338_mn_4	BIO_14663338_mn_1_4
BIO	14663338	mn	1	5	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	BIO_14663338_mn_1	BIO_14663338_mn_5	BIO_14663338_mn_1_5
BIO	14663338	mn	1	6	motivation_background	result	info-required	support	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	BIO_14663338_mn_1	BIO_14663338_mn_6	BIO_14663338_mn_1_6
BIO	14663338	mn	1	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	BIO_14663338_mn_1	BIO_14663338_mn_7	BIO_14663338_mn_1_7
BIO	14663338	mn	1	8	motivation_background	result	info-required	support	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_mn_1	BIO_14663338_mn_8	BIO_14663338_mn_1_8
BIO	14663338	mn	1	9	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_mn_1	BIO_14663338_mn_9	BIO_14663338_mn_1_9
BIO	14663338	mn	1	10	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_mn_1	BIO_14663338_mn_10	BIO_14663338_mn_1_10
BIO	14663338	mn	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	BIO_14663338_mn_2	BIO_14663338_mn_3	BIO_14663338_mn_2_3
BIO	14663338	mn	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	BIO_14663338_mn_2	BIO_14663338_mn_4	BIO_14663338_mn_2_4
BIO	14663338	mn	2	5	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	BIO_14663338_mn_2	BIO_14663338_mn_5	BIO_14663338_mn_2_5
BIO	14663338	mn	2	6	motivation_background	result	support	support	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	BIO_14663338_mn_2	BIO_14663338_mn_6	BIO_14663338_mn_2_6
BIO	14663338	mn	2	7	motivation_background	observation	support	support	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	BIO_14663338_mn_2	BIO_14663338_mn_7	BIO_14663338_mn_2_7
BIO	14663338	mn	2	8	motivation_background	result	support	support	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_mn_2	BIO_14663338_mn_8	BIO_14663338_mn_2_8
BIO	14663338	mn	2	9	motivation_background	result	support	elaboration	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_mn_2	BIO_14663338_mn_9	BIO_14663338_mn_2_9
BIO	14663338	mn	2	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_mn_2	BIO_14663338_mn_10	BIO_14663338_mn_2_10
BIO	14663338	mn	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	BIO_14663338_mn_3	BIO_14663338_mn_4	BIO_14663338_mn_3_4
BIO	14663338	mn	3	5	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	BIO_14663338_mn_3	BIO_14663338_mn_5	BIO_14663338_mn_3_5
BIO	14663338	mn	3	6	proposal	result	none	support	main	secondary	back	support	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	BIO_14663338_mn_3	BIO_14663338_mn_6	BIO_14663338_mn_3_6
BIO	14663338	mn	3	7	proposal	observation	none	support	main	secondary	none	none	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	BIO_14663338_mn_3	BIO_14663338_mn_7	BIO_14663338_mn_3_7
BIO	14663338	mn	3	8	proposal	result	none	support	main	secondary	back	support	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_mn_3	BIO_14663338_mn_8	BIO_14663338_mn_3_8
BIO	14663338	mn	3	9	proposal	result	none	elaboration	main	secondary	none	none	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_mn_3	BIO_14663338_mn_9	BIO_14663338_mn_3_9
BIO	14663338	mn	3	10	proposal	conclusion	none	support	main	secondary	back	support	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_mn_3	BIO_14663338_mn_10	BIO_14663338_mn_3_10
BIO	14663338	mn	4	5	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	BIO_14663338_mn_4	BIO_14663338_mn_5	BIO_14663338_mn_4_5
BIO	14663338	mn	4	6	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	BIO_14663338_mn_4	BIO_14663338_mn_6	BIO_14663338_mn_4_6
BIO	14663338	mn	4	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	BIO_14663338_mn_4	BIO_14663338_mn_7	BIO_14663338_mn_4_7
BIO	14663338	mn	4	8	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_mn_4	BIO_14663338_mn_8	BIO_14663338_mn_4_8
BIO	14663338	mn	4	9	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_mn_4	BIO_14663338_mn_9	BIO_14663338_mn_4_9
BIO	14663338	mn	4	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_mn_4	BIO_14663338_mn_10	BIO_14663338_mn_4_10
BIO	14663338	mn	5	6	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	BIO_14663338_mn_5	BIO_14663338_mn_6	BIO_14663338_mn_5_6
BIO	14663338	mn	5	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	BIO_14663338_mn_5	BIO_14663338_mn_7	BIO_14663338_mn_5_7
BIO	14663338	mn	5	8	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_mn_5	BIO_14663338_mn_8	BIO_14663338_mn_5_8
BIO	14663338	mn	5	9	proposal_implementation	result	elaboration	elaboration	secondary	secondary	none	none	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_mn_5	BIO_14663338_mn_9	BIO_14663338_mn_5_9
BIO	14663338	mn	5	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_mn_5	BIO_14663338_mn_10	BIO_14663338_mn_5_10
BIO	14663338	mn	6	7	result	observation	support	support	secondary	secondary	back	support	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	BIO_14663338_mn_6	BIO_14663338_mn_7	BIO_14663338_mn_6_7
BIO	14663338	mn	6	8	result	result	support	support	secondary	secondary	none	none	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_mn_6	BIO_14663338_mn_8	BIO_14663338_mn_6_8
BIO	14663338	mn	6	9	result	result	support	elaboration	secondary	secondary	none	none	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_mn_6	BIO_14663338_mn_9	BIO_14663338_mn_6_9
BIO	14663338	mn	6	10	result	conclusion	support	support	secondary	secondary	none	none	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_mn_6	BIO_14663338_mn_10	BIO_14663338_mn_6_10
BIO	14663338	mn	7	8	observation	result	support	support	secondary	secondary	none	none	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_mn_7	BIO_14663338_mn_8	BIO_14663338_mn_7_8
BIO	14663338	mn	7	9	observation	result	support	elaboration	secondary	secondary	none	none	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_mn_7	BIO_14663338_mn_9	BIO_14663338_mn_7_9
BIO	14663338	mn	7	10	observation	conclusion	support	support	secondary	secondary	none	none	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_mn_7	BIO_14663338_mn_10	BIO_14663338_mn_7_10
BIO	14663338	mn	8	9	result	result	support	elaboration	secondary	secondary	back	elaboration	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_mn_8	BIO_14663338_mn_9	BIO_14663338_mn_8_9
BIO	14663338	mn	8	10	result	conclusion	support	support	secondary	secondary	none	none	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_mn_8	BIO_14663338_mn_10	BIO_14663338_mn_8_10
BIO	14663338	mn	9	10	result	conclusion	elaboration	support	secondary	secondary	none	none	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_mn_9	BIO_14663338_mn_10	BIO_14663338_mn_9_10
BIO	14663338	mn	10	9	conclusion	result	support	elaboration	secondary	secondary	none	none	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_mn_10	BIO_14663338_mn_9	BIO_14663338_mn_9_10
BIO	15094511	mn	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	The 70 kDa heat shock protein (Hsp70) is synthesized in response to a variety of stresses, including ischemia, and is thought to act as a molecular chaperone to prevent protein denaturation and facilitate protein folding.	Matrix metalloproteinases (MMPs), a family of serine proteases, are also upregulated by ischemia and are thought to promote cell death and tissue injury.	BIO_15094511_mn_1	BIO_15094511_mn_2	BIO_15094511_mn_1_2
BIO	15094511	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	The 70 kDa heat shock protein (Hsp70) is synthesized in response to a variety of stresses, including ischemia, and is thought to act as a molecular chaperone to prevent protein denaturation and facilitate protein folding.	We examined the influence of Hsp70 on expression and activity of MMPs.	BIO_15094511_mn_1	BIO_15094511_mn_3	BIO_15094511_mn_1_3
BIO	15094511	mn	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	The 70 kDa heat shock protein (Hsp70) is synthesized in response to a variety of stresses, including ischemia, and is thought to act as a molecular chaperone to prevent protein denaturation and facilitate protein folding.	Astrocyte cultures were prepared from neonatal mice and transfected with retroviral vectors containing hsp70 or lacZ or mock infected, then exposed to oxygen-glucose deprivation followed by reperfusion.	BIO_15094511_mn_1	BIO_15094511_mn_4	BIO_15094511_mn_1_4
BIO	15094511	mn	1	5	motivation_background	result_means	info-required	support	secondary	secondary	none	none	The 70 kDa heat shock protein (Hsp70) is synthesized in response to a variety of stresses, including ischemia, and is thought to act as a molecular chaperone to prevent protein denaturation and facilitate protein folding.	Zymograms and Western blots showed that Hsp70 over-expression suppressed MMP-2 and MMP-9.	BIO_15094511_mn_1	BIO_15094511_mn_5	BIO_15094511_mn_1_5
BIO	15094511	mn	1	6	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	The 70 kDa heat shock protein (Hsp70) is synthesized in response to a variety of stresses, including ischemia, and is thought to act as a molecular chaperone to prevent protein denaturation and facilitate protein folding.	These findings suggest that Hsp70 may protect by regulating MMPs.	BIO_15094511_mn_1	BIO_15094511_mn_6	BIO_15094511_mn_1_6
BIO	15094511	mn	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	Matrix metalloproteinases (MMPs), a family of serine proteases, are also upregulated by ischemia and are thought to promote cell death and tissue injury.	We examined the influence of Hsp70 on expression and activity of MMPs.	BIO_15094511_mn_2	BIO_15094511_mn_3	BIO_15094511_mn_2_3
BIO	15094511	mn	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Matrix metalloproteinases (MMPs), a family of serine proteases, are also upregulated by ischemia and are thought to promote cell death and tissue injury.	Astrocyte cultures were prepared from neonatal mice and transfected with retroviral vectors containing hsp70 or lacZ or mock infected, then exposed to oxygen-glucose deprivation followed by reperfusion.	BIO_15094511_mn_2	BIO_15094511_mn_4	BIO_15094511_mn_2_4
BIO	15094511	mn	2	5	motivation_background	result_means	support	support	secondary	secondary	none	none	Matrix metalloproteinases (MMPs), a family of serine proteases, are also upregulated by ischemia and are thought to promote cell death and tissue injury.	Zymograms and Western blots showed that Hsp70 over-expression suppressed MMP-2 and MMP-9.	BIO_15094511_mn_2	BIO_15094511_mn_5	BIO_15094511_mn_2_5
BIO	15094511	mn	2	6	motivation_background	conclusion	support	support	secondary	secondary	none	none	Matrix metalloproteinases (MMPs), a family of serine proteases, are also upregulated by ischemia and are thought to promote cell death and tissue injury.	These findings suggest that Hsp70 may protect by regulating MMPs.	BIO_15094511_mn_2	BIO_15094511_mn_6	BIO_15094511_mn_2_6
BIO	15094511	mn	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	We examined the influence of Hsp70 on expression and activity of MMPs.	Astrocyte cultures were prepared from neonatal mice and transfected with retroviral vectors containing hsp70 or lacZ or mock infected, then exposed to oxygen-glucose deprivation followed by reperfusion.	BIO_15094511_mn_3	BIO_15094511_mn_4	BIO_15094511_mn_3_4
BIO	15094511	mn	3	5	proposal	result_means	none	support	main	secondary	back	support	We examined the influence of Hsp70 on expression and activity of MMPs.	Zymograms and Western blots showed that Hsp70 over-expression suppressed MMP-2 and MMP-9.	BIO_15094511_mn_3	BIO_15094511_mn_5	BIO_15094511_mn_3_5
BIO	15094511	mn	3	6	proposal	conclusion	none	support	main	secondary	back	support	We examined the influence of Hsp70 on expression and activity of MMPs.	These findings suggest that Hsp70 may protect by regulating MMPs.	BIO_15094511_mn_3	BIO_15094511_mn_6	BIO_15094511_mn_3_6
BIO	15094511	mn	4	5	proposal_implementation	result_means	elaboration	support	secondary	secondary	none	none	Astrocyte cultures were prepared from neonatal mice and transfected with retroviral vectors containing hsp70 or lacZ or mock infected, then exposed to oxygen-glucose deprivation followed by reperfusion.	Zymograms and Western blots showed that Hsp70 over-expression suppressed MMP-2 and MMP-9.	BIO_15094511_mn_4	BIO_15094511_mn_5	BIO_15094511_mn_4_5
BIO	15094511	mn	4	6	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Astrocyte cultures were prepared from neonatal mice and transfected with retroviral vectors containing hsp70 or lacZ or mock infected, then exposed to oxygen-glucose deprivation followed by reperfusion.	These findings suggest that Hsp70 may protect by regulating MMPs.	BIO_15094511_mn_4	BIO_15094511_mn_6	BIO_15094511_mn_4_6
BIO	15094511	mn	5	6	result_means	conclusion	support	support	secondary	secondary	none	none	Zymograms and Western blots showed that Hsp70 over-expression suppressed MMP-2 and MMP-9.	These findings suggest that Hsp70 may protect by regulating MMPs.	BIO_15094511_mn_5	BIO_15094511_mn_6	BIO_15094511_mn_5_6
BIO	15094511	mn	6	5	conclusion	result_means	support	support	secondary	secondary	none	none	These findings suggest that Hsp70 may protect by regulating MMPs.	Zymograms and Western blots showed that Hsp70 over-expression suppressed MMP-2 and MMP-9.	BIO_15094511_mn_6	BIO_15094511_mn_5	BIO_15094511_mn_5_6
BIO	15319009	mn	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	BIO_15319009_mn_1	BIO_15319009_mn_2	BIO_15319009_mn_1_2
BIO	15319009	mn	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	BIO_15319009_mn_1	BIO_15319009_mn_3	BIO_15319009_mn_1_3
BIO	15319009	mn	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	BIO_15319009_mn_1	BIO_15319009_mn_4	BIO_15319009_mn_1_4
BIO	15319009	mn	1	5	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	BIO_15319009_mn_1	BIO_15319009_mn_5	BIO_15319009_mn_1_5
BIO	15319009	mn	1	6	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	BIO_15319009_mn_1	BIO_15319009_mn_6	BIO_15319009_mn_1_6
BIO	15319009	mn	1	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	BIO_15319009_mn_1	BIO_15319009_mn_7	BIO_15319009_mn_1_7
BIO	15319009	mn	1	8	motivation_background	result	info-required	support	secondary	secondary	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_mn_1	BIO_15319009_mn_8	BIO_15319009_mn_1_8
BIO	15319009	mn	1	9	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_mn_1	BIO_15319009_mn_9	BIO_15319009_mn_1_9
BIO	15319009	mn	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	BIO_15319009_mn_2	BIO_15319009_mn_3	BIO_15319009_mn_2_3
BIO	15319009	mn	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	BIO_15319009_mn_2	BIO_15319009_mn_4	BIO_15319009_mn_2_4
BIO	15319009	mn	2	5	motivation_background	observation	support	support	secondary	secondary	none	none	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	BIO_15319009_mn_2	BIO_15319009_mn_5	BIO_15319009_mn_2_5
BIO	15319009	mn	2	6	motivation_background	observation	support	support	secondary	secondary	none	none	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	BIO_15319009_mn_2	BIO_15319009_mn_6	BIO_15319009_mn_2_6
BIO	15319009	mn	2	7	motivation_background	observation	support	support	secondary	secondary	none	none	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	BIO_15319009_mn_2	BIO_15319009_mn_7	BIO_15319009_mn_2_7
BIO	15319009	mn	2	8	motivation_background	result	support	support	secondary	secondary	none	none	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_mn_2	BIO_15319009_mn_8	BIO_15319009_mn_2_8
BIO	15319009	mn	2	9	motivation_background	conclusion	support	support	secondary	secondary	none	none	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_mn_2	BIO_15319009_mn_9	BIO_15319009_mn_2_9
BIO	15319009	mn	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	BIO_15319009_mn_3	BIO_15319009_mn_4	BIO_15319009_mn_3_4
BIO	15319009	mn	3	5	proposal	observation	none	support	main	secondary	none	none	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	BIO_15319009_mn_3	BIO_15319009_mn_5	BIO_15319009_mn_3_5
BIO	15319009	mn	3	6	proposal	observation	none	support	main	secondary	none	none	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	BIO_15319009_mn_3	BIO_15319009_mn_6	BIO_15319009_mn_3_6
BIO	15319009	mn	3	7	proposal	observation	none	support	main	secondary	none	none	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	BIO_15319009_mn_3	BIO_15319009_mn_7	BIO_15319009_mn_3_7
BIO	15319009	mn	3	8	proposal	result	none	support	main	secondary	back	support	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_mn_3	BIO_15319009_mn_8	BIO_15319009_mn_3_8
BIO	15319009	mn	3	9	proposal	conclusion	none	support	main	secondary	none	none	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_mn_3	BIO_15319009_mn_9	BIO_15319009_mn_3_9
BIO	15319009	mn	4	5	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	BIO_15319009_mn_4	BIO_15319009_mn_5	BIO_15319009_mn_4_5
BIO	15319009	mn	4	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	BIO_15319009_mn_4	BIO_15319009_mn_6	BIO_15319009_mn_4_6
BIO	15319009	mn	4	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	BIO_15319009_mn_4	BIO_15319009_mn_7	BIO_15319009_mn_4_7
BIO	15319009	mn	4	8	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_mn_4	BIO_15319009_mn_8	BIO_15319009_mn_4_8
BIO	15319009	mn	4	9	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_mn_4	BIO_15319009_mn_9	BIO_15319009_mn_4_9
BIO	15319009	mn	5	6	observation	observation	support	support	secondary	secondary	none	none	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	BIO_15319009_mn_5	BIO_15319009_mn_6	BIO_15319009_mn_5_6
BIO	15319009	mn	5	7	observation	observation	support	support	secondary	secondary	none	none	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	BIO_15319009_mn_5	BIO_15319009_mn_7	BIO_15319009_mn_5_7
BIO	15319009	mn	5	8	observation	result	support	support	secondary	secondary	forw	support	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_mn_5	BIO_15319009_mn_8	BIO_15319009_mn_5_8
BIO	15319009	mn	5	9	observation	conclusion	support	support	secondary	secondary	none	none	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_mn_5	BIO_15319009_mn_9	BIO_15319009_mn_5_9
BIO	15319009	mn	6	7	observation	observation	support	support	secondary	secondary	none	none	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	BIO_15319009_mn_6	BIO_15319009_mn_7	BIO_15319009_mn_6_7
BIO	15319009	mn	6	8	observation	result	support	support	secondary	secondary	forw	support	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_mn_6	BIO_15319009_mn_8	BIO_15319009_mn_6_8
BIO	15319009	mn	6	9	observation	conclusion	support	support	secondary	secondary	none	none	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_mn_6	BIO_15319009_mn_9	BIO_15319009_mn_6_9
BIO	15319009	mn	7	8	observation	result	support	support	secondary	secondary	forw	support	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_mn_7	BIO_15319009_mn_8	BIO_15319009_mn_7_8
BIO	15319009	mn	7	9	observation	conclusion	support	support	secondary	secondary	none	none	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_mn_7	BIO_15319009_mn_9	BIO_15319009_mn_7_9
BIO	15319009	mn	8	9	result	conclusion	support	support	secondary	secondary	back	support	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_mn_8	BIO_15319009_mn_9	BIO_15319009_mn_8_9
BIO	15319009	mn	9	8	conclusion	result	support	support	secondary	secondary	forw	support	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_mn_9	BIO_15319009_mn_8	BIO_15319009_mn_8_9
BIO	10024363	pa	1	2	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	BIO_10024363_pa_1	BIO_10024363_pa_2	BIO_10024363_pa_1_2
BIO	10024363	pa	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	BIO_10024363_pa_1	BIO_10024363_pa_3	BIO_10024363_pa_1_3
BIO	10024363	pa	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	BIO_10024363_pa_1	BIO_10024363_pa_4	BIO_10024363_pa_1_4
BIO	10024363	pa	1	5	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	BIO_10024363_pa_1	BIO_10024363_pa_5	BIO_10024363_pa_1_5
BIO	10024363	pa	1	6	motivation_background	observation	info-required	support	secondary	secondary	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	BIO_10024363_pa_1	BIO_10024363_pa_6	BIO_10024363_pa_1_6
BIO	10024363	pa	1	7	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	BIO_10024363_pa_1	BIO_10024363_pa_7	BIO_10024363_pa_1_7
BIO	10024363	pa	1	8	motivation_background	result	info-required	support	secondary	secondary	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_pa_1	BIO_10024363_pa_8	BIO_10024363_pa_1_8
BIO	10024363	pa	1	9	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Pathophysiological, lesion, and electrophysiological studies suggest that the cerebellar cortex is important for controlling the direction and speed of movement.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_pa_1	BIO_10024363_pa_9	BIO_10024363_pa_1_9
BIO	10024363	pa	2	3	motivation_problem	proposal	support	none	secondary	main	forw	support	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	BIO_10024363_pa_2	BIO_10024363_pa_3	BIO_10024363_pa_2_3
BIO	10024363	pa	2	4	motivation_problem	proposal_implementation	support	elaboration	secondary	secondary	none	none	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	BIO_10024363_pa_2	BIO_10024363_pa_4	BIO_10024363_pa_2_4
BIO	10024363	pa	2	5	motivation_problem	observation	support	info-required	secondary	secondary	none	none	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	BIO_10024363_pa_2	BIO_10024363_pa_5	BIO_10024363_pa_2_5
BIO	10024363	pa	2	6	motivation_problem	observation	support	support	secondary	secondary	none	none	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	BIO_10024363_pa_2	BIO_10024363_pa_6	BIO_10024363_pa_2_6
BIO	10024363	pa	2	7	motivation_problem	proposal_implementation	support	sequence	secondary	secondary	none	none	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	BIO_10024363_pa_2	BIO_10024363_pa_7	BIO_10024363_pa_2_7
BIO	10024363	pa	2	8	motivation_problem	result	support	support	secondary	secondary	none	none	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_pa_2	BIO_10024363_pa_8	BIO_10024363_pa_2_8
BIO	10024363	pa	2	9	motivation_problem	conclusion	support	support	secondary	secondary	none	none	The relationship of cerebellar Purkinje cell discharge to the control of arm movement parameters, however, remains unclear.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_pa_2	BIO_10024363_pa_9	BIO_10024363_pa_2_9
BIO	10024363	pa	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	BIO_10024363_pa_3	BIO_10024363_pa_4	BIO_10024363_pa_3_4
BIO	10024363	pa	3	5	proposal	observation	none	info-required	main	secondary	none	none	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	BIO_10024363_pa_3	BIO_10024363_pa_5	BIO_10024363_pa_3_5
BIO	10024363	pa	3	6	proposal	observation	none	support	main	secondary	none	none	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	BIO_10024363_pa_3	BIO_10024363_pa_6	BIO_10024363_pa_3_6
BIO	10024363	pa	3	7	proposal	proposal_implementation	none	sequence	main	secondary	none	none	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	BIO_10024363_pa_3	BIO_10024363_pa_7	BIO_10024363_pa_3_7
BIO	10024363	pa	3	8	proposal	result	none	support	main	secondary	none	none	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_pa_3	BIO_10024363_pa_8	BIO_10024363_pa_3_8
BIO	10024363	pa	3	9	proposal	conclusion	none	support	main	secondary	back	support	The goal of this study was to examine how movement direction and speed and their interaction-velocity-modulate Purkinje cell simple spike discharge in an arm movement task in which direction and speed were independently controlled.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_pa_3	BIO_10024363_pa_9	BIO_10024363_pa_3_9
BIO	10024363	pa	4	5	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	BIO_10024363_pa_4	BIO_10024363_pa_5	BIO_10024363_pa_4_5
BIO	10024363	pa	4	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	BIO_10024363_pa_4	BIO_10024363_pa_6	BIO_10024363_pa_4_6
BIO	10024363	pa	4	7	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	back	sequence	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	BIO_10024363_pa_4	BIO_10024363_pa_7	BIO_10024363_pa_4_7
BIO	10024363	pa	4	8	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_pa_4	BIO_10024363_pa_8	BIO_10024363_pa_4_8
BIO	10024363	pa	4	9	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	The simple spike discharge of 154 Purkinje cells was recorded in two monkeys during the performance of two visuomotor tasks that required the animals to track targets that moved in one of eight directions and at one of four speeds.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_pa_4	BIO_10024363_pa_9	BIO_10024363_pa_4_9
BIO	10024363	pa	5	6	observation	observation	info-required	support	secondary	secondary	forw	info-required	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	BIO_10024363_pa_5	BIO_10024363_pa_6	BIO_10024363_pa_5_6
BIO	10024363	pa	5	7	observation	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	BIO_10024363_pa_5	BIO_10024363_pa_7	BIO_10024363_pa_5_7
BIO	10024363	pa	5	8	observation	result	info-required	support	secondary	secondary	none	none	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_pa_5	BIO_10024363_pa_8	BIO_10024363_pa_5_8
BIO	10024363	pa	5	9	observation	conclusion	info-required	support	secondary	secondary	none	none	Single-parameter regression analyses revealed that a large proportion of cells had discharge modulation related to movement direction and speed.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_pa_5	BIO_10024363_pa_9	BIO_10024363_pa_5_9
BIO	10024363	pa	6	7	observation	proposal_implementation	support	sequence	secondary	secondary	forw	support	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	BIO_10024363_pa_6	BIO_10024363_pa_7	BIO_10024363_pa_6_7
BIO	10024363	pa	6	8	observation	result	support	support	secondary	secondary	none	none	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_pa_6	BIO_10024363_pa_8	BIO_10024363_pa_6_8
BIO	10024363	pa	6	9	observation	conclusion	support	support	secondary	secondary	none	none	Most cells with significant directional tuning, however, were modulated at one speed, and most cells with speed-related discharge were modulated along one direction; this suggested that the patterns of simple spike discharge were not adequately described by single-parameter models.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_pa_6	BIO_10024363_pa_9	BIO_10024363_pa_6_9
BIO	10024363	pa	7	8	proposal_implementation	result	sequence	support	secondary	secondary	none	none	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_pa_7	BIO_10024363_pa_8	BIO_10024363_pa_7_8
BIO	10024363	pa	7	9	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	Therefore, a regression surface was fitted to the data, which showed that the discharge could be tuned to specific direction-speed combinations (preferred velocities).	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_pa_7	BIO_10024363_pa_9	BIO_10024363_pa_7_9
BIO	10024363	pa	8	9	result	conclusion	support	support	secondary	secondary	forw	support	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	BIO_10024363_pa_8	BIO_10024363_pa_9	BIO_10024363_pa_8_9
BIO	10024363	pa	9	8	conclusion	result	support	support	secondary	secondary	back	support	Simple spike discharge therefore appears to integrate information about both the direction and speed of arm movements, thereby encoding movement velocity.	The overall variability in simple spike discharge was well described by the surface model, and the velocities corresponding to maximal and minimal discharge rates were distributed uniformly throughout the workspace.	BIO_10024363_pa_9	BIO_10024363_pa_8	BIO_10024363_pa_8_9
BIO	10400678	pa	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	BIO_10400678_pa_1	BIO_10400678_pa_2	BIO_10400678_pa_1_2
BIO	10400678	pa	1	3	motivation_background	motivation_background	info-required	elaboration	secondary	secondary	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	It could be one protease with dual specificity or two distinct enzymes.	BIO_10400678_pa_1	BIO_10400678_pa_3	BIO_10400678_pa_1_3
BIO	10400678	pa	1	4	motivation_background	proposal	info-required	none	secondary	main	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	BIO_10400678_pa_1	BIO_10400678_pa_4	BIO_10400678_pa_1_4
BIO	10400678	pa	1	5	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	BIO_10400678_pa_1	BIO_10400678_pa_5	BIO_10400678_pa_1_5
BIO	10400678	pa	1	6	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	BIO_10400678_pa_1	BIO_10400678_pa_6	BIO_10400678_pa_1_6
BIO	10400678	pa	1	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	BIO_10400678_pa_1	BIO_10400678_pa_7	BIO_10400678_pa_1_7
BIO	10400678	pa	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_pa_1	BIO_10400678_pa_8	BIO_10400678_pa_1_8
BIO	10400678	pa	1	9	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	The Alzheimer's disease amyloid peptide Abeta has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_pa_1	BIO_10400678_pa_9	BIO_10400678_pa_1_9
BIO	10400678	pa	2	3	motivation_background	motivation_background	support	elaboration	secondary	secondary	back	elaboration	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	It could be one protease with dual specificity or two distinct enzymes.	BIO_10400678_pa_2	BIO_10400678_pa_3	BIO_10400678_pa_2_3
BIO	10400678	pa	2	4	motivation_background	proposal	support	none	secondary	main	forw	support	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	BIO_10400678_pa_2	BIO_10400678_pa_4	BIO_10400678_pa_2_4
BIO	10400678	pa	2	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	BIO_10400678_pa_2	BIO_10400678_pa_5	BIO_10400678_pa_2_5
BIO	10400678	pa	2	6	motivation_background	observation	support	info-required	secondary	secondary	none	none	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	BIO_10400678_pa_2	BIO_10400678_pa_6	BIO_10400678_pa_2_6
BIO	10400678	pa	2	7	motivation_background	observation	support	info-required	secondary	secondary	none	none	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	BIO_10400678_pa_2	BIO_10400678_pa_7	BIO_10400678_pa_2_7
BIO	10400678	pa	2	8	motivation_background	observation	support	support	secondary	secondary	none	none	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_pa_2	BIO_10400678_pa_8	BIO_10400678_pa_2_8
BIO	10400678	pa	2	9	motivation_background	conclusion	support	support	secondary	secondary	none	none	The proteolytic activity that liberates the Abeta COOH terminus from the beta-amyloid precursor protein is called gamma-secretase.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_pa_2	BIO_10400678_pa_9	BIO_10400678_pa_2_9
BIO	10400678	pa	3	4	motivation_background	proposal	elaboration	none	secondary	main	none	none	It could be one protease with dual specificity or two distinct enzymes.	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	BIO_10400678_pa_3	BIO_10400678_pa_4	BIO_10400678_pa_3_4
BIO	10400678	pa	3	5	motivation_background	observation	elaboration	info-required	secondary	secondary	none	none	It could be one protease with dual specificity or two distinct enzymes.	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	BIO_10400678_pa_3	BIO_10400678_pa_5	BIO_10400678_pa_3_5
BIO	10400678	pa	3	6	motivation_background	observation	elaboration	info-required	secondary	secondary	none	none	It could be one protease with dual specificity or two distinct enzymes.	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	BIO_10400678_pa_3	BIO_10400678_pa_6	BIO_10400678_pa_3_6
BIO	10400678	pa	3	7	motivation_background	observation	elaboration	info-required	secondary	secondary	none	none	It could be one protease with dual specificity or two distinct enzymes.	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	BIO_10400678_pa_3	BIO_10400678_pa_7	BIO_10400678_pa_3_7
BIO	10400678	pa	3	8	motivation_background	observation	elaboration	support	secondary	secondary	none	none	It could be one protease with dual specificity or two distinct enzymes.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_pa_3	BIO_10400678_pa_8	BIO_10400678_pa_3_8
BIO	10400678	pa	3	9	motivation_background	conclusion	elaboration	support	secondary	secondary	none	none	It could be one protease with dual specificity or two distinct enzymes.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_pa_3	BIO_10400678_pa_9	BIO_10400678_pa_3_9
BIO	10400678	pa	4	5	proposal	observation	none	info-required	main	secondary	none	none	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	BIO_10400678_pa_4	BIO_10400678_pa_5	BIO_10400678_pa_4_5
BIO	10400678	pa	4	6	proposal	observation	none	info-required	main	secondary	none	none	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	BIO_10400678_pa_4	BIO_10400678_pa_6	BIO_10400678_pa_4_6
BIO	10400678	pa	4	7	proposal	observation	none	info-required	main	secondary	none	none	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	BIO_10400678_pa_4	BIO_10400678_pa_7	BIO_10400678_pa_4_7
BIO	10400678	pa	4	8	proposal	observation	none	support	main	secondary	none	none	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_pa_4	BIO_10400678_pa_8	BIO_10400678_pa_4_8
BIO	10400678	pa	4	9	proposal	conclusion	none	support	main	secondary	back	support	By using enzyme-linked immunosorbent assays selective for Abeta40 or Abeta42, we have measured Abeta secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse gamma-secretase inhibitors.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_pa_4	BIO_10400678_pa_9	BIO_10400678_pa_4_9
BIO	10400678	pa	5	6	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	BIO_10400678_pa_5	BIO_10400678_pa_6	BIO_10400678_pa_5_6
BIO	10400678	pa	5	7	observation	observation	info-required	info-required	secondary	secondary	none	none	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	BIO_10400678_pa_5	BIO_10400678_pa_7	BIO_10400678_pa_5_7
BIO	10400678	pa	5	8	observation	observation	info-required	support	secondary	secondary	none	none	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_pa_5	BIO_10400678_pa_8	BIO_10400678_pa_5_8
BIO	10400678	pa	5	9	observation	conclusion	info-required	support	secondary	secondary	none	none	The inhibitors lowered Abeta and p3 secretion and increased levels of the COOH-terminal 99-residue beta-amyloid precursor protein derivative that is the precursor for Abeta but did not alter secretion of beta-amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the gamma-secretase processing step.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_pa_5	BIO_10400678_pa_9	BIO_10400678_pa_5_9
BIO	10400678	pa	6	7	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	BIO_10400678_pa_6	BIO_10400678_pa_7	BIO_10400678_pa_6_7
BIO	10400678	pa	6	8	observation	observation	info-required	support	secondary	secondary	none	none	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_pa_6	BIO_10400678_pa_8	BIO_10400678_pa_6_8
BIO	10400678	pa	6	9	observation	conclusion	info-required	support	secondary	secondary	none	none	The dose-dependent inhibition of Abeta42 was unusual, as the compounds elevated Abeta42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_pa_6	BIO_10400678_pa_9	BIO_10400678_pa_6_9
BIO	10400678	pa	7	8	observation	observation	info-required	support	secondary	secondary	forw	info-required	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_pa_7	BIO_10400678_pa_8	BIO_10400678_pa_7_8
BIO	10400678	pa	7	9	observation	conclusion	info-required	support	secondary	secondary	none	none	A compound was identified that elevated Abeta42 secretion at a low concentration without inhibiting Abeta42 or Abeta40 at high concentrations, demonstrating that these phenomena are separable pharmacologically.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_pa_7	BIO_10400678_pa_9	BIO_10400678_pa_7_9
BIO	10400678	pa	8	9	observation	conclusion	support	support	secondary	secondary	forw	support	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	BIO_10400678_pa_8	BIO_10400678_pa_9	BIO_10400678_pa_8_9
BIO	10400678	pa	9	8	conclusion	observation	support	support	secondary	secondary	back	support	These results favor the hypothesis that Abeta variants ending at residue 40 or 42 are generated by a single gamma-secretase.	Using either of two methods, IC50 values for inhibition of Abeta42 and Abeta40 were found to have the same rank-order and fall on a trend line with near-unit slope.	BIO_10400678_pa_9	BIO_10400678_pa_8	BIO_10400678_pa_8_9
BIO	10581038N	pa	1	2	motivation_background	motivation_background	info-required	elaboration	secondary	secondary	back	elaboration	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein.	The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats.	BIO_10581038N_pa_1	BIO_10581038N_pa_2	BIO_10581038N_pa_1_2
BIO	10581038N	pa	1	3	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein.	HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion.	BIO_10581038N_pa_1	BIO_10581038N_pa_3	BIO_10581038N_pa_1_3
BIO	10581038N	pa	1	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein.	For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10).	BIO_10581038N_pa_1	BIO_10581038N_pa_4	BIO_10581038N_pa_1_4
BIO	10581038N	pa	1	5	motivation_background	motivation_hypothesis	info-required	support	secondary	secondary	none	none	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein.	With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation, suggesting important functional correlations between repeat length and pathology.	BIO_10581038N_pa_1	BIO_10581038N_pa_5	BIO_10581038N_pa_1_5
BIO	10581038N	pa	1	6	motivation_background	proposal	info-required	none	secondary	main	none	none	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein.	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	BIO_10581038N_pa_1	BIO_10581038N_pa_6	BIO_10581038N_pa_1_6
BIO	10581038N	pa	1	7	motivation_background	result	info-required	support	secondary	secondary	none	none	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein.	Our results show that Msh2 is required for somatic instability of the CAG repeat.	BIO_10581038N_pa_1	BIO_10581038N_pa_7	BIO_10581038N_pa_1_7
BIO	10581038N	pa	2	3	motivation_background	motivation_background	elaboration	info-required	secondary	secondary	none	none	The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats.	HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion.	BIO_10581038N_pa_2	BIO_10581038N_pa_3	BIO_10581038N_pa_2_3
BIO	10581038N	pa	2	4	motivation_background	motivation_background	elaboration	info-required	secondary	secondary	none	none	The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats.	For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10).	BIO_10581038N_pa_2	BIO_10581038N_pa_4	BIO_10581038N_pa_2_4
BIO	10581038N	pa	2	5	motivation_background	motivation_hypothesis	elaboration	support	secondary	secondary	none	none	The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats.	With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation, suggesting important functional correlations between repeat length and pathology.	BIO_10581038N_pa_2	BIO_10581038N_pa_5	BIO_10581038N_pa_2_5
BIO	10581038N	pa	2	6	motivation_background	proposal	elaboration	none	secondary	main	none	none	The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats.	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	BIO_10581038N_pa_2	BIO_10581038N_pa_6	BIO_10581038N_pa_2_6
BIO	10581038N	pa	2	7	motivation_background	result	elaboration	support	secondary	secondary	none	none	The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats.	Our results show that Msh2 is required for somatic instability of the CAG repeat.	BIO_10581038N_pa_2	BIO_10581038N_pa_7	BIO_10581038N_pa_2_7
BIO	10581038N	pa	3	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion.	For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10).	BIO_10581038N_pa_3	BIO_10581038N_pa_4	BIO_10581038N_pa_3_4
BIO	10581038N	pa	3	5	motivation_background	motivation_hypothesis	info-required	support	secondary	secondary	none	none	HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion.	With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation, suggesting important functional correlations between repeat length and pathology.	BIO_10581038N_pa_3	BIO_10581038N_pa_5	BIO_10581038N_pa_3_5
BIO	10581038N	pa	3	6	motivation_background	proposal	info-required	none	secondary	main	none	none	HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion.	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	BIO_10581038N_pa_3	BIO_10581038N_pa_6	BIO_10581038N_pa_3_6
BIO	10581038N	pa	3	7	motivation_background	result	info-required	support	secondary	secondary	none	none	HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion.	Our results show that Msh2 is required for somatic instability of the CAG repeat.	BIO_10581038N_pa_3	BIO_10581038N_pa_7	BIO_10581038N_pa_3_7
BIO	10581038N	pa	4	5	motivation_background	motivation_hypothesis	info-required	support	secondary	secondary	forw	info-required	For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10).	With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation, suggesting important functional correlations between repeat length and pathology.	BIO_10581038N_pa_4	BIO_10581038N_pa_5	BIO_10581038N_pa_4_5
BIO	10581038N	pa	4	6	motivation_background	proposal	info-required	none	secondary	main	none	none	For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10).	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	BIO_10581038N_pa_4	BIO_10581038N_pa_6	BIO_10581038N_pa_4_6
BIO	10581038N	pa	4	7	motivation_background	result	info-required	support	secondary	secondary	none	none	For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10).	Our results show that Msh2 is required for somatic instability of the CAG repeat.	BIO_10581038N_pa_4	BIO_10581038N_pa_7	BIO_10581038N_pa_4_7
BIO	10581038N	pa	5	6	motivation_hypothesis	proposal	support	none	secondary	main	forw	support	With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation, suggesting important functional correlations between repeat length and pathology.	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	BIO_10581038N_pa_5	BIO_10581038N_pa_6	BIO_10581038N_pa_5_6
BIO	10581038N	pa	5	7	motivation_hypothesis	result	support	support	secondary	secondary	none	none	With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation, suggesting important functional correlations between repeat length and pathology.	Our results show that Msh2 is required for somatic instability of the CAG repeat.	BIO_10581038N_pa_5	BIO_10581038N_pa_7	BIO_10581038N_pa_5_7
BIO	10581038N	pa	6	7	proposal	result	none	support	main	secondary	back	support	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	Our results show that Msh2 is required for somatic instability of the CAG repeat.	BIO_10581038N_pa_6	BIO_10581038N_pa_7	BIO_10581038N_pa_6_7
BIO	10581038N	pa	7	6	result	proposal	support	none	secondary	main	forw	support	Our results show that Msh2 is required for somatic instability of the CAG repeat.	Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2-/- mice.	BIO_10581038N_pa_7	BIO_10581038N_pa_6	BIO_10581038N_pa_6_7
BIO	10627141	pa	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	BIO_10627141_pa_1	BIO_10627141_pa_2	BIO_10627141_pa_1_2
BIO	10627141	pa	1	3	motivation_background	motivation_background	info-required	support	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	BIO_10627141_pa_1	BIO_10627141_pa_3	BIO_10627141_pa_1_3
BIO	10627141	pa	1	4	motivation_background	proposal	info-required	none	secondary	main	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	BIO_10627141_pa_1	BIO_10627141_pa_4	BIO_10627141_pa_1_4
BIO	10627141	pa	1	5	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	A total of 22 cancers were RER-positive.	BIO_10627141_pa_1	BIO_10627141_pa_5	BIO_10627141_pa_1_5
BIO	10627141	pa	1	6	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	BIO_10627141_pa_1	BIO_10627141_pa_6	BIO_10627141_pa_1_6
BIO	10627141	pa	1	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	We identified four previously undescribed mutations in four different samples.	BIO_10627141_pa_1	BIO_10627141_pa_7	BIO_10627141_pa_1_7
BIO	10627141	pa	1	8	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_pa_1	BIO_10627141_pa_8	BIO_10627141_pa_1_8
BIO	10627141	pa	1	9	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_pa_1	BIO_10627141_pa_9	BIO_10627141_pa_1_9
BIO	10627141	pa	1	10	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_pa_1	BIO_10627141_pa_10	BIO_10627141_pa_1_10
BIO	10627141	pa	1	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_pa_1	BIO_10627141_pa_11	BIO_10627141_pa_1_11
BIO	10627141	pa	1	12	motivation_background	result	info-required	support	secondary	secondary	none	none	Hereditary nonpolyposis colorectal cancer (HNPCC) is frequently associated with inherited mutation in one of four DNA mismatch repair genes.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_pa_1	BIO_10627141_pa_12	BIO_10627141_pa_1_12
BIO	10627141	pa	2	3	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	BIO_10627141_pa_2	BIO_10627141_pa_3	BIO_10627141_pa_2_3
BIO	10627141	pa	2	4	motivation_background	proposal	info-required	none	secondary	main	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	BIO_10627141_pa_2	BIO_10627141_pa_4	BIO_10627141_pa_2_4
BIO	10627141	pa	2	5	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	A total of 22 cancers were RER-positive.	BIO_10627141_pa_2	BIO_10627141_pa_5	BIO_10627141_pa_2_5
BIO	10627141	pa	2	6	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	BIO_10627141_pa_2	BIO_10627141_pa_6	BIO_10627141_pa_2_6
BIO	10627141	pa	2	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	We identified four previously undescribed mutations in four different samples.	BIO_10627141_pa_2	BIO_10627141_pa_7	BIO_10627141_pa_2_7
BIO	10627141	pa	2	8	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_pa_2	BIO_10627141_pa_8	BIO_10627141_pa_2_8
BIO	10627141	pa	2	9	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_pa_2	BIO_10627141_pa_9	BIO_10627141_pa_2_9
BIO	10627141	pa	2	10	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_pa_2	BIO_10627141_pa_10	BIO_10627141_pa_2_10
BIO	10627141	pa	2	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_pa_2	BIO_10627141_pa_11	BIO_10627141_pa_2_11
BIO	10627141	pa	2	12	motivation_background	result	info-required	support	secondary	secondary	none	none	Somatic mutations in the same genes are also found in a subset of sporadic colorectal cancers.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_pa_2	BIO_10627141_pa_12	BIO_10627141_pa_2_12
BIO	10627141	pa	3	4	motivation_background	proposal	support	none	secondary	main	forw	support	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	BIO_10627141_pa_3	BIO_10627141_pa_4	BIO_10627141_pa_3_4
BIO	10627141	pa	3	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	A total of 22 cancers were RER-positive.	BIO_10627141_pa_3	BIO_10627141_pa_5	BIO_10627141_pa_3_5
BIO	10627141	pa	3	6	motivation_background	proposal_implementation	support	sequence	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	BIO_10627141_pa_3	BIO_10627141_pa_6	BIO_10627141_pa_3_6
BIO	10627141	pa	3	7	motivation_background	observation	support	info-required	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	We identified four previously undescribed mutations in four different samples.	BIO_10627141_pa_3	BIO_10627141_pa_7	BIO_10627141_pa_3_7
BIO	10627141	pa	3	8	motivation_background	observation	support	elaboration	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_pa_3	BIO_10627141_pa_8	BIO_10627141_pa_3_8
BIO	10627141	pa	3	9	motivation_background	observation	support	elaboration	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_pa_3	BIO_10627141_pa_9	BIO_10627141_pa_3_9
BIO	10627141	pa	3	10	motivation_background	observation	support	elaboration	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_pa_3	BIO_10627141_pa_10	BIO_10627141_pa_3_10
BIO	10627141	pa	3	11	motivation_background	observation	support	support	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_pa_3	BIO_10627141_pa_11	BIO_10627141_pa_3_11
BIO	10627141	pa	3	12	motivation_background	result	support	support	secondary	secondary	none	none	A defect in DNA mismatch repair results in a RER (replication error) tumor phenotype.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_pa_3	BIO_10627141_pa_12	BIO_10627141_pa_3_12
BIO	10627141	pa	4	5	proposal	observation	none	info-required	main	secondary	none	none	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	A total of 22 cancers were RER-positive.	BIO_10627141_pa_4	BIO_10627141_pa_5	BIO_10627141_pa_4_5
BIO	10627141	pa	4	6	proposal	proposal_implementation	none	sequence	main	secondary	back	sequence	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	BIO_10627141_pa_4	BIO_10627141_pa_6	BIO_10627141_pa_4_6
BIO	10627141	pa	4	7	proposal	observation	none	info-required	main	secondary	none	none	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	We identified four previously undescribed mutations in four different samples.	BIO_10627141_pa_4	BIO_10627141_pa_7	BIO_10627141_pa_4_7
BIO	10627141	pa	4	8	proposal	observation	none	elaboration	main	secondary	none	none	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_pa_4	BIO_10627141_pa_8	BIO_10627141_pa_4_8
BIO	10627141	pa	4	9	proposal	observation	none	elaboration	main	secondary	none	none	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_pa_4	BIO_10627141_pa_9	BIO_10627141_pa_4_9
BIO	10627141	pa	4	10	proposal	observation	none	elaboration	main	secondary	none	none	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_pa_4	BIO_10627141_pa_10	BIO_10627141_pa_4_10
BIO	10627141	pa	4	11	proposal	observation	none	support	main	secondary	none	none	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_pa_4	BIO_10627141_pa_11	BIO_10627141_pa_4_11
BIO	10627141	pa	4	12	proposal	result	none	support	main	secondary	back	support	We screened 110 archival and 11 prospectively acquired colorectal cancers for the RER phenotype.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_pa_4	BIO_10627141_pa_12	BIO_10627141_pa_4_12
BIO	10627141	pa	5	6	observation	proposal_implementation	info-required	sequence	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	BIO_10627141_pa_5	BIO_10627141_pa_6	BIO_10627141_pa_5_6
BIO	10627141	pa	5	7	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	A total of 22 cancers were RER-positive.	We identified four previously undescribed mutations in four different samples.	BIO_10627141_pa_5	BIO_10627141_pa_7	BIO_10627141_pa_5_7
BIO	10627141	pa	5	8	observation	observation	info-required	elaboration	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_pa_5	BIO_10627141_pa_8	BIO_10627141_pa_5_8
BIO	10627141	pa	5	9	observation	observation	info-required	elaboration	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_pa_5	BIO_10627141_pa_9	BIO_10627141_pa_5_9
BIO	10627141	pa	5	10	observation	observation	info-required	elaboration	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_pa_5	BIO_10627141_pa_10	BIO_10627141_pa_5_10
BIO	10627141	pa	5	11	observation	observation	info-required	support	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_pa_5	BIO_10627141_pa_11	BIO_10627141_pa_5_11
BIO	10627141	pa	5	12	observation	result	info-required	support	secondary	secondary	none	none	A total of 22 cancers were RER-positive.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_pa_5	BIO_10627141_pa_12	BIO_10627141_pa_5_12
BIO	10627141	pa	6	7	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	We identified four previously undescribed mutations in four different samples.	BIO_10627141_pa_6	BIO_10627141_pa_7	BIO_10627141_pa_6_7
BIO	10627141	pa	6	8	proposal_implementation	observation	sequence	elaboration	secondary	secondary	none	none	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_pa_6	BIO_10627141_pa_8	BIO_10627141_pa_6_8
BIO	10627141	pa	6	9	proposal_implementation	observation	sequence	elaboration	secondary	secondary	none	none	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_pa_6	BIO_10627141_pa_9	BIO_10627141_pa_6_9
BIO	10627141	pa	6	10	proposal_implementation	observation	sequence	elaboration	secondary	secondary	none	none	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_pa_6	BIO_10627141_pa_10	BIO_10627141_pa_6_10
BIO	10627141	pa	6	11	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_pa_6	BIO_10627141_pa_11	BIO_10627141_pa_6_11
BIO	10627141	pa	6	12	proposal_implementation	result	sequence	support	secondary	secondary	none	none	RER-positive tumors were investigated for mutations in the DNA mismatch repair gene MLH1 using single-strand-conformation-polymorphism (SSCP) analysis.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_pa_6	BIO_10627141_pa_12	BIO_10627141_pa_6_12
BIO	10627141	pa	7	8	observation	observation	info-required	elaboration	secondary	secondary	back	elaboration	We identified four previously undescribed mutations in four different samples.	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	BIO_10627141_pa_7	BIO_10627141_pa_8	BIO_10627141_pa_7_8
BIO	10627141	pa	7	9	observation	observation	info-required	elaboration	secondary	secondary	back	elaboration	We identified four previously undescribed mutations in four different samples.	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_pa_7	BIO_10627141_pa_9	BIO_10627141_pa_7_9
BIO	10627141	pa	7	10	observation	observation	info-required	elaboration	secondary	secondary	back	elaboration	We identified four previously undescribed mutations in four different samples.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_pa_7	BIO_10627141_pa_10	BIO_10627141_pa_7_10
BIO	10627141	pa	7	11	observation	observation	info-required	support	secondary	secondary	forw	info-required	We identified four previously undescribed mutations in four different samples.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_pa_7	BIO_10627141_pa_11	BIO_10627141_pa_7_11
BIO	10627141	pa	7	12	observation	result	info-required	support	secondary	secondary	none	none	We identified four previously undescribed mutations in four different samples.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_pa_7	BIO_10627141_pa_12	BIO_10627141_pa_7_12
BIO	10627141	pa	8	9	observation	observation	elaboration	elaboration	secondary	secondary	none	none	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	BIO_10627141_pa_8	BIO_10627141_pa_9	BIO_10627141_pa_8_9
BIO	10627141	pa	8	10	observation	observation	elaboration	elaboration	secondary	secondary	none	none	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_pa_8	BIO_10627141_pa_10	BIO_10627141_pa_8_10
BIO	10627141	pa	8	11	observation	observation	elaboration	support	secondary	secondary	none	none	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_pa_8	BIO_10627141_pa_11	BIO_10627141_pa_8_11
BIO	10627141	pa	8	12	observation	result	elaboration	support	secondary	secondary	none	none	Three mutations were exonic: a point mutation at codon 69 (AGG-->AAG(arg-->lys]); a single base pair deletion at codon 42/43 (GCAAAATCC-->GCAAATCC) leading to a new stop codon downstream; and a point mutation at codon 757	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_pa_8	BIO_10627141_pa_12	BIO_10627141_pa_8_12
BIO	10627141	pa	9	10	observation	observation	elaboration	elaboration	secondary	secondary	none	none	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	BIO_10627141_pa_9	BIO_10627141_pa_10	BIO_10627141_pa_9_10
BIO	10627141	pa	9	11	observation	observation	elaboration	support	secondary	secondary	none	none	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_pa_9	BIO_10627141_pa_11	BIO_10627141_pa_9_11
BIO	10627141	pa	9	12	observation	result	elaboration	support	secondary	secondary	none	none	(TAA-->TAT [termination-->tyr] which extend the MLH1 peptide by 36 ammino acids.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_pa_9	BIO_10627141_pa_12	BIO_10627141_pa_9_12
BIO	10627141	pa	10	11	observation	observation	elaboration	support	secondary	secondary	none	none	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_pa_10	BIO_10627141_pa_11	BIO_10627141_pa_10_11
BIO	10627141	pa	10	12	observation	result	elaboration	support	secondary	secondary	none	none	The fourth mutation was a 1 base pair insertion six base pairs 5' to the start of exon 14 (tttgtttt-->tttggtttt).	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_pa_10	BIO_10627141_pa_12	BIO_10627141_pa_10_12
BIO	10627141	pa	11	12	observation	result	support	support	secondary	secondary	forw	support	The mutations were not seen in the patients' constitutional DNA.	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	BIO_10627141_pa_11	BIO_10627141_pa_12	BIO_10627141_pa_11_12
BIO	10627141	pa	12	11	result	observation	support	support	secondary	secondary	back	support	The somatic MLHI mutations identified appear to be causally associated with the RER phenotype.	The mutations were not seen in the patients' constitutional DNA.	BIO_10627141_pa_12	BIO_10627141_pa_11	BIO_10627141_pa_11_12
BIO	10762373	pa	1	2	proposal	motivation_hypothesis	none	support	main	secondary	back	support	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	BIO_10762373_pa_1	BIO_10762373_pa_2	BIO_10762373_pa_1_2
BIO	10762373	pa	1	3	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	BIO_10762373_pa_1	BIO_10762373_pa_3	BIO_10762373_pa_1_3
BIO	10762373	pa	1	4	proposal	proposal_implementation	none	sequence	main	secondary	none	none	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	BIO_10762373_pa_1	BIO_10762373_pa_4	BIO_10762373_pa_1_4
BIO	10762373	pa	1	5	proposal	result	none	support	main	secondary	none	none	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	BIO_10762373_pa_1	BIO_10762373_pa_5	BIO_10762373_pa_1_5
BIO	10762373	pa	1	6	proposal	observation	none	support	main	secondary	none	none	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	BIO_10762373_pa_1	BIO_10762373_pa_6	BIO_10762373_pa_1_6
BIO	10762373	pa	1	7	proposal	observation	none	support	main	secondary	none	none	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	BIO_10762373_pa_1	BIO_10762373_pa_7	BIO_10762373_pa_1_7
BIO	10762373	pa	1	8	proposal	conclusion	none	support	main	secondary	back	support	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_pa_1	BIO_10762373_pa_8	BIO_10762373_pa_1_8
BIO	10762373	pa	1	9	proposal	conclusion	none	elaboration	main	secondary	none	none	We wanted to know whether fast oscillations ( approximately 30-80 Hz) in striate cortex of awake monkeys show sharper orientation selectivity than (i) slower components, including spike rate modulations, and (ii) broad-band signals of the same recordings.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_pa_1	BIO_10762373_pa_9	BIO_10762373_pa_1_9
BIO	10762373	pa	2	3	motivation_hypothesis	proposal_implementation	support	elaboration	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	BIO_10762373_pa_2	BIO_10762373_pa_3	BIO_10762373_pa_2_3
BIO	10762373	pa	2	4	motivation_hypothesis	proposal_implementation	support	sequence	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	BIO_10762373_pa_2	BIO_10762373_pa_4	BIO_10762373_pa_2_4
BIO	10762373	pa	2	5	motivation_hypothesis	result	support	support	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	BIO_10762373_pa_2	BIO_10762373_pa_5	BIO_10762373_pa_2_5
BIO	10762373	pa	2	6	motivation_hypothesis	observation	support	support	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	BIO_10762373_pa_2	BIO_10762373_pa_6	BIO_10762373_pa_2_6
BIO	10762373	pa	2	7	motivation_hypothesis	observation	support	support	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	BIO_10762373_pa_2	BIO_10762373_pa_7	BIO_10762373_pa_2_7
BIO	10762373	pa	2	8	motivation_hypothesis	conclusion	support	support	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_pa_2	BIO_10762373_pa_8	BIO_10762373_pa_2_8
BIO	10762373	pa	2	9	motivation_hypothesis	conclusion	support	elaboration	secondary	secondary	none	none	As fast oscillations are probably of cortical origin this may further clarify whether cortical network mechanisms are substantially involved in generating orientation selectivity.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_pa_2	BIO_10762373_pa_9	BIO_10762373_pa_2_9
BIO	10762373	pa	3	4	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	back	sequence	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	BIO_10762373_pa_3	BIO_10762373_pa_4	BIO_10762373_pa_3_4
BIO	10762373	pa	3	5	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	BIO_10762373_pa_3	BIO_10762373_pa_5	BIO_10762373_pa_3_5
BIO	10762373	pa	3	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	BIO_10762373_pa_3	BIO_10762373_pa_6	BIO_10762373_pa_3_6
BIO	10762373	pa	3	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	BIO_10762373_pa_3	BIO_10762373_pa_7	BIO_10762373_pa_3_7
BIO	10762373	pa	3	8	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_pa_3	BIO_10762373_pa_8	BIO_10762373_pa_3_8
BIO	10762373	pa	3	9	proposal_implementation	conclusion	elaboration	elaboration	secondary	secondary	none	none	We recorded multi unit activity (MUA) and local field potentials (LFP, 1-140 Hz) by the same microelectrodes from upper layers of macaque striate cortex during visual stimulation with grating textures of different orientations.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_pa_3	BIO_10762373_pa_9	BIO_10762373_pa_3_9
BIO	10762373	pa	4	5	proposal_implementation	result	sequence	support	secondary	secondary	none	none	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	BIO_10762373_pa_4	BIO_10762373_pa_5	BIO_10762373_pa_4_5
BIO	10762373	pa	4	6	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	BIO_10762373_pa_4	BIO_10762373_pa_6	BIO_10762373_pa_4_6
BIO	10762373	pa	4	7	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	BIO_10762373_pa_4	BIO_10762373_pa_7	BIO_10762373_pa_4_7
BIO	10762373	pa	4	8	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_pa_4	BIO_10762373_pa_8	BIO_10762373_pa_4_8
BIO	10762373	pa	4	9	proposal_implementation	conclusion	sequence	elaboration	secondary	secondary	none	none	An orientation index (OI) was derived from the cortical responses in three frequency ranges (low, 0-11.7 Hz; medium, 11.7-31.3 Hz; and fast oscillations, 31.3-62.5 Hz) and for the broad-band LFP and MUA power.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_pa_4	BIO_10762373_pa_9	BIO_10762373_pa_4_9
BIO	10762373	pa	5	6	result	observation	support	support	secondary	secondary	back	support	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	BIO_10762373_pa_5	BIO_10762373_pa_6	BIO_10762373_pa_5_6
BIO	10762373	pa	5	7	result	observation	support	support	secondary	secondary	back	support	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	BIO_10762373_pa_5	BIO_10762373_pa_7	BIO_10762373_pa_5_7
BIO	10762373	pa	5	8	result	conclusion	support	support	secondary	secondary	forw	support	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_pa_5	BIO_10762373_pa_8	BIO_10762373_pa_5_8
BIO	10762373	pa	5	9	result	conclusion	support	elaboration	secondary	secondary	none	none	(i) Both LFP and MUA fast oscillations reveal a higher orientation index than signal components in the low and medium frequency ranges.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_pa_5	BIO_10762373_pa_9	BIO_10762373_pa_5_9
BIO	10762373	pa	6	7	observation	observation	support	support	secondary	secondary	none	none	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	BIO_10762373_pa_6	BIO_10762373_pa_7	BIO_10762373_pa_6_7
BIO	10762373	pa	6	8	observation	conclusion	support	support	secondary	secondary	none	none	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_pa_6	BIO_10762373_pa_8	BIO_10762373_pa_6_8
BIO	10762373	pa	6	9	observation	conclusion	support	elaboration	secondary	secondary	none	none	(ii) For MUA the orientation index was significantly higher with fast oscillations than for the lower frequency ranges and the initial broad-band transient responses.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_pa_6	BIO_10762373_pa_9	BIO_10762373_pa_6_9
BIO	10762373	pa	7	8	observation	conclusion	support	support	secondary	secondary	none	none	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_pa_7	BIO_10762373_pa_8	BIO_10762373_pa_7_8
BIO	10762373	pa	7	9	observation	conclusion	support	elaboration	secondary	secondary	none	none	(iii) LFPs show a significantly higher orientation index only for the fast oscillations during sustained activation compared with their broad-band power during the transient responses.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_pa_7	BIO_10762373_pa_9	BIO_10762373_pa_7_9
BIO	10762373	pa	8	9	conclusion	conclusion	support	elaboration	secondary	secondary	back	elaboration	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	BIO_10762373_pa_8	BIO_10762373_pa_9	BIO_10762373_pa_8_9
BIO	10762373	pa	9	8	conclusion	conclusion	elaboration	support	secondary	secondary	forw	elaboration	As fast oscillations occur synchronized in the awake monkey's striate cortex we assume that they have enhanced probability of activating successive stages of visual processing and hence contribute to the perception of orientation.	Thus, our main result is the sharper orientation tuning of fast oscillations in spike activities of local populations compared with slower components of the same broad-band recordings.	BIO_10762373_pa_9	BIO_10762373_pa_8	BIO_10762373_pa_8_9
BIO	10945643	pa	1	2	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	BIO_10945643_pa_1	BIO_10945643_pa_2	BIO_10945643_pa_1_2
BIO	10945643	pa	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	BIO_10945643_pa_1	BIO_10945643_pa_3	BIO_10945643_pa_1_3
BIO	10945643	pa	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	BIO_10945643_pa_1	BIO_10945643_pa_4	BIO_10945643_pa_1_4
BIO	10945643	pa	1	5	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	Day 0 grafts underwent immunohistochemical assessment of ER status.	BIO_10945643_pa_1	BIO_10945643_pa_5	BIO_10945643_pa_1_5
BIO	10945643	pa	1	6	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	BIO_10945643_pa_1	BIO_10945643_pa_6	BIO_10945643_pa_1_6
BIO	10945643	pa	1	7	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	BIO_10945643_pa_1	BIO_10945643_pa_7	BIO_10945643_pa_1_7
BIO	10945643	pa	1	8	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_pa_1	BIO_10945643_pa_8	BIO_10945643_pa_1_8
BIO	10945643	pa	1	9	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_pa_1	BIO_10945643_pa_9	BIO_10945643_pa_1_9
BIO	10945643	pa	1	10	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_pa_1	BIO_10945643_pa_10	BIO_10945643_pa_1_10
BIO	10945643	pa	1	11	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_pa_1	BIO_10945643_pa_11	BIO_10945643_pa_1_11
BIO	10945643	pa	1	12	motivation_background	observation	info-required	support	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_pa_1	BIO_10945643_pa_12	BIO_10945643_pa_1_12
BIO	10945643	pa	1	13	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Adjuvant antiestrogen (AE) therapy has been proposed for all women with ductal carcinoma in situ (DCIS).	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_pa_1	BIO_10945643_pa_13	BIO_10945643_pa_1_13
BIO	10945643	pa	2	3	motivation_problem	proposal	support	none	secondary	main	forw	support	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	BIO_10945643_pa_2	BIO_10945643_pa_3	BIO_10945643_pa_2_3
BIO	10945643	pa	2	4	motivation_problem	proposal_implementation	support	elaboration	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	BIO_10945643_pa_2	BIO_10945643_pa_4	BIO_10945643_pa_2_4
BIO	10945643	pa	2	5	motivation_problem	proposal_implementation	support	sequence	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	Day 0 grafts underwent immunohistochemical assessment of ER status.	BIO_10945643_pa_2	BIO_10945643_pa_5	BIO_10945643_pa_2_5
BIO	10945643	pa	2	6	motivation_problem	proposal_implementation	support	sequence	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	BIO_10945643_pa_2	BIO_10945643_pa_6	BIO_10945643_pa_2_6
BIO	10945643	pa	2	7	motivation_problem	proposal_implementation	support	sequence	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	BIO_10945643_pa_2	BIO_10945643_pa_7	BIO_10945643_pa_2_7
BIO	10945643	pa	2	8	motivation_problem	proposal_implementation	support	sequence	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_pa_2	BIO_10945643_pa_8	BIO_10945643_pa_2_8
BIO	10945643	pa	2	9	motivation_problem	observation	support	info-required	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_pa_2	BIO_10945643_pa_9	BIO_10945643_pa_2_9
BIO	10945643	pa	2	10	motivation_problem	observation	support	info-required	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_pa_2	BIO_10945643_pa_10	BIO_10945643_pa_2_10
BIO	10945643	pa	2	11	motivation_problem	observation	support	info-required	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_pa_2	BIO_10945643_pa_11	BIO_10945643_pa_2_11
BIO	10945643	pa	2	12	motivation_problem	observation	support	support	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_pa_2	BIO_10945643_pa_12	BIO_10945643_pa_2_12
BIO	10945643	pa	2	13	motivation_problem	conclusion	support	support	secondary	secondary	none	none	However, many cases of DCIS are of the high-grade, estrogen receptor (ER)-negative subtype that are unlikely to respond to AE treatment.	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_pa_2	BIO_10945643_pa_13	BIO_10945643_pa_2_13
BIO	10945643	pa	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	BIO_10945643_pa_3	BIO_10945643_pa_4	BIO_10945643_pa_3_4
BIO	10945643	pa	3	5	proposal	proposal_implementation	none	sequence	main	secondary	none	none	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	Day 0 grafts underwent immunohistochemical assessment of ER status.	BIO_10945643_pa_3	BIO_10945643_pa_5	BIO_10945643_pa_3_5
BIO	10945643	pa	3	6	proposal	proposal_implementation	none	sequence	main	secondary	none	none	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	BIO_10945643_pa_3	BIO_10945643_pa_6	BIO_10945643_pa_3_6
BIO	10945643	pa	3	7	proposal	proposal_implementation	none	sequence	main	secondary	none	none	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	BIO_10945643_pa_3	BIO_10945643_pa_7	BIO_10945643_pa_3_7
BIO	10945643	pa	3	8	proposal	proposal_implementation	none	sequence	main	secondary	none	none	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_pa_3	BIO_10945643_pa_8	BIO_10945643_pa_3_8
BIO	10945643	pa	3	9	proposal	observation	none	info-required	main	secondary	none	none	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_pa_3	BIO_10945643_pa_9	BIO_10945643_pa_3_9
BIO	10945643	pa	3	10	proposal	observation	none	info-required	main	secondary	none	none	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_pa_3	BIO_10945643_pa_10	BIO_10945643_pa_3_10
BIO	10945643	pa	3	11	proposal	observation	none	info-required	main	secondary	none	none	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_pa_3	BIO_10945643_pa_11	BIO_10945643_pa_3_11
BIO	10945643	pa	3	12	proposal	observation	none	support	main	secondary	none	none	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_pa_3	BIO_10945643_pa_12	BIO_10945643_pa_3_12
BIO	10945643	pa	3	13	proposal	conclusion	none	support	main	secondary	back	support	Hormonal agents work by increasing apoptosis and/or decreasing cell proliferation; therefore, we studied the effect of a pure AE on levels of apoptosis and proliferation in human DCIS xenografts using an in vivo model.	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_pa_3	BIO_10945643_pa_13	BIO_10945643_pa_3_13
BIO	10945643	pa	4	5	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	back	sequence	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	Day 0 grafts underwent immunohistochemical assessment of ER status.	BIO_10945643_pa_4	BIO_10945643_pa_5	BIO_10945643_pa_4_5
BIO	10945643	pa	4	6	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	BIO_10945643_pa_4	BIO_10945643_pa_6	BIO_10945643_pa_4_6
BIO	10945643	pa	4	7	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	BIO_10945643_pa_4	BIO_10945643_pa_7	BIO_10945643_pa_4_7
BIO	10945643	pa	4	8	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_pa_4	BIO_10945643_pa_8	BIO_10945643_pa_4_8
BIO	10945643	pa	4	9	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_pa_4	BIO_10945643_pa_9	BIO_10945643_pa_4_9
BIO	10945643	pa	4	10	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_pa_4	BIO_10945643_pa_10	BIO_10945643_pa_4_10
BIO	10945643	pa	4	11	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_pa_4	BIO_10945643_pa_11	BIO_10945643_pa_4_11
BIO	10945643	pa	4	12	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_pa_4	BIO_10945643_pa_12	BIO_10945643_pa_4_12
BIO	10945643	pa	4	13	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Women (n = 23) with mammographic microcalcification suggestive of DCIS were identified at the time of surgery (day 0), a sample of representative tissue was obtained, divided into multiple 2x2x1-mm xenografts, and implanted s.c. into female BALB/c nu/nu mice (eight xenografts/mouse).	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_pa_4	BIO_10945643_pa_13	BIO_10945643_pa_4_13
BIO	10945643	pa	5	6	proposal_implementation	proposal_implementation	sequence	sequence	secondary	secondary	back	sequence	Day 0 grafts underwent immunohistochemical assessment of ER status.	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	BIO_10945643_pa_5	BIO_10945643_pa_6	BIO_10945643_pa_5_6
BIO	10945643	pa	5	7	proposal_implementation	proposal_implementation	sequence	sequence	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	BIO_10945643_pa_5	BIO_10945643_pa_7	BIO_10945643_pa_5_7
BIO	10945643	pa	5	8	proposal_implementation	proposal_implementation	sequence	sequence	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_pa_5	BIO_10945643_pa_8	BIO_10945643_pa_5_8
BIO	10945643	pa	5	9	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_pa_5	BIO_10945643_pa_9	BIO_10945643_pa_5_9
BIO	10945643	pa	5	10	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_pa_5	BIO_10945643_pa_10	BIO_10945643_pa_5_10
BIO	10945643	pa	5	11	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_pa_5	BIO_10945643_pa_11	BIO_10945643_pa_5_11
BIO	10945643	pa	5	12	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_pa_5	BIO_10945643_pa_12	BIO_10945643_pa_5_12
BIO	10945643	pa	5	13	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	Day 0 grafts underwent immunohistochemical assessment of ER status.	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_pa_5	BIO_10945643_pa_13	BIO_10945643_pa_5_13
BIO	10945643	pa	6	7	proposal_implementation	proposal_implementation	sequence	sequence	secondary	secondary	back	sequence	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	BIO_10945643_pa_6	BIO_10945643_pa_7	BIO_10945643_pa_6_7
BIO	10945643	pa	6	8	proposal_implementation	proposal_implementation	sequence	sequence	secondary	secondary	none	none	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_pa_6	BIO_10945643_pa_8	BIO_10945643_pa_6_8
BIO	10945643	pa	6	9	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_pa_6	BIO_10945643_pa_9	BIO_10945643_pa_6_9
BIO	10945643	pa	6	10	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_pa_6	BIO_10945643_pa_10	BIO_10945643_pa_6_10
BIO	10945643	pa	6	11	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_pa_6	BIO_10945643_pa_11	BIO_10945643_pa_6_11
BIO	10945643	pa	6	12	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_pa_6	BIO_10945643_pa_12	BIO_10945643_pa_6_12
BIO	10945643	pa	6	13	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	Fourteen days after implantation, four xenografts were retrieved and mice were randomly divided into one of three treatment groups: (a) insertion of a slow release 2-mg 17beta-estradiol pellet; (b) weekly 5-mg injections of the pure AE Faslodex (Zeneca Pharmaceuticals); and (c) injections of a control vehicle oil alone.	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_pa_6	BIO_10945643_pa_13	BIO_10945643_pa_6_13
BIO	10945643	pa	7	8	proposal_implementation	proposal_implementation	sequence	sequence	secondary	secondary	back	sequence	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	BIO_10945643_pa_7	BIO_10945643_pa_8	BIO_10945643_pa_7_8
BIO	10945643	pa	7	9	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_pa_7	BIO_10945643_pa_9	BIO_10945643_pa_7_9
BIO	10945643	pa	7	10	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_pa_7	BIO_10945643_pa_10	BIO_10945643_pa_7_10
BIO	10945643	pa	7	11	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_pa_7	BIO_10945643_pa_11	BIO_10945643_pa_7_11
BIO	10945643	pa	7	12	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_pa_7	BIO_10945643_pa_12	BIO_10945643_pa_7_12
BIO	10945643	pa	7	13	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	After 2 weeks of treatment, the remaining four xenografts were retrieved from each mouse.	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_pa_7	BIO_10945643_pa_13	BIO_10945643_pa_7_13
BIO	10945643	pa	8	9	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	BIO_10945643_pa_8	BIO_10945643_pa_9	BIO_10945643_pa_8_9
BIO	10945643	pa	8	10	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_pa_8	BIO_10945643_pa_10	BIO_10945643_pa_8_10
BIO	10945643	pa	8	11	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_pa_8	BIO_10945643_pa_11	BIO_10945643_pa_8_11
BIO	10945643	pa	8	12	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_pa_8	BIO_10945643_pa_12	BIO_10945643_pa_8_12
BIO	10945643	pa	8	13	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	Retrieved xenografts containing DCIS were assessed for morphological evidence of apoptotic cell death (apoptotic index (AI)) and cell proliferation (by immunohistochemical detection of the Ki67 proliferation antigen LI).	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_pa_8	BIO_10945643_pa_13	BIO_10945643_pa_8_13
BIO	10945643	pa	9	10	observation	observation	info-required	info-required	secondary	secondary	none	none	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	BIO_10945643_pa_9	BIO_10945643_pa_10	BIO_10945643_pa_9_10
BIO	10945643	pa	9	11	observation	observation	info-required	info-required	secondary	secondary	back	info-required	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_pa_9	BIO_10945643_pa_11	BIO_10945643_pa_9_11
BIO	10945643	pa	9	12	observation	observation	info-required	support	secondary	secondary	forw	info-required	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_pa_9	BIO_10945643_pa_12	BIO_10945643_pa_9_12
BIO	10945643	pa	9	13	observation	conclusion	info-required	support	secondary	secondary	none	none	Both AI and LI were higher in the day 0 specimens of 16 ER- DCIS lesions compared with 7 ER+ DCIS lesions (mean values, 1.47% versus 0.32% and 20.6% versus 3.1%; both P less than 0.0001).	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_pa_9	BIO_10945643_pa_13	BIO_10945643_pa_9_13
BIO	10945643	pa	10	11	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	BIO_10945643_pa_10	BIO_10945643_pa_11	BIO_10945643_pa_10_11
BIO	10945643	pa	10	12	observation	observation	info-required	support	secondary	secondary	none	none	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_pa_10	BIO_10945643_pa_12	BIO_10945643_pa_10_12
BIO	10945643	pa	10	13	observation	conclusion	info-required	support	secondary	secondary	none	none	AI and LI values within ER- DCIS did not differ between xenografts exposed to 17beta-estradiol or AE treatment compared with the controls or pretreatment values (mean AI and LI in estradiol-treated, antiestrogen-treated, and control groups 1.04% versus 0.98% versus 1.29% and 17.2% versus 20.5% versus 17.7% respectively).	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_pa_10	BIO_10945643_pa_13	BIO_10945643_pa_10_13
BIO	10945643	pa	11	12	observation	observation	info-required	support	secondary	secondary	none	none	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_pa_11	BIO_10945643_pa_12	BIO_10945643_pa_11_12
BIO	10945643	pa	11	13	observation	conclusion	info-required	support	secondary	secondary	none	none	In contrast, treatment of mice bearing ER+ DCIS xenografts with 17beta-estradiol raised both the AI (1.03% versus 0.40%, P = 0.03) and LI (11.0% versus 5.1%, P = 0.007) compared with controls.	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_pa_11	BIO_10945643_pa_13	BIO_10945643_pa_11_13
BIO	10945643	pa	12	13	observation	conclusion	support	support	secondary	secondary	forw	support	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	BIO_10945643_pa_12	BIO_10945643_pa_13	BIO_10945643_pa_12_13
BIO	10945643	pa	13	12	conclusion	observation	support	support	secondary	secondary	back	support	AE therapy should be reserved for patients with estrogen receptor positive DCIS.	AE therapy of ER+ DCIS xenografts did not affect proliferation but resulted in higher apoptosis than in controls (0.9% versus 0.4% respectively, P = 0.04).	BIO_10945643_pa_13	BIO_10945643_pa_12	BIO_10945643_pa_12_13
BIO	10978169	pa	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	BIO_10978169_pa_1	BIO_10978169_pa_2	BIO_10978169_pa_1_2
BIO	10978169	pa	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	BIO_10978169_pa_1	BIO_10978169_pa_3	BIO_10978169_pa_1_3
BIO	10978169	pa	1	4	motivation_background	information_additional	info-required	info-optional	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	BIO_10978169_pa_1	BIO_10978169_pa_4	BIO_10978169_pa_1_4
BIO	10978169	pa	1	5	motivation_background	information_additional	info-required	info-optional	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	BIO_10978169_pa_1	BIO_10978169_pa_5	BIO_10978169_pa_1_5
BIO	10978169	pa	1	6	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	BIO_10978169_pa_1	BIO_10978169_pa_6	BIO_10978169_pa_1_6
BIO	10978169	pa	1	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	BIO_10978169_pa_1	BIO_10978169_pa_7	BIO_10978169_pa_1_7
BIO	10978169	pa	1	8	motivation_background	result	info-required	support	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_pa_1	BIO_10978169_pa_8	BIO_10978169_pa_1_8
BIO	10978169	pa	1	9	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_pa_1	BIO_10978169_pa_9	BIO_10978169_pa_1_9
BIO	10978169	pa	1	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_pa_1	BIO_10978169_pa_10	BIO_10978169_pa_1_10
BIO	10978169	pa	1	11	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_pa_1	BIO_10978169_pa_11	BIO_10978169_pa_1_11
BIO	10978169	pa	1	12	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_pa_1	BIO_10978169_pa_12	BIO_10978169_pa_1_12
BIO	10978169	pa	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	BIO_10978169_pa_2	BIO_10978169_pa_3	BIO_10978169_pa_2_3
BIO	10978169	pa	2	4	motivation_background	information_additional	support	info-optional	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	BIO_10978169_pa_2	BIO_10978169_pa_4	BIO_10978169_pa_2_4
BIO	10978169	pa	2	5	motivation_background	information_additional	support	info-optional	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	BIO_10978169_pa_2	BIO_10978169_pa_5	BIO_10978169_pa_2_5
BIO	10978169	pa	2	6	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	BIO_10978169_pa_2	BIO_10978169_pa_6	BIO_10978169_pa_2_6
BIO	10978169	pa	2	7	motivation_background	observation	support	support	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	BIO_10978169_pa_2	BIO_10978169_pa_7	BIO_10978169_pa_2_7
BIO	10978169	pa	2	8	motivation_background	result	support	support	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_pa_2	BIO_10978169_pa_8	BIO_10978169_pa_2_8
BIO	10978169	pa	2	9	motivation_background	proposal_implementation	support	sequence	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_pa_2	BIO_10978169_pa_9	BIO_10978169_pa_2_9
BIO	10978169	pa	2	10	motivation_background	observation	support	support	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_pa_2	BIO_10978169_pa_10	BIO_10978169_pa_2_10
BIO	10978169	pa	2	11	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_pa_2	BIO_10978169_pa_11	BIO_10978169_pa_2_11
BIO	10978169	pa	2	12	motivation_background	conclusion	support	support	secondary	secondary	none	none	Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_pa_2	BIO_10978169_pa_12	BIO_10978169_pa_2_12
BIO	10978169	pa	3	4	proposal	information_additional	none	info-optional	main	secondary	back	info-optional	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	BIO_10978169_pa_3	BIO_10978169_pa_4	BIO_10978169_pa_3_4
BIO	10978169	pa	3	5	proposal	information_additional	none	info-optional	main	secondary	back	info-optional	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	BIO_10978169_pa_3	BIO_10978169_pa_5	BIO_10978169_pa_3_5
BIO	10978169	pa	3	6	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	BIO_10978169_pa_3	BIO_10978169_pa_6	BIO_10978169_pa_3_6
BIO	10978169	pa	3	7	proposal	observation	none	support	main	secondary	none	none	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	BIO_10978169_pa_3	BIO_10978169_pa_7	BIO_10978169_pa_3_7
BIO	10978169	pa	3	8	proposal	result	none	support	main	secondary	none	none	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_pa_3	BIO_10978169_pa_8	BIO_10978169_pa_3_8
BIO	10978169	pa	3	9	proposal	proposal_implementation	none	sequence	main	secondary	none	none	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_pa_3	BIO_10978169_pa_9	BIO_10978169_pa_3_9
BIO	10978169	pa	3	10	proposal	observation	none	support	main	secondary	none	none	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_pa_3	BIO_10978169_pa_10	BIO_10978169_pa_3_10
BIO	10978169	pa	3	11	proposal	observation	none	elaboration	main	secondary	none	none	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_pa_3	BIO_10978169_pa_11	BIO_10978169_pa_3_11
BIO	10978169	pa	3	12	proposal	conclusion	none	support	main	secondary	back	support	Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_pa_3	BIO_10978169_pa_12	BIO_10978169_pa_3_12
BIO	10978169	pa	4	5	information_additional	information_additional	info-optional	info-optional	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	BIO_10978169_pa_4	BIO_10978169_pa_5	BIO_10978169_pa_4_5
BIO	10978169	pa	4	6	information_additional	proposal_implementation	info-optional	elaboration	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	BIO_10978169_pa_4	BIO_10978169_pa_6	BIO_10978169_pa_4_6
BIO	10978169	pa	4	7	information_additional	observation	info-optional	support	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	BIO_10978169_pa_4	BIO_10978169_pa_7	BIO_10978169_pa_4_7
BIO	10978169	pa	4	8	information_additional	result	info-optional	support	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_pa_4	BIO_10978169_pa_8	BIO_10978169_pa_4_8
BIO	10978169	pa	4	9	information_additional	proposal_implementation	info-optional	sequence	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_pa_4	BIO_10978169_pa_9	BIO_10978169_pa_4_9
BIO	10978169	pa	4	10	information_additional	observation	info-optional	support	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_pa_4	BIO_10978169_pa_10	BIO_10978169_pa_4_10
BIO	10978169	pa	4	11	information_additional	observation	info-optional	elaboration	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_pa_4	BIO_10978169_pa_11	BIO_10978169_pa_4_11
BIO	10978169	pa	4	12	information_additional	conclusion	info-optional	support	secondary	secondary	none	none	[Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_pa_4	BIO_10978169_pa_12	BIO_10978169_pa_4_12
BIO	10978169	pa	5	6	information_additional	proposal_implementation	info-optional	elaboration	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	BIO_10978169_pa_5	BIO_10978169_pa_6	BIO_10978169_pa_5_6
BIO	10978169	pa	5	7	information_additional	observation	info-optional	support	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	BIO_10978169_pa_5	BIO_10978169_pa_7	BIO_10978169_pa_5_7
BIO	10978169	pa	5	8	information_additional	result	info-optional	support	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_pa_5	BIO_10978169_pa_8	BIO_10978169_pa_5_8
BIO	10978169	pa	5	9	information_additional	proposal_implementation	info-optional	sequence	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_pa_5	BIO_10978169_pa_9	BIO_10978169_pa_5_9
BIO	10978169	pa	5	10	information_additional	observation	info-optional	support	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_pa_5	BIO_10978169_pa_10	BIO_10978169_pa_5_10
BIO	10978169	pa	5	11	information_additional	observation	info-optional	elaboration	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_pa_5	BIO_10978169_pa_11	BIO_10978169_pa_5_11
BIO	10978169	pa	5	12	information_additional	conclusion	info-optional	support	secondary	secondary	none	none	Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)].	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_pa_5	BIO_10978169_pa_12	BIO_10978169_pa_5_12
BIO	10978169	pa	6	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	BIO_10978169_pa_6	BIO_10978169_pa_7	BIO_10978169_pa_6_7
BIO	10978169	pa	6	8	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_pa_6	BIO_10978169_pa_8	BIO_10978169_pa_6_8
BIO	10978169	pa	6	9	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	back	sequence	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_pa_6	BIO_10978169_pa_9	BIO_10978169_pa_6_9
BIO	10978169	pa	6	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_pa_6	BIO_10978169_pa_10	BIO_10978169_pa_6_10
BIO	10978169	pa	6	11	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_pa_6	BIO_10978169_pa_11	BIO_10978169_pa_6_11
BIO	10978169	pa	6	12	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_pa_6	BIO_10978169_pa_12	BIO_10978169_pa_6_12
BIO	10978169	pa	7	8	observation	result	support	support	secondary	secondary	forw	support	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	BIO_10978169_pa_7	BIO_10978169_pa_8	BIO_10978169_pa_7_8
BIO	10978169	pa	7	9	observation	proposal_implementation	support	sequence	secondary	secondary	none	none	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_pa_7	BIO_10978169_pa_9	BIO_10978169_pa_7_9
BIO	10978169	pa	7	10	observation	observation	support	support	secondary	secondary	none	none	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_pa_7	BIO_10978169_pa_10	BIO_10978169_pa_7_10
BIO	10978169	pa	7	11	observation	observation	support	elaboration	secondary	secondary	none	none	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_pa_7	BIO_10978169_pa_11	BIO_10978169_pa_7_11
BIO	10978169	pa	7	12	observation	conclusion	support	support	secondary	secondary	none	none	Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_pa_7	BIO_10978169_pa_12	BIO_10978169_pa_7_12
BIO	10978169	pa	8	9	result	proposal_implementation	support	sequence	secondary	secondary	forw	support	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	BIO_10978169_pa_8	BIO_10978169_pa_9	BIO_10978169_pa_8_9
BIO	10978169	pa	8	10	result	observation	support	support	secondary	secondary	none	none	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_pa_8	BIO_10978169_pa_10	BIO_10978169_pa_8_10
BIO	10978169	pa	8	11	result	observation	support	elaboration	secondary	secondary	none	none	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_pa_8	BIO_10978169_pa_11	BIO_10978169_pa_8_11
BIO	10978169	pa	8	12	result	conclusion	support	support	secondary	secondary	none	none	This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_pa_8	BIO_10978169_pa_12	BIO_10978169_pa_8_12
BIO	10978169	pa	9	10	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	These dimers arose intracellularly rather than being derived from the medium by reuptake.	BIO_10978169_pa_9	BIO_10978169_pa_10	BIO_10978169_pa_9_10
BIO	10978169	pa	9	11	proposal_implementation	observation	sequence	elaboration	secondary	secondary	none	none	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_pa_9	BIO_10978169_pa_11	BIO_10978169_pa_9_11
BIO	10978169	pa	9	12	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_pa_9	BIO_10978169_pa_12	BIO_10978169_pa_9_12
BIO	10978169	pa	10	11	observation	observation	support	elaboration	secondary	secondary	back	elaboration	These dimers arose intracellularly rather than being derived from the medium by reuptake.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_pa_10	BIO_10978169_pa_11	BIO_10978169_pa_10_11
BIO	10978169	pa	10	12	observation	conclusion	support	support	secondary	secondary	forw	support	These dimers arose intracellularly rather than being derived from the medium by reuptake.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_pa_10	BIO_10978169_pa_12	BIO_10978169_pa_10_12
BIO	10978169	pa	11	12	observation	conclusion	elaboration	support	secondary	secondary	none	none	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	BIO_10978169_pa_11	BIO_10978169_pa_12	BIO_10978169_pa_11_12
BIO	10978169	pa	12	11	conclusion	observation	support	elaboration	secondary	secondary	none	none	We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.	The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells.	BIO_10978169_pa_12	BIO_10978169_pa_11	BIO_10978169_pa_11_12
BIO	11044594	pa	1	2	motivation_background	proposal	info-required	none	secondary	main	forw	info-required	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	BIO_11044594_pa_1	BIO_11044594_pa_2	BIO_11044594_pa_1_2
BIO	11044594	pa	1	3	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	BIO_11044594_pa_1	BIO_11044594_pa_3	BIO_11044594_pa_1_3
BIO	11044594	pa	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	BIO_11044594_pa_1	BIO_11044594_pa_4	BIO_11044594_pa_1_4
BIO	11044594	pa	1	5	motivation_background	result	info-required	info-required	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	BIO_11044594_pa_1	BIO_11044594_pa_5	BIO_11044594_pa_1_5
BIO	11044594	pa	1	6	motivation_background	result	info-required	support	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	BIO_11044594_pa_1	BIO_11044594_pa_6	BIO_11044594_pa_1_6
BIO	11044594	pa	1	7	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	BIO_11044594_pa_1	BIO_11044594_pa_7	BIO_11044594_pa_1_7
BIO	11044594	pa	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_pa_1	BIO_11044594_pa_8	BIO_11044594_pa_1_8
BIO	11044594	pa	1	9	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_pa_1	BIO_11044594_pa_9	BIO_11044594_pa_1_9
BIO	11044594	pa	1	10	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Previous studies have utilized a lesion model of cortical injury that produces transient behavioral impairments to investigate the recovery of function process.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_pa_1	BIO_11044594_pa_10	BIO_11044594_pa_1_10
BIO	11044594	pa	2	3	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	BIO_11044594_pa_2	BIO_11044594_pa_3	BIO_11044594_pa_2_3
BIO	11044594	pa	2	4	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	BIO_11044594_pa_2	BIO_11044594_pa_4	BIO_11044594_pa_2_4
BIO	11044594	pa	2	5	proposal	result	none	info-required	main	secondary	none	none	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	BIO_11044594_pa_2	BIO_11044594_pa_5	BIO_11044594_pa_2_5
BIO	11044594	pa	2	6	proposal	result	none	support	main	secondary	none	none	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	BIO_11044594_pa_2	BIO_11044594_pa_6	BIO_11044594_pa_2_6
BIO	11044594	pa	2	7	proposal	proposal_implementation	none	sequence	main	secondary	none	none	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	BIO_11044594_pa_2	BIO_11044594_pa_7	BIO_11044594_pa_2_7
BIO	11044594	pa	2	8	proposal	observation	none	support	main	secondary	none	none	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_pa_2	BIO_11044594_pa_8	BIO_11044594_pa_2_8
BIO	11044594	pa	2	9	proposal	observation	none	info-required	main	secondary	none	none	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_pa_2	BIO_11044594_pa_9	BIO_11044594_pa_2_9
BIO	11044594	pa	2	10	proposal	conclusion	none	support	main	secondary	back	support	To better understand the recovery process, it would be beneficial to use a lesion model that produces more severe, enduring, behavioral impairments.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_pa_2	BIO_11044594_pa_10	BIO_11044594_pa_2_10
BIO	11044594	pa	3	4	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	BIO_11044594_pa_3	BIO_11044594_pa_4	BIO_11044594_pa_3_4
BIO	11044594	pa	3	5	proposal_implementation	result	elaboration	info-required	secondary	secondary	none	none	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	BIO_11044594_pa_3	BIO_11044594_pa_5	BIO_11044594_pa_3_5
BIO	11044594	pa	3	6	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	BIO_11044594_pa_3	BIO_11044594_pa_6	BIO_11044594_pa_3_6
BIO	11044594	pa	3	7	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	back	sequence	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	BIO_11044594_pa_3	BIO_11044594_pa_7	BIO_11044594_pa_3_7
BIO	11044594	pa	3	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_pa_3	BIO_11044594_pa_8	BIO_11044594_pa_3_8
BIO	11044594	pa	3	9	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_pa_3	BIO_11044594_pa_9	BIO_11044594_pa_3_9
BIO	11044594	pa	3	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	The purpose of experiment 1 was to validate whether large lesions of the sensorimotor cortex (SMC), which included the rostral forelimb and caudal forelimb regions, produced enduring behavioral deficits.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_pa_3	BIO_11044594_pa_10	BIO_11044594_pa_3_10
BIO	11044594	pa	4	5	proposal_implementation	result	elaboration	info-required	secondary	secondary	none	none	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	BIO_11044594_pa_4	BIO_11044594_pa_5	BIO_11044594_pa_4_5
BIO	11044594	pa	4	6	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	BIO_11044594_pa_4	BIO_11044594_pa_6	BIO_11044594_pa_4_6
BIO	11044594	pa	4	7	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	none	none	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	BIO_11044594_pa_4	BIO_11044594_pa_7	BIO_11044594_pa_4_7
BIO	11044594	pa	4	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_pa_4	BIO_11044594_pa_8	BIO_11044594_pa_4_8
BIO	11044594	pa	4	9	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_pa_4	BIO_11044594_pa_9	BIO_11044594_pa_4_9
BIO	11044594	pa	4	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Rats were given large unilateral electrolytic lesions of the SMC, administered either the N-methyl-D-aspartate (NMDA) antagonist, MK-801 or saline 16 h after injury, and tested on a battery of behavioral tests.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_pa_4	BIO_11044594_pa_10	BIO_11044594_pa_4_10
BIO	11044594	pa	5	6	result	result	info-required	support	secondary	secondary	forw	info-required	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	BIO_11044594_pa_5	BIO_11044594_pa_6	BIO_11044594_pa_5_6
BIO	11044594	pa	5	7	result	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	BIO_11044594_pa_5	BIO_11044594_pa_7	BIO_11044594_pa_5_7
BIO	11044594	pa	5	8	result	observation	info-required	support	secondary	secondary	none	none	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_pa_5	BIO_11044594_pa_8	BIO_11044594_pa_5_8
BIO	11044594	pa	5	9	result	observation	info-required	info-required	secondary	secondary	none	none	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_pa_5	BIO_11044594_pa_9	BIO_11044594_pa_5_9
BIO	11044594	pa	5	10	result	conclusion	info-required	support	secondary	secondary	none	none	Enduring behavioral deficits were observed, for at least 6 months, on two tests of forelimb placing while transient deficits were observed on the foot-fault and somatosensory neutralization tests.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_pa_5	BIO_11044594_pa_10	BIO_11044594_pa_5_10
BIO	11044594	pa	6	7	result	proposal_implementation	support	sequence	secondary	secondary	forw	support	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	BIO_11044594_pa_6	BIO_11044594_pa_7	BIO_11044594_pa_6_7
BIO	11044594	pa	6	8	result	observation	support	support	secondary	secondary	none	none	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_pa_6	BIO_11044594_pa_8	BIO_11044594_pa_6_8
BIO	11044594	pa	6	9	result	observation	support	info-required	secondary	secondary	none	none	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_pa_6	BIO_11044594_pa_9	BIO_11044594_pa_6_9
BIO	11044594	pa	6	10	result	conclusion	support	support	secondary	secondary	none	none	Administration of MK-801 facilitated recovery on the somatosensory neutralization test; however, it did not induce recovery on either forelimb placing test.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_pa_6	BIO_11044594_pa_10	BIO_11044594_pa_6_10
BIO	11044594	pa	7	8	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	BIO_11044594_pa_7	BIO_11044594_pa_8	BIO_11044594_pa_7_8
BIO	11044594	pa	7	9	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_pa_7	BIO_11044594_pa_9	BIO_11044594_pa_7_9
BIO	11044594	pa	7	10	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	A second experiment was performed to determine if earlier administration of MK-801, the NMDA antagonist magnesium chloride (MgCl(2)), or the anti-oxidant N-tert-butyl-alpha-phenylnitrone (PBN) could induce behavioral recovery in this chronic model.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_pa_7	BIO_11044594_pa_10	BIO_11044594_pa_7_10
BIO	11044594	pa	8	9	observation	observation	support	info-required	secondary	secondary	back	info-required	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_pa_8	BIO_11044594_pa_9	BIO_11044594_pa_8_9
BIO	11044594	pa	8	10	observation	conclusion	support	support	secondary	secondary	forw	support	Treatment with these drugs induced behavioral recovery on the forelimb placing tests, whereas, the saline-treated rats did not show any signs of behavioral recovery for at least 3 months.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_pa_8	BIO_11044594_pa_10	BIO_11044594_pa_8_10
BIO	11044594	pa	9	10	observation	conclusion	info-required	support	secondary	secondary	none	none	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	BIO_11044594_pa_9	BIO_11044594_pa_10	BIO_11044594_pa_9_10
BIO	11044594	pa	10	9	conclusion	observation	support	info-required	secondary	secondary	none	none	These results suggest that administration of MK-801, MgCl(2), or PBN shortly after cortical injury can induce recovery of function when recovery is otherwise not expected in un-treated rats.	Anatomical analysis of the striatum showed that MK-801 and MgCl(2) but not PBN reduced the extent of lesion-induced striatal atrophy.	BIO_11044594_pa_10	BIO_11044594_pa_9	BIO_11044594_pa_9_10
BIO	11063736	pa	1	2	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Gender is known to influence the transmission of trinucleotide repeats in human disease.	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	BIO_11063736_pa_1	BIO_11063736_pa_2	BIO_11063736_pa_1_2
BIO	11063736	pa	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	BIO_11063736_pa_1	BIO_11063736_pa_3	BIO_11063736_pa_1_3
BIO	11063736	pa	1	4	motivation_background	result	info-required	info-required	secondary	secondary	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	BIO_11063736_pa_1	BIO_11063736_pa_4	BIO_11063736_pa_1_4
BIO	11063736	pa	1	5	motivation_background	result	info-required	support	secondary	secondary	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	BIO_11063736_pa_1	BIO_11063736_pa_5	BIO_11063736_pa_1_5
BIO	11063736	pa	1	6	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	Males predominantly expand the repeat whereas females predominantly contract the repeat.	BIO_11063736_pa_1	BIO_11063736_pa_6	BIO_11063736_pa_1_6
BIO	11063736	pa	1	7	motivation_background	result	info-required	elaboration	secondary	secondary	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	BIO_11063736_pa_1	BIO_11063736_pa_7	BIO_11063736_pa_1_7
BIO	11063736	pa	1	8	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_pa_1	BIO_11063736_pa_8	BIO_11063736_pa_1_8
BIO	11063736	pa	1	9	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Gender is known to influence the transmission of trinucleotide repeats in human disease.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_pa_1	BIO_11063736_pa_9	BIO_11063736_pa_1_9
BIO	11063736	pa	2	3	motivation_problem	proposal	support	none	secondary	main	forw	support	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	BIO_11063736_pa_2	BIO_11063736_pa_3	BIO_11063736_pa_2_3
BIO	11063736	pa	2	4	motivation_problem	result	support	info-required	secondary	secondary	none	none	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	BIO_11063736_pa_2	BIO_11063736_pa_4	BIO_11063736_pa_2_4
BIO	11063736	pa	2	5	motivation_problem	result	support	support	secondary	secondary	none	none	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	BIO_11063736_pa_2	BIO_11063736_pa_5	BIO_11063736_pa_2_5
BIO	11063736	pa	2	6	motivation_problem	result	support	elaboration	secondary	secondary	none	none	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	Males predominantly expand the repeat whereas females predominantly contract the repeat.	BIO_11063736_pa_2	BIO_11063736_pa_6	BIO_11063736_pa_2_6
BIO	11063736	pa	2	7	motivation_problem	result	support	elaboration	secondary	secondary	none	none	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	BIO_11063736_pa_2	BIO_11063736_pa_7	BIO_11063736_pa_2_7
BIO	11063736	pa	2	8	motivation_problem	conclusion	support	support	secondary	secondary	none	none	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_pa_2	BIO_11063736_pa_8	BIO_11063736_pa_2_8
BIO	11063736	pa	2	9	motivation_problem	conclusion	support	support	secondary	secondary	none	none	However, the molecular basis for the parent-of-origin effect associated with trinucleotide repeat expansion is not known.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_pa_2	BIO_11063736_pa_9	BIO_11063736_pa_2_9
BIO	11063736	pa	3	4	proposal	result	none	info-required	main	secondary	none	none	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	BIO_11063736_pa_3	BIO_11063736_pa_4	BIO_11063736_pa_3_4
BIO	11063736	pa	3	5	proposal	result	none	support	main	secondary	none	none	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	BIO_11063736_pa_3	BIO_11063736_pa_5	BIO_11063736_pa_3_5
BIO	11063736	pa	3	6	proposal	result	none	elaboration	main	secondary	none	none	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	Males predominantly expand the repeat whereas females predominantly contract the repeat.	BIO_11063736_pa_3	BIO_11063736_pa_6	BIO_11063736_pa_3_6
BIO	11063736	pa	3	7	proposal	result	none	elaboration	main	secondary	none	none	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	BIO_11063736_pa_3	BIO_11063736_pa_7	BIO_11063736_pa_3_7
BIO	11063736	pa	3	8	proposal	conclusion	none	support	main	secondary	none	none	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_pa_3	BIO_11063736_pa_8	BIO_11063736_pa_3_8
BIO	11063736	pa	3	9	proposal	conclusion	none	support	main	secondary	back	support	We have followed, during transmission, the fate of the CAG trinucleotide repeat in a transgene containing the exon 1 portion of the human Huntington's disease (HD) gene.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_pa_3	BIO_11063736_pa_9	BIO_11063736_pa_3_9
BIO	11063736	pa	4	5	result	result	info-required	support	secondary	secondary	forw	info-required	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	BIO_11063736_pa_4	BIO_11063736_pa_5	BIO_11063736_pa_4_5
BIO	11063736	pa	4	6	result	result	info-required	elaboration	secondary	secondary	none	none	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	Males predominantly expand the repeat whereas females predominantly contract the repeat.	BIO_11063736_pa_4	BIO_11063736_pa_6	BIO_11063736_pa_4_6
BIO	11063736	pa	4	7	result	result	info-required	elaboration	secondary	secondary	none	none	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	BIO_11063736_pa_4	BIO_11063736_pa_7	BIO_11063736_pa_4_7
BIO	11063736	pa	4	8	result	conclusion	info-required	support	secondary	secondary	none	none	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_pa_4	BIO_11063736_pa_8	BIO_11063736_pa_4_8
BIO	11063736	pa	4	9	result	conclusion	info-required	support	secondary	secondary	none	none	Similar to humans, the mouse transmits expansions predominantly through the male germ line.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_pa_4	BIO_11063736_pa_9	BIO_11063736_pa_4_9
BIO	11063736	pa	5	6	result	result	support	elaboration	secondary	secondary	none	none	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	Males predominantly expand the repeat whereas females predominantly contract the repeat.	BIO_11063736_pa_5	BIO_11063736_pa_6	BIO_11063736_pa_5_6
BIO	11063736	pa	5	7	result	result	support	elaboration	secondary	secondary	back	elaboration	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	BIO_11063736_pa_5	BIO_11063736_pa_7	BIO_11063736_pa_5_7
BIO	11063736	pa	5	8	result	conclusion	support	support	secondary	secondary	forw	support	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_pa_5	BIO_11063736_pa_8	BIO_11063736_pa_5_8
BIO	11063736	pa	5	9	result	conclusion	support	support	secondary	secondary	none	none	Surprisingly, we find that the CAG repeat size of the mutant human HD gene is different in male and female progeny from identical fathers.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_pa_5	BIO_11063736_pa_9	BIO_11063736_pa_5_9
BIO	11063736	pa	6	7	result	result	elaboration	elaboration	secondary	secondary	forw	elaboration	Males predominantly expand the repeat whereas females predominantly contract the repeat.	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	BIO_11063736_pa_6	BIO_11063736_pa_7	BIO_11063736_pa_6_7
BIO	11063736	pa	6	8	result	conclusion	elaboration	support	secondary	secondary	none	none	Males predominantly expand the repeat whereas females predominantly contract the repeat.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_pa_6	BIO_11063736_pa_8	BIO_11063736_pa_6_8
BIO	11063736	pa	6	9	result	conclusion	elaboration	support	secondary	secondary	none	none	Males predominantly expand the repeat whereas females predominantly contract the repeat.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_pa_6	BIO_11063736_pa_9	BIO_11063736_pa_6_9
BIO	11063736	pa	7	8	result	conclusion	elaboration	support	secondary	secondary	none	none	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_pa_7	BIO_11063736_pa_8	BIO_11063736_pa_7_8
BIO	11063736	pa	7	9	result	conclusion	elaboration	support	secondary	secondary	none	none	In contrast to the classic definition of imprinting, CAG expansion is influenced by the gender of the embryo.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_pa_7	BIO_11063736_pa_9	BIO_11063736_pa_7_9
BIO	11063736	pa	8	9	conclusion	conclusion	support	support	secondary	secondary	forw	support	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	BIO_11063736_pa_8	BIO_11063736_pa_9	BIO_11063736_pa_8_9
BIO	11063736	pa	9	8	conclusion	conclusion	support	support	secondary	secondary	back	support	Gender dependence in the embryo may explain why expansion in HD from premutation to disease primarily occurs through the paternal line.	Our results raise the possibility that there are X- or Y-encoded factors that influence repair or replication of DNA in the embryo.	BIO_11063736_pa_9	BIO_11063736_pa_8	BIO_11063736_pa_8_9
BIO	11129784	pa	1	2	motivation_background	proposal	support	none	secondary	main	forw	support	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	BIO_11129784_pa_1	BIO_11129784_pa_2	BIO_11129784_pa_1_2
BIO	11129784	pa	1	3	motivation_background	result_means	support	info-required	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	BIO_11129784_pa_1	BIO_11129784_pa_3	BIO_11129784_pa_1_3
BIO	11129784	pa	1	4	motivation_background	result_means	support	info-required	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	BIO_11129784_pa_1	BIO_11129784_pa_4	BIO_11129784_pa_1_4
BIO	11129784	pa	1	5	motivation_background	result	support	support	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	BIO_11129784_pa_1	BIO_11129784_pa_5	BIO_11129784_pa_1_5
BIO	11129784	pa	1	6	motivation_background	result	support	elaboration	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	BIO_11129784_pa_1	BIO_11129784_pa_6	BIO_11129784_pa_1_6
BIO	11129784	pa	1	7	motivation_background	observation	support	info-required	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	BIO_11129784_pa_1	BIO_11129784_pa_7	BIO_11129784_pa_1_7
BIO	11129784	pa	1	8	motivation_background	observation	support	info-required	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_pa_1	BIO_11129784_pa_8	BIO_11129784_pa_1_8
BIO	11129784	pa	1	9	motivation_background	observation	support	support	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_pa_1	BIO_11129784_pa_9	BIO_11129784_pa_1_9
BIO	11129784	pa	1	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_pa_1	BIO_11129784_pa_10	BIO_11129784_pa_1_10
BIO	11129784	pa	2	3	proposal	result_means	none	info-required	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	BIO_11129784_pa_2	BIO_11129784_pa_3	BIO_11129784_pa_2_3
BIO	11129784	pa	2	4	proposal	result_means	none	info-required	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	BIO_11129784_pa_2	BIO_11129784_pa_4	BIO_11129784_pa_2_4
BIO	11129784	pa	2	5	proposal	result	none	support	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	BIO_11129784_pa_2	BIO_11129784_pa_5	BIO_11129784_pa_2_5
BIO	11129784	pa	2	6	proposal	result	none	elaboration	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	BIO_11129784_pa_2	BIO_11129784_pa_6	BIO_11129784_pa_2_6
BIO	11129784	pa	2	7	proposal	observation	none	info-required	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	BIO_11129784_pa_2	BIO_11129784_pa_7	BIO_11129784_pa_2_7
BIO	11129784	pa	2	8	proposal	observation	none	info-required	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_pa_2	BIO_11129784_pa_8	BIO_11129784_pa_2_8
BIO	11129784	pa	2	9	proposal	observation	none	support	main	secondary	none	none	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_pa_2	BIO_11129784_pa_9	BIO_11129784_pa_2_9
BIO	11129784	pa	2	10	proposal	conclusion	none	support	main	secondary	back	support	In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_pa_2	BIO_11129784_pa_10	BIO_11129784_pa_2_10
BIO	11129784	pa	3	4	result_means	result_means	info-required	info-required	secondary	secondary	forw	info-required	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	BIO_11129784_pa_3	BIO_11129784_pa_4	BIO_11129784_pa_3_4
BIO	11129784	pa	3	5	result_means	result	info-required	support	secondary	secondary	none	none	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	BIO_11129784_pa_3	BIO_11129784_pa_5	BIO_11129784_pa_3_5
BIO	11129784	pa	3	6	result_means	result	info-required	elaboration	secondary	secondary	none	none	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	BIO_11129784_pa_3	BIO_11129784_pa_6	BIO_11129784_pa_3_6
BIO	11129784	pa	3	7	result_means	observation	info-required	info-required	secondary	secondary	none	none	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	BIO_11129784_pa_3	BIO_11129784_pa_7	BIO_11129784_pa_3_7
BIO	11129784	pa	3	8	result_means	observation	info-required	info-required	secondary	secondary	none	none	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_pa_3	BIO_11129784_pa_8	BIO_11129784_pa_3_8
BIO	11129784	pa	3	9	result_means	observation	info-required	support	secondary	secondary	none	none	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_pa_3	BIO_11129784_pa_9	BIO_11129784_pa_3_9
BIO	11129784	pa	3	10	result_means	conclusion	info-required	support	secondary	secondary	none	none	Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_pa_3	BIO_11129784_pa_10	BIO_11129784_pa_3_10
BIO	11129784	pa	4	5	result_means	result	info-required	support	secondary	secondary	forw	info-required	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	BIO_11129784_pa_4	BIO_11129784_pa_5	BIO_11129784_pa_4_5
BIO	11129784	pa	4	6	result_means	result	info-required	elaboration	secondary	secondary	none	none	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	BIO_11129784_pa_4	BIO_11129784_pa_6	BIO_11129784_pa_4_6
BIO	11129784	pa	4	7	result_means	observation	info-required	info-required	secondary	secondary	none	none	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	BIO_11129784_pa_4	BIO_11129784_pa_7	BIO_11129784_pa_4_7
BIO	11129784	pa	4	8	result_means	observation	info-required	info-required	secondary	secondary	none	none	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_pa_4	BIO_11129784_pa_8	BIO_11129784_pa_4_8
BIO	11129784	pa	4	9	result_means	observation	info-required	support	secondary	secondary	none	none	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_pa_4	BIO_11129784_pa_9	BIO_11129784_pa_4_9
BIO	11129784	pa	4	10	result_means	conclusion	info-required	support	secondary	secondary	none	none	Reverse transcription polymerase chain reaction showed increased transcription of MMP-9.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_pa_4	BIO_11129784_pa_10	BIO_11129784_pa_4_10
BIO	11129784	pa	5	6	result	result	support	elaboration	secondary	secondary	back	elaboration	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	BIO_11129784_pa_5	BIO_11129784_pa_6	BIO_11129784_pa_5_6
BIO	11129784	pa	5	7	result	observation	support	info-required	secondary	secondary	none	none	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	BIO_11129784_pa_5	BIO_11129784_pa_7	BIO_11129784_pa_5_7
BIO	11129784	pa	5	8	result	observation	support	info-required	secondary	secondary	none	none	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_pa_5	BIO_11129784_pa_8	BIO_11129784_pa_5_8
BIO	11129784	pa	5	9	result	observation	support	support	secondary	secondary	back	support	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_pa_5	BIO_11129784_pa_9	BIO_11129784_pa_5_9
BIO	11129784	pa	5	10	result	conclusion	support	support	secondary	secondary	forw	support	There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_pa_5	BIO_11129784_pa_10	BIO_11129784_pa_5_10
BIO	11129784	pa	6	7	result	observation	elaboration	info-required	secondary	secondary	none	none	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	BIO_11129784_pa_6	BIO_11129784_pa_7	BIO_11129784_pa_6_7
BIO	11129784	pa	6	8	result	observation	elaboration	info-required	secondary	secondary	none	none	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_pa_6	BIO_11129784_pa_8	BIO_11129784_pa_6_8
BIO	11129784	pa	6	9	result	observation	elaboration	support	secondary	secondary	none	none	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_pa_6	BIO_11129784_pa_9	BIO_11129784_pa_6_9
BIO	11129784	pa	6	10	result	conclusion	elaboration	support	secondary	secondary	none	none	After induction of focal ischemia, similar reductions in cerebral blood flow were obtained.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_pa_6	BIO_11129784_pa_10	BIO_11129784_pa_6_10
BIO	11129784	pa	7	8	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	BIO_11129784_pa_7	BIO_11129784_pa_8	BIO_11129784_pa_7_8
BIO	11129784	pa	7	9	observation	observation	info-required	support	secondary	secondary	none	none	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_pa_7	BIO_11129784_pa_9	BIO_11129784_pa_7_9
BIO	11129784	pa	7	10	observation	conclusion	info-required	support	secondary	secondary	none	none	In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_pa_7	BIO_11129784_pa_10	BIO_11129784_pa_7_10
BIO	11129784	pa	8	9	observation	observation	info-required	support	secondary	secondary	forw	info-required	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_pa_8	BIO_11129784_pa_9	BIO_11129784_pa_8_9
BIO	11129784	pa	8	10	observation	conclusion	info-required	support	secondary	secondary	none	none	In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_pa_8	BIO_11129784_pa_10	BIO_11129784_pa_8_10
BIO	11129784	pa	9	10	observation	conclusion	support	support	secondary	secondary	none	none	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	BIO_11129784_pa_9	BIO_11129784_pa_10	BIO_11129784_pa_9_10
BIO	11129784	pa	10	9	conclusion	observation	support	support	secondary	secondary	none	none	These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.	However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia.	BIO_11129784_pa_10	BIO_11129784_pa_9	BIO_11129784_pa_9_10
BIO	11154280	pa	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	BIO_11154280_pa_1	BIO_11154280_pa_2	BIO_11154280_pa_1_2
BIO	11154280	pa	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	Here we investigate the mechanism of this mutator effect.	BIO_11154280_pa_1	BIO_11154280_pa_3	BIO_11154280_pa_1_3
BIO	11154280	pa	1	4	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	BIO_11154280_pa_1	BIO_11154280_pa_4	BIO_11154280_pa_1_4
BIO	11154280	pa	1	5	motivation_background	observation	info-required	support	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	BIO_11154280_pa_1	BIO_11154280_pa_5	BIO_11154280_pa_1_5
BIO	11154280	pa	1	6	motivation_background	conclusion	info-required	info-required	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	BIO_11154280_pa_1	BIO_11154280_pa_6	BIO_11154280_pa_1_6
BIO	11154280	pa	1	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	BIO_11154280_pa_1	BIO_11154280_pa_7	BIO_11154280_pa_1_7
BIO	11154280	pa	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_pa_1	BIO_11154280_pa_8	BIO_11154280_pa_1_8
BIO	11154280	pa	1	9	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_pa_1	BIO_11154280_pa_9	BIO_11154280_pa_1_9
BIO	11154280	pa	1	10	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Inactivation of DNA mismatch repair by mutation or by transcriptional silencing of the MLH1 gene results in genome instability and cancer predisposition.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_pa_1	BIO_11154280_pa_10	BIO_11154280_pa_1_10
BIO	11154280	pa	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	Here we investigate the mechanism of this mutator effect.	BIO_11154280_pa_2	BIO_11154280_pa_3	BIO_11154280_pa_2_3
BIO	11154280	pa	2	4	motivation_background	observation	support	info-required	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	BIO_11154280_pa_2	BIO_11154280_pa_4	BIO_11154280_pa_2_4
BIO	11154280	pa	2	5	motivation_background	observation	support	support	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	BIO_11154280_pa_2	BIO_11154280_pa_5	BIO_11154280_pa_2_5
BIO	11154280	pa	2	6	motivation_background	conclusion	support	info-required	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	BIO_11154280_pa_2	BIO_11154280_pa_6	BIO_11154280_pa_2_6
BIO	11154280	pa	2	7	motivation_background	observation	support	info-required	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	BIO_11154280_pa_2	BIO_11154280_pa_7	BIO_11154280_pa_2_7
BIO	11154280	pa	2	8	motivation_background	observation	support	support	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_pa_2	BIO_11154280_pa_8	BIO_11154280_pa_2_8
BIO	11154280	pa	2	9	motivation_background	observation	support	elaboration	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_pa_2	BIO_11154280_pa_9	BIO_11154280_pa_2_9
BIO	11154280	pa	2	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	We recently found (P. V. Shcherbakova and T. A. Kunkel, Mol. Cell. Biol. 19:3177-3183, 1999) that an elevated spontaneous mutation rate can also result from increased expression of yeast MLH1.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_pa_2	BIO_11154280_pa_10	BIO_11154280_pa_2_10
BIO	11154280	pa	3	4	proposal	observation	none	info-required	main	secondary	none	none	Here we investigate the mechanism of this mutator effect.	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	BIO_11154280_pa_3	BIO_11154280_pa_4	BIO_11154280_pa_3_4
BIO	11154280	pa	3	5	proposal	observation	none	support	main	secondary	none	none	Here we investigate the mechanism of this mutator effect.	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	BIO_11154280_pa_3	BIO_11154280_pa_5	BIO_11154280_pa_3_5
BIO	11154280	pa	3	6	proposal	conclusion	none	info-required	main	secondary	none	none	Here we investigate the mechanism of this mutator effect.	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	BIO_11154280_pa_3	BIO_11154280_pa_6	BIO_11154280_pa_3_6
BIO	11154280	pa	3	7	proposal	observation	none	info-required	main	secondary	none	none	Here we investigate the mechanism of this mutator effect.	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	BIO_11154280_pa_3	BIO_11154280_pa_7	BIO_11154280_pa_3_7
BIO	11154280	pa	3	8	proposal	observation	none	support	main	secondary	none	none	Here we investigate the mechanism of this mutator effect.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_pa_3	BIO_11154280_pa_8	BIO_11154280_pa_3_8
BIO	11154280	pa	3	9	proposal	observation	none	elaboration	main	secondary	none	none	Here we investigate the mechanism of this mutator effect.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_pa_3	BIO_11154280_pa_9	BIO_11154280_pa_3_9
BIO	11154280	pa	3	10	proposal	conclusion	none	support	main	secondary	back	support	Here we investigate the mechanism of this mutator effect.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_pa_3	BIO_11154280_pa_10	BIO_11154280_pa_3_10
BIO	11154280	pa	4	5	observation	observation	info-required	support	secondary	secondary	forw	info-required	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	BIO_11154280_pa_4	BIO_11154280_pa_5	BIO_11154280_pa_4_5
BIO	11154280	pa	4	6	observation	conclusion	info-required	info-required	secondary	secondary	none	none	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	BIO_11154280_pa_4	BIO_11154280_pa_6	BIO_11154280_pa_4_6
BIO	11154280	pa	4	7	observation	observation	info-required	info-required	secondary	secondary	none	none	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	BIO_11154280_pa_4	BIO_11154280_pa_7	BIO_11154280_pa_4_7
BIO	11154280	pa	4	8	observation	observation	info-required	support	secondary	secondary	none	none	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_pa_4	BIO_11154280_pa_8	BIO_11154280_pa_4_8
BIO	11154280	pa	4	9	observation	observation	info-required	elaboration	secondary	secondary	none	none	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_pa_4	BIO_11154280_pa_9	BIO_11154280_pa_4_9
BIO	11154280	pa	4	10	observation	conclusion	info-required	support	secondary	secondary	none	none	Hybridization of poly(A)(+) mRNA to DNA microarrays containing 96.4% of yeast open reading frames revealed that MLH1 overexpression did not induce changes in expression of other genes involved in DNA replication or repair.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_pa_4	BIO_11154280_pa_10	BIO_11154280_pa_4_10
BIO	11154280	pa	5	6	observation	conclusion	support	info-required	secondary	secondary	forw	support	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	BIO_11154280_pa_5	BIO_11154280_pa_6	BIO_11154280_pa_5_6
BIO	11154280	pa	5	7	observation	observation	support	info-required	secondary	secondary	none	none	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	BIO_11154280_pa_5	BIO_11154280_pa_7	BIO_11154280_pa_5_7
BIO	11154280	pa	5	8	observation	observation	support	support	secondary	secondary	none	none	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_pa_5	BIO_11154280_pa_8	BIO_11154280_pa_5_8
BIO	11154280	pa	5	9	observation	observation	support	elaboration	secondary	secondary	none	none	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_pa_5	BIO_11154280_pa_9	BIO_11154280_pa_5_9
BIO	11154280	pa	5	10	observation	conclusion	support	support	secondary	secondary	none	none	MLH1 overexpression strongly enhanced spontaneous mutagenesis in yeast strains with defects in the 3'-->5' exonuclease activity of replicative DNA polymerases delta and epsilon but did not enhance the mutation rate in strains with deletions of MSH2, MLH1, or PMS1.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_pa_5	BIO_11154280_pa_10	BIO_11154280_pa_5_10
BIO	11154280	pa	6	7	conclusion	observation	info-required	info-required	secondary	secondary	none	none	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	BIO_11154280_pa_6	BIO_11154280_pa_7	BIO_11154280_pa_6_7
BIO	11154280	pa	6	8	conclusion	observation	info-required	support	secondary	secondary	forw	info-required	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_pa_6	BIO_11154280_pa_8	BIO_11154280_pa_6_8
BIO	11154280	pa	6	9	conclusion	observation	info-required	elaboration	secondary	secondary	none	none	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_pa_6	BIO_11154280_pa_9	BIO_11154280_pa_6_9
BIO	11154280	pa	6	10	conclusion	conclusion	info-required	support	secondary	secondary	none	none	This suggests that overexpression of MLH1 inactivates mismatch repair of replication errors.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_pa_6	BIO_11154280_pa_10	BIO_11154280_pa_6_10
BIO	11154280	pa	7	8	observation	observation	info-required	support	secondary	secondary	forw	info-required	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	BIO_11154280_pa_7	BIO_11154280_pa_8	BIO_11154280_pa_7_8
BIO	11154280	pa	7	9	observation	observation	info-required	elaboration	secondary	secondary	none	none	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_pa_7	BIO_11154280_pa_9	BIO_11154280_pa_7_9
BIO	11154280	pa	7	10	observation	conclusion	info-required	support	secondary	secondary	none	none	Overexpression of the PMS1 gene alone caused a moderate increase in the mutation rate and strongly suppressed the mutator effect caused by MLH1 overexpression.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_pa_7	BIO_11154280_pa_10	BIO_11154280_pa_7_10
BIO	11154280	pa	8	9	observation	observation	support	elaboration	secondary	secondary	back	elaboration	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_pa_8	BIO_11154280_pa_9	BIO_11154280_pa_8_9
BIO	11154280	pa	8	10	observation	conclusion	support	support	secondary	secondary	forw	support	The mutator effect was also reduced by a missense mutation in the MLH1 gene that disrupted Mlh1p-Pms1p interaction.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_pa_8	BIO_11154280_pa_10	BIO_11154280_pa_8_10
BIO	11154280	pa	9	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	BIO_11154280_pa_9	BIO_11154280_pa_10	BIO_11154280_pa_9_10
BIO	11154280	pa	10	9	conclusion	observation	support	elaboration	secondary	secondary	none	none	These observations suggest that the mismatch repair defect in cells overexpressing MLH1 results from an imbalance in the levels of Mlh1p and Pms1p and that this imbalance might lead to formation of nonfunctional mismatch repair complexes containing Mlh1p homodimers.	Analytical ultracentrifugation experiments showed that purified Mlh1p forms a homodimer in solution, albeit with a K(d) of 3.14 microM, 36-fold higher than that for Mlh1p-Pms1p heterodimerization.	BIO_11154280_pa_10	BIO_11154280_pa_9	BIO_11154280_pa_9_10
BIO	11226671	pa	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	BIO_11226671_pa_1	BIO_11226671_pa_2	BIO_11226671_pa_1_2
BIO	11226671	pa	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	BIO_11226671_pa_1	BIO_11226671_pa_3	BIO_11226671_pa_1_3
BIO	11226671	pa	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	BIO_11226671_pa_1	BIO_11226671_pa_4	BIO_11226671_pa_1_4
BIO	11226671	pa	1	5	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	BIO_11226671_pa_1	BIO_11226671_pa_5	BIO_11226671_pa_1_5
BIO	11226671	pa	1	6	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	BIO_11226671_pa_1	BIO_11226671_pa_6	BIO_11226671_pa_1_6
BIO	11226671	pa	1	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	BIO_11226671_pa_1	BIO_11226671_pa_7	BIO_11226671_pa_1_7
BIO	11226671	pa	1	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_pa_1	BIO_11226671_pa_8	BIO_11226671_pa_1_8
BIO	11226671	pa	1	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_pa_1	BIO_11226671_pa_9	BIO_11226671_pa_1_9
BIO	11226671	pa	1	10	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Neuronal accumulation of excess Ca2+ has been implicated in cellular death following several forms of physical and chemotoxic insult.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_pa_1	BIO_11226671_pa_10	BIO_11226671_pa_1_10
BIO	11226671	pa	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	BIO_11226671_pa_2	BIO_11226671_pa_3	BIO_11226671_pa_2_3
BIO	11226671	pa	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	BIO_11226671_pa_2	BIO_11226671_pa_4	BIO_11226671_pa_2_4
BIO	11226671	pa	2	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	BIO_11226671_pa_2	BIO_11226671_pa_5	BIO_11226671_pa_2_5
BIO	11226671	pa	2	6	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	BIO_11226671_pa_2	BIO_11226671_pa_6	BIO_11226671_pa_2_6
BIO	11226671	pa	2	7	motivation_background	observation	support	info-required	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	BIO_11226671_pa_2	BIO_11226671_pa_7	BIO_11226671_pa_2_7
BIO	11226671	pa	2	8	motivation_background	observation	support	info-required	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_pa_2	BIO_11226671_pa_8	BIO_11226671_pa_2_8
BIO	11226671	pa	2	9	motivation_background	observation	support	support	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_pa_2	BIO_11226671_pa_9	BIO_11226671_pa_2_9
BIO	11226671	pa	2	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	Recent studies have suggested that exposure to agonists at brain nicotinic acetylcholine receptors reduces cytotoxic consequences of increased intracellular Ca2+ following some insults.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_pa_2	BIO_11226671_pa_10	BIO_11226671_pa_2_10
BIO	11226671	pa	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	BIO_11226671_pa_3	BIO_11226671_pa_4	BIO_11226671_pa_3_4
BIO	11226671	pa	3	5	proposal	observation	none	info-required	main	secondary	none	none	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	BIO_11226671_pa_3	BIO_11226671_pa_5	BIO_11226671_pa_3_5
BIO	11226671	pa	3	6	proposal	observation	none	elaboration	main	secondary	none	none	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	BIO_11226671_pa_3	BIO_11226671_pa_6	BIO_11226671_pa_3_6
BIO	11226671	pa	3	7	proposal	observation	none	info-required	main	secondary	none	none	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	BIO_11226671_pa_3	BIO_11226671_pa_7	BIO_11226671_pa_3_7
BIO	11226671	pa	3	8	proposal	observation	none	info-required	main	secondary	none	none	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_pa_3	BIO_11226671_pa_8	BIO_11226671_pa_3_8
BIO	11226671	pa	3	9	proposal	observation	none	support	main	secondary	none	none	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_pa_3	BIO_11226671_pa_9	BIO_11226671_pa_3_9
BIO	11226671	pa	3	10	proposal	conclusion	none	support	main	secondary	back	support	In the present study, the ability of chronic exposure to (-)-nicotine to reduce cytotoxicity and attenuate increases in intracellular Ca2+ caused by exposure to N-methyl-D-aspartate were examined in organotypic cultures of rat hippocampus.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_pa_3	BIO_11226671_pa_10	BIO_11226671_pa_3_10
BIO	11226671	pa	4	5	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	BIO_11226671_pa_4	BIO_11226671_pa_5	BIO_11226671_pa_4_5
BIO	11226671	pa	4	6	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	BIO_11226671_pa_4	BIO_11226671_pa_6	BIO_11226671_pa_4_6
BIO	11226671	pa	4	7	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	BIO_11226671_pa_4	BIO_11226671_pa_7	BIO_11226671_pa_4_7
BIO	11226671	pa	4	8	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_pa_4	BIO_11226671_pa_8	BIO_11226671_pa_4_8
BIO	11226671	pa	4	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_pa_4	BIO_11226671_pa_9	BIO_11226671_pa_4_9
BIO	11226671	pa	4	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Cultures were exposed to nicotine (0.1-10.0 microM) for five days prior to excitotoxic insult with N-methyl-D-aspartate.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_pa_4	BIO_11226671_pa_10	BIO_11226671_pa_4_10
BIO	11226671	pa	5	6	observation	observation	info-required	elaboration	secondary	secondary	back	elaboration	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	BIO_11226671_pa_5	BIO_11226671_pa_6	BIO_11226671_pa_5_6
BIO	11226671	pa	5	7	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	BIO_11226671_pa_5	BIO_11226671_pa_7	BIO_11226671_pa_5_7
BIO	11226671	pa	5	8	observation	observation	info-required	info-required	secondary	secondary	none	none	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_pa_5	BIO_11226671_pa_8	BIO_11226671_pa_5_8
BIO	11226671	pa	5	9	observation	observation	info-required	support	secondary	secondary	none	none	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_pa_5	BIO_11226671_pa_9	BIO_11226671_pa_5_9
BIO	11226671	pa	5	10	observation	conclusion	info-required	support	secondary	secondary	none	none	Exposure to N-methyl-D-aspartate produced concentration-dependent increases in both accumulation of 45Ca and in early and delayed cell death in the CA1, CA3 and dentate gyrus regions of cultures.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_pa_5	BIO_11226671_pa_10	BIO_11226671_pa_5_10
BIO	11226671	pa	6	7	observation	observation	elaboration	info-required	secondary	secondary	none	none	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	BIO_11226671_pa_6	BIO_11226671_pa_7	BIO_11226671_pa_6_7
BIO	11226671	pa	6	8	observation	observation	elaboration	info-required	secondary	secondary	none	none	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_pa_6	BIO_11226671_pa_8	BIO_11226671_pa_6_8
BIO	11226671	pa	6	9	observation	observation	elaboration	support	secondary	secondary	none	none	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_pa_6	BIO_11226671_pa_9	BIO_11226671_pa_6_9
BIO	11226671	pa	6	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	The CA1 region of the hippocampus displayed the greatest sensitivity to cytotoxic effects of N-methyl-D-aspartate exposure; however, this regional difference was not associated with increased accumulation of 45Ca.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_pa_6	BIO_11226671_pa_10	BIO_11226671_pa_6_10
BIO	11226671	pa	7	8	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	BIO_11226671_pa_7	BIO_11226671_pa_8	BIO_11226671_pa_7_8
BIO	11226671	pa	7	9	observation	observation	info-required	support	secondary	secondary	none	none	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_pa_7	BIO_11226671_pa_9	BIO_11226671_pa_7_9
BIO	11226671	pa	7	10	observation	conclusion	info-required	support	secondary	secondary	none	none	Prior exposure to nicotine markedly attenuated N-methyl-D-aspartate-induced early and delayed cell death in each hippocampal region at concentrations as low as 0.1microM.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_pa_7	BIO_11226671_pa_10	BIO_11226671_pa_7_10
BIO	11226671	pa	8	9	observation	observation	info-required	support	secondary	secondary	forw	info-required	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_pa_8	BIO_11226671_pa_9	BIO_11226671_pa_8_9
BIO	11226671	pa	8	10	observation	conclusion	info-required	support	secondary	secondary	none	none	However, nicotine did not alter the initial N-methyl-D-aspartate-stimulated influx of 45Ca or enhance extrusion of accumulated 45Ca measured at several time-points after insult.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_pa_8	BIO_11226671_pa_10	BIO_11226671_pa_8_10
BIO	11226671	pa	9	10	observation	conclusion	support	support	secondary	secondary	forw	support	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	BIO_11226671_pa_9	BIO_11226671_pa_10	BIO_11226671_pa_9_10
BIO	11226671	pa	10	9	conclusion	observation	support	support	secondary	secondary	back	support	These findings suggest that the potent protective effects of chronic nicotine exposure against neuronal overexcitation are not likely attributable to attenuations of Ca2+ accumulation, but are likely related to increased buffering of accumulated Ca2+.	Five days of exposure to nicotine markedly increased immunoreactivity of the Ca2+ binding protein calbindin-D28K in each region of hippocampal cultures, effects reduced by mecamylamine co-exposure.	BIO_11226671_pa_10	BIO_11226671_pa_9	BIO_11226671_pa_9_10
BIO	11494364	pa	1	2	motivation_background	proposal	support	none	secondary	main	forw	support	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	BIO_11494364_pa_1	BIO_11494364_pa_2	BIO_11494364_pa_1_2
BIO	11494364	pa	1	3	motivation_background	observation	support	info-optional	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	BIO_11494364_pa_1	BIO_11494364_pa_3	BIO_11494364_pa_1_3
BIO	11494364	pa	1	4	motivation_background	observation	support	info-optional	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	BIO_11494364_pa_1	BIO_11494364_pa_4	BIO_11494364_pa_1_4
BIO	11494364	pa	1	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	BIO_11494364_pa_1	BIO_11494364_pa_5	BIO_11494364_pa_1_5
BIO	11494364	pa	1	6	motivation_background	observation	support	info-required	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	BIO_11494364_pa_1	BIO_11494364_pa_6	BIO_11494364_pa_1_6
BIO	11494364	pa	1	7	motivation_background	observation	support	support	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	BIO_11494364_pa_1	BIO_11494364_pa_7	BIO_11494364_pa_1_7
BIO	11494364	pa	1	8	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_pa_1	BIO_11494364_pa_8	BIO_11494364_pa_1_8
BIO	11494364	pa	1	9	motivation_background	result	support	support	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_pa_1	BIO_11494364_pa_9	BIO_11494364_pa_1_9
BIO	11494364	pa	1	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_pa_1	BIO_11494364_pa_10	BIO_11494364_pa_1_10
BIO	11494364	pa	2	3	proposal	observation	none	info-optional	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	BIO_11494364_pa_2	BIO_11494364_pa_3	BIO_11494364_pa_2_3
BIO	11494364	pa	2	4	proposal	observation	none	info-optional	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	BIO_11494364_pa_2	BIO_11494364_pa_4	BIO_11494364_pa_2_4
BIO	11494364	pa	2	5	proposal	observation	none	info-required	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	BIO_11494364_pa_2	BIO_11494364_pa_5	BIO_11494364_pa_2_5
BIO	11494364	pa	2	6	proposal	observation	none	info-required	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	BIO_11494364_pa_2	BIO_11494364_pa_6	BIO_11494364_pa_2_6
BIO	11494364	pa	2	7	proposal	observation	none	support	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	BIO_11494364_pa_2	BIO_11494364_pa_7	BIO_11494364_pa_2_7
BIO	11494364	pa	2	8	proposal	observation	none	elaboration	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_pa_2	BIO_11494364_pa_8	BIO_11494364_pa_2_8
BIO	11494364	pa	2	9	proposal	result	none	support	main	secondary	none	none	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_pa_2	BIO_11494364_pa_9	BIO_11494364_pa_2_9
BIO	11494364	pa	2	10	proposal	conclusion	none	support	main	secondary	back	support	To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene with expansion to 77 CAG repeats.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_pa_2	BIO_11494364_pa_10	BIO_11494364_pa_2_10
BIO	11494364	pa	3	4	observation	observation	info-optional	info-optional	secondary	secondary	none	none	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	BIO_11494364_pa_3	BIO_11494364_pa_4	BIO_11494364_pa_3_4
BIO	11494364	pa	3	5	observation	observation	info-optional	info-required	secondary	secondary	forw	info-optional	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	BIO_11494364_pa_3	BIO_11494364_pa_5	BIO_11494364_pa_3_5
BIO	11494364	pa	3	6	observation	observation	info-optional	info-required	secondary	secondary	none	none	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	BIO_11494364_pa_3	BIO_11494364_pa_6	BIO_11494364_pa_3_6
BIO	11494364	pa	3	7	observation	observation	info-optional	support	secondary	secondary	none	none	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	BIO_11494364_pa_3	BIO_11494364_pa_7	BIO_11494364_pa_3_7
BIO	11494364	pa	3	8	observation	observation	info-optional	elaboration	secondary	secondary	none	none	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_pa_3	BIO_11494364_pa_8	BIO_11494364_pa_3_8
BIO	11494364	pa	3	9	observation	result	info-optional	support	secondary	secondary	none	none	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_pa_3	BIO_11494364_pa_9	BIO_11494364_pa_3_9
BIO	11494364	pa	3	10	observation	conclusion	info-optional	support	secondary	secondary	none	none	Chimeric proteins composed of human mutated exon 1 and mouse huntingtin are expressed ubiquitously in brain and peripheral tissues.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_pa_3	BIO_11494364_pa_10	BIO_11494364_pa_3_10
BIO	11494364	pa	4	5	observation	observation	info-optional	info-required	secondary	secondary	forw	info-optional	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	BIO_11494364_pa_4	BIO_11494364_pa_5	BIO_11494364_pa_4_5
BIO	11494364	pa	4	6	observation	observation	info-optional	info-required	secondary	secondary	none	none	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	BIO_11494364_pa_4	BIO_11494364_pa_6	BIO_11494364_pa_4_6
BIO	11494364	pa	4	7	observation	observation	info-optional	support	secondary	secondary	none	none	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	BIO_11494364_pa_4	BIO_11494364_pa_7	BIO_11494364_pa_4_7
BIO	11494364	pa	4	8	observation	observation	info-optional	elaboration	secondary	secondary	none	none	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_pa_4	BIO_11494364_pa_8	BIO_11494364_pa_4_8
BIO	11494364	pa	4	9	observation	result	info-optional	support	secondary	secondary	none	none	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_pa_4	BIO_11494364_pa_9	BIO_11494364_pa_4_9
BIO	11494364	pa	4	10	observation	conclusion	info-optional	support	secondary	secondary	none	none	One or two CAG repeat expansion was found in litters from paternal transmission, whereas contraction of CAG repeat in litters was observed through maternal transmission.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_pa_4	BIO_11494364_pa_10	BIO_11494364_pa_4_10
BIO	11494364	pa	5	6	observation	observation	info-required	info-required	secondary	secondary	none	none	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	BIO_11494364_pa_5	BIO_11494364_pa_6	BIO_11494364_pa_5_6
BIO	11494364	pa	5	7	observation	observation	info-required	support	secondary	secondary	forw	info-required	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	BIO_11494364_pa_5	BIO_11494364_pa_7	BIO_11494364_pa_5_7
BIO	11494364	pa	5	8	observation	observation	info-required	elaboration	secondary	secondary	back	elaboration	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_pa_5	BIO_11494364_pa_8	BIO_11494364_pa_5_8
BIO	11494364	pa	5	9	observation	result	info-required	support	secondary	secondary	none	none	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_pa_5	BIO_11494364_pa_9	BIO_11494364_pa_5_9
BIO	11494364	pa	5	10	observation	conclusion	info-required	support	secondary	secondary	none	none	Elderly mice show greater CAG repeat instability than younger mice, and a unique case was observed of an expanded 97 CAG repeat mouse.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_pa_5	BIO_11494364_pa_10	BIO_11494364_pa_5_10
BIO	11494364	pa	6	7	observation	observation	info-required	support	secondary	secondary	none	none	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	BIO_11494364_pa_6	BIO_11494364_pa_7	BIO_11494364_pa_6_7
BIO	11494364	pa	6	8	observation	observation	info-required	elaboration	secondary	secondary	forw	info-required	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_pa_6	BIO_11494364_pa_8	BIO_11494364_pa_6_8
BIO	11494364	pa	6	9	observation	result	info-required	support	secondary	secondary	none	none	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_pa_6	BIO_11494364_pa_9	BIO_11494364_pa_6_9
BIO	11494364	pa	6	10	observation	conclusion	info-required	support	secondary	secondary	none	none	Somatic CAG repeat instability is particularly pronounced in the liver, kidney, stomach, and brain but not in the cerebellum of 100-week-old mice.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_pa_6	BIO_11494364_pa_10	BIO_11494364_pa_6_10
BIO	11494364	pa	7	8	observation	observation	support	elaboration	secondary	secondary	none	none	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	BIO_11494364_pa_7	BIO_11494364_pa_8	BIO_11494364_pa_7_8
BIO	11494364	pa	7	9	observation	result	support	support	secondary	secondary	forw	support	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_pa_7	BIO_11494364_pa_9	BIO_11494364_pa_7_9
BIO	11494364	pa	7	10	observation	conclusion	support	support	secondary	secondary	none	none	The same results of expanded CAG repeat instability as observed in this HD model mouse were confirmed in the human brain of HD patients.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_pa_7	BIO_11494364_pa_10	BIO_11494364_pa_7_10
BIO	11494364	pa	8	9	observation	result	elaboration	support	secondary	secondary	none	none	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_pa_8	BIO_11494364_pa_9	BIO_11494364_pa_8_9
BIO	11494364	pa	8	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	Glial fibrillary acidic protein (GFAP)-positive cells have been found to be increased in the substantia nigra (SN), globus pallidus (GP), and striatum (St) in the brains of 40-week-old affected mice, although without neuronal cell death.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_pa_8	BIO_11494364_pa_10	BIO_11494364_pa_8_10
BIO	11494364	pa	9	10	result	conclusion	support	support	secondary	secondary	forw	support	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	BIO_11494364_pa_9	BIO_11494364_pa_10	BIO_11494364_pa_9_10
BIO	11494364	pa	10	9	conclusion	result	support	support	secondary	secondary	back	support	The HD model mouse may therefore have advantages for investigations of molecular mechanisms underlying instability of CAG repeats.	The CAG repeat instability and increase in GFAP-positive cells in this mouse model appear to mirror the abnormalities in HD patients.	BIO_11494364_pa_10	BIO_11494364_pa_9	BIO_11494364_pa_9_10
BIO	11567062	pa	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	BIO_11567062_pa_1	BIO_11567062_pa_2	BIO_11567062_pa_1_2
BIO	11567062	pa	1	3	motivation_background	proposal	info-required	none	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	BIO_11567062_pa_1	BIO_11567062_pa_3	BIO_11567062_pa_1_3
BIO	11567062	pa	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	BIO_11567062_pa_1	BIO_11567062_pa_4	BIO_11567062_pa_1_4
BIO	11567062	pa	1	5	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	BIO_11567062_pa_1	BIO_11567062_pa_5	BIO_11567062_pa_1_5
BIO	11567062	pa	1	6	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	BIO_11567062_pa_1	BIO_11567062_pa_6	BIO_11567062_pa_1_6
BIO	11567062	pa	1	7	motivation_background	observation	info-required	info-optional	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	BIO_11567062_pa_1	BIO_11567062_pa_7	BIO_11567062_pa_1_7
BIO	11567062	pa	1	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_pa_1	BIO_11567062_pa_8	BIO_11567062_pa_1_8
BIO	11567062	pa	1	9	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_pa_1	BIO_11567062_pa_9	BIO_11567062_pa_1_9
BIO	11567062	pa	1	10	motivation_background	observation	info-required	info-optional	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_pa_1	BIO_11567062_pa_10	BIO_11567062_pa_1_10
BIO	11567062	pa	1	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_pa_1	BIO_11567062_pa_11	BIO_11567062_pa_1_11
BIO	11567062	pa	1	12	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_pa_1	BIO_11567062_pa_12	BIO_11567062_pa_1_12
BIO	11567062	pa	2	3	motivation_background	proposal	support	none	secondary	secondary	forw	support	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	BIO_11567062_pa_2	BIO_11567062_pa_3	BIO_11567062_pa_2_3
BIO	11567062	pa	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	BIO_11567062_pa_2	BIO_11567062_pa_4	BIO_11567062_pa_2_4
BIO	11567062	pa	2	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	BIO_11567062_pa_2	BIO_11567062_pa_5	BIO_11567062_pa_2_5
BIO	11567062	pa	2	6	motivation_background	observation	support	info-required	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	BIO_11567062_pa_2	BIO_11567062_pa_6	BIO_11567062_pa_2_6
BIO	11567062	pa	2	7	motivation_background	observation	support	info-optional	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	BIO_11567062_pa_2	BIO_11567062_pa_7	BIO_11567062_pa_2_7
BIO	11567062	pa	2	8	motivation_background	observation	support	info-required	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_pa_2	BIO_11567062_pa_8	BIO_11567062_pa_2_8
BIO	11567062	pa	2	9	motivation_background	observation	support	info-required	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_pa_2	BIO_11567062_pa_9	BIO_11567062_pa_2_9
BIO	11567062	pa	2	10	motivation_background	observation	support	info-optional	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_pa_2	BIO_11567062_pa_10	BIO_11567062_pa_2_10
BIO	11567062	pa	2	11	motivation_background	observation	support	support	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_pa_2	BIO_11567062_pa_11	BIO_11567062_pa_2_11
BIO	11567062	pa	2	12	motivation_background	conclusion	support	support	secondary	secondary	none	none	We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic and traumatic brain injury.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_pa_2	BIO_11567062_pa_12	BIO_11567062_pa_2_12
BIO	11567062	pa	3	4	proposal	proposal_implementation	none	elaboration	secondary	secondary	back	elaboration	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	BIO_11567062_pa_3	BIO_11567062_pa_4	BIO_11567062_pa_3_4
BIO	11567062	pa	3	5	proposal	observation	none	info-required	secondary	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	BIO_11567062_pa_3	BIO_11567062_pa_5	BIO_11567062_pa_3_5
BIO	11567062	pa	3	6	proposal	observation	none	info-required	secondary	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	BIO_11567062_pa_3	BIO_11567062_pa_6	BIO_11567062_pa_3_6
BIO	11567062	pa	3	7	proposal	observation	none	info-optional	secondary	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	BIO_11567062_pa_3	BIO_11567062_pa_7	BIO_11567062_pa_3_7
BIO	11567062	pa	3	8	proposal	observation	none	info-required	secondary	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_pa_3	BIO_11567062_pa_8	BIO_11567062_pa_3_8
BIO	11567062	pa	3	9	proposal	observation	none	info-required	secondary	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_pa_3	BIO_11567062_pa_9	BIO_11567062_pa_3_9
BIO	11567062	pa	3	10	proposal	observation	none	info-optional	secondary	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_pa_3	BIO_11567062_pa_10	BIO_11567062_pa_3_10
BIO	11567062	pa	3	11	proposal	observation	none	support	secondary	secondary	none	none	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_pa_3	BIO_11567062_pa_11	BIO_11567062_pa_3_11
BIO	11567062	pa	3	12	proposal	conclusion	none	support	secondary	secondary	back	support	In this study, we examined the mechanisms involved by focusing on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_pa_3	BIO_11567062_pa_12	BIO_11567062_pa_3_12
BIO	11567062	pa	4	5	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	BIO_11567062_pa_4	BIO_11567062_pa_5	BIO_11567062_pa_4_5
BIO	11567062	pa	4	6	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	BIO_11567062_pa_4	BIO_11567062_pa_6	BIO_11567062_pa_4_6
BIO	11567062	pa	4	7	proposal_implementation	observation	elaboration	info-optional	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	BIO_11567062_pa_4	BIO_11567062_pa_7	BIO_11567062_pa_4_7
BIO	11567062	pa	4	8	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_pa_4	BIO_11567062_pa_8	BIO_11567062_pa_4_8
BIO	11567062	pa	4	9	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_pa_4	BIO_11567062_pa_9	BIO_11567062_pa_4_9
BIO	11567062	pa	4	10	proposal_implementation	observation	elaboration	info-optional	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_pa_4	BIO_11567062_pa_10	BIO_11567062_pa_4_10
BIO	11567062	pa	4	11	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_pa_4	BIO_11567062_pa_11	BIO_11567062_pa_4_11
BIO	11567062	pa	4	12	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_pa_4	BIO_11567062_pa_12	BIO_11567062_pa_4_12
BIO	11567062	pa	5	6	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	BIO_11567062_pa_5	BIO_11567062_pa_6	BIO_11567062_pa_5_6
BIO	11567062	pa	5	7	observation	observation	info-required	info-optional	secondary	secondary	none	none	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	BIO_11567062_pa_5	BIO_11567062_pa_7	BIO_11567062_pa_5_7
BIO	11567062	pa	5	8	observation	observation	info-required	info-required	secondary	secondary	none	none	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_pa_5	BIO_11567062_pa_8	BIO_11567062_pa_5_8
BIO	11567062	pa	5	9	observation	observation	info-required	info-required	secondary	secondary	none	none	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_pa_5	BIO_11567062_pa_9	BIO_11567062_pa_5_9
BIO	11567062	pa	5	10	observation	observation	info-required	info-optional	secondary	secondary	none	none	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_pa_5	BIO_11567062_pa_10	BIO_11567062_pa_5_10
BIO	11567062	pa	5	11	observation	observation	info-required	support	secondary	secondary	none	none	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_pa_5	BIO_11567062_pa_11	BIO_11567062_pa_5_11
BIO	11567062	pa	5	12	observation	conclusion	info-required	support	secondary	secondary	none	none	MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_pa_5	BIO_11567062_pa_12	BIO_11567062_pa_5_12
BIO	11567062	pa	6	7	observation	observation	info-required	info-optional	secondary	secondary	back	info-optional	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	BIO_11567062_pa_6	BIO_11567062_pa_7	BIO_11567062_pa_6_7
BIO	11567062	pa	6	8	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_pa_6	BIO_11567062_pa_8	BIO_11567062_pa_6_8
BIO	11567062	pa	6	9	observation	observation	info-required	info-required	secondary	secondary	none	none	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_pa_6	BIO_11567062_pa_9	BIO_11567062_pa_6_9
BIO	11567062	pa	6	10	observation	observation	info-required	info-optional	secondary	secondary	none	none	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_pa_6	BIO_11567062_pa_10	BIO_11567062_pa_6_10
BIO	11567062	pa	6	11	observation	observation	info-required	support	secondary	secondary	none	none	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_pa_6	BIO_11567062_pa_11	BIO_11567062_pa_6_11
BIO	11567062	pa	6	12	observation	conclusion	info-required	support	secondary	secondary	none	none	Western blots showed that the blood-brain barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_pa_6	BIO_11567062_pa_12	BIO_11567062_pa_6_12
BIO	11567062	pa	7	8	observation	observation	info-optional	info-required	secondary	secondary	none	none	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	BIO_11567062_pa_7	BIO_11567062_pa_8	BIO_11567062_pa_7_8
BIO	11567062	pa	7	9	observation	observation	info-optional	info-required	secondary	secondary	none	none	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_pa_7	BIO_11567062_pa_9	BIO_11567062_pa_7_9
BIO	11567062	pa	7	10	observation	observation	info-optional	info-optional	secondary	secondary	none	none	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_pa_7	BIO_11567062_pa_10	BIO_11567062_pa_7_10
BIO	11567062	pa	7	11	observation	observation	info-optional	support	secondary	secondary	none	none	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_pa_7	BIO_11567062_pa_11	BIO_11567062_pa_7_11
BIO	11567062	pa	7	12	observation	conclusion	info-optional	support	secondary	secondary	none	none	There were no detectable changes in another blood-brain barrier-associated protein, occludin.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_pa_7	BIO_11567062_pa_12	BIO_11567062_pa_7_12
BIO	11567062	pa	8	9	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	BIO_11567062_pa_8	BIO_11567062_pa_9	BIO_11567062_pa_8_9
BIO	11567062	pa	8	10	observation	observation	info-required	info-optional	secondary	secondary	none	none	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_pa_8	BIO_11567062_pa_10	BIO_11567062_pa_8_10
BIO	11567062	pa	8	11	observation	observation	info-required	support	secondary	secondary	none	none	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_pa_8	BIO_11567062_pa_11	BIO_11567062_pa_8_11
BIO	11567062	pa	8	12	observation	conclusion	info-required	support	secondary	secondary	none	none	Correspondingly, blood-brain barrier disruption assessed via Evans Blue leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_pa_8	BIO_11567062_pa_12	BIO_11567062_pa_8_12
BIO	11567062	pa	9	10	observation	observation	info-required	info-optional	secondary	secondary	back	info-optional	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	BIO_11567062_pa_9	BIO_11567062_pa_10	BIO_11567062_pa_9_10
BIO	11567062	pa	9	11	observation	observation	info-required	support	secondary	secondary	forw	info-required	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_pa_9	BIO_11567062_pa_11	BIO_11567062_pa_9_11
BIO	11567062	pa	9	12	observation	conclusion	info-required	support	secondary	secondary	none	none	In white matter, ischemic degradation of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20).	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_pa_9	BIO_11567062_pa_12	BIO_11567062_pa_9_12
BIO	11567062	pa	10	11	observation	observation	info-optional	support	secondary	secondary	none	none	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_pa_10	BIO_11567062_pa_11	BIO_11567062_pa_10_11
BIO	11567062	pa	10	12	observation	conclusion	info-optional	support	secondary	secondary	none	none	There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_pa_10	BIO_11567062_pa_12	BIO_11567062_pa_10_12
BIO	11567062	pa	11	12	observation	conclusion	support	support	secondary	secondary	forw	support	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	BIO_11567062_pa_11	BIO_11567062_pa_12	BIO_11567062_pa_11_12
BIO	11567062	pa	12	11	conclusion	observation	support	support	secondary	secondary	back	support	These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types.	BIO_11567062_pa_12	BIO_11567062_pa_11	BIO_11567062_pa_11_12
BIO	11591455	pa	1	2	motivation_background	proposal	support	none	secondary	main	forw	support	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	BIO_11591455_pa_1	BIO_11591455_pa_2	BIO_11591455_pa_1_2
BIO	11591455	pa	1	3	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	BIO_11591455_pa_1	BIO_11591455_pa_3	BIO_11591455_pa_1_3
BIO	11591455	pa	1	4	motivation_background	observation	support	info-required	secondary	secondary	none	none	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	BIO_11591455_pa_1	BIO_11591455_pa_4	BIO_11591455_pa_1_4
BIO	11591455	pa	1	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	BIO_11591455_pa_1	BIO_11591455_pa_5	BIO_11591455_pa_1_5
BIO	11591455	pa	1	6	motivation_background	observation	support	support	secondary	secondary	none	none	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	BIO_11591455_pa_1	BIO_11591455_pa_6	BIO_11591455_pa_1_6
BIO	11591455	pa	1	7	motivation_background	result	support	support	secondary	secondary	none	none	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_pa_1	BIO_11591455_pa_7	BIO_11591455_pa_1_7
BIO	11591455	pa	1	8	motivation_background	conclusion	support	support	secondary	secondary	none	none	The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve functional performance in experimental models of cerebral ischemia and acute subdural hematoma.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_pa_1	BIO_11591455_pa_8	BIO_11591455_pa_1_8
BIO	11591455	pa	2	3	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	BIO_11591455_pa_2	BIO_11591455_pa_3	BIO_11591455_pa_2_3
BIO	11591455	pa	2	4	proposal	observation	none	info-required	main	secondary	none	none	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	BIO_11591455_pa_2	BIO_11591455_pa_4	BIO_11591455_pa_2_4
BIO	11591455	pa	2	5	proposal	observation	none	info-required	main	secondary	none	none	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	BIO_11591455_pa_2	BIO_11591455_pa_5	BIO_11591455_pa_2_5
BIO	11591455	pa	2	6	proposal	observation	none	support	main	secondary	none	none	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	BIO_11591455_pa_2	BIO_11591455_pa_6	BIO_11591455_pa_2_6
BIO	11591455	pa	2	7	proposal	result	none	support	main	secondary	none	none	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_pa_2	BIO_11591455_pa_7	BIO_11591455_pa_2_7
BIO	11591455	pa	2	8	proposal	conclusion	none	support	main	secondary	back	support	Using a clinically relevant contusion model of traumatic brain injury, we tested the hypothesis that a 4-h continuous infusion of Repinotan HCl (10 microg/kg/h i.v.) commencing 5 min post-injury would ameliorate functional outcome and attenuate histopathology.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_pa_2	BIO_11591455_pa_8	BIO_11591455_pa_2_8
BIO	11591455	pa	3	4	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	BIO_11591455_pa_3	BIO_11591455_pa_4	BIO_11591455_pa_3_4
BIO	11591455	pa	3	5	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	BIO_11591455_pa_3	BIO_11591455_pa_5	BIO_11591455_pa_3_5
BIO	11591455	pa	3	6	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	BIO_11591455_pa_3	BIO_11591455_pa_6	BIO_11591455_pa_3_6
BIO	11591455	pa	3	7	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_pa_3	BIO_11591455_pa_7	BIO_11591455_pa_3_7
BIO	11591455	pa	3	8	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Forty isoflurane-anesthetized male adult rats were randomly assigned to receive either a controlled cortical impact (2.7 mm tissue deformation, 4 m/s) or sham injury (Injury/Vehicle=10, Injury/MK-801=10, Injury/Repinotan HCl=10, Sham/Vehicle=10), then tested for vestibulomotor function on post-operative days 1-5 and for spatial learning on days 14-18.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_pa_3	BIO_11591455_pa_8	BIO_11591455_pa_3_8
BIO	11591455	pa	4	5	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	BIO_11591455_pa_4	BIO_11591455_pa_5	BIO_11591455_pa_4_5
BIO	11591455	pa	4	6	observation	observation	info-required	support	secondary	secondary	none	none	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	BIO_11591455_pa_4	BIO_11591455_pa_6	BIO_11591455_pa_4_6
BIO	11591455	pa	4	7	observation	result	info-required	support	secondary	secondary	none	none	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_pa_4	BIO_11591455_pa_7	BIO_11591455_pa_4_7
BIO	11591455	pa	4	8	observation	conclusion	info-required	support	secondary	secondary	none	none	Neither Repinotan HCl nor the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, which served as a positive control, improved vestibulomotor function on beam balance and beam walk tasks relative to the Injury/Vehicle group, but both did significantly attenuate spatial learning and memory deficits on a water maze task.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_pa_4	BIO_11591455_pa_8	BIO_11591455_pa_4_8
BIO	11591455	pa	5	6	observation	observation	info-required	support	secondary	secondary	forw	info-required	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	BIO_11591455_pa_5	BIO_11591455_pa_6	BIO_11591455_pa_5_6
BIO	11591455	pa	5	7	observation	result	info-required	support	secondary	secondary	none	none	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_pa_5	BIO_11591455_pa_7	BIO_11591455_pa_5_7
BIO	11591455	pa	5	8	observation	conclusion	info-required	support	secondary	secondary	none	none	Repinotan HCl also reduced hippocampal CA(1) and CA(3) neuronal loss, as well as cortical tissue damage, compared to the Injury/Vehicle group at 4 weeks post-trauma.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_pa_5	BIO_11591455_pa_8	BIO_11591455_pa_5_8
BIO	11591455	pa	6	7	observation	result	support	support	secondary	secondary	forw	support	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_pa_6	BIO_11591455_pa_7	BIO_11591455_pa_6_7
BIO	11591455	pa	6	8	observation	conclusion	support	support	secondary	secondary	none	none	No significant difference in histological outcome was revealed between the Repinotan HCl- and MK-801-treated groups.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_pa_6	BIO_11591455_pa_8	BIO_11591455_pa_6_8
BIO	11591455	pa	7	8	result	conclusion	support	support	secondary	secondary	forw	support	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	BIO_11591455_pa_7	BIO_11591455_pa_8	BIO_11591455_pa_7_8
BIO	11591455	pa	8	7	conclusion	result	support	support	secondary	secondary	back	support	This treatment strategy may be beneficial in a clinical context where memory impairments are common following human traumatic brain injury.	These findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury.	BIO_11591455_pa_8	BIO_11591455_pa_7	BIO_11591455_pa_7_8
BIO	11850540	pa	1	2	motivation_background	motivation_problem	support	support	secondary	secondary	forw	support	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	BIO_11850540_pa_1	BIO_11850540_pa_2	BIO_11850540_pa_1_2
BIO	11850540	pa	1	3	motivation_background	proposal	support	none	secondary	main	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	BIO_11850540_pa_1	BIO_11850540_pa_3	BIO_11850540_pa_1_3
BIO	11850540	pa	1	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	BIO_11850540_pa_1	BIO_11850540_pa_4	BIO_11850540_pa_1_4
BIO	11850540	pa	1	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	BIO_11850540_pa_1	BIO_11850540_pa_5	BIO_11850540_pa_1_5
BIO	11850540	pa	1	6	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	BIO_11850540_pa_1	BIO_11850540_pa_6	BIO_11850540_pa_1_6
BIO	11850540	pa	1	7	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	There was no amplification in DH or normal ductal epithelium.	BIO_11850540_pa_1	BIO_11850540_pa_7	BIO_11850540_pa_1_7
BIO	11850540	pa	1	8	motivation_background	observation	support	info-required	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_pa_1	BIO_11850540_pa_8	BIO_11850540_pa_1_8
BIO	11850540	pa	1	9	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_pa_1	BIO_11850540_pa_9	BIO_11850540_pa_1_9
BIO	11850540	pa	1	10	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_pa_1	BIO_11850540_pa_10	BIO_11850540_pa_1_10
BIO	11850540	pa	1	11	motivation_background	means	support	by-means	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_pa_1	BIO_11850540_pa_11	BIO_11850540_pa_1_11
BIO	11850540	pa	1	12	motivation_background	observation	support	info-required	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_pa_1	BIO_11850540_pa_12	BIO_11850540_pa_1_12
BIO	11850540	pa	1	13	motivation_background	observation	support	info-required	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_pa_1	BIO_11850540_pa_13	BIO_11850540_pa_1_13
BIO	11850540	pa	1	14	motivation_background	observation	support	support	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_1	BIO_11850540_pa_14	BIO_11850540_pa_1_14
BIO	11850540	pa	1	15	motivation_background	result	support	info-required	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_1	BIO_11850540_pa_15	BIO_11850540_pa_1_15
BIO	11850540	pa	1	16	motivation_background	result	support	support	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_1	BIO_11850540_pa_16	BIO_11850540_pa_1_16
BIO	11850540	pa	1	17	motivation_background	conclusion	support	support	secondary	secondary	none	none	Amplification of Her-2/neu in breast carcinoma is associated with poor prognosis, short disease-free interval, and short survival time in both node-negative and -positive patients.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_1	BIO_11850540_pa_17	BIO_11850540_pa_1_17
BIO	11850540	pa	2	3	motivation_problem	proposal	support	none	secondary	main	forw	support	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	BIO_11850540_pa_2	BIO_11850540_pa_3	BIO_11850540_pa_2_3
BIO	11850540	pa	2	4	motivation_problem	proposal_implementation	support	elaboration	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	BIO_11850540_pa_2	BIO_11850540_pa_4	BIO_11850540_pa_2_4
BIO	11850540	pa	2	5	motivation_problem	observation	support	info-required	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	BIO_11850540_pa_2	BIO_11850540_pa_5	BIO_11850540_pa_2_5
BIO	11850540	pa	2	6	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	BIO_11850540_pa_2	BIO_11850540_pa_6	BIO_11850540_pa_2_6
BIO	11850540	pa	2	7	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	There was no amplification in DH or normal ductal epithelium.	BIO_11850540_pa_2	BIO_11850540_pa_7	BIO_11850540_pa_2_7
BIO	11850540	pa	2	8	motivation_problem	observation	support	info-required	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_pa_2	BIO_11850540_pa_8	BIO_11850540_pa_2_8
BIO	11850540	pa	2	9	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_pa_2	BIO_11850540_pa_9	BIO_11850540_pa_2_9
BIO	11850540	pa	2	10	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_pa_2	BIO_11850540_pa_10	BIO_11850540_pa_2_10
BIO	11850540	pa	2	11	motivation_problem	means	support	by-means	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_pa_2	BIO_11850540_pa_11	BIO_11850540_pa_2_11
BIO	11850540	pa	2	12	motivation_problem	observation	support	info-required	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_pa_2	BIO_11850540_pa_12	BIO_11850540_pa_2_12
BIO	11850540	pa	2	13	motivation_problem	observation	support	info-required	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_pa_2	BIO_11850540_pa_13	BIO_11850540_pa_2_13
BIO	11850540	pa	2	14	motivation_problem	observation	support	support	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_2	BIO_11850540_pa_14	BIO_11850540_pa_2_14
BIO	11850540	pa	2	15	motivation_problem	result	support	info-required	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_2	BIO_11850540_pa_15	BIO_11850540_pa_2_15
BIO	11850540	pa	2	16	motivation_problem	result	support	support	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_2	BIO_11850540_pa_16	BIO_11850540_pa_2_16
BIO	11850540	pa	2	17	motivation_problem	conclusion	support	support	secondary	secondary	none	none	Little is known about the starting point of amplification of Her-2/neu and how it progresses from benign to malignant breast lesions.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_2	BIO_11850540_pa_17	BIO_11850540_pa_2_17
BIO	11850540	pa	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	BIO_11850540_pa_3	BIO_11850540_pa_4	BIO_11850540_pa_3_4
BIO	11850540	pa	3	5	proposal	observation	none	info-required	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	BIO_11850540_pa_3	BIO_11850540_pa_5	BIO_11850540_pa_3_5
BIO	11850540	pa	3	6	proposal	observation	none	elaboration	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	BIO_11850540_pa_3	BIO_11850540_pa_6	BIO_11850540_pa_3_6
BIO	11850540	pa	3	7	proposal	observation	none	elaboration	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	There was no amplification in DH or normal ductal epithelium.	BIO_11850540_pa_3	BIO_11850540_pa_7	BIO_11850540_pa_3_7
BIO	11850540	pa	3	8	proposal	observation	none	info-required	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_pa_3	BIO_11850540_pa_8	BIO_11850540_pa_3_8
BIO	11850540	pa	3	9	proposal	observation	none	elaboration	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_pa_3	BIO_11850540_pa_9	BIO_11850540_pa_3_9
BIO	11850540	pa	3	10	proposal	observation	none	elaboration	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_pa_3	BIO_11850540_pa_10	BIO_11850540_pa_3_10
BIO	11850540	pa	3	11	proposal	means	none	by-means	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_pa_3	BIO_11850540_pa_11	BIO_11850540_pa_3_11
BIO	11850540	pa	3	12	proposal	observation	none	info-required	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_pa_3	BIO_11850540_pa_12	BIO_11850540_pa_3_12
BIO	11850540	pa	3	13	proposal	observation	none	info-required	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_pa_3	BIO_11850540_pa_13	BIO_11850540_pa_3_13
BIO	11850540	pa	3	14	proposal	observation	none	support	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_3	BIO_11850540_pa_14	BIO_11850540_pa_3_14
BIO	11850540	pa	3	15	proposal	result	none	info-required	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_3	BIO_11850540_pa_15	BIO_11850540_pa_3_15
BIO	11850540	pa	3	16	proposal	result	none	support	main	secondary	none	none	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_3	BIO_11850540_pa_16	BIO_11850540_pa_3_16
BIO	11850540	pa	3	17	proposal	conclusion	none	support	main	secondary	back	support	We attempted to address these questions by evaluating amplification of Her-2/neu in benign, premalignant, and malignant lesions using fluorescence in situ hybridization (FISH).	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_3	BIO_11850540_pa_17	BIO_11850540_pa_3_17
BIO	11850540	pa	4	5	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	BIO_11850540_pa_4	BIO_11850540_pa_5	BIO_11850540_pa_4_5
BIO	11850540	pa	4	6	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	BIO_11850540_pa_4	BIO_11850540_pa_6	BIO_11850540_pa_4_6
BIO	11850540	pa	4	7	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	There was no amplification in DH or normal ductal epithelium.	BIO_11850540_pa_4	BIO_11850540_pa_7	BIO_11850540_pa_4_7
BIO	11850540	pa	4	8	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_pa_4	BIO_11850540_pa_8	BIO_11850540_pa_4_8
BIO	11850540	pa	4	9	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_pa_4	BIO_11850540_pa_9	BIO_11850540_pa_4_9
BIO	11850540	pa	4	10	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_pa_4	BIO_11850540_pa_10	BIO_11850540_pa_4_10
BIO	11850540	pa	4	11	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_pa_4	BIO_11850540_pa_11	BIO_11850540_pa_4_11
BIO	11850540	pa	4	12	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_pa_4	BIO_11850540_pa_12	BIO_11850540_pa_4_12
BIO	11850540	pa	4	13	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_pa_4	BIO_11850540_pa_13	BIO_11850540_pa_4_13
BIO	11850540	pa	4	14	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_4	BIO_11850540_pa_14	BIO_11850540_pa_4_14
BIO	11850540	pa	4	15	proposal_implementation	result	elaboration	info-required	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_4	BIO_11850540_pa_15	BIO_11850540_pa_4_15
BIO	11850540	pa	4	16	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_4	BIO_11850540_pa_16	BIO_11850540_pa_4_16
BIO	11850540	pa	4	17	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Twenty-six patients with Her-2/neu-overexpressing invasive ductal carcinomas (as judged by strong immunoreactivity with Her-2/neu antibody) and coexisting lesions of ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) in the vicinity of the invasive tumor (as judged by review of the hematoxylin and eosin-stained sections), as well as metastatic carcinoma in axillary lymph nodes (mets) were selected for this study.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_4	BIO_11850540_pa_17	BIO_11850540_pa_4_17
BIO	11850540	pa	5	6	observation	observation	info-required	elaboration	secondary	secondary	back	elaboration	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	BIO_11850540_pa_5	BIO_11850540_pa_6	BIO_11850540_pa_5_6
BIO	11850540	pa	5	7	observation	observation	info-required	elaboration	secondary	secondary	back	elaboration	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	There was no amplification in DH or normal ductal epithelium.	BIO_11850540_pa_5	BIO_11850540_pa_7	BIO_11850540_pa_5_7
BIO	11850540	pa	5	8	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_pa_5	BIO_11850540_pa_8	BIO_11850540_pa_5_8
BIO	11850540	pa	5	9	observation	observation	info-required	elaboration	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_pa_5	BIO_11850540_pa_9	BIO_11850540_pa_5_9
BIO	11850540	pa	5	10	observation	observation	info-required	elaboration	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_pa_5	BIO_11850540_pa_10	BIO_11850540_pa_5_10
BIO	11850540	pa	5	11	observation	means	info-required	by-means	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_pa_5	BIO_11850540_pa_11	BIO_11850540_pa_5_11
BIO	11850540	pa	5	12	observation	observation	info-required	info-required	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_pa_5	BIO_11850540_pa_12	BIO_11850540_pa_5_12
BIO	11850540	pa	5	13	observation	observation	info-required	info-required	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_pa_5	BIO_11850540_pa_13	BIO_11850540_pa_5_13
BIO	11850540	pa	5	14	observation	observation	info-required	support	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_5	BIO_11850540_pa_14	BIO_11850540_pa_5_14
BIO	11850540	pa	5	15	observation	result	info-required	info-required	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_5	BIO_11850540_pa_15	BIO_11850540_pa_5_15
BIO	11850540	pa	5	16	observation	result	info-required	support	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_5	BIO_11850540_pa_16	BIO_11850540_pa_5_16
BIO	11850540	pa	5	17	observation	conclusion	info-required	support	secondary	secondary	none	none	In the primary carcinomas, a close relationship was present between overexpression as detected by immunohistochemistry (IHC) and amplification as demonstrated by FISH (85% concordance).	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_5	BIO_11850540_pa_17	BIO_11850540_pa_5_17
BIO	11850540	pa	6	7	observation	observation	elaboration	elaboration	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	There was no amplification in DH or normal ductal epithelium.	BIO_11850540_pa_6	BIO_11850540_pa_7	BIO_11850540_pa_6_7
BIO	11850540	pa	6	8	observation	observation	elaboration	info-required	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_pa_6	BIO_11850540_pa_8	BIO_11850540_pa_6_8
BIO	11850540	pa	6	9	observation	observation	elaboration	elaboration	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_pa_6	BIO_11850540_pa_9	BIO_11850540_pa_6_9
BIO	11850540	pa	6	10	observation	observation	elaboration	elaboration	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_pa_6	BIO_11850540_pa_10	BIO_11850540_pa_6_10
BIO	11850540	pa	6	11	observation	means	elaboration	by-means	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_pa_6	BIO_11850540_pa_11	BIO_11850540_pa_6_11
BIO	11850540	pa	6	12	observation	observation	elaboration	info-required	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_pa_6	BIO_11850540_pa_12	BIO_11850540_pa_6_12
BIO	11850540	pa	6	13	observation	observation	elaboration	info-required	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_pa_6	BIO_11850540_pa_13	BIO_11850540_pa_6_13
BIO	11850540	pa	6	14	observation	observation	elaboration	support	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_6	BIO_11850540_pa_14	BIO_11850540_pa_6_14
BIO	11850540	pa	6	15	observation	result	elaboration	info-required	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_6	BIO_11850540_pa_15	BIO_11850540_pa_6_15
BIO	11850540	pa	6	16	observation	result	elaboration	support	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_6	BIO_11850540_pa_16	BIO_11850540_pa_6_16
BIO	11850540	pa	6	17	observation	conclusion	elaboration	support	secondary	secondary	none	none	Among these patients, amplification of Her-2/neu in ADH was demonstrated in 7 of 13 cases with ADH, and in DCIS, in 21 of 22 cases with DCIS.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_6	BIO_11850540_pa_17	BIO_11850540_pa_6_17
BIO	11850540	pa	7	8	observation	observation	elaboration	info-required	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	BIO_11850540_pa_7	BIO_11850540_pa_8	BIO_11850540_pa_7_8
BIO	11850540	pa	7	9	observation	observation	elaboration	elaboration	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_pa_7	BIO_11850540_pa_9	BIO_11850540_pa_7_9
BIO	11850540	pa	7	10	observation	observation	elaboration	elaboration	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_pa_7	BIO_11850540_pa_10	BIO_11850540_pa_7_10
BIO	11850540	pa	7	11	observation	means	elaboration	by-means	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_pa_7	BIO_11850540_pa_11	BIO_11850540_pa_7_11
BIO	11850540	pa	7	12	observation	observation	elaboration	info-required	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_pa_7	BIO_11850540_pa_12	BIO_11850540_pa_7_12
BIO	11850540	pa	7	13	observation	observation	elaboration	info-required	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_pa_7	BIO_11850540_pa_13	BIO_11850540_pa_7_13
BIO	11850540	pa	7	14	observation	observation	elaboration	support	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_7	BIO_11850540_pa_14	BIO_11850540_pa_7_14
BIO	11850540	pa	7	15	observation	result	elaboration	info-required	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_7	BIO_11850540_pa_15	BIO_11850540_pa_7_15
BIO	11850540	pa	7	16	observation	result	elaboration	support	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_7	BIO_11850540_pa_16	BIO_11850540_pa_7_16
BIO	11850540	pa	7	17	observation	conclusion	elaboration	support	secondary	secondary	none	none	There was no amplification in DH or normal ductal epithelium.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_7	BIO_11850540_pa_17	BIO_11850540_pa_7_17
BIO	11850540	pa	8	9	observation	observation	info-required	elaboration	secondary	secondary	back	elaboration	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	BIO_11850540_pa_8	BIO_11850540_pa_9	BIO_11850540_pa_8_9
BIO	11850540	pa	8	10	observation	observation	info-required	elaboration	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_pa_8	BIO_11850540_pa_10	BIO_11850540_pa_8_10
BIO	11850540	pa	8	11	observation	means	info-required	by-means	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_pa_8	BIO_11850540_pa_11	BIO_11850540_pa_8_11
BIO	11850540	pa	8	12	observation	observation	info-required	info-required	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_pa_8	BIO_11850540_pa_12	BIO_11850540_pa_8_12
BIO	11850540	pa	8	13	observation	observation	info-required	info-required	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_pa_8	BIO_11850540_pa_13	BIO_11850540_pa_8_13
BIO	11850540	pa	8	14	observation	observation	info-required	support	secondary	secondary	forw	info-required	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_8	BIO_11850540_pa_14	BIO_11850540_pa_8_14
BIO	11850540	pa	8	15	observation	result	info-required	info-required	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_8	BIO_11850540_pa_15	BIO_11850540_pa_8_15
BIO	11850540	pa	8	16	observation	result	info-required	support	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_8	BIO_11850540_pa_16	BIO_11850540_pa_8_16
BIO	11850540	pa	8	17	observation	conclusion	info-required	support	secondary	secondary	none	none	Significantly, in all 12 patients with synchronous positive axillary lymph nodes, there was concordant amplification of Her-2/neu in the primary and metastatic carcinoma.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_8	BIO_11850540_pa_17	BIO_11850540_pa_8_17
BIO	11850540	pa	9	10	observation	observation	elaboration	elaboration	secondary	secondary	back	elaboration	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	BIO_11850540_pa_9	BIO_11850540_pa_10	BIO_11850540_pa_9_10
BIO	11850540	pa	9	11	observation	means	elaboration	by-means	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_pa_9	BIO_11850540_pa_11	BIO_11850540_pa_9_11
BIO	11850540	pa	9	12	observation	observation	elaboration	info-required	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_pa_9	BIO_11850540_pa_12	BIO_11850540_pa_9_12
BIO	11850540	pa	9	13	observation	observation	elaboration	info-required	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_pa_9	BIO_11850540_pa_13	BIO_11850540_pa_9_13
BIO	11850540	pa	9	14	observation	observation	elaboration	support	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_9	BIO_11850540_pa_14	BIO_11850540_pa_9_14
BIO	11850540	pa	9	15	observation	result	elaboration	info-required	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_9	BIO_11850540_pa_15	BIO_11850540_pa_9_15
BIO	11850540	pa	9	16	observation	result	elaboration	support	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_9	BIO_11850540_pa_16	BIO_11850540_pa_9_16
BIO	11850540	pa	9	17	observation	conclusion	elaboration	support	secondary	secondary	none	none	Amplification was consistent in multifocal metastases, despite morphological heterogeneity in some patients.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_9	BIO_11850540_pa_17	BIO_11850540_pa_9_17
BIO	11850540	pa	10	11	observation	means	elaboration	by-means	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	BIO_11850540_pa_10	BIO_11850540_pa_11	BIO_11850540_pa_10_11
BIO	11850540	pa	10	12	observation	observation	elaboration	info-required	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_pa_10	BIO_11850540_pa_12	BIO_11850540_pa_10_12
BIO	11850540	pa	10	13	observation	observation	elaboration	info-required	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_pa_10	BIO_11850540_pa_13	BIO_11850540_pa_10_13
BIO	11850540	pa	10	14	observation	observation	elaboration	support	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_10	BIO_11850540_pa_14	BIO_11850540_pa_10_14
BIO	11850540	pa	10	15	observation	result	elaboration	info-required	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_10	BIO_11850540_pa_15	BIO_11850540_pa_10_15
BIO	11850540	pa	10	16	observation	result	elaboration	support	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_10	BIO_11850540_pa_16	BIO_11850540_pa_10_16
BIO	11850540	pa	10	17	observation	conclusion	elaboration	support	secondary	secondary	none	none	Amplification ratios increased from ADH to DCIS to invasive carcinoma (P  less than .01, ADH versus DCIS; P  less than .05, DCIS versus invasive cancer), but there was no difference in amplification ratios between primary cancers and synchronous axillary metastases (P  greater than .05).	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_10	BIO_11850540_pa_17	BIO_11850540_pa_10_17
BIO	11850540	pa	11	12	means	observation	by-means	info-required	secondary	secondary	none	none	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	BIO_11850540_pa_11	BIO_11850540_pa_12	BIO_11850540_pa_11_12
BIO	11850540	pa	11	13	means	observation	by-means	info-required	secondary	secondary	none	none	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_pa_11	BIO_11850540_pa_13	BIO_11850540_pa_11_13
BIO	11850540	pa	11	14	means	observation	by-means	support	secondary	secondary	forw	by-means	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_11	BIO_11850540_pa_14	BIO_11850540_pa_11_14
BIO	11850540	pa	11	15	means	result	by-means	info-required	secondary	secondary	none	none	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_11	BIO_11850540_pa_15	BIO_11850540_pa_11_15
BIO	11850540	pa	11	16	means	result	by-means	support	secondary	secondary	none	none	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_11	BIO_11850540_pa_16	BIO_11850540_pa_11_16
BIO	11850540	pa	11	17	means	conclusion	by-means	support	secondary	secondary	none	none	We also evaluated Her-2/neu amplification in 21 patients without Her-2/neu overexpression in their primary carcinomas (as judged by absent immunoreactivity with Her-2/neu antibody).	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_11	BIO_11850540_pa_17	BIO_11850540_pa_11_17
BIO	11850540	pa	12	13	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	One patient had amplification in the primary tumor but not in an axillary metastasis.	BIO_11850540_pa_12	BIO_11850540_pa_13	BIO_11850540_pa_12_13
BIO	11850540	pa	12	14	observation	observation	info-required	support	secondary	secondary	none	none	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_12	BIO_11850540_pa_14	BIO_11850540_pa_12_14
BIO	11850540	pa	12	15	observation	result	info-required	info-required	secondary	secondary	none	none	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_12	BIO_11850540_pa_15	BIO_11850540_pa_12_15
BIO	11850540	pa	12	16	observation	result	info-required	support	secondary	secondary	none	none	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_12	BIO_11850540_pa_16	BIO_11850540_pa_12_16
BIO	11850540	pa	12	17	observation	conclusion	info-required	support	secondary	secondary	none	none	Three showed amplification in both primary and metastatic lesions, with a low amplification ratio (approximately 2).	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_12	BIO_11850540_pa_17	BIO_11850540_pa_12_17
BIO	11850540	pa	13	14	observation	observation	info-required	support	secondary	secondary	forw	info-required	One patient had amplification in the primary tumor but not in an axillary metastasis.	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	BIO_11850540_pa_13	BIO_11850540_pa_14	BIO_11850540_pa_13_14
BIO	11850540	pa	13	15	observation	result	info-required	info-required	secondary	secondary	none	none	One patient had amplification in the primary tumor but not in an axillary metastasis.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_13	BIO_11850540_pa_15	BIO_11850540_pa_13_15
BIO	11850540	pa	13	16	observation	result	info-required	support	secondary	secondary	none	none	One patient had amplification in the primary tumor but not in an axillary metastasis.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_13	BIO_11850540_pa_16	BIO_11850540_pa_13_16
BIO	11850540	pa	13	17	observation	conclusion	info-required	support	secondary	secondary	none	none	One patient had amplification in the primary tumor but not in an axillary metastasis.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_13	BIO_11850540_pa_17	BIO_11850540_pa_13_17
BIO	11850540	pa	14	15	observation	result	support	info-required	secondary	secondary	forw	support	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	BIO_11850540_pa_14	BIO_11850540_pa_15	BIO_11850540_pa_14_15
BIO	11850540	pa	14	16	observation	result	support	support	secondary	secondary	none	none	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_14	BIO_11850540_pa_16	BIO_11850540_pa_14_16
BIO	11850540	pa	14	17	observation	conclusion	support	support	secondary	secondary	none	none	Two patients exhibited slight amplification in the metastatic carcinoma (ratios 1.6 and 2), but not in their primary cancers.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_14	BIO_11850540_pa_17	BIO_11850540_pa_14_17
BIO	11850540	pa	15	16	result	result	info-required	support	secondary	secondary	forw	info-required	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_15	BIO_11850540_pa_16	BIO_11850540_pa_15_16
BIO	11850540	pa	15	17	result	conclusion	info-required	support	secondary	secondary	none	none	This FISH study indicates that amplification of Her-2/neu can emerge de novo in any stage of the disease process, from ADH to metastatic lesions, but most often appears first in ADH or DCIS.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_15	BIO_11850540_pa_17	BIO_11850540_pa_15_17
BIO	11850540	pa	16	17	result	conclusion	support	support	secondary	secondary	forw	support	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	BIO_11850540_pa_16	BIO_11850540_pa_17	BIO_11850540_pa_16_17
BIO	11850540	pa	17	16	conclusion	result	support	support	secondary	secondary	back	support	Our data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain.	The degree of Her-2/neu amplification increases with progression to invasive carcinoma, there being no further increase in synchronous metastasis.	BIO_11850540_pa_17	BIO_11850540_pa_16	BIO_11850540_pa_16_17
BIO	11860483	pa	1	2	motivation_background	motivation_problem	support	support	secondary	secondary	forw	support	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	BIO_11860483_pa_1	BIO_11860483_pa_2	BIO_11860483_pa_1_2
BIO	11860483	pa	1	3	motivation_background	proposal	support	none	secondary	main	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	BIO_11860483_pa_1	BIO_11860483_pa_3	BIO_11860483_pa_1_3
BIO	11860483	pa	1	4	motivation_background	observation	support	info-required	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	BIO_11860483_pa_1	BIO_11860483_pa_4	BIO_11860483_pa_1_4
BIO	11860483	pa	1	5	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	BIO_11860483_pa_1	BIO_11860483_pa_5	BIO_11860483_pa_1_5
BIO	11860483	pa	1	6	motivation_background	observation	support	info-required	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	As in previous EEG studies, we found that, on average, correlation decreased during movements.	BIO_11860483_pa_1	BIO_11860483_pa_6	BIO_11860483_pa_1_6
BIO	11860483	pa	1	7	motivation_background	observation	support	info-required	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	BIO_11860483_pa_1	BIO_11860483_pa_7	BIO_11860483_pa_1_7
BIO	11860483	pa	1	8	motivation_background	observation	support	info-required	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_pa_1	BIO_11860483_pa_8	BIO_11860483_pa_1_8
BIO	11860483	pa	1	9	motivation_background	observation	support	info-required	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_pa_1	BIO_11860483_pa_9	BIO_11860483_pa_1_9
BIO	11860483	pa	1	10	motivation_background	observation	support	support	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_pa_1	BIO_11860483_pa_10	BIO_11860483_pa_1_10
BIO	11860483	pa	1	11	motivation_background	conclusion	support	support	secondary	secondary	none	none	Cortico-cortical connections through the corpus callosum are a major candidate for mediating bimanual coordination.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_pa_1	BIO_11860483_pa_11	BIO_11860483_pa_1_11
BIO	11860483	pa	2	3	motivation_problem	proposal	support	none	secondary	main	forw	support	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	BIO_11860483_pa_2	BIO_11860483_pa_3	BIO_11860483_pa_2_3
BIO	11860483	pa	2	4	motivation_problem	observation	support	info-required	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	BIO_11860483_pa_2	BIO_11860483_pa_4	BIO_11860483_pa_2_4
BIO	11860483	pa	2	5	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	BIO_11860483_pa_2	BIO_11860483_pa_5	BIO_11860483_pa_2_5
BIO	11860483	pa	2	6	motivation_problem	observation	support	info-required	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	As in previous EEG studies, we found that, on average, correlation decreased during movements.	BIO_11860483_pa_2	BIO_11860483_pa_6	BIO_11860483_pa_2_6
BIO	11860483	pa	2	7	motivation_problem	observation	support	info-required	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	BIO_11860483_pa_2	BIO_11860483_pa_7	BIO_11860483_pa_2_7
BIO	11860483	pa	2	8	motivation_problem	observation	support	info-required	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_pa_2	BIO_11860483_pa_8	BIO_11860483_pa_2_8
BIO	11860483	pa	2	9	motivation_problem	observation	support	info-required	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_pa_2	BIO_11860483_pa_9	BIO_11860483_pa_2_9
BIO	11860483	pa	2	10	motivation_problem	observation	support	support	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_pa_2	BIO_11860483_pa_10	BIO_11860483_pa_2_10
BIO	11860483	pa	2	11	motivation_problem	conclusion	support	support	secondary	secondary	none	none	However, aside from the deficits observed after lesioning this connection, little positive evidence indicates its function in bimanual tasks.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_pa_2	BIO_11860483_pa_11	BIO_11860483_pa_2_11
BIO	11860483	pa	3	4	proposal	observation	none	info-required	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	BIO_11860483_pa_3	BIO_11860483_pa_4	BIO_11860483_pa_3_4
BIO	11860483	pa	3	5	proposal	observation	none	elaboration	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	BIO_11860483_pa_3	BIO_11860483_pa_5	BIO_11860483_pa_3_5
BIO	11860483	pa	3	6	proposal	observation	none	info-required	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	As in previous EEG studies, we found that, on average, correlation decreased during movements.	BIO_11860483_pa_3	BIO_11860483_pa_6	BIO_11860483_pa_3_6
BIO	11860483	pa	3	7	proposal	observation	none	info-required	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	BIO_11860483_pa_3	BIO_11860483_pa_7	BIO_11860483_pa_3_7
BIO	11860483	pa	3	8	proposal	observation	none	info-required	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_pa_3	BIO_11860483_pa_8	BIO_11860483_pa_3_8
BIO	11860483	pa	3	9	proposal	observation	none	info-required	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_pa_3	BIO_11860483_pa_9	BIO_11860483_pa_3_9
BIO	11860483	pa	3	10	proposal	observation	none	support	main	secondary	none	none	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_pa_3	BIO_11860483_pa_10	BIO_11860483_pa_3_10
BIO	11860483	pa	3	11	proposal	conclusion	none	support	main	secondary	back	support	In order to address this issue, we simultaneously recorded neuronal activity at multiple sites within the arm area of motor cortex in both hemispheres of awake primates performing different bimanual and unimanual movements.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_pa_3	BIO_11860483_pa_11	BIO_11860483_pa_3_11
BIO	11860483	pa	4	5	observation	observation	info-required	elaboration	secondary	secondary	back	elaboration	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	BIO_11860483_pa_4	BIO_11860483_pa_5	BIO_11860483_pa_4_5
BIO	11860483	pa	4	6	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	As in previous EEG studies, we found that, on average, correlation decreased during movements.	BIO_11860483_pa_4	BIO_11860483_pa_6	BIO_11860483_pa_4_6
BIO	11860483	pa	4	7	observation	observation	info-required	info-required	secondary	secondary	none	none	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	BIO_11860483_pa_4	BIO_11860483_pa_7	BIO_11860483_pa_4_7
BIO	11860483	pa	4	8	observation	observation	info-required	info-required	secondary	secondary	none	none	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_pa_4	BIO_11860483_pa_8	BIO_11860483_pa_4_8
BIO	11860483	pa	4	9	observation	observation	info-required	info-required	secondary	secondary	none	none	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_pa_4	BIO_11860483_pa_9	BIO_11860483_pa_4_9
BIO	11860483	pa	4	10	observation	observation	info-required	support	secondary	secondary	none	none	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_pa_4	BIO_11860483_pa_10	BIO_11860483_pa_4_10
BIO	11860483	pa	4	11	observation	conclusion	info-required	support	secondary	secondary	none	none	By employing an adapted form of the joint peri-stimulus time histogram technique, we discovered rapid movement-related correlation changes between the local field potentials (LFPs) of the two hemispheres that escaped detection by time-averaged cross-correlation methods.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_pa_4	BIO_11860483_pa_11	BIO_11860483_pa_4_11
BIO	11860483	pa	5	6	observation	observation	elaboration	info-required	secondary	secondary	none	none	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	As in previous EEG studies, we found that, on average, correlation decreased during movements.	BIO_11860483_pa_5	BIO_11860483_pa_6	BIO_11860483_pa_5_6
BIO	11860483	pa	5	7	observation	observation	elaboration	info-required	secondary	secondary	none	none	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	BIO_11860483_pa_5	BIO_11860483_pa_7	BIO_11860483_pa_5_7
BIO	11860483	pa	5	8	observation	observation	elaboration	info-required	secondary	secondary	none	none	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_pa_5	BIO_11860483_pa_8	BIO_11860483_pa_5_8
BIO	11860483	pa	5	9	observation	observation	elaboration	info-required	secondary	secondary	none	none	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_pa_5	BIO_11860483_pa_9	BIO_11860483_pa_5_9
BIO	11860483	pa	5	10	observation	observation	elaboration	support	secondary	secondary	none	none	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_pa_5	BIO_11860483_pa_10	BIO_11860483_pa_5_10
BIO	11860483	pa	5	11	observation	conclusion	elaboration	support	secondary	secondary	none	none	The frequency and amplitude of dynamic modifications in correlations between the hemispheres were similar to those within the same hemisphere.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_pa_5	BIO_11860483_pa_11	BIO_11860483_pa_5_11
BIO	11860483	pa	6	7	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	As in previous EEG studies, we found that, on average, correlation decreased during movements.	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	BIO_11860483_pa_6	BIO_11860483_pa_7	BIO_11860483_pa_6_7
BIO	11860483	pa	6	8	observation	observation	info-required	info-required	secondary	secondary	none	none	As in previous EEG studies, we found that, on average, correlation decreased during movements.	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_pa_6	BIO_11860483_pa_8	BIO_11860483_pa_6_8
BIO	11860483	pa	6	9	observation	observation	info-required	info-required	secondary	secondary	none	none	As in previous EEG studies, we found that, on average, correlation decreased during movements.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_pa_6	BIO_11860483_pa_9	BIO_11860483_pa_6_9
BIO	11860483	pa	6	10	observation	observation	info-required	support	secondary	secondary	none	none	As in previous EEG studies, we found that, on average, correlation decreased during movements.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_pa_6	BIO_11860483_pa_10	BIO_11860483_pa_6_10
BIO	11860483	pa	6	11	observation	conclusion	info-required	support	secondary	secondary	none	none	As in previous EEG studies, we found that, on average, correlation decreased during movements.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_pa_6	BIO_11860483_pa_11	BIO_11860483_pa_6_11
BIO	11860483	pa	7	8	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	BIO_11860483_pa_7	BIO_11860483_pa_8	BIO_11860483_pa_7_8
BIO	11860483	pa	7	9	observation	observation	info-required	info-required	secondary	secondary	none	none	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_pa_7	BIO_11860483_pa_9	BIO_11860483_pa_7_9
BIO	11860483	pa	7	10	observation	observation	info-required	support	secondary	secondary	none	none	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_pa_7	BIO_11860483_pa_10	BIO_11860483_pa_7_10
BIO	11860483	pa	7	11	observation	conclusion	info-required	support	secondary	secondary	none	none	However, a subset of recording site pairs did show transiently increased correlations around movement onset (57% of all pairs and conditions in monkey G, 39% in monkey P).	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_pa_7	BIO_11860483_pa_11	BIO_11860483_pa_7_11
BIO	11860483	pa	8	9	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	BIO_11860483_pa_8	BIO_11860483_pa_9	BIO_11860483_pa_8_9
BIO	11860483	pa	8	10	observation	observation	info-required	support	secondary	secondary	none	none	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_pa_8	BIO_11860483_pa_10	BIO_11860483_pa_8_10
BIO	11860483	pa	8	11	observation	conclusion	info-required	support	secondary	secondary	none	none	In interhemispheric pairs, these increases were consistently related to the mode of coupling between the two arms.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_pa_8	BIO_11860483_pa_11	BIO_11860483_pa_8_11
BIO	11860483	pa	9	10	observation	observation	info-required	support	secondary	secondary	forw	info-required	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_pa_9	BIO_11860483_pa_10	BIO_11860483_pa_9_10
BIO	11860483	pa	9	11	observation	conclusion	info-required	support	secondary	secondary	none	none	Both the correlations between the movements themselves and the interhemispheric LFP correlation increases were strongest during bimanual symmetric movements, and weaker during bimanual asymmetric and unimanual movements.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_pa_9	BIO_11860483_pa_11	BIO_11860483_pa_9_11
BIO	11860483	pa	10	11	observation	conclusion	support	support	secondary	secondary	forw	support	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	BIO_11860483_pa_10	BIO_11860483_pa_11	BIO_11860483_pa_10_11
BIO	11860483	pa	11	10	conclusion	observation	support	support	secondary	secondary	back	support	The task-specific way in which interhemispheric correlations are modulated is compatible with the notion that interactions between the hemispheres contribute to behavioural coupling between the arms.	Increased correlations occurred mainly around movement onset, whilst decreases in correlation dominated during movement execution.	BIO_11860483_pa_11	BIO_11860483_pa_10	BIO_11860483_pa_10_11
BIO	11978821	pa	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	BIO_11978821_pa_1	BIO_11978821_pa_2	BIO_11978821_pa_1_2
BIO	11978821	pa	1	3	motivation_background	information_additional	info-required	info-optional	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	BIO_11978821_pa_1	BIO_11978821_pa_3	BIO_11978821_pa_1_3
BIO	11978821	pa	1	4	motivation_background	proposal_implementation	info-required	none	secondary	main	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	BIO_11978821_pa_1	BIO_11978821_pa_4	BIO_11978821_pa_1_4
BIO	11978821	pa	1	5	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	BIO_11978821_pa_1	BIO_11978821_pa_5	BIO_11978821_pa_1_5
BIO	11978821	pa	1	6	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	BIO_11978821_pa_1	BIO_11978821_pa_6	BIO_11978821_pa_1_6
BIO	11978821	pa	1	7	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	BIO_11978821_pa_1	BIO_11978821_pa_7	BIO_11978821_pa_1_7
BIO	11978821	pa	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_pa_1	BIO_11978821_pa_8	BIO_11978821_pa_1_8
BIO	11978821	pa	1	9	motivation_background	result	info-required	info-required	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_pa_1	BIO_11978821_pa_9	BIO_11978821_pa_1_9
BIO	11978821	pa	1	10	motivation_background	result	info-required	support	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_pa_1	BIO_11978821_pa_10	BIO_11978821_pa_1_10
BIO	11978821	pa	1	11	motivation_background	conclusion	info-required	info-required	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_pa_1	BIO_11978821_pa_11	BIO_11978821_pa_1_11
BIO	11978821	pa	1	12	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_pa_1	BIO_11978821_pa_12	BIO_11978821_pa_1_12
BIO	11978821	pa	2	3	motivation_background	information_additional	support	info-optional	secondary	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	BIO_11978821_pa_2	BIO_11978821_pa_3	BIO_11978821_pa_2_3
BIO	11978821	pa	2	4	motivation_background	proposal_implementation	support	none	secondary	main	forw	support	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	BIO_11978821_pa_2	BIO_11978821_pa_4	BIO_11978821_pa_2_4
BIO	11978821	pa	2	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	BIO_11978821_pa_2	BIO_11978821_pa_5	BIO_11978821_pa_2_5
BIO	11978821	pa	2	6	motivation_background	observation	support	info-required	secondary	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	BIO_11978821_pa_2	BIO_11978821_pa_6	BIO_11978821_pa_2_6
BIO	11978821	pa	2	7	motivation_background	observation	support	elaboration	secondary	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	BIO_11978821_pa_2	BIO_11978821_pa_7	BIO_11978821_pa_2_7
BIO	11978821	pa	2	8	motivation_background	observation	support	support	secondary	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_pa_2	BIO_11978821_pa_8	BIO_11978821_pa_2_8
BIO	11978821	pa	2	9	motivation_background	result	support	info-required	secondary	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_pa_2	BIO_11978821_pa_9	BIO_11978821_pa_2_9
BIO	11978821	pa	2	10	motivation_background	result	support	support	secondary	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_pa_2	BIO_11978821_pa_10	BIO_11978821_pa_2_10
BIO	11978821	pa	2	11	motivation_background	conclusion	support	info-required	secondary	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_pa_2	BIO_11978821_pa_11	BIO_11978821_pa_2_11
BIO	11978821	pa	2	12	motivation_background	conclusion	support	support	secondary	secondary	none	none	A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_pa_2	BIO_11978821_pa_12	BIO_11978821_pa_2_12
BIO	11978821	pa	3	4	information_additional	proposal_implementation	info-optional	none	secondary	main	forw	info-optional	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	BIO_11978821_pa_3	BIO_11978821_pa_4	BIO_11978821_pa_3_4
BIO	11978821	pa	3	5	information_additional	observation	info-optional	info-required	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	BIO_11978821_pa_3	BIO_11978821_pa_5	BIO_11978821_pa_3_5
BIO	11978821	pa	3	6	information_additional	observation	info-optional	info-required	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	BIO_11978821_pa_3	BIO_11978821_pa_6	BIO_11978821_pa_3_6
BIO	11978821	pa	3	7	information_additional	observation	info-optional	elaboration	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	BIO_11978821_pa_3	BIO_11978821_pa_7	BIO_11978821_pa_3_7
BIO	11978821	pa	3	8	information_additional	observation	info-optional	support	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_pa_3	BIO_11978821_pa_8	BIO_11978821_pa_3_8
BIO	11978821	pa	3	9	information_additional	result	info-optional	info-required	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_pa_3	BIO_11978821_pa_9	BIO_11978821_pa_3_9
BIO	11978821	pa	3	10	information_additional	result	info-optional	support	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_pa_3	BIO_11978821_pa_10	BIO_11978821_pa_3_10
BIO	11978821	pa	3	11	information_additional	conclusion	info-optional	info-required	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_pa_3	BIO_11978821_pa_11	BIO_11978821_pa_3_11
BIO	11978821	pa	3	12	information_additional	conclusion	info-optional	support	secondary	secondary	none	none	Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_pa_3	BIO_11978821_pa_12	BIO_11978821_pa_3_12
BIO	11978821	pa	4	5	proposal_implementation	observation	none	info-required	main	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	BIO_11978821_pa_4	BIO_11978821_pa_5	BIO_11978821_pa_4_5
BIO	11978821	pa	4	6	proposal_implementation	observation	none	info-required	main	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	BIO_11978821_pa_4	BIO_11978821_pa_6	BIO_11978821_pa_4_6
BIO	11978821	pa	4	7	proposal_implementation	observation	none	elaboration	main	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	BIO_11978821_pa_4	BIO_11978821_pa_7	BIO_11978821_pa_4_7
BIO	11978821	pa	4	8	proposal_implementation	observation	none	support	main	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_pa_4	BIO_11978821_pa_8	BIO_11978821_pa_4_8
BIO	11978821	pa	4	9	proposal_implementation	result	none	info-required	main	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_pa_4	BIO_11978821_pa_9	BIO_11978821_pa_4_9
BIO	11978821	pa	4	10	proposal_implementation	result	none	support	main	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_pa_4	BIO_11978821_pa_10	BIO_11978821_pa_4_10
BIO	11978821	pa	4	11	proposal_implementation	conclusion	none	info-required	main	secondary	none	none	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_pa_4	BIO_11978821_pa_11	BIO_11978821_pa_4_11
BIO	11978821	pa	4	12	proposal_implementation	conclusion	none	support	main	secondary	back	support	By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_pa_4	BIO_11978821_pa_12	BIO_11978821_pa_4_12
BIO	11978821	pa	5	6	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	BIO_11978821_pa_5	BIO_11978821_pa_6	BIO_11978821_pa_5_6
BIO	11978821	pa	5	7	observation	observation	info-required	elaboration	secondary	secondary	none	none	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	BIO_11978821_pa_5	BIO_11978821_pa_7	BIO_11978821_pa_5_7
BIO	11978821	pa	5	8	observation	observation	info-required	support	secondary	secondary	none	none	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_pa_5	BIO_11978821_pa_8	BIO_11978821_pa_5_8
BIO	11978821	pa	5	9	observation	result	info-required	info-required	secondary	secondary	none	none	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_pa_5	BIO_11978821_pa_9	BIO_11978821_pa_5_9
BIO	11978821	pa	5	10	observation	result	info-required	support	secondary	secondary	none	none	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_pa_5	BIO_11978821_pa_10	BIO_11978821_pa_5_10
BIO	11978821	pa	5	11	observation	conclusion	info-required	info-required	secondary	secondary	none	none	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_pa_5	BIO_11978821_pa_11	BIO_11978821_pa_5_11
BIO	11978821	pa	5	12	observation	conclusion	info-required	support	secondary	secondary	none	none	In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_pa_5	BIO_11978821_pa_12	BIO_11978821_pa_5_12
BIO	11978821	pa	6	7	observation	observation	info-required	elaboration	secondary	secondary	back	elaboration	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	BIO_11978821_pa_6	BIO_11978821_pa_7	BIO_11978821_pa_6_7
BIO	11978821	pa	6	8	observation	observation	info-required	support	secondary	secondary	forw	info-required	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_pa_6	BIO_11978821_pa_8	BIO_11978821_pa_6_8
BIO	11978821	pa	6	9	observation	result	info-required	info-required	secondary	secondary	none	none	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_pa_6	BIO_11978821_pa_9	BIO_11978821_pa_6_9
BIO	11978821	pa	6	10	observation	result	info-required	support	secondary	secondary	none	none	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_pa_6	BIO_11978821_pa_10	BIO_11978821_pa_6_10
BIO	11978821	pa	6	11	observation	conclusion	info-required	info-required	secondary	secondary	none	none	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_pa_6	BIO_11978821_pa_11	BIO_11978821_pa_6_11
BIO	11978821	pa	6	12	observation	conclusion	info-required	support	secondary	secondary	none	none	In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_pa_6	BIO_11978821_pa_12	BIO_11978821_pa_6_12
BIO	11978821	pa	7	8	observation	observation	elaboration	support	secondary	secondary	none	none	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	BIO_11978821_pa_7	BIO_11978821_pa_8	BIO_11978821_pa_7_8
BIO	11978821	pa	7	9	observation	result	elaboration	info-required	secondary	secondary	none	none	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_pa_7	BIO_11978821_pa_9	BIO_11978821_pa_7_9
BIO	11978821	pa	7	10	observation	result	elaboration	support	secondary	secondary	none	none	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_pa_7	BIO_11978821_pa_10	BIO_11978821_pa_7_10
BIO	11978821	pa	7	11	observation	conclusion	elaboration	info-required	secondary	secondary	none	none	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_pa_7	BIO_11978821_pa_11	BIO_11978821_pa_7_11
BIO	11978821	pa	7	12	observation	conclusion	elaboration	support	secondary	secondary	none	none	This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_pa_7	BIO_11978821_pa_12	BIO_11978821_pa_7_12
BIO	11978821	pa	8	9	observation	result	support	info-required	secondary	secondary	forw	support	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	BIO_11978821_pa_8	BIO_11978821_pa_9	BIO_11978821_pa_8_9
BIO	11978821	pa	8	10	observation	result	support	support	secondary	secondary	none	none	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_pa_8	BIO_11978821_pa_10	BIO_11978821_pa_8_10
BIO	11978821	pa	8	11	observation	conclusion	support	info-required	secondary	secondary	none	none	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_pa_8	BIO_11978821_pa_11	BIO_11978821_pa_8_11
BIO	11978821	pa	8	12	observation	conclusion	support	support	secondary	secondary	none	none	In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_pa_8	BIO_11978821_pa_12	BIO_11978821_pa_8_12
BIO	11978821	pa	9	10	result	result	info-required	support	secondary	secondary	forw	info-required	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	BIO_11978821_pa_9	BIO_11978821_pa_10	BIO_11978821_pa_9_10
BIO	11978821	pa	9	11	result	conclusion	info-required	info-required	secondary	secondary	none	none	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_pa_9	BIO_11978821_pa_11	BIO_11978821_pa_9_11
BIO	11978821	pa	9	12	result	conclusion	info-required	support	secondary	secondary	none	none	The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_pa_9	BIO_11978821_pa_12	BIO_11978821_pa_9_12
BIO	11978821	pa	10	11	result	conclusion	support	info-required	secondary	secondary	forw	support	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_pa_10	BIO_11978821_pa_11	BIO_11978821_pa_10_11
BIO	11978821	pa	10	12	result	conclusion	support	support	secondary	secondary	none	none	Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_pa_10	BIO_11978821_pa_12	BIO_11978821_pa_10_12
BIO	11978821	pa	11	12	conclusion	conclusion	info-required	support	secondary	secondary	forw	info-required	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	BIO_11978821_pa_11	BIO_11978821_pa_12	BIO_11978821_pa_11_12
BIO	11978821	pa	12	11	conclusion	conclusion	support	info-required	secondary	secondary	back	info-required	In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain.	This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity.	BIO_11978821_pa_12	BIO_11978821_pa_11	BIO_11978821_pa_11_12
BIO	12044662	pa	1	2	proposal_implementation	proposal_implementation	none	elaboration	main	secondary	back	elaboration	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	BIO_12044662_pa_1	BIO_12044662_pa_2	BIO_12044662_pa_1_2
BIO	12044662	pa	1	3	proposal_implementation	proposal_implementation	none	sequence	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	BIO_12044662_pa_1	BIO_12044662_pa_3	BIO_12044662_pa_1_3
BIO	12044662	pa	1	4	proposal_implementation	result	none	support	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	BIO_12044662_pa_1	BIO_12044662_pa_4	BIO_12044662_pa_1_4
BIO	12044662	pa	1	5	proposal_implementation	means	none	by-means	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	BIO_12044662_pa_1	BIO_12044662_pa_5	BIO_12044662_pa_1_5
BIO	12044662	pa	1	6	proposal_implementation	result_means	none	support	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	BIO_12044662_pa_1	BIO_12044662_pa_6	BIO_12044662_pa_1_6
BIO	12044662	pa	1	7	proposal_implementation	observation	none	info-required	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	BIO_12044662_pa_1	BIO_12044662_pa_7	BIO_12044662_pa_1_7
BIO	12044662	pa	1	8	proposal_implementation	observation	none	info-required	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_pa_1	BIO_12044662_pa_8	BIO_12044662_pa_1_8
BIO	12044662	pa	1	9	proposal_implementation	observation	none	support	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_pa_1	BIO_12044662_pa_9	BIO_12044662_pa_1_9
BIO	12044662	pa	1	10	proposal_implementation	observation	none	info-required	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_pa_1	BIO_12044662_pa_10	BIO_12044662_pa_1_10
BIO	12044662	pa	1	11	proposal_implementation	observation	none	info-required	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_pa_1	BIO_12044662_pa_11	BIO_12044662_pa_1_11
BIO	12044662	pa	1	12	proposal_implementation	observation	none	info-required	main	secondary	none	none	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_pa_1	BIO_12044662_pa_12	BIO_12044662_pa_1_12
BIO	12044662	pa	1	13	proposal_implementation	conclusion	none	support	main	secondary	back	support	To determine the activity of matrix metalloproteinases (MMP), especially MMP-2 and MMP-9, which play an important role in ischemic stroke and intracerebral hemorrhage, we adapted a simple and rapid method for localizing gelatinase activity to a gelatin film in situ-overlay technique previously used in cancer research.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_pa_1	BIO_12044662_pa_13	BIO_12044662_pa_1_13
BIO	12044662	pa	2	3	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	back	sequence	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	BIO_12044662_pa_2	BIO_12044662_pa_3	BIO_12044662_pa_2_3
BIO	12044662	pa	2	4	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	BIO_12044662_pa_2	BIO_12044662_pa_4	BIO_12044662_pa_2_4
BIO	12044662	pa	2	5	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	BIO_12044662_pa_2	BIO_12044662_pa_5	BIO_12044662_pa_2_5
BIO	12044662	pa	2	6	proposal_implementation	result_means	elaboration	support	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	BIO_12044662_pa_2	BIO_12044662_pa_6	BIO_12044662_pa_2_6
BIO	12044662	pa	2	7	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	BIO_12044662_pa_2	BIO_12044662_pa_7	BIO_12044662_pa_2_7
BIO	12044662	pa	2	8	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_pa_2	BIO_12044662_pa_8	BIO_12044662_pa_2_8
BIO	12044662	pa	2	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_pa_2	BIO_12044662_pa_9	BIO_12044662_pa_2_9
BIO	12044662	pa	2	10	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_pa_2	BIO_12044662_pa_10	BIO_12044662_pa_2_10
BIO	12044662	pa	2	11	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_pa_2	BIO_12044662_pa_11	BIO_12044662_pa_2_11
BIO	12044662	pa	2	12	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_pa_2	BIO_12044662_pa_12	BIO_12044662_pa_2_12
BIO	12044662	pa	2	13	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Ten micrometer cryosections of rat brain from controls and animals subjected to 3 h of ischemia and 48 h of reperfusion (suture model for transient cerebral ischemia) were used.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_pa_2	BIO_12044662_pa_13	BIO_12044662_pa_2_13
BIO	12044662	pa	3	4	proposal_implementation	result	sequence	support	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	BIO_12044662_pa_3	BIO_12044662_pa_4	BIO_12044662_pa_3_4
BIO	12044662	pa	3	5	proposal_implementation	means	sequence	by-means	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	BIO_12044662_pa_3	BIO_12044662_pa_5	BIO_12044662_pa_3_5
BIO	12044662	pa	3	6	proposal_implementation	result_means	sequence	support	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	BIO_12044662_pa_3	BIO_12044662_pa_6	BIO_12044662_pa_3_6
BIO	12044662	pa	3	7	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	BIO_12044662_pa_3	BIO_12044662_pa_7	BIO_12044662_pa_3_7
BIO	12044662	pa	3	8	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_pa_3	BIO_12044662_pa_8	BIO_12044662_pa_3_8
BIO	12044662	pa	3	9	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_pa_3	BIO_12044662_pa_9	BIO_12044662_pa_3_9
BIO	12044662	pa	3	10	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_pa_3	BIO_12044662_pa_10	BIO_12044662_pa_3_10
BIO	12044662	pa	3	11	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_pa_3	BIO_12044662_pa_11	BIO_12044662_pa_3_11
BIO	12044662	pa	3	12	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_pa_3	BIO_12044662_pa_12	BIO_12044662_pa_3_12
BIO	12044662	pa	3	13	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	After thawing, a gelatin film with a polyester base was put on the slide, incubated for 24 h at 37 degrees C, stained with Ponceau S, and then discolored in bi-distilled water.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_pa_3	BIO_12044662_pa_13	BIO_12044662_pa_3_13
BIO	12044662	pa	4	5	result	means	support	by-means	secondary	secondary	back	by-means	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	BIO_12044662_pa_4	BIO_12044662_pa_5	BIO_12044662_pa_4_5
BIO	12044662	pa	4	6	result	result_means	support	support	secondary	secondary	back	support	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	BIO_12044662_pa_4	BIO_12044662_pa_6	BIO_12044662_pa_4_6
BIO	12044662	pa	4	7	result	observation	support	info-required	secondary	secondary	none	none	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	BIO_12044662_pa_4	BIO_12044662_pa_7	BIO_12044662_pa_4_7
BIO	12044662	pa	4	8	result	observation	support	info-required	secondary	secondary	none	none	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_pa_4	BIO_12044662_pa_8	BIO_12044662_pa_4_8
BIO	12044662	pa	4	9	result	observation	support	support	secondary	secondary	back	support	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_pa_4	BIO_12044662_pa_9	BIO_12044662_pa_4_9
BIO	12044662	pa	4	10	result	observation	support	info-required	secondary	secondary	none	none	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_pa_4	BIO_12044662_pa_10	BIO_12044662_pa_4_10
BIO	12044662	pa	4	11	result	observation	support	info-required	secondary	secondary	none	none	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_pa_4	BIO_12044662_pa_11	BIO_12044662_pa_4_11
BIO	12044662	pa	4	12	result	observation	support	info-required	secondary	secondary	none	none	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_pa_4	BIO_12044662_pa_12	BIO_12044662_pa_4_12
BIO	12044662	pa	4	13	result	conclusion	support	support	secondary	secondary	forw	support	Non-staining areas on the film corresponded to lysis zones, caused by activated MMPs.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_pa_4	BIO_12044662_pa_13	BIO_12044662_pa_4_13
BIO	12044662	pa	5	6	means	result_means	by-means	support	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	BIO_12044662_pa_5	BIO_12044662_pa_6	BIO_12044662_pa_5_6
BIO	12044662	pa	5	7	means	observation	by-means	info-required	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	BIO_12044662_pa_5	BIO_12044662_pa_7	BIO_12044662_pa_5_7
BIO	12044662	pa	5	8	means	observation	by-means	info-required	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_pa_5	BIO_12044662_pa_8	BIO_12044662_pa_5_8
BIO	12044662	pa	5	9	means	observation	by-means	support	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_pa_5	BIO_12044662_pa_9	BIO_12044662_pa_5_9
BIO	12044662	pa	5	10	means	observation	by-means	info-required	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_pa_5	BIO_12044662_pa_10	BIO_12044662_pa_5_10
BIO	12044662	pa	5	11	means	observation	by-means	info-required	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_pa_5	BIO_12044662_pa_11	BIO_12044662_pa_5_11
BIO	12044662	pa	5	12	means	observation	by-means	info-required	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_pa_5	BIO_12044662_pa_12	BIO_12044662_pa_5_12
BIO	12044662	pa	5	13	means	conclusion	by-means	support	secondary	secondary	none	none	This was proven by MMP incubation at various concentrations on the plain gelatin film and pretreatment with EDTA (an MMP inhibitor), which prevents lysis zones in normal and ischemic brains.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_pa_5	BIO_12044662_pa_13	BIO_12044662_pa_5_13
BIO	12044662	pa	6	7	result_means	observation	support	info-required	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	BIO_12044662_pa_6	BIO_12044662_pa_7	BIO_12044662_pa_6_7
BIO	12044662	pa	6	8	result_means	observation	support	info-required	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_pa_6	BIO_12044662_pa_8	BIO_12044662_pa_6_8
BIO	12044662	pa	6	9	result_means	observation	support	support	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_pa_6	BIO_12044662_pa_9	BIO_12044662_pa_6_9
BIO	12044662	pa	6	10	result_means	observation	support	info-required	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_pa_6	BIO_12044662_pa_10	BIO_12044662_pa_6_10
BIO	12044662	pa	6	11	result_means	observation	support	info-required	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_pa_6	BIO_12044662_pa_11	BIO_12044662_pa_6_11
BIO	12044662	pa	6	12	result_means	observation	support	info-required	secondary	secondary	back	info-required	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_pa_6	BIO_12044662_pa_12	BIO_12044662_pa_6_12
BIO	12044662	pa	6	13	result_means	conclusion	support	support	secondary	secondary	none	none	As confirmatory tests, SDS-PAGE zymography was used to define MMP activity, and also MMP-2 immunohistochemistry to detect the possibly cellular origin of MMPs.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_pa_6	BIO_12044662_pa_13	BIO_12044662_pa_6_13
BIO	12044662	pa	7	8	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	BIO_12044662_pa_7	BIO_12044662_pa_8	BIO_12044662_pa_7_8
BIO	12044662	pa	7	9	observation	observation	info-required	support	secondary	secondary	none	none	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_pa_7	BIO_12044662_pa_9	BIO_12044662_pa_7_9
BIO	12044662	pa	7	10	observation	observation	info-required	info-required	secondary	secondary	none	none	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_pa_7	BIO_12044662_pa_10	BIO_12044662_pa_7_10
BIO	12044662	pa	7	11	observation	observation	info-required	info-required	secondary	secondary	none	none	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_pa_7	BIO_12044662_pa_11	BIO_12044662_pa_7_11
BIO	12044662	pa	7	12	observation	observation	info-required	info-required	secondary	secondary	none	none	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_pa_7	BIO_12044662_pa_12	BIO_12044662_pa_7_12
BIO	12044662	pa	7	13	observation	conclusion	info-required	support	secondary	secondary	none	none	Normal rat brain exhibited a low background activity, which was visible as a light halo-like lysis zone over and around the brain.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_pa_7	BIO_12044662_pa_13	BIO_12044662_pa_7_13
BIO	12044662	pa	8	9	observation	observation	info-required	support	secondary	secondary	forw	info-required	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	BIO_12044662_pa_8	BIO_12044662_pa_9	BIO_12044662_pa_8_9
BIO	12044662	pa	8	10	observation	observation	info-required	info-required	secondary	secondary	none	none	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_pa_8	BIO_12044662_pa_10	BIO_12044662_pa_8_10
BIO	12044662	pa	8	11	observation	observation	info-required	info-required	secondary	secondary	none	none	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_pa_8	BIO_12044662_pa_11	BIO_12044662_pa_8_11
BIO	12044662	pa	8	12	observation	observation	info-required	info-required	secondary	secondary	none	none	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_pa_8	BIO_12044662_pa_12	BIO_12044662_pa_8_12
BIO	12044662	pa	8	13	observation	conclusion	info-required	support	secondary	secondary	none	none	Areas in normal brain with medium MMP activity were within the white matter (corpus callosum, anterior commissure, and cerebellum).	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_pa_8	BIO_12044662_pa_13	BIO_12044662_pa_8_13
BIO	12044662	pa	9	10	observation	observation	support	info-required	secondary	secondary	none	none	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	BIO_12044662_pa_9	BIO_12044662_pa_10	BIO_12044662_pa_9_10
BIO	12044662	pa	9	11	observation	observation	support	info-required	secondary	secondary	none	none	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_pa_9	BIO_12044662_pa_11	BIO_12044662_pa_9_11
BIO	12044662	pa	9	12	observation	observation	support	info-required	secondary	secondary	none	none	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_pa_9	BIO_12044662_pa_12	BIO_12044662_pa_9_12
BIO	12044662	pa	9	13	observation	conclusion	support	support	secondary	secondary	none	none	Ischemic brain exhibited high activity lysis zones within the infarcted area (detected by microtubuli associated protein-2 staining).	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_pa_9	BIO_12044662_pa_13	BIO_12044662_pa_9_13
BIO	12044662	pa	10	11	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	BIO_12044662_pa_10	BIO_12044662_pa_11	BIO_12044662_pa_10_11
BIO	12044662	pa	10	12	observation	observation	info-required	info-required	secondary	secondary	none	none	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_pa_10	BIO_12044662_pa_12	BIO_12044662_pa_10_12
BIO	12044662	pa	10	13	observation	conclusion	info-required	support	secondary	secondary	none	none	These zones consisted of microscopically small lysis holes with a diameter of about 10-20 microm.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_pa_10	BIO_12044662_pa_13	BIO_12044662_pa_10_13
BIO	12044662	pa	11	12	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_pa_11	BIO_12044662_pa_12	BIO_12044662_pa_11_12
BIO	12044662	pa	11	13	observation	conclusion	info-required	support	secondary	secondary	none	none	Immunohistochemistry showed that especially microvessels expressed MMP antigen.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_pa_11	BIO_12044662_pa_13	BIO_12044662_pa_11_13
BIO	12044662	pa	12	13	observation	conclusion	info-required	support	secondary	secondary	none	none	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	BIO_12044662_pa_12	BIO_12044662_pa_13	BIO_12044662_pa_12_13
BIO	12044662	pa	13	12	conclusion	observation	support	info-required	secondary	secondary	none	none	The gelatin film in situ-overlay technique is able to localize MMP activity in ischemic rat brain tissue on a microscopic level.	SDS-PAGE zymography differentiated between a high level of activated MMPs in the ischemic area and a low level in the non-ischemic basal ganglia.	BIO_12044662_pa_13	BIO_12044662_pa_12	BIO_12044662_pa_12_13
BIO	12064471	pa	1	2	motivation_background	proposal	support	none	secondary	main	forw	support	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	BIO_12064471_pa_1	BIO_12064471_pa_2	BIO_12064471_pa_1_2
BIO	12064471	pa	1	3	motivation_background	observation	support	info-required	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	BIO_12064471_pa_1	BIO_12064471_pa_3	BIO_12064471_pa_1_3
BIO	12064471	pa	1	4	motivation_background	observation	support	elaboration	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	These vesicles also contain Abeta(1-42), measured by RIA.	BIO_12064471_pa_1	BIO_12064471_pa_4	BIO_12064471_pa_1_4
BIO	12064471	pa	1	5	motivation_background	observation	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	BIO_12064471_pa_1	BIO_12064471_pa_5	BIO_12064471_pa_1_5
BIO	12064471	pa	1	6	motivation_background	conclusion	support	info-required	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	BIO_12064471_pa_1	BIO_12064471_pa_6	BIO_12064471_pa_1_6
BIO	12064471	pa	1	7	motivation_background	observation	support	info-required	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	BIO_12064471_pa_1	BIO_12064471_pa_7	BIO_12064471_pa_1_7
BIO	12064471	pa	1	8	motivation_background	observation	support	info-required	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_pa_1	BIO_12064471_pa_8	BIO_12064471_pa_1_8
BIO	12064471	pa	1	9	motivation_background	observation	support	info-required	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_pa_1	BIO_12064471_pa_9	BIO_12064471_pa_1_9
BIO	12064471	pa	1	10	motivation_background	observation	support	info-required	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_pa_1	BIO_12064471_pa_10	BIO_12064471_pa_1_10
BIO	12064471	pa	1	11	motivation_background	observation	support	info-required	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_pa_1	BIO_12064471_pa_11	BIO_12064471_pa_1_11
BIO	12064471	pa	1	12	motivation_background	observation	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_pa_1	BIO_12064471_pa_12	BIO_12064471_pa_1_12
BIO	12064471	pa	1	13	motivation_background	result	support	info-required	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_pa_1	BIO_12064471_pa_13	BIO_12064471_pa_1_13
BIO	12064471	pa	1	14	motivation_background	result	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_1	BIO_12064471_pa_14	BIO_12064471_pa_1_14
BIO	12064471	pa	1	15	motivation_background	conclusion	support	support	secondary	secondary	none	none	A key factor in Alzheimer's disease (AD) is the beta-secretase activity that is required for the production of beta-amyloid (Abeta) peptide from its amyloid precursor protein (APP) precursor.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_1	BIO_12064471_pa_15	BIO_12064471_pa_1_15
BIO	12064471	pa	2	3	proposal	observation	none	info-required	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	BIO_12064471_pa_2	BIO_12064471_pa_3	BIO_12064471_pa_2_3
BIO	12064471	pa	2	4	proposal	observation	none	elaboration	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	These vesicles also contain Abeta(1-42), measured by RIA.	BIO_12064471_pa_2	BIO_12064471_pa_4	BIO_12064471_pa_2_4
BIO	12064471	pa	2	5	proposal	observation	none	support	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	BIO_12064471_pa_2	BIO_12064471_pa_5	BIO_12064471_pa_2_5
BIO	12064471	pa	2	6	proposal	conclusion	none	info-required	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	BIO_12064471_pa_2	BIO_12064471_pa_6	BIO_12064471_pa_2_6
BIO	12064471	pa	2	7	proposal	observation	none	info-required	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	BIO_12064471_pa_2	BIO_12064471_pa_7	BIO_12064471_pa_2_7
BIO	12064471	pa	2	8	proposal	observation	none	info-required	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_pa_2	BIO_12064471_pa_8	BIO_12064471_pa_2_8
BIO	12064471	pa	2	9	proposal	observation	none	info-required	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_pa_2	BIO_12064471_pa_9	BIO_12064471_pa_2_9
BIO	12064471	pa	2	10	proposal	observation	none	info-required	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_pa_2	BIO_12064471_pa_10	BIO_12064471_pa_2_10
BIO	12064471	pa	2	11	proposal	observation	none	info-required	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_pa_2	BIO_12064471_pa_11	BIO_12064471_pa_2_11
BIO	12064471	pa	2	12	proposal	observation	none	support	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_pa_2	BIO_12064471_pa_12	BIO_12064471_pa_2_12
BIO	12064471	pa	2	13	proposal	result	none	info-required	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_pa_2	BIO_12064471_pa_13	BIO_12064471_pa_2_13
BIO	12064471	pa	2	14	proposal	result	none	support	main	secondary	none	none	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_2	BIO_12064471_pa_14	BIO_12064471_pa_2_14
BIO	12064471	pa	2	15	proposal	conclusion	none	support	main	secondary	back	support	In this study, the majority of Abeta secretion from neuronal chromaffin cells was found to occur via the regulated secretory pathway, compared with the constitutive secretory pathway; therefore, beta-secretase activity in the regulated secretory pathway was examined for the production and secretion of Abeta in chromaffin cells obtained from in vivo adrenal medullary tissue.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_2	BIO_12064471_pa_15	BIO_12064471_pa_2_15
BIO	12064471	pa	3	4	observation	observation	info-required	elaboration	secondary	secondary	back	elaboration	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	These vesicles also contain Abeta(1-42), measured by RIA.	BIO_12064471_pa_3	BIO_12064471_pa_4	BIO_12064471_pa_3_4
BIO	12064471	pa	3	5	observation	observation	info-required	support	secondary	secondary	forw	info-required	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	BIO_12064471_pa_3	BIO_12064471_pa_5	BIO_12064471_pa_3_5
BIO	12064471	pa	3	6	observation	conclusion	info-required	info-required	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	BIO_12064471_pa_3	BIO_12064471_pa_6	BIO_12064471_pa_3_6
BIO	12064471	pa	3	7	observation	observation	info-required	info-required	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	BIO_12064471_pa_3	BIO_12064471_pa_7	BIO_12064471_pa_3_7
BIO	12064471	pa	3	8	observation	observation	info-required	info-required	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_pa_3	BIO_12064471_pa_8	BIO_12064471_pa_3_8
BIO	12064471	pa	3	9	observation	observation	info-required	info-required	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_pa_3	BIO_12064471_pa_9	BIO_12064471_pa_3_9
BIO	12064471	pa	3	10	observation	observation	info-required	info-required	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_pa_3	BIO_12064471_pa_10	BIO_12064471_pa_3_10
BIO	12064471	pa	3	11	observation	observation	info-required	info-required	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_pa_3	BIO_12064471_pa_11	BIO_12064471_pa_3_11
BIO	12064471	pa	3	12	observation	observation	info-required	support	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_pa_3	BIO_12064471_pa_12	BIO_12064471_pa_3_12
BIO	12064471	pa	3	13	observation	result	info-required	info-required	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_pa_3	BIO_12064471_pa_13	BIO_12064471_pa_3_13
BIO	12064471	pa	3	14	observation	result	info-required	support	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_3	BIO_12064471_pa_14	BIO_12064471_pa_3_14
BIO	12064471	pa	3	15	observation	conclusion	info-required	support	secondary	secondary	none	none	The presence of Abeta(1-40) in APP-containing chromaffin vesicles, which represent regulated secretory vesicles, was demonstrated by radioimmunoassay (RIA) and reverse-phase high-performance liquid chromatography.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_3	BIO_12064471_pa_15	BIO_12064471_pa_3_15
BIO	12064471	pa	4	5	observation	observation	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	BIO_12064471_pa_4	BIO_12064471_pa_5	BIO_12064471_pa_4_5
BIO	12064471	pa	4	6	observation	conclusion	elaboration	info-required	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	BIO_12064471_pa_4	BIO_12064471_pa_6	BIO_12064471_pa_4_6
BIO	12064471	pa	4	7	observation	observation	elaboration	info-required	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	BIO_12064471_pa_4	BIO_12064471_pa_7	BIO_12064471_pa_4_7
BIO	12064471	pa	4	8	observation	observation	elaboration	info-required	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_pa_4	BIO_12064471_pa_8	BIO_12064471_pa_4_8
BIO	12064471	pa	4	9	observation	observation	elaboration	info-required	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_pa_4	BIO_12064471_pa_9	BIO_12064471_pa_4_9
BIO	12064471	pa	4	10	observation	observation	elaboration	info-required	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_pa_4	BIO_12064471_pa_10	BIO_12064471_pa_4_10
BIO	12064471	pa	4	11	observation	observation	elaboration	info-required	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_pa_4	BIO_12064471_pa_11	BIO_12064471_pa_4_11
BIO	12064471	pa	4	12	observation	observation	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_pa_4	BIO_12064471_pa_12	BIO_12064471_pa_4_12
BIO	12064471	pa	4	13	observation	result	elaboration	info-required	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_pa_4	BIO_12064471_pa_13	BIO_12064471_pa_4_13
BIO	12064471	pa	4	14	observation	result	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_4	BIO_12064471_pa_14	BIO_12064471_pa_4_14
BIO	12064471	pa	4	15	observation	conclusion	elaboration	support	secondary	secondary	none	none	These vesicles also contain Abeta(1-42), measured by RIA.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_4	BIO_12064471_pa_15	BIO_12064471_pa_4_15
BIO	12064471	pa	5	6	observation	conclusion	support	info-required	secondary	secondary	forw	support	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	BIO_12064471_pa_5	BIO_12064471_pa_6	BIO_12064471_pa_5_6
BIO	12064471	pa	5	7	observation	observation	support	info-required	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	BIO_12064471_pa_5	BIO_12064471_pa_7	BIO_12064471_pa_5_7
BIO	12064471	pa	5	8	observation	observation	support	info-required	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_pa_5	BIO_12064471_pa_8	BIO_12064471_pa_5_8
BIO	12064471	pa	5	9	observation	observation	support	info-required	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_pa_5	BIO_12064471_pa_9	BIO_12064471_pa_5_9
BIO	12064471	pa	5	10	observation	observation	support	info-required	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_pa_5	BIO_12064471_pa_10	BIO_12064471_pa_5_10
BIO	12064471	pa	5	11	observation	observation	support	info-required	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_pa_5	BIO_12064471_pa_11	BIO_12064471_pa_5_11
BIO	12064471	pa	5	12	observation	observation	support	support	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_pa_5	BIO_12064471_pa_12	BIO_12064471_pa_5_12
BIO	12064471	pa	5	13	observation	result	support	info-required	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_pa_5	BIO_12064471_pa_13	BIO_12064471_pa_5_13
BIO	12064471	pa	5	14	observation	result	support	support	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_5	BIO_12064471_pa_14	BIO_12064471_pa_5_14
BIO	12064471	pa	5	15	observation	conclusion	support	support	secondary	secondary	none	none	Significantly, regulated secretion of Abeta(1-40) from chromaffin cells represented the majority of secreted Abeta (> 95% of total secreted Abeta), compared with low levels of constitutively secreted Abeta(1-40).	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_5	BIO_12064471_pa_15	BIO_12064471_pa_5_15
BIO	12064471	pa	6	7	conclusion	observation	info-required	info-required	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	BIO_12064471_pa_6	BIO_12064471_pa_7	BIO_12064471_pa_6_7
BIO	12064471	pa	6	8	conclusion	observation	info-required	info-required	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_pa_6	BIO_12064471_pa_8	BIO_12064471_pa_6_8
BIO	12064471	pa	6	9	conclusion	observation	info-required	info-required	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_pa_6	BIO_12064471_pa_9	BIO_12064471_pa_6_9
BIO	12064471	pa	6	10	conclusion	observation	info-required	info-required	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_pa_6	BIO_12064471_pa_10	BIO_12064471_pa_6_10
BIO	12064471	pa	6	11	conclusion	observation	info-required	info-required	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_pa_6	BIO_12064471_pa_11	BIO_12064471_pa_6_11
BIO	12064471	pa	6	12	conclusion	observation	info-required	support	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_pa_6	BIO_12064471_pa_12	BIO_12064471_pa_6_12
BIO	12064471	pa	6	13	conclusion	result	info-required	info-required	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_pa_6	BIO_12064471_pa_13	BIO_12064471_pa_6_13
BIO	12064471	pa	6	14	conclusion	result	info-required	support	secondary	secondary	forw	info-required	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_6	BIO_12064471_pa_14	BIO_12064471_pa_6_14
BIO	12064471	pa	6	15	conclusion	conclusion	info-required	support	secondary	secondary	none	none	These results indicate the importance of Abeta production and secretion in the regulated secretory pathway as a major source of extracellular Abeta.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_6	BIO_12064471_pa_15	BIO_12064471_pa_6_15
BIO	12064471	pa	7	8	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	BIO_12064471_pa_7	BIO_12064471_pa_8	BIO_12064471_pa_7_8
BIO	12064471	pa	7	9	observation	observation	info-required	info-required	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_pa_7	BIO_12064471_pa_9	BIO_12064471_pa_7_9
BIO	12064471	pa	7	10	observation	observation	info-required	info-required	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_pa_7	BIO_12064471_pa_10	BIO_12064471_pa_7_10
BIO	12064471	pa	7	11	observation	observation	info-required	info-required	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_pa_7	BIO_12064471_pa_11	BIO_12064471_pa_7_11
BIO	12064471	pa	7	12	observation	observation	info-required	support	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_pa_7	BIO_12064471_pa_12	BIO_12064471_pa_7_12
BIO	12064471	pa	7	13	observation	result	info-required	info-required	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_pa_7	BIO_12064471_pa_13	BIO_12064471_pa_7_13
BIO	12064471	pa	7	14	observation	result	info-required	support	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_7	BIO_12064471_pa_14	BIO_12064471_pa_7_14
BIO	12064471	pa	7	15	observation	conclusion	info-required	support	secondary	secondary	none	none	Beta-secretase activity in isolated chromaffin vesicles was detected with the substrate Z-Val-Lys-Met-/MCA (methylcoumarinamide) that contains the beta-secretase cleavage site.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_7	BIO_12064471_pa_15	BIO_12064471_pa_7_15
BIO	12064471	pa	8	9	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	BIO_12064471_pa_8	BIO_12064471_pa_9	BIO_12064471_pa_8_9
BIO	12064471	pa	8	10	observation	observation	info-required	info-required	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_pa_8	BIO_12064471_pa_10	BIO_12064471_pa_8_10
BIO	12064471	pa	8	11	observation	observation	info-required	info-required	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_pa_8	BIO_12064471_pa_11	BIO_12064471_pa_8_11
BIO	12064471	pa	8	12	observation	observation	info-required	support	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_pa_8	BIO_12064471_pa_12	BIO_12064471_pa_8_12
BIO	12064471	pa	8	13	observation	result	info-required	info-required	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_pa_8	BIO_12064471_pa_13	BIO_12064471_pa_8_13
BIO	12064471	pa	8	14	observation	result	info-required	support	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_8	BIO_12064471_pa_14	BIO_12064471_pa_8_14
BIO	12064471	pa	8	15	observation	conclusion	info-required	support	secondary	secondary	none	none	Optimum beta-secretase activity in these vesicles required reducing conditions and acidic pH (pH 5-6), consistent with the in vivo intravesicular environment.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_8	BIO_12064471_pa_15	BIO_12064471_pa_8_15
BIO	12064471	pa	9	10	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	BIO_12064471_pa_9	BIO_12064471_pa_10	BIO_12064471_pa_9_10
BIO	12064471	pa	9	11	observation	observation	info-required	info-required	secondary	secondary	none	none	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_pa_9	BIO_12064471_pa_11	BIO_12064471_pa_9_11
BIO	12064471	pa	9	12	observation	observation	info-required	support	secondary	secondary	none	none	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_pa_9	BIO_12064471_pa_12	BIO_12064471_pa_9_12
BIO	12064471	pa	9	13	observation	result	info-required	info-required	secondary	secondary	none	none	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_pa_9	BIO_12064471_pa_13	BIO_12064471_pa_9_13
BIO	12064471	pa	9	14	observation	result	info-required	support	secondary	secondary	none	none	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_9	BIO_12064471_pa_14	BIO_12064471_pa_9_14
BIO	12064471	pa	9	15	observation	conclusion	info-required	support	secondary	secondary	none	none	Evidence for cysteine protease activity was shown by E64c inhibition of Z-Val-Lys-Met-MCA-cleaving activity, and E64c inhibition of Abeta(1-40) production in isolated chromaffin vesicles.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_9	BIO_12064471_pa_15	BIO_12064471_pa_9_15
BIO	12064471	pa	10	11	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	BIO_12064471_pa_10	BIO_12064471_pa_11	BIO_12064471_pa_10_11
BIO	12064471	pa	10	12	observation	observation	info-required	support	secondary	secondary	none	none	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_pa_10	BIO_12064471_pa_12	BIO_12064471_pa_10_12
BIO	12064471	pa	10	13	observation	result	info-required	info-required	secondary	secondary	none	none	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_pa_10	BIO_12064471_pa_13	BIO_12064471_pa_10_13
BIO	12064471	pa	10	14	observation	result	info-required	support	secondary	secondary	none	none	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_10	BIO_12064471_pa_14	BIO_12064471_pa_10_14
BIO	12064471	pa	10	15	observation	conclusion	info-required	support	secondary	secondary	none	none	Chromatography resolved the beta-secretase activity into two distinct proteolytic pathways consisting of: (i) direct cleavage of the beta-secretase site at Met-/Asp by two cysteine proteolytic activities represented by peaks Il-A and Il-B, and (ii) an aminopeptidase-dependent pathway represented by peak I cysteine protease activity that cleaves between Lys-/Met, followed by Met-aminopeptidase that would generate the beta-secretase cleavage site.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_10	BIO_12064471_pa_15	BIO_12064471_pa_10_15
BIO	12064471	pa	11	12	observation	observation	info-required	support	secondary	secondary	forw	info-required	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	BIO_12064471_pa_11	BIO_12064471_pa_12	BIO_12064471_pa_11_12
BIO	12064471	pa	11	13	observation	result	info-required	info-required	secondary	secondary	none	none	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_pa_11	BIO_12064471_pa_13	BIO_12064471_pa_11_13
BIO	12064471	pa	11	14	observation	result	info-required	support	secondary	secondary	none	none	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_11	BIO_12064471_pa_14	BIO_12064471_pa_11_14
BIO	12064471	pa	11	15	observation	conclusion	info-required	support	secondary	secondary	none	none	Treatment of chromaffin cells in primary culture with the cysteine protease inhibitor E64d reduced the production of the beta-secretase product, a 12-14 kDa C-terminal APP fragment.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_11	BIO_12064471_pa_15	BIO_12064471_pa_11_15
BIO	12064471	pa	12	13	observation	result	support	info-required	secondary	secondary	forw	support	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	BIO_12064471_pa_12	BIO_12064471_pa_13	BIO_12064471_pa_12_13
BIO	12064471	pa	12	14	observation	result	support	support	secondary	secondary	none	none	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_12	BIO_12064471_pa_14	BIO_12064471_pa_12_14
BIO	12064471	pa	12	15	observation	conclusion	support	support	secondary	secondary	none	none	In addition, BACE 1 and BACE 2 were detected in chromaffin vesicles; BACE 1 represented a small fraction of total beta-secretase activity in these vesicles.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_12	BIO_12064471_pa_15	BIO_12064471_pa_12_15
BIO	12064471	pa	13	14	result	result	info-required	support	secondary	secondary	forw	info-required	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_13	BIO_12064471_pa_14	BIO_12064471_pa_13_14
BIO	12064471	pa	13	15	result	conclusion	info-required	support	secondary	secondary	none	none	These results illustrate that multiple cysteine proteases, in combination with BACE 1, contribute to beta-secretase activity in the regulated secretory pathway.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_13	BIO_12064471_pa_15	BIO_12064471_pa_13_15
BIO	12064471	pa	14	15	result	conclusion	support	support	secondary	secondary	forw	support	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	BIO_12064471_pa_14	BIO_12064471_pa_15	BIO_12064471_pa_14_15
BIO	12064471	pa	15	14	conclusion	result	support	support	secondary	secondary	back	support	These findings suggest that drug inhibition of several proteases may be required for reducing Abeta levels as a potential therapeutic approach for AD.	These results complement earlier findings for BACE 1 as beta3-secretase for Abeta production in the constitutive secretory pathway that provides basal secretion of Abeta into conditioned media.	BIO_12064471_pa_15	BIO_12064471_pa_14	BIO_12064471_pa_14_15
BIO	12091911	pa	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	BIO_12091911_pa_1	BIO_12091911_pa_2	BIO_12091911_pa_1_2
BIO	12091911	pa	1	3	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	BIO_12091911_pa_1	BIO_12091911_pa_3	BIO_12091911_pa_1_3
BIO	12091911	pa	1	4	motivation_background	motivation_background	info-required	support	secondary	secondary	none	none	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	BIO_12091911_pa_1	BIO_12091911_pa_4	BIO_12091911_pa_1_4
BIO	12091911	pa	1	5	motivation_background	proposal	info-required	none	secondary	main	none	none	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	BIO_12091911_pa_1	BIO_12091911_pa_5	BIO_12091911_pa_1_5
BIO	12091911	pa	1	6	motivation_background	result	info-required	support	secondary	secondary	none	none	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	Here we show that Mlh3(-/-) mice are viable but sterile.	BIO_12091911_pa_1	BIO_12091911_pa_6	BIO_12091911_pa_1_6
BIO	12091911	pa	1	7	motivation_background	result	info-required	support	secondary	secondary	none	none	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_pa_1	BIO_12091911_pa_7	BIO_12091911_pa_1_7
BIO	12091911	pa	1	8	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_pa_1	BIO_12091911_pa_8	BIO_12091911_pa_1_8
BIO	12091911	pa	2	3	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	BIO_12091911_pa_2	BIO_12091911_pa_3	BIO_12091911_pa_2_3
BIO	12091911	pa	2	4	motivation_background	motivation_background	info-required	support	secondary	secondary	none	none	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	BIO_12091911_pa_2	BIO_12091911_pa_4	BIO_12091911_pa_2_4
BIO	12091911	pa	2	5	motivation_background	proposal	info-required	none	secondary	main	none	none	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	BIO_12091911_pa_2	BIO_12091911_pa_5	BIO_12091911_pa_2_5
BIO	12091911	pa	2	6	motivation_background	result	info-required	support	secondary	secondary	none	none	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	Here we show that Mlh3(-/-) mice are viable but sterile.	BIO_12091911_pa_2	BIO_12091911_pa_6	BIO_12091911_pa_2_6
BIO	12091911	pa	2	7	motivation_background	result	info-required	support	secondary	secondary	none	none	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_pa_2	BIO_12091911_pa_7	BIO_12091911_pa_2_7
BIO	12091911	pa	2	8	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2 6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_pa_2	BIO_12091911_pa_8	BIO_12091911_pa_2_8
BIO	12091911	pa	3	4	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	BIO_12091911_pa_3	BIO_12091911_pa_4	BIO_12091911_pa_3_4
BIO	12091911	pa	3	5	motivation_background	proposal	info-required	none	secondary	main	none	none	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	BIO_12091911_pa_3	BIO_12091911_pa_5	BIO_12091911_pa_3_5
BIO	12091911	pa	3	6	motivation_background	result	info-required	support	secondary	secondary	none	none	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	Here we show that Mlh3(-/-) mice are viable but sterile.	BIO_12091911_pa_3	BIO_12091911_pa_6	BIO_12091911_pa_3_6
BIO	12091911	pa	3	7	motivation_background	result	info-required	support	secondary	secondary	none	none	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_pa_3	BIO_12091911_pa_7	BIO_12091911_pa_3_7
BIO	12091911	pa	3	8	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors, and two others, Msh4 and Msh5, have specific roles in meiosis.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_pa_3	BIO_12091911_pa_8	BIO_12091911_pa_3_8
BIO	12091911	pa	4	5	motivation_background	proposal	support	none	secondary	main	forw	support	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	BIO_12091911_pa_4	BIO_12091911_pa_5	BIO_12091911_pa_4_5
BIO	12091911	pa	4	6	motivation_background	result	support	support	secondary	secondary	none	none	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	Here we show that Mlh3(-/-) mice are viable but sterile.	BIO_12091911_pa_4	BIO_12091911_pa_6	BIO_12091911_pa_4_6
BIO	12091911	pa	4	7	motivation_background	result	support	support	secondary	secondary	none	none	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_pa_4	BIO_12091911_pa_7	BIO_12091911_pa_4_7
BIO	12091911	pa	4	8	motivation_background	conclusion	support	support	secondary	secondary	none	none	Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_pa_4	BIO_12091911_pa_8	BIO_12091911_pa_4_8
BIO	12091911	pa	5	6	proposal	result	none	support	main	secondary	none	none	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	Here we show that Mlh3(-/-) mice are viable but sterile.	BIO_12091911_pa_5	BIO_12091911_pa_6	BIO_12091911_pa_5_6
BIO	12091911	pa	5	7	proposal	result	none	support	main	secondary	none	none	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_pa_5	BIO_12091911_pa_7	BIO_12091911_pa_5_7
BIO	12091911	pa	5	8	proposal	conclusion	none	support	main	secondary	back	support	To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_pa_5	BIO_12091911_pa_8	BIO_12091911_pa_5_8
BIO	12091911	pa	6	7	result	result	support	support	secondary	secondary	back	support	Here we show that Mlh3(-/-) mice are viable but sterile.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_pa_6	BIO_12091911_pa_7	BIO_12091911_pa_6_7
BIO	12091911	pa	6	8	result	conclusion	support	support	secondary	secondary	forw	support	Here we show that Mlh3(-/-) mice are viable but sterile.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_pa_6	BIO_12091911_pa_8	BIO_12091911_pa_6_8
BIO	12091911	pa	7	8	result	conclusion	support	support	secondary	secondary	none	none	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	BIO_12091911_pa_7	BIO_12091911_pa_8	BIO_12091911_pa_7_8
BIO	12091911	pa	8	7	conclusion	result	support	support	secondary	secondary	none	none	Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization.	BIO_12091911_pa_8	BIO_12091911_pa_7	BIO_12091911_pa_7_8
BIO	12217951	pa	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size.	Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in Hdh(Q111) mice, although these abnormalities are not manifest in Hdh(Q50) mice, with 50-glutamine mutant protein.	BIO_12217951_pa_1	BIO_12217951_pa_2	BIO_12217951_pa_1_2
BIO	12217951	pa	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size.	Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins.	BIO_12217951_pa_1	BIO_12217951_pa_3	BIO_12217951_pa_1_3
BIO	12217951	pa	1	4	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size.	Probes generated from Hdh(Q111) homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein.	BIO_12217951_pa_1	BIO_12217951_pa_4	BIO_12217951_pa_1_4
BIO	12217951	pa	1	5	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size.	Subsequent, quantitative RT-PCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous Hdh(Q111) striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in Hdh(Q50) striatum.	BIO_12217951_pa_1	BIO_12217951_pa_5	BIO_12217951_pa_1_5
BIO	12217951	pa	1	6	motivation_background	observation	info-required	support	secondary	secondary	none	none	The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size.	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	BIO_12217951_pa_1	BIO_12217951_pa_6	BIO_12217951_pa_1_6
BIO	12217951	pa	1	7	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size.	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	BIO_12217951_pa_1	BIO_12217951_pa_7	BIO_12217951_pa_1_7
BIO	12217951	pa	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in Hdh(Q111) mice, although these abnormalities are not manifest in Hdh(Q50) mice, with 50-glutamine mutant protein.	Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins.	BIO_12217951_pa_2	BIO_12217951_pa_3	BIO_12217951_pa_2_3
BIO	12217951	pa	2	4	motivation_background	observation	support	info-required	secondary	secondary	none	none	Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in Hdh(Q111) mice, although these abnormalities are not manifest in Hdh(Q50) mice, with 50-glutamine mutant protein.	Probes generated from Hdh(Q111) homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein.	BIO_12217951_pa_2	BIO_12217951_pa_4	BIO_12217951_pa_2_4
BIO	12217951	pa	2	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in Hdh(Q111) mice, although these abnormalities are not manifest in Hdh(Q50) mice, with 50-glutamine mutant protein.	Subsequent, quantitative RT-PCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous Hdh(Q111) striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in Hdh(Q50) striatum.	BIO_12217951_pa_2	BIO_12217951_pa_5	BIO_12217951_pa_2_5
BIO	12217951	pa	2	6	motivation_background	observation	support	support	secondary	secondary	none	none	Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in Hdh(Q111) mice, although these abnormalities are not manifest in Hdh(Q50) mice, with 50-glutamine mutant protein.	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	BIO_12217951_pa_2	BIO_12217951_pa_6	BIO_12217951_pa_2_6
BIO	12217951	pa	2	7	motivation_background	conclusion	support	support	secondary	secondary	none	none	Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in Hdh(Q111) mice, although these abnormalities are not manifest in Hdh(Q50) mice, with 50-glutamine mutant protein.	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	BIO_12217951_pa_2	BIO_12217951_pa_7	BIO_12217951_pa_2_7
BIO	12217951	pa	3	4	proposal	observation	none	info-required	main	secondary	none	none	Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins.	Probes generated from Hdh(Q111) homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein.	BIO_12217951_pa_3	BIO_12217951_pa_4	BIO_12217951_pa_3_4
BIO	12217951	pa	3	5	proposal	observation	none	info-required	main	secondary	none	none	Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins.	Subsequent, quantitative RT-PCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous Hdh(Q111) striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in Hdh(Q50) striatum.	BIO_12217951_pa_3	BIO_12217951_pa_5	BIO_12217951_pa_3_5
BIO	12217951	pa	3	6	proposal	observation	none	support	main	secondary	none	none	Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins.	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	BIO_12217951_pa_3	BIO_12217951_pa_6	BIO_12217951_pa_3_6
BIO	12217951	pa	3	7	proposal	conclusion	none	support	main	secondary	back	support	Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins.	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	BIO_12217951_pa_3	BIO_12217951_pa_7	BIO_12217951_pa_3_7
BIO	12217951	pa	4	5	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Probes generated from Hdh(Q111) homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein.	Subsequent, quantitative RT-PCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous Hdh(Q111) striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in Hdh(Q50) striatum.	BIO_12217951_pa_4	BIO_12217951_pa_5	BIO_12217951_pa_4_5
BIO	12217951	pa	4	6	observation	observation	info-required	support	secondary	secondary	none	none	Probes generated from Hdh(Q111) homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein.	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	BIO_12217951_pa_4	BIO_12217951_pa_6	BIO_12217951_pa_4_6
BIO	12217951	pa	4	7	observation	conclusion	info-required	support	secondary	secondary	none	none	Probes generated from Hdh(Q111) homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein.	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	BIO_12217951_pa_4	BIO_12217951_pa_7	BIO_12217951_pa_4_7
BIO	12217951	pa	5	6	observation	observation	info-required	support	secondary	secondary	forw	info-required	Subsequent, quantitative RT-PCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous Hdh(Q111) striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in Hdh(Q50) striatum.	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	BIO_12217951_pa_5	BIO_12217951_pa_6	BIO_12217951_pa_5_6
BIO	12217951	pa	5	7	observation	conclusion	info-required	support	secondary	secondary	none	none	Subsequent, quantitative RT-PCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous Hdh(Q111) striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in Hdh(Q50) striatum.	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	BIO_12217951_pa_5	BIO_12217951_pa_7	BIO_12217951_pa_5_7
BIO	12217951	pa	6	7	observation	conclusion	support	support	secondary	secondary	forw	support	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	BIO_12217951_pa_6	BIO_12217951_pa_7	BIO_12217951_pa_6_7
BIO	12217951	pa	7	6	conclusion	observation	support	support	secondary	secondary	back	support	These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.	Moreover, quantitative RT-PCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain.	BIO_12217951_pa_7	BIO_12217951_pa_6	BIO_12217951_pa_6_7
BIO	12423249	pa	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	BIO_12423249_pa_1	BIO_12423249_pa_2	BIO_12423249_pa_1_2
BIO	12423249	pa	1	3	motivation_background	motivation_problem	info-required	info-required	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	BIO_12423249_pa_1	BIO_12423249_pa_3	BIO_12423249_pa_1_3
BIO	12423249	pa	1	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	BIO_12423249_pa_1	BIO_12423249_pa_4	BIO_12423249_pa_1_4
BIO	12423249	pa	1	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	However, the proteolytic activity of PS1 remains a matter of debate.	BIO_12423249_pa_1	BIO_12423249_pa_5	BIO_12423249_pa_1_5
BIO	12423249	pa	1	6	motivation_background	proposal_implementation	info-required	none	secondary	main	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	BIO_12423249_pa_1	BIO_12423249_pa_6	BIO_12423249_pa_1_6
BIO	12423249	pa	1	7	motivation_background	result	info-required	info-required	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	BIO_12423249_pa_1	BIO_12423249_pa_7	BIO_12423249_pa_1_7
BIO	12423249	pa	1	8	motivation_background	result	info-required	info-required	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_pa_1	BIO_12423249_pa_8	BIO_12423249_pa_1_8
BIO	12423249	pa	1	9	motivation_background	result	info-required	support	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_pa_1	BIO_12423249_pa_9	BIO_12423249_pa_1_9
BIO	12423249	pa	1	10	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Aggregates of beta-amyloid peptide (Abeta) are the major component of the amyloid core of the senile plaques observed in Alzheimer's disease (AD).	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_pa_1	BIO_12423249_pa_10	BIO_12423249_pa_1_10
BIO	12423249	pa	2	3	motivation_background	motivation_problem	info-required	info-required	secondary	secondary	forw	info-required	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	BIO_12423249_pa_2	BIO_12423249_pa_3	BIO_12423249_pa_2_3
BIO	12423249	pa	2	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	BIO_12423249_pa_2	BIO_12423249_pa_4	BIO_12423249_pa_2_4
BIO	12423249	pa	2	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	However, the proteolytic activity of PS1 remains a matter of debate.	BIO_12423249_pa_2	BIO_12423249_pa_5	BIO_12423249_pa_2_5
BIO	12423249	pa	2	6	motivation_background	proposal_implementation	info-required	none	secondary	main	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	BIO_12423249_pa_2	BIO_12423249_pa_6	BIO_12423249_pa_2_6
BIO	12423249	pa	2	7	motivation_background	result	info-required	info-required	secondary	secondary	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	BIO_12423249_pa_2	BIO_12423249_pa_7	BIO_12423249_pa_2_7
BIO	12423249	pa	2	8	motivation_background	result	info-required	info-required	secondary	secondary	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_pa_2	BIO_12423249_pa_8	BIO_12423249_pa_2_8
BIO	12423249	pa	2	9	motivation_background	result	info-required	support	secondary	secondary	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_pa_2	BIO_12423249_pa_9	BIO_12423249_pa_2_9
BIO	12423249	pa	2	10	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Abeta results from the amyloidogenic processing of its precursor, the amyloid precursor protein (APP), by beta- and gamma-secretase activities.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_pa_2	BIO_12423249_pa_10	BIO_12423249_pa_2_10
BIO	12423249	pa	3	4	motivation_problem	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	BIO_12423249_pa_3	BIO_12423249_pa_4	BIO_12423249_pa_3_4
BIO	12423249	pa	3	5	motivation_problem	motivation_problem	info-required	support	secondary	secondary	none	none	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	However, the proteolytic activity of PS1 remains a matter of debate.	BIO_12423249_pa_3	BIO_12423249_pa_5	BIO_12423249_pa_3_5
BIO	12423249	pa	3	6	motivation_problem	proposal_implementation	info-required	none	secondary	main	none	none	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	BIO_12423249_pa_3	BIO_12423249_pa_6	BIO_12423249_pa_3_6
BIO	12423249	pa	3	7	motivation_problem	result	info-required	info-required	secondary	secondary	none	none	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	BIO_12423249_pa_3	BIO_12423249_pa_7	BIO_12423249_pa_3_7
BIO	12423249	pa	3	8	motivation_problem	result	info-required	info-required	secondary	secondary	none	none	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_pa_3	BIO_12423249_pa_8	BIO_12423249_pa_3_8
BIO	12423249	pa	3	9	motivation_problem	result	info-required	support	secondary	secondary	none	none	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_pa_3	BIO_12423249_pa_9	BIO_12423249_pa_3_9
BIO	12423249	pa	3	10	motivation_problem	conclusion	info-required	support	secondary	secondary	none	none	If beta-secretase has recently been identified and termed BACE, the identity of gamma-secretase is still obscure.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_pa_3	BIO_12423249_pa_10	BIO_12423249_pa_3_10
BIO	12423249	pa	4	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	However, the proteolytic activity of PS1 remains a matter of debate.	BIO_12423249_pa_4	BIO_12423249_pa_5	BIO_12423249_pa_4_5
BIO	12423249	pa	4	6	motivation_background	proposal_implementation	info-required	none	secondary	main	none	none	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	BIO_12423249_pa_4	BIO_12423249_pa_6	BIO_12423249_pa_4_6
BIO	12423249	pa	4	7	motivation_background	result	info-required	info-required	secondary	secondary	none	none	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	BIO_12423249_pa_4	BIO_12423249_pa_7	BIO_12423249_pa_4_7
BIO	12423249	pa	4	8	motivation_background	result	info-required	info-required	secondary	secondary	none	none	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_pa_4	BIO_12423249_pa_8	BIO_12423249_pa_4_8
BIO	12423249	pa	4	9	motivation_background	result	info-required	support	secondary	secondary	none	none	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_pa_4	BIO_12423249_pa_9	BIO_12423249_pa_4_9
BIO	12423249	pa	4	10	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Studies with knock-out mice showed that presenilin 1 (PS1), of which mutations are known to be the first cause of inherited AD, is mandatory for the gamma-secretase activity.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_pa_4	BIO_12423249_pa_10	BIO_12423249_pa_4_10
BIO	12423249	pa	5	6	motivation_problem	proposal_implementation	support	none	secondary	main	forw	support	However, the proteolytic activity of PS1 remains a matter of debate.	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	BIO_12423249_pa_5	BIO_12423249_pa_6	BIO_12423249_pa_5_6
BIO	12423249	pa	5	7	motivation_problem	result	support	info-required	secondary	secondary	none	none	However, the proteolytic activity of PS1 remains a matter of debate.	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	BIO_12423249_pa_5	BIO_12423249_pa_7	BIO_12423249_pa_5_7
BIO	12423249	pa	5	8	motivation_problem	result	support	info-required	secondary	secondary	none	none	However, the proteolytic activity of PS1 remains a matter of debate.	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_pa_5	BIO_12423249_pa_8	BIO_12423249_pa_5_8
BIO	12423249	pa	5	9	motivation_problem	result	support	support	secondary	secondary	none	none	However, the proteolytic activity of PS1 remains a matter of debate.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_pa_5	BIO_12423249_pa_9	BIO_12423249_pa_5_9
BIO	12423249	pa	5	10	motivation_problem	conclusion	support	support	secondary	secondary	none	none	However, the proteolytic activity of PS1 remains a matter of debate.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_pa_5	BIO_12423249_pa_10	BIO_12423249_pa_5_10
BIO	12423249	pa	6	7	proposal_implementation	result	none	info-required	main	secondary	none	none	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	BIO_12423249_pa_6	BIO_12423249_pa_7	BIO_12423249_pa_6_7
BIO	12423249	pa	6	8	proposal_implementation	result	none	info-required	main	secondary	none	none	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_pa_6	BIO_12423249_pa_8	BIO_12423249_pa_6_8
BIO	12423249	pa	6	9	proposal_implementation	result	none	support	main	secondary	none	none	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_pa_6	BIO_12423249_pa_9	BIO_12423249_pa_6_9
BIO	12423249	pa	6	10	proposal_implementation	conclusion	none	support	main	secondary	back	support	Here we used transfected Sf9 insect cells, a cellular model lacking endogenous beta- and/or gamma-secretase activities, to characterize the role of BACE and PS1 in the amyloidogenic processing of human APP.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_pa_6	BIO_12423249_pa_10	BIO_12423249_pa_6_10
BIO	12423249	pa	7	8	result	result	info-required	info-required	secondary	secondary	forw	info-required	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	BIO_12423249_pa_7	BIO_12423249_pa_8	BIO_12423249_pa_7_8
BIO	12423249	pa	7	9	result	result	info-required	support	secondary	secondary	none	none	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_pa_7	BIO_12423249_pa_9	BIO_12423249_pa_7_9
BIO	12423249	pa	7	10	result	conclusion	info-required	support	secondary	secondary	none	none	We show that, in Sf9 cells, BACE performs the expected beta-secretase cleavage of APP, generating C99.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_pa_7	BIO_12423249_pa_10	BIO_12423249_pa_7_10
BIO	12423249	pa	8	9	result	result	info-required	support	secondary	secondary	forw	info-required	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_pa_8	BIO_12423249_pa_9	BIO_12423249_pa_8_9
BIO	12423249	pa	8	10	result	conclusion	info-required	support	secondary	secondary	none	none	We also show that C99, which is a substrate of gamma-secretase, tightly binds to the human PS1.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_pa_8	BIO_12423249_pa_10	BIO_12423249_pa_8_10
BIO	12423249	pa	9	10	result	conclusion	support	support	secondary	secondary	forw	support	Despite this interaction, Sf9 cells still do not produce Abeta.	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	BIO_12423249_pa_9	BIO_12423249_pa_10	BIO_12423249_pa_9_10
BIO	12423249	pa	10	9	conclusion	result	support	support	secondary	secondary	back	support	This strongly argues against a direct proteolytic activity of PS1 in APP processing, and points toward an implication of PS1 in trafficking/presenting its substrate to the gamma-secretase.	Despite this interaction, Sf9 cells still do not produce Abeta.	BIO_12423249_pa_10	BIO_12423249_pa_9	BIO_12423249_pa_9_10
BIO	12468047	pa	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	BIO_12468047_pa_1	BIO_12468047_pa_2	BIO_12468047_pa_1_2
BIO	12468047	pa	1	3	motivation_background	motivation_background	info-required	support	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	Memantine has neuroprotective actions in several in vitro and in vivo models.	BIO_12468047_pa_1	BIO_12468047_pa_3	BIO_12468047_pa_1_3
BIO	12468047	pa	1	4	motivation_background	proposal	info-required	none	secondary	main	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	BIO_12468047_pa_1	BIO_12468047_pa_4	BIO_12468047_pa_1_4
BIO	12468047	pa	1	5	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	BIO_12468047_pa_1	BIO_12468047_pa_5	BIO_12468047_pa_1_5
BIO	12468047	pa	1	6	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	BIO_12468047_pa_1	BIO_12468047_pa_6	BIO_12468047_pa_1_6
BIO	12468047	pa	1	7	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	BIO_12468047_pa_1	BIO_12468047_pa_7	BIO_12468047_pa_1_7
BIO	12468047	pa	1	8	motivation_background	means	info-required	by-means	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_pa_1	BIO_12468047_pa_8	BIO_12468047_pa_1_8
BIO	12468047	pa	1	9	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_pa_1	BIO_12468047_pa_9	BIO_12468047_pa_1_9
BIO	12468047	pa	1	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_pa_1	BIO_12468047_pa_10	BIO_12468047_pa_1_10
BIO	12468047	pa	1	11	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Progressive neuronal loss and cognitive decline in Alzheimer's disease (AD) might be aggravated by beta-amyloid-enhanced excitotoxicity.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_pa_1	BIO_12468047_pa_11	BIO_12468047_pa_1_11
BIO	12468047	pa	2	3	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	Memantine has neuroprotective actions in several in vitro and in vivo models.	BIO_12468047_pa_2	BIO_12468047_pa_3	BIO_12468047_pa_2_3
BIO	12468047	pa	2	4	motivation_background	proposal	info-required	none	secondary	main	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	BIO_12468047_pa_2	BIO_12468047_pa_4	BIO_12468047_pa_2_4
BIO	12468047	pa	2	5	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	BIO_12468047_pa_2	BIO_12468047_pa_5	BIO_12468047_pa_2_5
BIO	12468047	pa	2	6	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	BIO_12468047_pa_2	BIO_12468047_pa_6	BIO_12468047_pa_2_6
BIO	12468047	pa	2	7	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	BIO_12468047_pa_2	BIO_12468047_pa_7	BIO_12468047_pa_2_7
BIO	12468047	pa	2	8	motivation_background	means	info-required	by-means	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_pa_2	BIO_12468047_pa_8	BIO_12468047_pa_2_8
BIO	12468047	pa	2	9	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_pa_2	BIO_12468047_pa_9	BIO_12468047_pa_2_9
BIO	12468047	pa	2	10	motivation_background	observation	info-required	support	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_pa_2	BIO_12468047_pa_10	BIO_12468047_pa_2_10
BIO	12468047	pa	2	11	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Memantine is an uncompetitive NMDA receptor antagonist under clinical development for the treatment of AD.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_pa_2	BIO_12468047_pa_11	BIO_12468047_pa_2_11
BIO	12468047	pa	3	4	motivation_background	proposal	support	none	secondary	main	forw	support	Memantine has neuroprotective actions in several in vitro and in vivo models.	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	BIO_12468047_pa_3	BIO_12468047_pa_4	BIO_12468047_pa_3_4
BIO	12468047	pa	3	5	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	BIO_12468047_pa_3	BIO_12468047_pa_5	BIO_12468047_pa_3_5
BIO	12468047	pa	3	6	motivation_background	proposal_implementation	support	sequence	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	BIO_12468047_pa_3	BIO_12468047_pa_6	BIO_12468047_pa_3_6
BIO	12468047	pa	3	7	motivation_background	proposal_implementation	support	sequence	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	BIO_12468047_pa_3	BIO_12468047_pa_7	BIO_12468047_pa_3_7
BIO	12468047	pa	3	8	motivation_background	means	support	by-means	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_pa_3	BIO_12468047_pa_8	BIO_12468047_pa_3_8
BIO	12468047	pa	3	9	motivation_background	observation	support	info-required	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_pa_3	BIO_12468047_pa_9	BIO_12468047_pa_3_9
BIO	12468047	pa	3	10	motivation_background	observation	support	support	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_pa_3	BIO_12468047_pa_10	BIO_12468047_pa_3_10
BIO	12468047	pa	3	11	motivation_background	conclusion	support	support	secondary	secondary	none	none	Memantine has neuroprotective actions in several in vitro and in vivo models.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_pa_3	BIO_12468047_pa_11	BIO_12468047_pa_3_11
BIO	12468047	pa	4	5	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	BIO_12468047_pa_4	BIO_12468047_pa_5	BIO_12468047_pa_4_5
BIO	12468047	pa	4	6	proposal	proposal_implementation	none	sequence	main	secondary	none	none	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	BIO_12468047_pa_4	BIO_12468047_pa_6	BIO_12468047_pa_4_6
BIO	12468047	pa	4	7	proposal	proposal_implementation	none	sequence	main	secondary	none	none	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	BIO_12468047_pa_4	BIO_12468047_pa_7	BIO_12468047_pa_4_7
BIO	12468047	pa	4	8	proposal	means	none	by-means	main	secondary	none	none	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_pa_4	BIO_12468047_pa_8	BIO_12468047_pa_4_8
BIO	12468047	pa	4	9	proposal	observation	none	info-required	main	secondary	none	none	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_pa_4	BIO_12468047_pa_9	BIO_12468047_pa_4_9
BIO	12468047	pa	4	10	proposal	observation	none	support	main	secondary	none	none	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_pa_4	BIO_12468047_pa_10	BIO_12468047_pa_4_10
BIO	12468047	pa	4	11	proposal	conclusion	none	support	main	secondary	back	support	In the present study, we determined whether memantine protected against beta-amyloid induced neurotoxicity and learning impairment in rats.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_pa_4	BIO_12468047_pa_11	BIO_12468047_pa_4_11
BIO	12468047	pa	5	6	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	back	sequence	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	BIO_12468047_pa_5	BIO_12468047_pa_6	BIO_12468047_pa_5_6
BIO	12468047	pa	5	7	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	none	none	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	BIO_12468047_pa_5	BIO_12468047_pa_7	BIO_12468047_pa_5_7
BIO	12468047	pa	5	8	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_pa_5	BIO_12468047_pa_8	BIO_12468047_pa_5_8
BIO	12468047	pa	5	9	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_pa_5	BIO_12468047_pa_9	BIO_12468047_pa_5_9
BIO	12468047	pa	5	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_pa_5	BIO_12468047_pa_10	BIO_12468047_pa_5_10
BIO	12468047	pa	5	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Twenty Sprague-Dawley rats received vehicle or vehicle plus memantine (steady-state plasma concentrations of 2.34+/-0.23 microM, n=10) s.c. by osmotic pump for 9 days.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_pa_5	BIO_12468047_pa_11	BIO_12468047_pa_5_11
BIO	12468047	pa	6	7	proposal_implementation	proposal_implementation	sequence	sequence	secondary	secondary	back	sequence	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	BIO_12468047_pa_6	BIO_12468047_pa_7	BIO_12468047_pa_6_7
BIO	12468047	pa	6	8	proposal_implementation	means	sequence	by-means	secondary	secondary	none	none	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_pa_6	BIO_12468047_pa_8	BIO_12468047_pa_6_8
BIO	12468047	pa	6	9	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_pa_6	BIO_12468047_pa_9	BIO_12468047_pa_6_9
BIO	12468047	pa	6	10	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_pa_6	BIO_12468047_pa_10	BIO_12468047_pa_6_10
BIO	12468047	pa	6	11	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	After 2 days of treatment, 2 microl of water containing beta-amyloid 1-40 (Abeta(1-40)) were injected into the hippocampal fissure.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_pa_6	BIO_12468047_pa_11	BIO_12468047_pa_6_11
BIO	12468047	pa	7	8	proposal_implementation	means	sequence	by-means	secondary	secondary	none	none	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	BIO_12468047_pa_7	BIO_12468047_pa_8	BIO_12468047_pa_7_8
BIO	12468047	pa	7	9	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_pa_7	BIO_12468047_pa_9	BIO_12468047_pa_7_9
BIO	12468047	pa	7	10	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_pa_7	BIO_12468047_pa_10	BIO_12468047_pa_7_10
BIO	12468047	pa	7	11	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	On the ninth day of treatment, animals were sacrificed, and morphological and immunohistochemical techniques were used to determine the extent of neuronal degeneration and astrocytic and microglial activation in the hippocampus.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_pa_7	BIO_12468047_pa_11	BIO_12468047_pa_7_11
BIO	12468047	pa	8	9	means	observation	by-means	info-required	secondary	secondary	none	none	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	BIO_12468047_pa_8	BIO_12468047_pa_9	BIO_12468047_pa_8_9
BIO	12468047	pa	8	10	means	observation	by-means	support	secondary	secondary	forw	by-means	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_pa_8	BIO_12468047_pa_10	BIO_12468047_pa_8_10
BIO	12468047	pa	8	11	means	conclusion	by-means	support	secondary	secondary	none	none	Psychomotor activity and spatial discrimination were tested on the eighth day of treatment.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_pa_8	BIO_12468047_pa_11	BIO_12468047_pa_8_11
BIO	12468047	pa	9	10	observation	observation	info-required	support	secondary	secondary	forw	info-required	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_pa_9	BIO_12468047_pa_10	BIO_12468047_pa_9_10
BIO	12468047	pa	9	11	observation	conclusion	info-required	support	secondary	secondary	none	none	Abeta(1-40), but not water, injections into hippocampus led to neuronal loss in the CA1 subfield, evidence of widespread apoptosis, and astrocytic and microglial activation and hypertrophy.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_pa_9	BIO_12468047_pa_11	BIO_12468047_pa_9_11
BIO	12468047	pa	10	11	observation	conclusion	support	support	secondary	secondary	forw	support	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	BIO_12468047_pa_10	BIO_12468047_pa_11	BIO_12468047_pa_10_11
BIO	12468047	pa	11	10	conclusion	observation	support	support	secondary	secondary	back	support	These data suggest that memantine, at therapeutically relevant concentrations, can protect against neuronal degeneration induced by beta-amyloid.	Memantine treated animals had significant reductions in the amount of neuronal degeneration, pyknotic nuclei, and GFAP immunostaining as compared with vehicle treated animals.	BIO_12468047_pa_11	BIO_12468047_pa_10	BIO_12468047_pa_10_11
BIO	12483089	pa	1	2	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	BIO_12483089_pa_1	BIO_12483089_pa_2	BIO_12483089_pa_1_2
BIO	12483089	pa	1	3	proposal	proposal_implementation	none	elaboration	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	BIO_12483089_pa_1	BIO_12483089_pa_3	BIO_12483089_pa_1_3
BIO	12483089	pa	1	4	proposal	means	none	by-means	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	BIO_12483089_pa_1	BIO_12483089_pa_4	BIO_12483089_pa_1_4
BIO	12483089	pa	1	5	proposal	means	none	by-means	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	BIO_12483089_pa_1	BIO_12483089_pa_5	BIO_12483089_pa_1_5
BIO	12483089	pa	1	6	proposal	proposal_implementation	none	sequence	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	BIO_12483089_pa_1	BIO_12483089_pa_6	BIO_12483089_pa_1_6
BIO	12483089	pa	1	7	proposal	observation	none	info-required	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	BIO_12483089_pa_1	BIO_12483089_pa_7	BIO_12483089_pa_1_7
BIO	12483089	pa	1	8	proposal	observation	none	info-required	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_pa_1	BIO_12483089_pa_8	BIO_12483089_pa_1_8
BIO	12483089	pa	1	9	proposal	observation	none	info-required	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_pa_1	BIO_12483089_pa_9	BIO_12483089_pa_1_9
BIO	12483089	pa	1	10	proposal	observation	none	support	main	secondary	none	none	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_pa_1	BIO_12483089_pa_10	BIO_12483089_pa_1_10
BIO	12483089	pa	1	11	proposal	conclusion	none	support	main	secondary	back	support	PURPOSE: To evaluate the neuroprotective effect of memantine, an NMDA receptor channel blocker, in two retinal ganglion cell (RGC) injury models in rats.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_pa_1	BIO_12483089_pa_11	BIO_12483089_pa_1_11
BIO	12483089	pa	2	3	proposal_implementation	proposal_implementation	elaboration	elaboration	secondary	secondary	back	elaboration	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	BIO_12483089_pa_2	BIO_12483089_pa_3	BIO_12483089_pa_2_3
BIO	12483089	pa	2	4	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	BIO_12483089_pa_2	BIO_12483089_pa_4	BIO_12483089_pa_2_4
BIO	12483089	pa	2	5	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	BIO_12483089_pa_2	BIO_12483089_pa_5	BIO_12483089_pa_2_5
BIO	12483089	pa	2	6	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	BIO_12483089_pa_2	BIO_12483089_pa_6	BIO_12483089_pa_2_6
BIO	12483089	pa	2	7	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	BIO_12483089_pa_2	BIO_12483089_pa_7	BIO_12483089_pa_2_7
BIO	12483089	pa	2	8	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_pa_2	BIO_12483089_pa_8	BIO_12483089_pa_2_8
BIO	12483089	pa	2	9	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_pa_2	BIO_12483089_pa_9	BIO_12483089_pa_2_9
BIO	12483089	pa	2	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_pa_2	BIO_12483089_pa_10	BIO_12483089_pa_2_10
BIO	12483089	pa	2	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	METHODS: Neuroprotective effect of memantine was tested in partial optic nerve injury and chronic ocular hypertensive models.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_pa_2	BIO_12483089_pa_11	BIO_12483089_pa_2_11
BIO	12483089	pa	3	4	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	BIO_12483089_pa_3	BIO_12483089_pa_4	BIO_12483089_pa_3_4
BIO	12483089	pa	3	5	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	BIO_12483089_pa_3	BIO_12483089_pa_5	BIO_12483089_pa_3_5
BIO	12483089	pa	3	6	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	back	sequence	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	BIO_12483089_pa_3	BIO_12483089_pa_6	BIO_12483089_pa_3_6
BIO	12483089	pa	3	7	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	BIO_12483089_pa_3	BIO_12483089_pa_7	BIO_12483089_pa_3_7
BIO	12483089	pa	3	8	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_pa_3	BIO_12483089_pa_8	BIO_12483089_pa_3_8
BIO	12483089	pa	3	9	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_pa_3	BIO_12483089_pa_9	BIO_12483089_pa_3_9
BIO	12483089	pa	3	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_pa_3	BIO_12483089_pa_10	BIO_12483089_pa_3_10
BIO	12483089	pa	3	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	In the optic nerve injury model, memantine (0.1 - 30 mg/kg) was injected intraperitoneally immediately after injury.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_pa_3	BIO_12483089_pa_11	BIO_12483089_pa_3_11
BIO	12483089	pa	4	5	means	means	by-means	by-means	secondary	secondary	none	none	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	BIO_12483089_pa_4	BIO_12483089_pa_5	BIO_12483089_pa_4_5
BIO	12483089	pa	4	6	means	proposal_implementation	by-means	sequence	secondary	secondary	none	none	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	BIO_12483089_pa_4	BIO_12483089_pa_6	BIO_12483089_pa_4_6
BIO	12483089	pa	4	7	means	observation	by-means	info-required	secondary	secondary	forw	by-means	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	BIO_12483089_pa_4	BIO_12483089_pa_7	BIO_12483089_pa_4_7
BIO	12483089	pa	4	8	means	observation	by-means	info-required	secondary	secondary	none	none	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_pa_4	BIO_12483089_pa_8	BIO_12483089_pa_4_8
BIO	12483089	pa	4	9	means	observation	by-means	info-required	secondary	secondary	none	none	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_pa_4	BIO_12483089_pa_9	BIO_12483089_pa_4_9
BIO	12483089	pa	4	10	means	observation	by-means	support	secondary	secondary	none	none	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_pa_4	BIO_12483089_pa_10	BIO_12483089_pa_4_10
BIO	12483089	pa	4	11	means	conclusion	by-means	support	secondary	secondary	none	none	Two weeks later, optic nerve function was determined by measuring compound action potential and surviving RGC was determined by retrograde labeling with dextran tetramethyl rhodamine.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_pa_4	BIO_12483089_pa_11	BIO_12483089_pa_4_11
BIO	12483089	pa	5	6	means	proposal_implementation	by-means	sequence	secondary	secondary	none	none	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	BIO_12483089_pa_5	BIO_12483089_pa_6	BIO_12483089_pa_5_6
BIO	12483089	pa	5	7	means	observation	by-means	info-required	secondary	secondary	none	none	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	BIO_12483089_pa_5	BIO_12483089_pa_7	BIO_12483089_pa_5_7
BIO	12483089	pa	5	8	means	observation	by-means	info-required	secondary	secondary	none	none	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_pa_5	BIO_12483089_pa_8	BIO_12483089_pa_5_8
BIO	12483089	pa	5	9	means	observation	by-means	info-required	secondary	secondary	forw	by-means	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_pa_5	BIO_12483089_pa_9	BIO_12483089_pa_5_9
BIO	12483089	pa	5	10	means	observation	by-means	support	secondary	secondary	none	none	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_pa_5	BIO_12483089_pa_10	BIO_12483089_pa_5_10
BIO	12483089	pa	5	11	means	conclusion	by-means	support	secondary	secondary	none	none	Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_pa_5	BIO_12483089_pa_11	BIO_12483089_pa_5_11
BIO	12483089	pa	6	7	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	BIO_12483089_pa_6	BIO_12483089_pa_7	BIO_12483089_pa_6_7
BIO	12483089	pa	6	8	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_pa_6	BIO_12483089_pa_8	BIO_12483089_pa_6_8
BIO	12483089	pa	6	9	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_pa_6	BIO_12483089_pa_9	BIO_12483089_pa_6_9
BIO	12483089	pa	6	10	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_pa_6	BIO_12483089_pa_10	BIO_12483089_pa_6_10
BIO	12483089	pa	6	11	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	Memantine (5 or 10 mg/kg) was administered continuously each day with an osmotic pump, either immediately after or 10 days after first laser photocoagulation, for 3 weeks, after which RGC survival was determined.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_pa_6	BIO_12483089_pa_11	BIO_12483089_pa_6_11
BIO	12483089	pa	7	8	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	BIO_12483089_pa_7	BIO_12483089_pa_8	BIO_12483089_pa_7_8
BIO	12483089	pa	7	9	observation	observation	info-required	info-required	secondary	secondary	none	none	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_pa_7	BIO_12483089_pa_9	BIO_12483089_pa_7_9
BIO	12483089	pa	7	10	observation	observation	info-required	support	secondary	secondary	none	none	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_pa_7	BIO_12483089_pa_10	BIO_12483089_pa_7_10
BIO	12483089	pa	7	11	observation	conclusion	info-required	support	secondary	secondary	none	none	RESULTS: Two weeks after partial optic nerve injury, there was approximately 80% reduction in RGC number.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_pa_7	BIO_12483089_pa_11	BIO_12483089_pa_7_11
BIO	12483089	pa	8	9	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	BIO_12483089_pa_8	BIO_12483089_pa_9	BIO_12483089_pa_8_9
BIO	12483089	pa	8	10	observation	observation	info-required	support	secondary	secondary	none	none	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_pa_8	BIO_12483089_pa_10	BIO_12483089_pa_8_10
BIO	12483089	pa	8	11	observation	conclusion	info-required	support	secondary	secondary	none	none	Memantine (5 mg/kg) caused a twofold increase in compound action potential amplitude and a 1.7-fold increase in survival of RGCs, respectively.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_pa_8	BIO_12483089_pa_11	BIO_12483089_pa_8_11
BIO	12483089	pa	9	10	observation	observation	info-required	support	secondary	secondary	forw	info-required	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_pa_9	BIO_12483089_pa_10	BIO_12483089_pa_9_10
BIO	12483089	pa	9	11	observation	conclusion	info-required	support	secondary	secondary	none	none	In the chronic ocular hypertension model there was 37% decrease in RGCs after 3 weeks of elevated intraocular pressure.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_pa_9	BIO_12483089_pa_11	BIO_12483089_pa_9_11
BIO	12483089	pa	10	11	observation	conclusion	support	support	secondary	secondary	forw	support	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	BIO_12483089_pa_10	BIO_12483089_pa_11	BIO_12483089_pa_10_11
BIO	12483089	pa	11	10	conclusion	observation	support	support	secondary	secondary	back	support	CONCLUSION: The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models.	Memantine (10 mg/kg daily) reduced ganglion cell loss to 12% when applied immediately after first laser photocoagulation, and prevented any further loss when applied 10 days after first laser photocoagulation.	BIO_12483089_pa_11	BIO_12483089_pa_10	BIO_12483089_pa_10_11
BIO	12573519	pa	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	Recent clinical trials have found that few neuroprotectants are effective.	BIO_12573519_pa_1	BIO_12573519_pa_2	BIO_12573519_pa_1_2
BIO	12573519	pa	1	3	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	BIO_12573519_pa_1	BIO_12573519_pa_3	BIO_12573519_pa_1_3
BIO	12573519	pa	1	4	motivation_background	proposal	info-required	none	secondary	main	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	BIO_12573519_pa_1	BIO_12573519_pa_4	BIO_12573519_pa_1_4
BIO	12573519	pa	1	5	motivation_background	observation	info-required	support	secondary	secondary	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	BIO_12573519_pa_1	BIO_12573519_pa_5	BIO_12573519_pa_1_5
BIO	12573519	pa	1	6	motivation_background	proposal	info-required	sequence	secondary	secondary	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	BIO_12573519_pa_1	BIO_12573519_pa_6	BIO_12573519_pa_1_6
BIO	12573519	pa	1	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	BIO_12573519_pa_1	BIO_12573519_pa_7	BIO_12573519_pa_1_7
BIO	12573519	pa	1	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_pa_1	BIO_12573519_pa_8	BIO_12573519_pa_1_8
BIO	12573519	pa	1	9	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Although stroke is a major cause of death and disability in the elderly, the inhibitory effects of neuroprotectants in acute stroke have been investigated using experimental cerebral ischemic models of young animals.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_pa_1	BIO_12573519_pa_9	BIO_12573519_pa_1_9
BIO	12573519	pa	2	3	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	Recent clinical trials have found that few neuroprotectants are effective.	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	BIO_12573519_pa_2	BIO_12573519_pa_3	BIO_12573519_pa_2_3
BIO	12573519	pa	2	4	motivation_background	proposal	info-required	none	secondary	main	none	none	Recent clinical trials have found that few neuroprotectants are effective.	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	BIO_12573519_pa_2	BIO_12573519_pa_4	BIO_12573519_pa_2_4
BIO	12573519	pa	2	5	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recent clinical trials have found that few neuroprotectants are effective.	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	BIO_12573519_pa_2	BIO_12573519_pa_5	BIO_12573519_pa_2_5
BIO	12573519	pa	2	6	motivation_background	proposal	info-required	sequence	secondary	secondary	none	none	Recent clinical trials have found that few neuroprotectants are effective.	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	BIO_12573519_pa_2	BIO_12573519_pa_6	BIO_12573519_pa_2_6
BIO	12573519	pa	2	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Recent clinical trials have found that few neuroprotectants are effective.	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	BIO_12573519_pa_2	BIO_12573519_pa_7	BIO_12573519_pa_2_7
BIO	12573519	pa	2	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Recent clinical trials have found that few neuroprotectants are effective.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_pa_2	BIO_12573519_pa_8	BIO_12573519_pa_2_8
BIO	12573519	pa	2	9	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Recent clinical trials have found that few neuroprotectants are effective.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_pa_2	BIO_12573519_pa_9	BIO_12573519_pa_2_9
BIO	12573519	pa	3	4	motivation_problem	proposal	support	none	secondary	main	forw	support	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	BIO_12573519_pa_3	BIO_12573519_pa_4	BIO_12573519_pa_3_4
BIO	12573519	pa	3	5	motivation_problem	observation	support	support	secondary	secondary	none	none	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	BIO_12573519_pa_3	BIO_12573519_pa_5	BIO_12573519_pa_3_5
BIO	12573519	pa	3	6	motivation_problem	proposal	support	sequence	secondary	secondary	none	none	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	BIO_12573519_pa_3	BIO_12573519_pa_6	BIO_12573519_pa_3_6
BIO	12573519	pa	3	7	motivation_problem	observation	support	info-required	secondary	secondary	none	none	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	BIO_12573519_pa_3	BIO_12573519_pa_7	BIO_12573519_pa_3_7
BIO	12573519	pa	3	8	motivation_problem	observation	support	info-required	secondary	secondary	none	none	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_pa_3	BIO_12573519_pa_8	BIO_12573519_pa_3_8
BIO	12573519	pa	3	9	motivation_problem	conclusion	support	support	secondary	secondary	none	none	These observations indicate that effects in the clinical setting do not always reflect data from young animals.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_pa_3	BIO_12573519_pa_9	BIO_12573519_pa_3_9
BIO	12573519	pa	4	5	proposal	observation	none	support	main	secondary	none	none	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	BIO_12573519_pa_4	BIO_12573519_pa_5	BIO_12573519_pa_4_5
BIO	12573519	pa	4	6	proposal	proposal	none	sequence	main	secondary	back	sequence	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	BIO_12573519_pa_4	BIO_12573519_pa_6	BIO_12573519_pa_4_6
BIO	12573519	pa	4	7	proposal	observation	none	info-required	main	secondary	none	none	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	BIO_12573519_pa_4	BIO_12573519_pa_7	BIO_12573519_pa_4_7
BIO	12573519	pa	4	8	proposal	observation	none	info-required	main	secondary	none	none	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_pa_4	BIO_12573519_pa_8	BIO_12573519_pa_4_8
BIO	12573519	pa	4	9	proposal	conclusion	none	support	main	secondary	back	support	Thus, we compared the effects of the NMDA receptor antagonist MK-801 and of the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinixaline) on ischemic cerebral damage in the photothrombosis model of aged and young rats.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_pa_4	BIO_12573519_pa_9	BIO_12573519_pa_4_9
BIO	12573519	pa	5	6	observation	proposal	support	sequence	secondary	secondary	none	none	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	BIO_12573519_pa_5	BIO_12573519_pa_6	BIO_12573519_pa_5_6
BIO	12573519	pa	5	7	observation	observation	support	info-required	secondary	secondary	none	none	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	BIO_12573519_pa_5	BIO_12573519_pa_7	BIO_12573519_pa_5_7
BIO	12573519	pa	5	8	observation	observation	support	info-required	secondary	secondary	back	info-required	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_pa_5	BIO_12573519_pa_8	BIO_12573519_pa_5_8
BIO	12573519	pa	5	9	observation	conclusion	support	support	secondary	secondary	forw	support	MK-801 administered immediately after MCA occlusion significantly (P less than 0.05) reduced the extent of cerebral damage in young, but not in aged, rats and the effects of NBQX were similar.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_pa_5	BIO_12573519_pa_9	BIO_12573519_pa_5_9
BIO	12573519	pa	6	7	proposal	observation	sequence	info-required	secondary	secondary	none	none	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	BIO_12573519_pa_6	BIO_12573519_pa_7	BIO_12573519_pa_6_7
BIO	12573519	pa	6	8	proposal	observation	sequence	info-required	secondary	secondary	none	none	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_pa_6	BIO_12573519_pa_8	BIO_12573519_pa_6_8
BIO	12573519	pa	6	9	proposal	conclusion	sequence	support	secondary	secondary	none	none	In separate experiments, we evaluated brain damage after microinjecting NMDA or kainic acid into the cortex using a stereotaxic apparatus.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_pa_6	BIO_12573519_pa_9	BIO_12573519_pa_6_9
BIO	12573519	pa	7	8	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_pa_7	BIO_12573519_pa_8	BIO_12573519_pa_7_8
BIO	12573519	pa	7	9	observation	conclusion	info-required	support	secondary	secondary	none	none	We found no significant differences in focal cerebral damage caused by NMDA between young and aged rats.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_pa_7	BIO_12573519_pa_9	BIO_12573519_pa_7_9
BIO	12573519	pa	8	9	observation	conclusion	info-required	support	secondary	secondary	none	none	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	BIO_12573519_pa_8	BIO_12573519_pa_9	BIO_12573519_pa_8_9
BIO	12573519	pa	9	8	conclusion	observation	support	info-required	secondary	secondary	none	none	Our observations indicate that NMDA and AMPA receptor antagonists are less effective in aged, than in young, rats and that cerebral damage by receptor agonists depends on the type of receptor, such as NMDA and AMPA.	On the other hand, kainic acid caused all of the aged rats tested to die, but none of the young rats.	BIO_12573519_pa_9	BIO_12573519_pa_8	BIO_12573519_pa_8_9
BIO	12609492	pa	1	2	motivation_background	proposal	support	none	secondary	main	forw	support	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	BIO_12609492_pa_1	BIO_12609492_pa_2	BIO_12609492_pa_1_2
BIO	12609492	pa	1	3	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	BIO_12609492_pa_1	BIO_12609492_pa_3	BIO_12609492_pa_1_3
BIO	12609492	pa	1	4	motivation_background	proposal_implementation	support	info-required	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	BIO_12609492_pa_1	BIO_12609492_pa_4	BIO_12609492_pa_1_4
BIO	12609492	pa	1	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	BIO_12609492_pa_1	BIO_12609492_pa_5	BIO_12609492_pa_1_5
BIO	12609492	pa	1	6	motivation_background	observation	support	info-required	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	BIO_12609492_pa_1	BIO_12609492_pa_6	BIO_12609492_pa_1_6
BIO	12609492	pa	1	7	motivation_background	observation	support	elaboration	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	BIO_12609492_pa_1	BIO_12609492_pa_7	BIO_12609492_pa_1_7
BIO	12609492	pa	1	8	motivation_background	observation	support	support	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_pa_1	BIO_12609492_pa_8	BIO_12609492_pa_1_8
BIO	12609492	pa	1	9	motivation_background	result	support	support	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_pa_1	BIO_12609492_pa_9	BIO_12609492_pa_1_9
BIO	12609492	pa	1	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_pa_1	BIO_12609492_pa_10	BIO_12609492_pa_1_10
BIO	12609492	pa	1	11	motivation_background	conclusion	support	support	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_pa_1	BIO_12609492_pa_11	BIO_12609492_pa_1_11
BIO	12609492	pa	1	12	motivation_background	conclusion	support	elaboration	secondary	secondary	none	none	Although experimental studies have widely shown that the pharmacological blockade of ionotropic glutamate receptors reduces ischemic damage, clinical trials with classical AMPA and NMDA glutamate receptor antagonists have provided negative results.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_pa_1	BIO_12609492_pa_12	BIO_12609492_pa_1_12
BIO	12609492	pa	2	3	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	BIO_12609492_pa_2	BIO_12609492_pa_3	BIO_12609492_pa_2_3
BIO	12609492	pa	2	4	proposal	proposal_implementation	none	info-required	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	BIO_12609492_pa_2	BIO_12609492_pa_4	BIO_12609492_pa_2_4
BIO	12609492	pa	2	5	proposal	observation	none	info-required	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	BIO_12609492_pa_2	BIO_12609492_pa_5	BIO_12609492_pa_2_5
BIO	12609492	pa	2	6	proposal	observation	none	info-required	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	BIO_12609492_pa_2	BIO_12609492_pa_6	BIO_12609492_pa_2_6
BIO	12609492	pa	2	7	proposal	observation	none	elaboration	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	BIO_12609492_pa_2	BIO_12609492_pa_7	BIO_12609492_pa_2_7
BIO	12609492	pa	2	8	proposal	observation	none	support	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_pa_2	BIO_12609492_pa_8	BIO_12609492_pa_2_8
BIO	12609492	pa	2	9	proposal	result	none	support	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_pa_2	BIO_12609492_pa_9	BIO_12609492_pa_2_9
BIO	12609492	pa	2	10	proposal	conclusion	none	support	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_pa_2	BIO_12609492_pa_10	BIO_12609492_pa_2_10
BIO	12609492	pa	2	11	proposal	conclusion	none	support	main	secondary	back	support	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_pa_2	BIO_12609492_pa_11	BIO_12609492_pa_2_11
BIO	12609492	pa	2	12	proposal	conclusion	none	elaboration	main	secondary	none	none	To address the involvement of ionotropic glutamate receptors in ischemic damage, corticostriatal brain slices were prepared from adult rats.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_pa_2	BIO_12609492_pa_12	BIO_12609492_pa_2_12
BIO	12609492	pa	3	4	proposal_implementation	proposal_implementation	elaboration	info-required	secondary	secondary	back	info-required	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	BIO_12609492_pa_3	BIO_12609492_pa_4	BIO_12609492_pa_3_4
BIO	12609492	pa	3	5	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	BIO_12609492_pa_3	BIO_12609492_pa_5	BIO_12609492_pa_3_5
BIO	12609492	pa	3	6	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	BIO_12609492_pa_3	BIO_12609492_pa_6	BIO_12609492_pa_3_6
BIO	12609492	pa	3	7	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	BIO_12609492_pa_3	BIO_12609492_pa_7	BIO_12609492_pa_3_7
BIO	12609492	pa	3	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_pa_3	BIO_12609492_pa_8	BIO_12609492_pa_3_8
BIO	12609492	pa	3	9	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_pa_3	BIO_12609492_pa_9	BIO_12609492_pa_3_9
BIO	12609492	pa	3	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_pa_3	BIO_12609492_pa_10	BIO_12609492_pa_3_10
BIO	12609492	pa	3	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_pa_3	BIO_12609492_pa_11	BIO_12609492_pa_3_11
BIO	12609492	pa	3	12	proposal_implementation	conclusion	elaboration	elaboration	secondary	secondary	none	none	Extracellular recordings were performed in the striatum after stimulation of the glutamatergic corticostriatal fibres.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_pa_3	BIO_12609492_pa_12	BIO_12609492_pa_3_12
BIO	12609492	pa	4	5	proposal_implementation	observation	info-required	info-required	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	BIO_12609492_pa_4	BIO_12609492_pa_5	BIO_12609492_pa_4_5
BIO	12609492	pa	4	6	proposal_implementation	observation	info-required	info-required	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	BIO_12609492_pa_4	BIO_12609492_pa_6	BIO_12609492_pa_4_6
BIO	12609492	pa	4	7	proposal_implementation	observation	info-required	elaboration	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	BIO_12609492_pa_4	BIO_12609492_pa_7	BIO_12609492_pa_4_7
BIO	12609492	pa	4	8	proposal_implementation	observation	info-required	support	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_pa_4	BIO_12609492_pa_8	BIO_12609492_pa_4_8
BIO	12609492	pa	4	9	proposal_implementation	result	info-required	support	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_pa_4	BIO_12609492_pa_9	BIO_12609492_pa_4_9
BIO	12609492	pa	4	10	proposal_implementation	conclusion	info-required	support	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_pa_4	BIO_12609492_pa_10	BIO_12609492_pa_4_10
BIO	12609492	pa	4	11	proposal_implementation	conclusion	info-required	support	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_pa_4	BIO_12609492_pa_11	BIO_12609492_pa_4_11
BIO	12609492	pa	4	12	proposal_implementation	conclusion	info-required	elaboration	secondary	secondary	none	none	In vitro ischemia was induced for a 10-min period by omitting oxygen and glucose from the external medium.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_pa_4	BIO_12609492_pa_12	BIO_12609492_pa_4_12
BIO	12609492	pa	5	6	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	BIO_12609492_pa_5	BIO_12609492_pa_6	BIO_12609492_pa_5_6
BIO	12609492	pa	5	7	observation	observation	info-required	elaboration	secondary	secondary	none	none	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	BIO_12609492_pa_5	BIO_12609492_pa_7	BIO_12609492_pa_5_7
BIO	12609492	pa	5	8	observation	observation	info-required	support	secondary	secondary	none	none	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_pa_5	BIO_12609492_pa_8	BIO_12609492_pa_5_8
BIO	12609492	pa	5	9	observation	result	info-required	support	secondary	secondary	none	none	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_pa_5	BIO_12609492_pa_9	BIO_12609492_pa_5_9
BIO	12609492	pa	5	10	observation	conclusion	info-required	support	secondary	secondary	none	none	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_pa_5	BIO_12609492_pa_10	BIO_12609492_pa_5_10
BIO	12609492	pa	5	11	observation	conclusion	info-required	support	secondary	secondary	none	none	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_pa_5	BIO_12609492_pa_11	BIO_12609492_pa_5_11
BIO	12609492	pa	5	12	observation	conclusion	info-required	elaboration	secondary	secondary	none	none	Under control conditions, ischemia produced an irreversible loss of the corticostriatal field potential amplitude, AP5, a competitive NMDA receptor antagonist, induced a slight rescue of the potential, while ifenprodil, a positive modulator of the proton sensor of the NMDA receptors, allowed a complete recovery from the ischemic insult.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_pa_5	BIO_12609492_pa_12	BIO_12609492_pa_5_12
BIO	12609492	pa	6	7	observation	observation	info-required	elaboration	secondary	secondary	back	elaboration	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	BIO_12609492_pa_6	BIO_12609492_pa_7	BIO_12609492_pa_6_7
BIO	12609492	pa	6	8	observation	observation	info-required	support	secondary	secondary	forw	info-required	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_pa_6	BIO_12609492_pa_8	BIO_12609492_pa_6_8
BIO	12609492	pa	6	9	observation	result	info-required	support	secondary	secondary	none	none	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_pa_6	BIO_12609492_pa_9	BIO_12609492_pa_6_9
BIO	12609492	pa	6	10	observation	conclusion	info-required	support	secondary	secondary	none	none	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_pa_6	BIO_12609492_pa_10	BIO_12609492_pa_6_10
BIO	12609492	pa	6	11	observation	conclusion	info-required	support	secondary	secondary	none	none	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_pa_6	BIO_12609492_pa_11	BIO_12609492_pa_6_11
BIO	12609492	pa	6	12	observation	conclusion	info-required	elaboration	secondary	secondary	none	none	Similar neuroprotection was achieved by utilizing either CNQX, a broad spectrum AMPA receptors antagonist, or Joro spider toxin, a selective blocker of calcium permeable AMPA receptors.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_pa_6	BIO_12609492_pa_12	BIO_12609492_pa_6_12
BIO	12609492	pa	7	8	observation	observation	elaboration	support	secondary	secondary	none	none	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	BIO_12609492_pa_7	BIO_12609492_pa_8	BIO_12609492_pa_7_8
BIO	12609492	pa	7	9	observation	result	elaboration	support	secondary	secondary	none	none	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_pa_7	BIO_12609492_pa_9	BIO_12609492_pa_7_9
BIO	12609492	pa	7	10	observation	conclusion	elaboration	support	secondary	secondary	none	none	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_pa_7	BIO_12609492_pa_10	BIO_12609492_pa_7_10
BIO	12609492	pa	7	11	observation	conclusion	elaboration	support	secondary	secondary	none	none	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_pa_7	BIO_12609492_pa_11	BIO_12609492_pa_7_11
BIO	12609492	pa	7	12	observation	conclusion	elaboration	elaboration	secondary	secondary	none	none	Interestingly, while CNZX also fully suppressed physiological excitatory transmission, Joro spider toxin was ineffective on this parameter.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_pa_7	BIO_12609492_pa_12	BIO_12609492_pa_7_12
BIO	12609492	pa	8	9	observation	result	support	support	secondary	secondary	none	none	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	BIO_12609492_pa_8	BIO_12609492_pa_9	BIO_12609492_pa_8_9
BIO	12609492	pa	8	10	observation	conclusion	support	support	secondary	secondary	none	none	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_pa_8	BIO_12609492_pa_10	BIO_12609492_pa_8_10
BIO	12609492	pa	8	11	observation	conclusion	support	support	secondary	secondary	forw	support	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_pa_8	BIO_12609492_pa_11	BIO_12609492_pa_8_11
BIO	12609492	pa	8	12	observation	conclusion	support	elaboration	secondary	secondary	none	none	Finally, lamotrigine and remacemide, two antiepileptic drugs that differentially affect excitatory transmission, exerted neuroprotective effects against ischemia.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_pa_8	BIO_12609492_pa_12	BIO_12609492_pa_8_12
BIO	12609492	pa	9	10	result	conclusion	support	support	secondary	secondary	forw	support	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	BIO_12609492_pa_9	BIO_12609492_pa_10	BIO_12609492_pa_9_10
BIO	12609492	pa	9	11	result	conclusion	support	support	secondary	secondary	none	none	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_pa_9	BIO_12609492_pa_11	BIO_12609492_pa_9_11
BIO	12609492	pa	9	12	result	conclusion	support	elaboration	secondary	secondary	none	none	Noticeably, a combination of low concentrations of these two drugs exerted a stronger neuroprotection than a single drug given in isolation.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_pa_9	BIO_12609492_pa_12	BIO_12609492_pa_9_12
BIO	12609492	pa	10	11	conclusion	conclusion	support	support	secondary	secondary	none	none	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_pa_10	BIO_12609492_pa_11	BIO_12609492_pa_10_11
BIO	12609492	pa	10	12	conclusion	conclusion	support	elaboration	secondary	secondary	forw	support	Thus, it might be possible to reach a neuroprotective action by utilizing doses of these compounds low enough to avoid side effects.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_pa_10	BIO_12609492_pa_12	BIO_12609492_pa_10_12
BIO	12609492	pa	11	12	conclusion	conclusion	support	elaboration	secondary	secondary	back	elaboration	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	BIO_12609492_pa_11	BIO_12609492_pa_12	BIO_12609492_pa_11_12
BIO	12609492	pa	12	11	conclusion	conclusion	elaboration	support	secondary	secondary	forw	elaboration	In addition, our findings support the concept that it is possible to produce a significant neuroprotective action in the absence of a relevant interference with normal synaptic transmission.	Our experimental data still support the idea that a negative modulation of excitatory transmission can be neuroprotective against ischemia.	BIO_12609492_pa_12	BIO_12609492_pa_11	BIO_12609492_pa_11_12
BIO	12612044	pa	1	2	proposal	proposal_implementation	none	info-required	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	A virtual target and cursor image were viewed co-planar with the manipulandum.	BIO_12612044_pa_1	BIO_12612044_pa_2	BIO_12612044_pa_1_2
BIO	12612044	pa	1	3	proposal	proposal_implementation	none	info-required	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	BIO_12612044_pa_1	BIO_12612044_pa_3	BIO_12612044_pa_1_3
BIO	12612044	pa	1	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	BIO_12612044_pa_1	BIO_12612044_pa_4	BIO_12612044_pa_1_4
BIO	12612044	pa	1	5	proposal	observation	none	info-required	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	BIO_12612044_pa_1	BIO_12612044_pa_5	BIO_12612044_pa_1_5
BIO	12612044	pa	1	6	proposal	means	none	by-means	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	BIO_12612044_pa_1	BIO_12612044_pa_6	BIO_12612044_pa_1_6
BIO	12612044	pa	1	7	proposal	observation	none	info-required	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	Most task-related neurons (68%) showed no significant directional modulation.	BIO_12612044_pa_1	BIO_12612044_pa_7	BIO_12612044_pa_1_7
BIO	12612044	pa	1	8	proposal	observation	none	info-required	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_pa_1	BIO_12612044_pa_8	BIO_12612044_pa_1_8
BIO	12612044	pa	1	9	proposal	observation	none	support	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_pa_1	BIO_12612044_pa_9	BIO_12612044_pa_1_9
BIO	12612044	pa	1	10	proposal	observation	none	elaboration	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_pa_1	BIO_12612044_pa_10	BIO_12612044_pa_1_10
BIO	12612044	pa	1	11	proposal	conclusion	none	support	main	secondary	back	support	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_pa_1	BIO_12612044_pa_11	BIO_12612044_pa_1_11
BIO	12612044	pa	1	12	proposal	conclusion	none	elaboration	main	secondary	none	none	Testing the hypothesis that the lateral cerebellum forms a sensory representation of arm movements, we investigated cortical neuronal activity in two monkeys performing visually guided step-tracking movements with a manipulandum.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_pa_1	BIO_12612044_pa_12	BIO_12612044_pa_1_12
BIO	12612044	pa	2	3	proposal_implementation	proposal_implementation	info-required	info-required	secondary	secondary	forw	info-required	A virtual target and cursor image were viewed co-planar with the manipulandum.	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	BIO_12612044_pa_2	BIO_12612044_pa_3	BIO_12612044_pa_2_3
BIO	12612044	pa	2	4	proposal_implementation	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	BIO_12612044_pa_2	BIO_12612044_pa_4	BIO_12612044_pa_2_4
BIO	12612044	pa	2	5	proposal_implementation	observation	info-required	info-required	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	BIO_12612044_pa_2	BIO_12612044_pa_5	BIO_12612044_pa_2_5
BIO	12612044	pa	2	6	proposal_implementation	means	info-required	by-means	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	BIO_12612044_pa_2	BIO_12612044_pa_6	BIO_12612044_pa_2_6
BIO	12612044	pa	2	7	proposal_implementation	observation	info-required	info-required	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	Most task-related neurons (68%) showed no significant directional modulation.	BIO_12612044_pa_2	BIO_12612044_pa_7	BIO_12612044_pa_2_7
BIO	12612044	pa	2	8	proposal_implementation	observation	info-required	info-required	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_pa_2	BIO_12612044_pa_8	BIO_12612044_pa_2_8
BIO	12612044	pa	2	9	proposal_implementation	observation	info-required	support	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_pa_2	BIO_12612044_pa_9	BIO_12612044_pa_2_9
BIO	12612044	pa	2	10	proposal_implementation	observation	info-required	elaboration	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_pa_2	BIO_12612044_pa_10	BIO_12612044_pa_2_10
BIO	12612044	pa	2	11	proposal_implementation	conclusion	info-required	support	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_pa_2	BIO_12612044_pa_11	BIO_12612044_pa_2_11
BIO	12612044	pa	2	12	proposal_implementation	conclusion	info-required	elaboration	secondary	secondary	none	none	A virtual target and cursor image were viewed co-planar with the manipulandum.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_pa_2	BIO_12612044_pa_12	BIO_12612044_pa_2_12
BIO	12612044	pa	3	4	proposal_implementation	proposal_implementation	info-required	elaboration	secondary	secondary	forw	info-required	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	BIO_12612044_pa_3	BIO_12612044_pa_4	BIO_12612044_pa_3_4
BIO	12612044	pa	3	5	proposal_implementation	observation	info-required	info-required	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	BIO_12612044_pa_3	BIO_12612044_pa_5	BIO_12612044_pa_3_5
BIO	12612044	pa	3	6	proposal_implementation	means	info-required	by-means	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	BIO_12612044_pa_3	BIO_12612044_pa_6	BIO_12612044_pa_3_6
BIO	12612044	pa	3	7	proposal_implementation	observation	info-required	info-required	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	Most task-related neurons (68%) showed no significant directional modulation.	BIO_12612044_pa_3	BIO_12612044_pa_7	BIO_12612044_pa_3_7
BIO	12612044	pa	3	8	proposal_implementation	observation	info-required	info-required	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_pa_3	BIO_12612044_pa_8	BIO_12612044_pa_3_8
BIO	12612044	pa	3	9	proposal_implementation	observation	info-required	support	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_pa_3	BIO_12612044_pa_9	BIO_12612044_pa_3_9
BIO	12612044	pa	3	10	proposal_implementation	observation	info-required	elaboration	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_pa_3	BIO_12612044_pa_10	BIO_12612044_pa_3_10
BIO	12612044	pa	3	11	proposal_implementation	conclusion	info-required	support	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_pa_3	BIO_12612044_pa_11	BIO_12612044_pa_3_11
BIO	12612044	pa	3	12	proposal_implementation	conclusion	info-required	elaboration	secondary	secondary	none	none	In the normal task, manipulandum and cursor moved in the same direction; in the mirror task, the cursor was left-right reversed.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_pa_3	BIO_12612044_pa_12	BIO_12612044_pa_3_12
BIO	12612044	pa	4	5	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	BIO_12612044_pa_4	BIO_12612044_pa_5	BIO_12612044_pa_4_5
BIO	12612044	pa	4	6	proposal_implementation	means	elaboration	by-means	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	BIO_12612044_pa_4	BIO_12612044_pa_6	BIO_12612044_pa_4_6
BIO	12612044	pa	4	7	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	Most task-related neurons (68%) showed no significant directional modulation.	BIO_12612044_pa_4	BIO_12612044_pa_7	BIO_12612044_pa_4_7
BIO	12612044	pa	4	8	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_pa_4	BIO_12612044_pa_8	BIO_12612044_pa_4_8
BIO	12612044	pa	4	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_pa_4	BIO_12612044_pa_9	BIO_12612044_pa_4_9
BIO	12612044	pa	4	10	proposal_implementation	observation	elaboration	elaboration	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_pa_4	BIO_12612044_pa_10	BIO_12612044_pa_4_10
BIO	12612044	pa	4	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_pa_4	BIO_12612044_pa_11	BIO_12612044_pa_4_11
BIO	12612044	pa	4	12	proposal_implementation	conclusion	elaboration	elaboration	secondary	secondary	none	none	In one monkey, 70- and 200-ms time delays were introduced on cursor movement.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_pa_4	BIO_12612044_pa_12	BIO_12612044_pa_4_12
BIO	12612044	pa	5	6	observation	means	info-required	by-means	secondary	secondary	none	none	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	BIO_12612044_pa_5	BIO_12612044_pa_6	BIO_12612044_pa_5_6
BIO	12612044	pa	5	7	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	Most task-related neurons (68%) showed no significant directional modulation.	BIO_12612044_pa_5	BIO_12612044_pa_7	BIO_12612044_pa_5_7
BIO	12612044	pa	5	8	observation	observation	info-required	info-required	secondary	secondary	none	none	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_pa_5	BIO_12612044_pa_8	BIO_12612044_pa_5_8
BIO	12612044	pa	5	9	observation	observation	info-required	support	secondary	secondary	none	none	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_pa_5	BIO_12612044_pa_9	BIO_12612044_pa_5_9
BIO	12612044	pa	5	10	observation	observation	info-required	elaboration	secondary	secondary	none	none	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_pa_5	BIO_12612044_pa_10	BIO_12612044_pa_5_10
BIO	12612044	pa	5	11	observation	conclusion	info-required	support	secondary	secondary	none	none	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_pa_5	BIO_12612044_pa_11	BIO_12612044_pa_5_11
BIO	12612044	pa	5	12	observation	conclusion	info-required	elaboration	secondary	secondary	none	none	Significant task-related activity was recorded in 31 cells in one animal and 142 cells in the second: 10.2% increased activity before arm movements onset, 77.1% during arm movement, and 12.7% after the new position was reached.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_pa_5	BIO_12612044_pa_12	BIO_12612044_pa_5_12
BIO	12612044	pa	6	7	means	observation	by-means	info-required	secondary	secondary	forw	by-means	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	Most task-related neurons (68%) showed no significant directional modulation.	BIO_12612044_pa_6	BIO_12612044_pa_7	BIO_12612044_pa_6_7
BIO	12612044	pa	6	8	means	observation	by-means	info-required	secondary	secondary	none	none	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_pa_6	BIO_12612044_pa_8	BIO_12612044_pa_6_8
BIO	12612044	pa	6	9	means	observation	by-means	support	secondary	secondary	none	none	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_pa_6	BIO_12612044_pa_9	BIO_12612044_pa_6_9
BIO	12612044	pa	6	10	means	observation	by-means	elaboration	secondary	secondary	none	none	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_pa_6	BIO_12612044_pa_10	BIO_12612044_pa_6_10
BIO	12612044	pa	6	11	means	conclusion	by-means	support	secondary	secondary	none	none	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_pa_6	BIO_12612044_pa_11	BIO_12612044_pa_6_11
BIO	12612044	pa	6	12	means	conclusion	by-means	elaboration	secondary	secondary	none	none	To test for neural representation of the visual outcome of movement, firing rate modulation was compared in normal and mirror step-tracking.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_pa_6	BIO_12612044_pa_12	BIO_12612044_pa_6_12
BIO	12612044	pa	7	8	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Most task-related neurons (68%) showed no significant directional modulation.	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	BIO_12612044_pa_7	BIO_12612044_pa_8	BIO_12612044_pa_7_8
BIO	12612044	pa	7	9	observation	observation	info-required	support	secondary	secondary	none	none	Most task-related neurons (68%) showed no significant directional modulation.	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_pa_7	BIO_12612044_pa_9	BIO_12612044_pa_7_9
BIO	12612044	pa	7	10	observation	observation	info-required	elaboration	secondary	secondary	none	none	Most task-related neurons (68%) showed no significant directional modulation.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_pa_7	BIO_12612044_pa_10	BIO_12612044_pa_7_10
BIO	12612044	pa	7	11	observation	conclusion	info-required	support	secondary	secondary	none	none	Most task-related neurons (68%) showed no significant directional modulation.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_pa_7	BIO_12612044_pa_11	BIO_12612044_pa_7_11
BIO	12612044	pa	7	12	observation	conclusion	info-required	elaboration	secondary	secondary	none	none	Most task-related neurons (68%) showed no significant directional modulation.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_pa_7	BIO_12612044_pa_12	BIO_12612044_pa_7_12
BIO	12612044	pa	8	9	observation	observation	info-required	support	secondary	secondary	forw	info-required	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	BIO_12612044_pa_8	BIO_12612044_pa_9	BIO_12612044_pa_8_9
BIO	12612044	pa	8	10	observation	observation	info-required	elaboration	secondary	secondary	none	none	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_pa_8	BIO_12612044_pa_10	BIO_12612044_pa_8_10
BIO	12612044	pa	8	11	observation	conclusion	info-required	support	secondary	secondary	none	none	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_pa_8	BIO_12612044_pa_11	BIO_12612044_pa_8_11
BIO	12612044	pa	8	12	observation	conclusion	info-required	elaboration	secondary	secondary	none	none	Of 70 directionally sensitive cells, almost one-half (n = 34, 48%) modulated firing with a consistent cursor movement direction, many fewer responding to the manipulandum direction (n = 9, 13%).	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_pa_8	BIO_12612044_pa_12	BIO_12612044_pa_8_12
BIO	12612044	pa	9	10	observation	observation	support	elaboration	secondary	secondary	back	elaboration	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	Hence, activity returned to baseline about when the delayed cursor reached the target.	BIO_12612044_pa_9	BIO_12612044_pa_10	BIO_12612044_pa_9_10
BIO	12612044	pa	9	11	observation	conclusion	support	support	secondary	secondary	forw	support	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_pa_9	BIO_12612044_pa_11	BIO_12612044_pa_9_11
BIO	12612044	pa	9	12	observation	conclusion	support	elaboration	secondary	secondary	none	none	For those "cursor-related" cells tested with delayed cursor movement, increased activity onset was time-locked to arm movement and not cursor movement, but activation duration was extended by an amount similar to the applied delay.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_pa_9	BIO_12612044_pa_12	BIO_12612044_pa_9_12
BIO	12612044	pa	10	11	observation	conclusion	elaboration	support	secondary	secondary	none	none	Hence, activity returned to baseline about when the delayed cursor reached the target.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_pa_10	BIO_12612044_pa_11	BIO_12612044_pa_10_11
BIO	12612044	pa	10	12	observation	conclusion	elaboration	elaboration	secondary	secondary	none	none	Hence, activity returned to baseline about when the delayed cursor reached the target.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_pa_10	BIO_12612044_pa_12	BIO_12612044_pa_10_12
BIO	12612044	pa	11	12	conclusion	conclusion	support	elaboration	secondary	secondary	back	elaboration	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	BIO_12612044_pa_11	BIO_12612044_pa_12	BIO_12612044_pa_11_12
BIO	12612044	pa	12	11	conclusion	conclusion	elaboration	support	secondary	secondary	forw	elaboration	Such a predictive representation of the arm movement could be used in the guidance of visuo-motor actions.	We conclude that many cells in the lateral cerebellar cortex signaled the direction of cursor movement during active step-tracking.	BIO_12612044_pa_12	BIO_12612044_pa_11	BIO_12612044_pa_11_12
BIO	12622405	pa	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	BIO_12622405_pa_1	BIO_12622405_pa_2	BIO_12622405_pa_1_2
BIO	12622405	pa	1	3	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	BIO_12622405_pa_1	BIO_12622405_pa_3	BIO_12622405_pa_1_3
BIO	12622405	pa	1	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	BIO_12622405_pa_1	BIO_12622405_pa_4	BIO_12622405_pa_1_4
BIO	12622405	pa	1	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Their neuroprotective activity against excitotoxic insults remains elusive.	BIO_12622405_pa_1	BIO_12622405_pa_5	BIO_12622405_pa_1_5
BIO	12622405	pa	1	6	motivation_background	proposal	info-required	none	secondary	main	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	BIO_12622405_pa_1	BIO_12622405_pa_6	BIO_12622405_pa_1_6
BIO	12622405	pa	1	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	BIO_12622405_pa_1	BIO_12622405_pa_7	BIO_12622405_pa_1_7
BIO	12622405	pa	1	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_pa_1	BIO_12622405_pa_8	BIO_12622405_pa_1_8
BIO	12622405	pa	1	9	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_pa_1	BIO_12622405_pa_9	BIO_12622405_pa_1_9
BIO	12622405	pa	1	10	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_pa_1	BIO_12622405_pa_10	BIO_12622405_pa_1_10
BIO	12622405	pa	1	11	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_pa_1	BIO_12622405_pa_11	BIO_12622405_pa_1_11
BIO	12622405	pa	1	12	motivation_background	observation	info-required	support	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_pa_1	BIO_12622405_pa_12	BIO_12622405_pa_1_12
BIO	12622405	pa	1	13	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_1	BIO_12622405_pa_13	BIO_12622405_pa_1_13
BIO	12622405	pa	1	14	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Excessive activation of glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype is considered a relevant initial step underlying different neurodegenerative diseases.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_1	BIO_12622405_pa_14	BIO_12622405_pa_1_14
BIO	12622405	pa	2	3	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	BIO_12622405_pa_2	BIO_12622405_pa_3	BIO_12622405_pa_2_3
BIO	12622405	pa	2	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	BIO_12622405_pa_2	BIO_12622405_pa_4	BIO_12622405_pa_2_4
BIO	12622405	pa	2	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Their neuroprotective activity against excitotoxic insults remains elusive.	BIO_12622405_pa_2	BIO_12622405_pa_5	BIO_12622405_pa_2_5
BIO	12622405	pa	2	6	motivation_background	proposal	info-required	none	secondary	main	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	BIO_12622405_pa_2	BIO_12622405_pa_6	BIO_12622405_pa_2_6
BIO	12622405	pa	2	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	BIO_12622405_pa_2	BIO_12622405_pa_7	BIO_12622405_pa_2_7
BIO	12622405	pa	2	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_pa_2	BIO_12622405_pa_8	BIO_12622405_pa_2_8
BIO	12622405	pa	2	9	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_pa_2	BIO_12622405_pa_9	BIO_12622405_pa_2_9
BIO	12622405	pa	2	10	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_pa_2	BIO_12622405_pa_10	BIO_12622405_pa_2_10
BIO	12622405	pa	2	11	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_pa_2	BIO_12622405_pa_11	BIO_12622405_pa_2_11
BIO	12622405	pa	2	12	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_pa_2	BIO_12622405_pa_12	BIO_12622405_pa_2_12
BIO	12622405	pa	2	13	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_2	BIO_12622405_pa_13	BIO_12622405_pa_2_13
BIO	12622405	pa	2	14	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Recently, with the approval of memantine to treat Alzheimer dementia, NMDA receptors have regained clinical interest.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_2	BIO_12622405_pa_14	BIO_12622405_pa_2_14
BIO	12622405	pa	3	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	BIO_12622405_pa_3	BIO_12622405_pa_4	BIO_12622405_pa_3_4
BIO	12622405	pa	3	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	Their neuroprotective activity against excitotoxic insults remains elusive.	BIO_12622405_pa_3	BIO_12622405_pa_5	BIO_12622405_pa_3_5
BIO	12622405	pa	3	6	motivation_background	proposal	info-required	none	secondary	main	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	BIO_12622405_pa_3	BIO_12622405_pa_6	BIO_12622405_pa_3_6
BIO	12622405	pa	3	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	BIO_12622405_pa_3	BIO_12622405_pa_7	BIO_12622405_pa_3_7
BIO	12622405	pa	3	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_pa_3	BIO_12622405_pa_8	BIO_12622405_pa_3_8
BIO	12622405	pa	3	9	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_pa_3	BIO_12622405_pa_9	BIO_12622405_pa_3_9
BIO	12622405	pa	3	10	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_pa_3	BIO_12622405_pa_10	BIO_12622405_pa_3_10
BIO	12622405	pa	3	11	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_pa_3	BIO_12622405_pa_11	BIO_12622405_pa_3_11
BIO	12622405	pa	3	12	motivation_background	observation	info-required	support	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_pa_3	BIO_12622405_pa_12	BIO_12622405_pa_3_12
BIO	12622405	pa	3	13	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_3	BIO_12622405_pa_13	BIO_12622405_pa_3_13
BIO	12622405	pa	3	14	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Accordingly, the development and validation of NMDA receptor antagonists is being reconsidered.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_3	BIO_12622405_pa_14	BIO_12622405_pa_3_14
BIO	12622405	pa	4	5	motivation_background	motivation_problem	info-required	support	secondary	secondary	forw	info-required	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	Their neuroprotective activity against excitotoxic insults remains elusive.	BIO_12622405_pa_4	BIO_12622405_pa_5	BIO_12622405_pa_4_5
BIO	12622405	pa	4	6	motivation_background	proposal	info-required	none	secondary	main	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	BIO_12622405_pa_4	BIO_12622405_pa_6	BIO_12622405_pa_4_6
BIO	12622405	pa	4	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	BIO_12622405_pa_4	BIO_12622405_pa_7	BIO_12622405_pa_4_7
BIO	12622405	pa	4	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_pa_4	BIO_12622405_pa_8	BIO_12622405_pa_4_8
BIO	12622405	pa	4	9	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_pa_4	BIO_12622405_pa_9	BIO_12622405_pa_4_9
BIO	12622405	pa	4	10	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_pa_4	BIO_12622405_pa_10	BIO_12622405_pa_4_10
BIO	12622405	pa	4	11	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_pa_4	BIO_12622405_pa_11	BIO_12622405_pa_4_11
BIO	12622405	pa	4	12	motivation_background	observation	info-required	support	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_pa_4	BIO_12622405_pa_12	BIO_12622405_pa_4_12
BIO	12622405	pa	4	13	motivation_background	observation	info-required	elaboration	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_4	BIO_12622405_pa_13	BIO_12622405_pa_4_13
BIO	12622405	pa	4	14	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	We recently identified a family of trialkylglycines that act as channel blockers of the NMDAreceptor.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_4	BIO_12622405_pa_14	BIO_12622405_pa_4_14
BIO	12622405	pa	5	6	motivation_problem	proposal	support	none	secondary	main	forw	support	Their neuroprotective activity against excitotoxic insults remains elusive.	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	BIO_12622405_pa_5	BIO_12622405_pa_6	BIO_12622405_pa_5_6
BIO	12622405	pa	5	7	motivation_problem	observation	support	info-required	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	BIO_12622405_pa_5	BIO_12622405_pa_7	BIO_12622405_pa_5_7
BIO	12622405	pa	5	8	motivation_problem	observation	support	info-required	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_pa_5	BIO_12622405_pa_8	BIO_12622405_pa_5_8
BIO	12622405	pa	5	9	motivation_problem	observation	support	info-required	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_pa_5	BIO_12622405_pa_9	BIO_12622405_pa_5_9
BIO	12622405	pa	5	10	motivation_problem	observation	support	info-required	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_pa_5	BIO_12622405_pa_10	BIO_12622405_pa_5_10
BIO	12622405	pa	5	11	motivation_problem	observation	support	info-required	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_pa_5	BIO_12622405_pa_11	BIO_12622405_pa_5_11
BIO	12622405	pa	5	12	motivation_problem	observation	support	support	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_pa_5	BIO_12622405_pa_12	BIO_12622405_pa_5_12
BIO	12622405	pa	5	13	motivation_problem	observation	support	elaboration	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_5	BIO_12622405_pa_13	BIO_12622405_pa_5_13
BIO	12622405	pa	5	14	motivation_problem	conclusion	support	support	secondary	secondary	none	none	Their neuroprotective activity against excitotoxic insults remains elusive.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_5	BIO_12622405_pa_14	BIO_12622405_pa_5_14
BIO	12622405	pa	6	7	proposal	observation	none	info-required	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	BIO_12622405_pa_6	BIO_12622405_pa_7	BIO_12622405_pa_6_7
BIO	12622405	pa	6	8	proposal	observation	none	info-required	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_pa_6	BIO_12622405_pa_8	BIO_12622405_pa_6_8
BIO	12622405	pa	6	9	proposal	observation	none	info-required	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_pa_6	BIO_12622405_pa_9	BIO_12622405_pa_6_9
BIO	12622405	pa	6	10	proposal	observation	none	info-required	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_pa_6	BIO_12622405_pa_10	BIO_12622405_pa_6_10
BIO	12622405	pa	6	11	proposal	observation	none	info-required	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_pa_6	BIO_12622405_pa_11	BIO_12622405_pa_6_11
BIO	12622405	pa	6	12	proposal	observation	none	support	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_pa_6	BIO_12622405_pa_12	BIO_12622405_pa_6_12
BIO	12622405	pa	6	13	proposal	observation	none	elaboration	main	secondary	none	none	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_6	BIO_12622405_pa_13	BIO_12622405_pa_6_13
BIO	12622405	pa	6	14	proposal	conclusion	none	support	main	secondary	back	support	To address this issue, we first characterized the contribution of glutamate receptor subtypes to hippocampal death in culture as a function of days in culture in vitro (DIV).	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_6	BIO_12622405_pa_14	BIO_12622405_pa_6_14
BIO	12622405	pa	7	8	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	Similar results were obtained for L-glutamate at 14 DIV.	BIO_12622405_pa_7	BIO_12622405_pa_8	BIO_12622405_pa_7_8
BIO	12622405	pa	7	9	observation	observation	info-required	info-required	secondary	secondary	none	none	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_pa_7	BIO_12622405_pa_9	BIO_12622405_pa_7_9
BIO	12622405	pa	7	10	observation	observation	info-required	info-required	secondary	secondary	none	none	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_pa_7	BIO_12622405_pa_10	BIO_12622405_pa_7_10
BIO	12622405	pa	7	11	observation	observation	info-required	info-required	secondary	secondary	none	none	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_pa_7	BIO_12622405_pa_11	BIO_12622405_pa_7_11
BIO	12622405	pa	7	12	observation	observation	info-required	support	secondary	secondary	none	none	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_pa_7	BIO_12622405_pa_12	BIO_12622405_pa_7_12
BIO	12622405	pa	7	13	observation	observation	info-required	elaboration	secondary	secondary	none	none	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_7	BIO_12622405_pa_13	BIO_12622405_pa_7_13
BIO	12622405	pa	7	14	observation	conclusion	info-required	support	secondary	secondary	none	none	Whereas at 7 DIV neither NMDA nor glutamate produced a significant neuronal death, at 14 and 21 DIV, NMDA produced the death of 40% of the neurons exposed to this receptor agonist that was fully protected by MK-801.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_7	BIO_12622405_pa_14	BIO_12622405_pa_7_14
BIO	12622405	pa	8	9	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Similar results were obtained for L-glutamate at 14 DIV.	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	BIO_12622405_pa_8	BIO_12622405_pa_9	BIO_12622405_pa_8_9
BIO	12622405	pa	8	10	observation	observation	info-required	info-required	secondary	secondary	none	none	Similar results were obtained for L-glutamate at 14 DIV.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_pa_8	BIO_12622405_pa_10	BIO_12622405_pa_8_10
BIO	12622405	pa	8	11	observation	observation	info-required	info-required	secondary	secondary	none	none	Similar results were obtained for L-glutamate at 14 DIV.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_pa_8	BIO_12622405_pa_11	BIO_12622405_pa_8_11
BIO	12622405	pa	8	12	observation	observation	info-required	support	secondary	secondary	none	none	Similar results were obtained for L-glutamate at 14 DIV.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_pa_8	BIO_12622405_pa_12	BIO_12622405_pa_8_12
BIO	12622405	pa	8	13	observation	observation	info-required	elaboration	secondary	secondary	none	none	Similar results were obtained for L-glutamate at 14 DIV.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_8	BIO_12622405_pa_13	BIO_12622405_pa_8_13
BIO	12622405	pa	8	14	observation	conclusion	info-required	support	secondary	secondary	none	none	Similar results were obtained for L-glutamate at 14 DIV.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_8	BIO_12622405_pa_14	BIO_12622405_pa_8_14
BIO	12622405	pa	9	10	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	BIO_12622405_pa_9	BIO_12622405_pa_10	BIO_12622405_pa_9_10
BIO	12622405	pa	9	11	observation	observation	info-required	info-required	secondary	secondary	none	none	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_pa_9	BIO_12622405_pa_11	BIO_12622405_pa_9_11
BIO	12622405	pa	9	12	observation	observation	info-required	support	secondary	secondary	none	none	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_pa_9	BIO_12622405_pa_12	BIO_12622405_pa_9_12
BIO	12622405	pa	9	13	observation	observation	info-required	elaboration	secondary	secondary	none	none	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_9	BIO_12622405_pa_13	BIO_12622405_pa_9_13
BIO	12622405	pa	9	14	observation	conclusion	info-required	support	secondary	secondary	none	none	In contrast, when neurons at 21 DIV were used, glutamate killed 51.1 +/- 4.9% of the neuronal population.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_9	BIO_12622405_pa_14	BIO_12622405_pa_9_14
BIO	12622405	pa	10	11	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	BIO_12622405_pa_10	BIO_12622405_pa_11	BIO_12622405_pa_10_11
BIO	12622405	pa	10	12	observation	observation	info-required	support	secondary	secondary	none	none	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_pa_10	BIO_12622405_pa_12	BIO_12622405_pa_10_12
BIO	12622405	pa	10	13	observation	observation	info-required	elaboration	secondary	secondary	none	none	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_10	BIO_12622405_pa_13	BIO_12622405_pa_10_13
BIO	12622405	pa	10	14	observation	conclusion	info-required	support	secondary	secondary	none	none	This neuronal death was only partially prevented by MK-801, and fully abrogated by a combination of MK-801 and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_10	BIO_12622405_pa_14	BIO_12622405_pa_10_14
BIO	12622405	pa	11	12	observation	observation	info-required	support	secondary	secondary	forw	info-required	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	BIO_12622405_pa_11	BIO_12622405_pa_12	BIO_12622405_pa_11_12
BIO	12622405	pa	11	13	observation	observation	info-required	elaboration	secondary	secondary	none	none	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_11	BIO_12622405_pa_13	BIO_12622405_pa_11_13
BIO	12622405	pa	11	14	observation	conclusion	info-required	support	secondary	secondary	none	none	Glucose deprivation injured 37.1 +/- 9.2% of the neurons through a mechanism sensitive to MK-801.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_11	BIO_12622405_pa_14	BIO_12622405_pa_11_14
BIO	12622405	pa	12	13	observation	observation	support	elaboration	secondary	secondary	back	elaboration	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_12	BIO_12622405_pa_13	BIO_12622405_pa_12_13
BIO	12622405	pa	12	14	observation	conclusion	support	support	secondary	secondary	forw	support	The family of recently identified N-alkylglycines tested protected neurons against NMDA and glucosedeprivation toxicity, but not against glutamate toxicity.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_12	BIO_12622405_pa_14	BIO_12622405_pa_12_14
BIO	12622405	pa	13	14	observation	conclusion	elaboration	support	secondary	secondary	none	none	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	BIO_12622405_pa_13	BIO_12622405_pa_14	BIO_12622405_pa_13_14
BIO	12622405	pa	14	13	conclusion	observation	support	elaboration	secondary	secondary	none	none	Collectively, these findings imply both NMDA and non-NMDA receptors in excitotoxicity of hippocampal neurons, and suggest that blockade of NMDA receptors alone may not suffice to efficiently abrogate neurodegeneration.	Noteworthy, N-alkylglicines with a moderate protection against NMDA-induced toxicity strongly protected from beta-amyloid toxicity.	BIO_12622405_pa_14	BIO_12622405_pa_13	BIO_12622405_pa_13_14
BIO	12663096	pa	1	2	motivation_background	motivation_background	support	support	secondary	secondary	forw	support	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	BIO_12663096_pa_1	BIO_12663096_pa_2	BIO_12663096_pa_1_2
BIO	12663096	pa	1	3	motivation_background	proposal	support	none	secondary	main	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	BIO_12663096_pa_1	BIO_12663096_pa_3	BIO_12663096_pa_1_3
BIO	12663096	pa	1	4	motivation_background	means	support	by-means	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	BIO_12663096_pa_1	BIO_12663096_pa_4	BIO_12663096_pa_1_4
BIO	12663096	pa	1	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	BIO_12663096_pa_1	BIO_12663096_pa_5	BIO_12663096_pa_1_5
BIO	12663096	pa	1	6	motivation_background	observation	support	info-required	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	BIO_12663096_pa_1	BIO_12663096_pa_6	BIO_12663096_pa_1_6
BIO	12663096	pa	1	7	motivation_background	observation	support	info-required	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	BIO_12663096_pa_1	BIO_12663096_pa_7	BIO_12663096_pa_1_7
BIO	12663096	pa	1	8	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_pa_1	BIO_12663096_pa_8	BIO_12663096_pa_1_8
BIO	12663096	pa	1	9	motivation_background	observation	support	info-required	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_pa_1	BIO_12663096_pa_9	BIO_12663096_pa_1_9
BIO	12663096	pa	1	10	motivation_background	observation	support	support	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_pa_1	BIO_12663096_pa_10	BIO_12663096_pa_1_10
BIO	12663096	pa	1	11	motivation_background	conclusion	support	support	secondary	secondary	none	none	Accumulation of amyloid-beta peptide (Abeta) is widely believed to play a critical role in the pathogenesis of Alzheimer's disease.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_pa_1	BIO_12663096_pa_11	BIO_12663096_pa_1_11
BIO	12663096	pa	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	BIO_12663096_pa_2	BIO_12663096_pa_3	BIO_12663096_pa_2_3
BIO	12663096	pa	2	4	motivation_background	means	support	by-means	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	BIO_12663096_pa_2	BIO_12663096_pa_4	BIO_12663096_pa_2_4
BIO	12663096	pa	2	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	BIO_12663096_pa_2	BIO_12663096_pa_5	BIO_12663096_pa_2_5
BIO	12663096	pa	2	6	motivation_background	observation	support	info-required	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	BIO_12663096_pa_2	BIO_12663096_pa_6	BIO_12663096_pa_2_6
BIO	12663096	pa	2	7	motivation_background	observation	support	info-required	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	BIO_12663096_pa_2	BIO_12663096_pa_7	BIO_12663096_pa_2_7
BIO	12663096	pa	2	8	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_pa_2	BIO_12663096_pa_8	BIO_12663096_pa_2_8
BIO	12663096	pa	2	9	motivation_background	observation	support	info-required	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_pa_2	BIO_12663096_pa_9	BIO_12663096_pa_2_9
BIO	12663096	pa	2	10	motivation_background	observation	support	support	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_pa_2	BIO_12663096_pa_10	BIO_12663096_pa_2_10
BIO	12663096	pa	2	11	motivation_background	conclusion	support	support	secondary	secondary	none	none	Although amyloid-containing plaques are a key neuropathological feature of AD, soluble forms of Abeta can interfere with synaptic plasticity in the brain, suggesting that this form of the peptide may be responsible for much of the memory deficit seen early in the disease.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_pa_2	BIO_12663096_pa_11	BIO_12663096_pa_2_11
BIO	12663096	pa	3	4	proposal	means	none	by-means	main	secondary	none	none	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	BIO_12663096_pa_3	BIO_12663096_pa_4	BIO_12663096_pa_3_4
BIO	12663096	pa	3	5	proposal	observation	none	info-required	main	secondary	none	none	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	BIO_12663096_pa_3	BIO_12663096_pa_5	BIO_12663096_pa_3_5
BIO	12663096	pa	3	6	proposal	observation	none	info-required	main	secondary	none	none	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	BIO_12663096_pa_3	BIO_12663096_pa_6	BIO_12663096_pa_3_6
BIO	12663096	pa	3	7	proposal	observation	none	info-required	main	secondary	none	none	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	BIO_12663096_pa_3	BIO_12663096_pa_7	BIO_12663096_pa_3_7
BIO	12663096	pa	3	8	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_pa_3	BIO_12663096_pa_8	BIO_12663096_pa_3_8
BIO	12663096	pa	3	9	proposal	observation	none	info-required	main	secondary	none	none	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_pa_3	BIO_12663096_pa_9	BIO_12663096_pa_3_9
BIO	12663096	pa	3	10	proposal	observation	none	support	main	secondary	none	none	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_pa_3	BIO_12663096_pa_10	BIO_12663096_pa_3_10
BIO	12663096	pa	3	11	proposal	conclusion	none	support	main	secondary	back	support	Here, we investigate the mechanism underlying the effects of Abeta on long-term potentiation (LTP) in area CA1 of rat hippocampus.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_pa_3	BIO_12663096_pa_11	BIO_12663096_pa_3_11
BIO	12663096	pa	4	5	means	observation	by-means	info-required	secondary	secondary	forw	by-means	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	BIO_12663096_pa_4	BIO_12663096_pa_5	BIO_12663096_pa_4_5
BIO	12663096	pa	4	6	means	observation	by-means	info-required	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	BIO_12663096_pa_4	BIO_12663096_pa_6	BIO_12663096_pa_4_6
BIO	12663096	pa	4	7	means	observation	by-means	info-required	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	BIO_12663096_pa_4	BIO_12663096_pa_7	BIO_12663096_pa_4_7
BIO	12663096	pa	4	8	means	proposal_implementation	by-means	elaboration	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_pa_4	BIO_12663096_pa_8	BIO_12663096_pa_4_8
BIO	12663096	pa	4	9	means	observation	by-means	info-required	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_pa_4	BIO_12663096_pa_9	BIO_12663096_pa_4_9
BIO	12663096	pa	4	10	means	observation	by-means	support	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_pa_4	BIO_12663096_pa_10	BIO_12663096_pa_4_10
BIO	12663096	pa	4	11	means	conclusion	by-means	support	secondary	secondary	none	none	Extracellular field recordings were made in area CA1 of hippocampal slices taken from young, adult male rats.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_pa_4	BIO_12663096_pa_11	BIO_12663096_pa_4_11
BIO	12663096	pa	5	6	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	BIO_12663096_pa_5	BIO_12663096_pa_6	BIO_12663096_pa_5_6
BIO	12663096	pa	5	7	observation	observation	info-required	info-required	secondary	secondary	none	none	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	BIO_12663096_pa_5	BIO_12663096_pa_7	BIO_12663096_pa_5_7
BIO	12663096	pa	5	8	observation	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_pa_5	BIO_12663096_pa_8	BIO_12663096_pa_5_8
BIO	12663096	pa	5	9	observation	observation	info-required	info-required	secondary	secondary	none	none	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_pa_5	BIO_12663096_pa_9	BIO_12663096_pa_5_9
BIO	12663096	pa	5	10	observation	observation	info-required	support	secondary	secondary	none	none	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_pa_5	BIO_12663096_pa_10	BIO_12663096_pa_5_10
BIO	12663096	pa	5	11	observation	conclusion	info-required	support	secondary	secondary	none	none	A non-toxic concentration of Abeta (200 nM) produced a rapid inhibition of LTP induced by 100 Hz stimulation while having no long-term effect on normal synaptic transmission.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_pa_5	BIO_12663096_pa_11	BIO_12663096_pa_5_11
BIO	12663096	pa	6	7	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	BIO_12663096_pa_6	BIO_12663096_pa_7	BIO_12663096_pa_6_7
BIO	12663096	pa	6	8	observation	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_pa_6	BIO_12663096_pa_8	BIO_12663096_pa_6_8
BIO	12663096	pa	6	9	observation	observation	info-required	info-required	secondary	secondary	none	none	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_pa_6	BIO_12663096_pa_9	BIO_12663096_pa_6_9
BIO	12663096	pa	6	10	observation	observation	info-required	support	secondary	secondary	none	none	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_pa_6	BIO_12663096_pa_10	BIO_12663096_pa_6_10
BIO	12663096	pa	6	11	observation	conclusion	info-required	support	secondary	secondary	none	none	The same dose of Abeta had no effect on long-term depression (LTD) induced by 1200 pulses at 1 or 3 Hz.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_pa_6	BIO_12663096_pa_11	BIO_12663096_pa_6_11
BIO	12663096	pa	7	8	observation	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	BIO_12663096_pa_7	BIO_12663096_pa_8	BIO_12663096_pa_7_8
BIO	12663096	pa	7	9	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_pa_7	BIO_12663096_pa_9	BIO_12663096_pa_7_9
BIO	12663096	pa	7	10	observation	observation	info-required	support	secondary	secondary	none	none	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_pa_7	BIO_12663096_pa_10	BIO_12663096_pa_7_10
BIO	12663096	pa	7	11	observation	conclusion	info-required	support	secondary	secondary	none	none	Picrotoxin had no effect on the inhibition of LTP, suggesting Abeta does not act by enhancing GABAergic transmission.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_pa_7	BIO_12663096_pa_11	BIO_12663096_pa_7_11
BIO	12663096	pa	8	9	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	BIO_12663096_pa_8	BIO_12663096_pa_9	BIO_12663096_pa_8_9
BIO	12663096	pa	8	10	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_pa_8	BIO_12663096_pa_10	BIO_12663096_pa_8_10
BIO	12663096	pa	8	11	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Since the LTP induction in this study was dependent on N-methyl-D-aspartate (NMDA) receptor activation, we looked at the effect of Abeta on isolated NMDA receptor-mediated field potentials.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_pa_8	BIO_12663096_pa_11	BIO_12663096_pa_8_11
BIO	12663096	pa	9	10	observation	observation	info-required	support	secondary	secondary	forw	info-required	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_pa_9	BIO_12663096_pa_10	BIO_12663096_pa_9_10
BIO	12663096	pa	9	11	observation	conclusion	info-required	support	secondary	secondary	none	none	Abeta produced a small but significant inhibition of NMDA receptor-mediated synaptic potentials ( approximately 25%).	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_pa_9	BIO_12663096_pa_11	BIO_12663096_pa_9_11
BIO	12663096	pa	10	11	observation	conclusion	support	support	secondary	secondary	forw	support	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	BIO_12663096_pa_10	BIO_12663096_pa_11	BIO_12663096_pa_10_11
BIO	12663096	pa	11	10	conclusion	observation	support	support	secondary	secondary	back	support	These results suggest that Abeta does not inhibit LTP via effects on NMDA receptors, but rather interferes with a downstream pathway.	However, a low dose of MK-801 (0.5 microM) that produced a similar inhibition of NMDA potentials had no effect on LTP induction but completely blocked LTD induction.	BIO_12663096_pa_11	BIO_12663096_pa_10	BIO_12663096_pa_10_11
BIO	12710980	pa	1	2	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	BIO_12710980_pa_1	BIO_12710980_pa_2	BIO_12710980_pa_1_2
BIO	12710980	pa	1	3	motivation_background	motivation_problem	info-required	info-required	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	BIO_12710980_pa_1	BIO_12710980_pa_3	BIO_12710980_pa_1_3
BIO	12710980	pa	1	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	At present, pharmacological prevention of limbic sclerosis is not available.	BIO_12710980_pa_1	BIO_12710980_pa_4	BIO_12710980_pa_1_4
BIO	12710980	pa	1	5	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	BIO_12710980_pa_1	BIO_12710980_pa_5	BIO_12710980_pa_1_5
BIO	12710980	pa	1	6	motivation_background	motivation_hypothesis	info-required	support	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	BIO_12710980_pa_1	BIO_12710980_pa_6	BIO_12710980_pa_1_6
BIO	12710980	pa	1	7	motivation_background	proposal_implementation	info-required	none	secondary	main	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	BIO_12710980_pa_1	BIO_12710980_pa_7	BIO_12710980_pa_1_7
BIO	12710980	pa	1	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_pa_1	BIO_12710980_pa_8	BIO_12710980_pa_1_8
BIO	12710980	pa	1	9	motivation_background	means	info-required	by-means	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_pa_1	BIO_12710980_pa_9	BIO_12710980_pa_1_9
BIO	12710980	pa	1	10	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_pa_1	BIO_12710980_pa_10	BIO_12710980_pa_1_10
BIO	12710980	pa	1	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_pa_1	BIO_12710980_pa_11	BIO_12710980_pa_1_11
BIO	12710980	pa	1	12	motivation_background	result	info-required	support	secondary	secondary	none	none	Most patients with temporal lobe epilepsy (TLE), the most common type of epilepsy, show pronounced loss of neurons in limbic brain regions, including the hippocampus.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_pa_1	BIO_12710980_pa_12	BIO_12710980_pa_1_12
BIO	12710980	pa	2	3	motivation_background	motivation_problem	info-required	info-required	secondary	secondary	forw	info-required	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	BIO_12710980_pa_2	BIO_12710980_pa_3	BIO_12710980_pa_2_3
BIO	12710980	pa	2	4	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	At present, pharmacological prevention of limbic sclerosis is not available.	BIO_12710980_pa_2	BIO_12710980_pa_4	BIO_12710980_pa_2_4
BIO	12710980	pa	2	5	motivation_background	motivation_background	info-required	info-required	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	BIO_12710980_pa_2	BIO_12710980_pa_5	BIO_12710980_pa_2_5
BIO	12710980	pa	2	6	motivation_background	motivation_hypothesis	info-required	support	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	BIO_12710980_pa_2	BIO_12710980_pa_6	BIO_12710980_pa_2_6
BIO	12710980	pa	2	7	motivation_background	proposal_implementation	info-required	none	secondary	main	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	BIO_12710980_pa_2	BIO_12710980_pa_7	BIO_12710980_pa_2_7
BIO	12710980	pa	2	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_pa_2	BIO_12710980_pa_8	BIO_12710980_pa_2_8
BIO	12710980	pa	2	9	motivation_background	means	info-required	by-means	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_pa_2	BIO_12710980_pa_9	BIO_12710980_pa_2_9
BIO	12710980	pa	2	10	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_pa_2	BIO_12710980_pa_10	BIO_12710980_pa_2_10
BIO	12710980	pa	2	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_pa_2	BIO_12710980_pa_11	BIO_12710980_pa_2_11
BIO	12710980	pa	2	12	motivation_background	result	info-required	support	secondary	secondary	none	none	The massive neurodegeneration in the hippocampus is known as hippocampal sclerosis, and is considered one of the hallmarks of this type of difficult-to-treat epilepsy.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_pa_2	BIO_12710980_pa_12	BIO_12710980_pa_2_12
BIO	12710980	pa	3	4	motivation_problem	motivation_background	info-required	info-required	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	At present, pharmacological prevention of limbic sclerosis is not available.	BIO_12710980_pa_3	BIO_12710980_pa_4	BIO_12710980_pa_3_4
BIO	12710980	pa	3	5	motivation_problem	motivation_background	info-required	info-required	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	BIO_12710980_pa_3	BIO_12710980_pa_5	BIO_12710980_pa_3_5
BIO	12710980	pa	3	6	motivation_problem	motivation_hypothesis	info-required	support	secondary	secondary	forw	info-required	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	BIO_12710980_pa_3	BIO_12710980_pa_6	BIO_12710980_pa_3_6
BIO	12710980	pa	3	7	motivation_problem	proposal_implementation	info-required	none	secondary	main	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	BIO_12710980_pa_3	BIO_12710980_pa_7	BIO_12710980_pa_3_7
BIO	12710980	pa	3	8	motivation_problem	observation	info-required	info-required	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_pa_3	BIO_12710980_pa_8	BIO_12710980_pa_3_8
BIO	12710980	pa	3	9	motivation_problem	means	info-required	by-means	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_pa_3	BIO_12710980_pa_9	BIO_12710980_pa_3_9
BIO	12710980	pa	3	10	motivation_problem	observation	info-required	info-required	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_pa_3	BIO_12710980_pa_10	BIO_12710980_pa_3_10
BIO	12710980	pa	3	11	motivation_problem	observation	info-required	support	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_pa_3	BIO_12710980_pa_11	BIO_12710980_pa_3_11
BIO	12710980	pa	3	12	motivation_problem	result	info-required	support	secondary	secondary	none	none	There is a long and ongoing debate on whether this sclerosis is the result of an initial pathological event, such as a status epilepticus (S.E.), stroke or head trauma, which often precedes the development of TLE, or is caused by the spontaneous recurrent seizures (SRS) once epilepsy has developed.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_pa_3	BIO_12710980_pa_12	BIO_12710980_pa_3_12
BIO	12710980	pa	4	5	motivation_background	motivation_background	info-required	info-required	secondary	secondary	forw	info-required	At present, pharmacological prevention of limbic sclerosis is not available.	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	BIO_12710980_pa_4	BIO_12710980_pa_5	BIO_12710980_pa_4_5
BIO	12710980	pa	4	6	motivation_background	motivation_hypothesis	info-required	support	secondary	secondary	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	BIO_12710980_pa_4	BIO_12710980_pa_6	BIO_12710980_pa_4_6
BIO	12710980	pa	4	7	motivation_background	proposal_implementation	info-required	none	secondary	main	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	BIO_12710980_pa_4	BIO_12710980_pa_7	BIO_12710980_pa_4_7
BIO	12710980	pa	4	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_pa_4	BIO_12710980_pa_8	BIO_12710980_pa_4_8
BIO	12710980	pa	4	9	motivation_background	means	info-required	by-means	secondary	secondary	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_pa_4	BIO_12710980_pa_9	BIO_12710980_pa_4_9
BIO	12710980	pa	4	10	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_pa_4	BIO_12710980_pa_10	BIO_12710980_pa_4_10
BIO	12710980	pa	4	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_pa_4	BIO_12710980_pa_11	BIO_12710980_pa_4_11
BIO	12710980	pa	4	12	motivation_background	result	info-required	support	secondary	secondary	none	none	At present, pharmacological prevention of limbic sclerosis is not available.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_pa_4	BIO_12710980_pa_12	BIO_12710980_pa_4_12
BIO	12710980	pa	5	6	motivation_background	motivation_hypothesis	info-required	support	secondary	secondary	forw	info-required	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	BIO_12710980_pa_5	BIO_12710980_pa_6	BIO_12710980_pa_5_6
BIO	12710980	pa	5	7	motivation_background	proposal_implementation	info-required	none	secondary	main	none	none	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	BIO_12710980_pa_5	BIO_12710980_pa_7	BIO_12710980_pa_5_7
BIO	12710980	pa	5	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_pa_5	BIO_12710980_pa_8	BIO_12710980_pa_5_8
BIO	12710980	pa	5	9	motivation_background	means	info-required	by-means	secondary	secondary	none	none	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_pa_5	BIO_12710980_pa_9	BIO_12710980_pa_5_9
BIO	12710980	pa	5	10	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_pa_5	BIO_12710980_pa_10	BIO_12710980_pa_5_10
BIO	12710980	pa	5	11	motivation_background	observation	info-required	support	secondary	secondary	none	none	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_pa_5	BIO_12710980_pa_11	BIO_12710980_pa_5_11
BIO	12710980	pa	5	12	motivation_background	result	info-required	support	secondary	secondary	none	none	In a clinical situation, such prevention would only be possible if delayed cell death developing after an initial pathological event is involved.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_pa_5	BIO_12710980_pa_12	BIO_12710980_pa_5_12
BIO	12710980	pa	6	7	motivation_hypothesis	proposal_implementation	support	none	secondary	main	forw	support	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	BIO_12710980_pa_6	BIO_12710980_pa_7	BIO_12710980_pa_6_7
BIO	12710980	pa	6	8	motivation_hypothesis	observation	support	info-required	secondary	secondary	none	none	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_pa_6	BIO_12710980_pa_8	BIO_12710980_pa_6_8
BIO	12710980	pa	6	9	motivation_hypothesis	means	support	by-means	secondary	secondary	none	none	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_pa_6	BIO_12710980_pa_9	BIO_12710980_pa_6_9
BIO	12710980	pa	6	10	motivation_hypothesis	observation	support	info-required	secondary	secondary	none	none	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_pa_6	BIO_12710980_pa_10	BIO_12710980_pa_6_10
BIO	12710980	pa	6	11	motivation_hypothesis	observation	support	support	secondary	secondary	none	none	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_pa_6	BIO_12710980_pa_11	BIO_12710980_pa_6_11
BIO	12710980	pa	6	12	motivation_hypothesis	result	support	support	secondary	secondary	none	none	Assuming that sclerotic brain lesions provoke epileptogenesis and that delayed cell death is involved in these lesions, it should be possible to prevent both the lesions and the epilepsy by a prophylactic treatment after an initial insult such as an S.E.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_pa_6	BIO_12710980_pa_12	BIO_12710980_pa_6_12
BIO	12710980	pa	7	8	proposal_implementation	observation	none	info-required	main	secondary	none	none	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	BIO_12710980_pa_7	BIO_12710980_pa_8	BIO_12710980_pa_7_8
BIO	12710980	pa	7	9	proposal_implementation	means	none	by-means	main	secondary	none	none	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_pa_7	BIO_12710980_pa_9	BIO_12710980_pa_7_9
BIO	12710980	pa	7	10	proposal_implementation	observation	none	info-required	main	secondary	none	none	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_pa_7	BIO_12710980_pa_10	BIO_12710980_pa_7_10
BIO	12710980	pa	7	11	proposal_implementation	observation	none	support	main	secondary	none	none	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_pa_7	BIO_12710980_pa_11	BIO_12710980_pa_7_11
BIO	12710980	pa	7	12	proposal_implementation	result	none	support	main	secondary	back	support	In order to test this hypothesis, we used a rat model of TLE in which limbic brain lesions and epilepsy with SRS develop after a kainate-induced S.E.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_pa_7	BIO_12710980_pa_12	BIO_12710980_pa_7_12
BIO	12710980	pa	8	9	observation	means	info-required	by-means	secondary	secondary	back	by-means	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	BIO_12710980_pa_8	BIO_12710980_pa_9	BIO_12710980_pa_8_9
BIO	12710980	pa	8	10	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_pa_8	BIO_12710980_pa_10	BIO_12710980_pa_8_10
BIO	12710980	pa	8	11	observation	observation	info-required	support	secondary	secondary	none	none	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_pa_8	BIO_12710980_pa_11	BIO_12710980_pa_8_11
BIO	12710980	pa	8	12	observation	result	info-required	support	secondary	secondary	none	none	A single low dose of the N-methyl-D-aspartate (NMDA) receptor blocker dizocilpine (MK-801) significantly reduced the damage in limbic regions, including the hippocampus and piriform cortex, and completely protected several rats from such damage when given after an S.E. of 90 min induced by kainate, strongly suggesting that delayed cell death is involved in the damage.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_pa_8	BIO_12710980_pa_12	BIO_12710980_pa_8_12
BIO	12710980	pa	9	10	means	observation	by-means	info-required	secondary	secondary	none	none	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	BIO_12710980_pa_9	BIO_12710980_pa_10	BIO_12710980_pa_9_10
BIO	12710980	pa	9	11	means	observation	by-means	support	secondary	secondary	none	none	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_pa_9	BIO_12710980_pa_11	BIO_12710980_pa_9_11
BIO	12710980	pa	9	12	means	result	by-means	support	secondary	secondary	none	none	This was substantiated by the use of molecular and immunohistochemical markers of delayed active ('programmed') cell death.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_pa_9	BIO_12710980_pa_12	BIO_12710980_pa_9_12
BIO	12710980	pa	10	11	observation	observation	info-required	support	secondary	secondary	forw	info-required	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_pa_10	BIO_12710980_pa_11	BIO_12710980_pa_10_11
BIO	12710980	pa	10	12	observation	result	info-required	support	secondary	secondary	none	none	However, the neuroprotection by dizocilpine did not prevent the development of SRS after the S.E., suggesting that structures not protected by dizocilpine may play a role in the genesis of SRS or that epileptogenesis is not the consequence of structural lesions in the limbic system.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_pa_10	BIO_12710980_pa_12	BIO_12710980_pa_10_12
BIO	12710980	pa	11	12	observation	result	support	support	secondary	secondary	forw	support	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	BIO_12710980_pa_11	BIO_12710980_pa_12	BIO_12710980_pa_11_12
BIO	12710980	pa	12	11	result	observation	support	support	secondary	secondary	back	support	The data indicate that NMDA receptor blockade immediately after a prolonged S.E. is an effective means to reduce the damage produced by a sustained S.E. in several brain regions, including the hippocampus, but show that this partial neuroprotection of the limbic system does not prevent the development of epilepsy.	The only brain regions that exhibited neuronal damage in all rats with SRS were the hilus of the dentate gyrus and the mediodorsal thalamus, although treatment with dizocilpine reduced the severity of damage in the latter region.	BIO_12710980_pa_12	BIO_12710980_pa_11	BIO_12710980_pa_11_12
BIO	14523085	pa	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	BIO_14523085_pa_1	BIO_14523085_pa_2	BIO_14523085_pa_1_2
BIO	14523085	pa	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	BIO_14523085_pa_1	BIO_14523085_pa_3	BIO_14523085_pa_1_3
BIO	14523085	pa	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	BIO_14523085_pa_1	BIO_14523085_pa_4	BIO_14523085_pa_1_4
BIO	14523085	pa	1	5	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	BIO_14523085_pa_1	BIO_14523085_pa_5	BIO_14523085_pa_1_5
BIO	14523085	pa	1	6	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	BIO_14523085_pa_1	BIO_14523085_pa_6	BIO_14523085_pa_1_6
BIO	14523085	pa	1	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	These changes differed from changes seen in tissue lysates from the same animals.	BIO_14523085_pa_1	BIO_14523085_pa_7	BIO_14523085_pa_1_7
BIO	14523085	pa	1	8	motivation_background	observation	info-required	support	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_pa_1	BIO_14523085_pa_8	BIO_14523085_pa_1_8
BIO	14523085	pa	1	9	motivation_background	result	info-required	support	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_pa_1	BIO_14523085_pa_9	BIO_14523085_pa_1_9
BIO	14523085	pa	1	10	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_pa_1	BIO_14523085_pa_10	BIO_14523085_pa_1_10
BIO	14523085	pa	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	BIO_14523085_pa_2	BIO_14523085_pa_3	BIO_14523085_pa_2_3
BIO	14523085	pa	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	BIO_14523085_pa_2	BIO_14523085_pa_4	BIO_14523085_pa_2_4
BIO	14523085	pa	2	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	BIO_14523085_pa_2	BIO_14523085_pa_5	BIO_14523085_pa_2_5
BIO	14523085	pa	2	6	motivation_background	observation	support	info-required	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	BIO_14523085_pa_2	BIO_14523085_pa_6	BIO_14523085_pa_2_6
BIO	14523085	pa	2	7	motivation_background	observation	support	info-required	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	These changes differed from changes seen in tissue lysates from the same animals.	BIO_14523085_pa_2	BIO_14523085_pa_7	BIO_14523085_pa_2_7
BIO	14523085	pa	2	8	motivation_background	observation	support	support	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_pa_2	BIO_14523085_pa_8	BIO_14523085_pa_2_8
BIO	14523085	pa	2	9	motivation_background	result	support	support	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_pa_2	BIO_14523085_pa_9	BIO_14523085_pa_2_9
BIO	14523085	pa	2	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_pa_2	BIO_14523085_pa_10	BIO_14523085_pa_2_10
BIO	14523085	pa	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	BIO_14523085_pa_3	BIO_14523085_pa_4	BIO_14523085_pa_3_4
BIO	14523085	pa	3	5	proposal	observation	none	info-required	main	secondary	none	none	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	BIO_14523085_pa_3	BIO_14523085_pa_5	BIO_14523085_pa_3_5
BIO	14523085	pa	3	6	proposal	observation	none	info-required	main	secondary	none	none	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	BIO_14523085_pa_3	BIO_14523085_pa_6	BIO_14523085_pa_3_6
BIO	14523085	pa	3	7	proposal	observation	none	info-required	main	secondary	none	none	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	These changes differed from changes seen in tissue lysates from the same animals.	BIO_14523085_pa_3	BIO_14523085_pa_7	BIO_14523085_pa_3_7
BIO	14523085	pa	3	8	proposal	observation	none	support	main	secondary	none	none	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_pa_3	BIO_14523085_pa_8	BIO_14523085_pa_3_8
BIO	14523085	pa	3	9	proposal	result	none	support	main	secondary	none	none	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_pa_3	BIO_14523085_pa_9	BIO_14523085_pa_3_9
BIO	14523085	pa	3	10	proposal	conclusion	none	support	main	secondary	back	support	Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_pa_3	BIO_14523085_pa_10	BIO_14523085_pa_3_10
BIO	14523085	pa	4	5	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	BIO_14523085_pa_4	BIO_14523085_pa_5	BIO_14523085_pa_4_5
BIO	14523085	pa	4	6	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	BIO_14523085_pa_4	BIO_14523085_pa_6	BIO_14523085_pa_4_6
BIO	14523085	pa	4	7	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	These changes differed from changes seen in tissue lysates from the same animals.	BIO_14523085_pa_4	BIO_14523085_pa_7	BIO_14523085_pa_4_7
BIO	14523085	pa	4	8	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_pa_4	BIO_14523085_pa_8	BIO_14523085_pa_4_8
BIO	14523085	pa	4	9	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_pa_4	BIO_14523085_pa_9	BIO_14523085_pa_4_9
BIO	14523085	pa	4	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_pa_4	BIO_14523085_pa_10	BIO_14523085_pa_4_10
BIO	14523085	pa	5	6	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	BIO_14523085_pa_5	BIO_14523085_pa_6	BIO_14523085_pa_5_6
BIO	14523085	pa	5	7	observation	observation	info-required	info-required	secondary	secondary	none	none	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	These changes differed from changes seen in tissue lysates from the same animals.	BIO_14523085_pa_5	BIO_14523085_pa_7	BIO_14523085_pa_5_7
BIO	14523085	pa	5	8	observation	observation	info-required	support	secondary	secondary	none	none	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_pa_5	BIO_14523085_pa_8	BIO_14523085_pa_5_8
BIO	14523085	pa	5	9	observation	result	info-required	support	secondary	secondary	none	none	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_pa_5	BIO_14523085_pa_9	BIO_14523085_pa_5_9
BIO	14523085	pa	5	10	observation	conclusion	info-required	support	secondary	secondary	none	none	Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_pa_5	BIO_14523085_pa_10	BIO_14523085_pa_5_10
BIO	14523085	pa	6	7	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	These changes differed from changes seen in tissue lysates from the same animals.	BIO_14523085_pa_6	BIO_14523085_pa_7	BIO_14523085_pa_6_7
BIO	14523085	pa	6	8	observation	observation	info-required	support	secondary	secondary	none	none	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_pa_6	BIO_14523085_pa_8	BIO_14523085_pa_6_8
BIO	14523085	pa	6	9	observation	result	info-required	support	secondary	secondary	none	none	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_pa_6	BIO_14523085_pa_9	BIO_14523085_pa_6_9
BIO	14523085	pa	6	10	observation	conclusion	info-required	support	secondary	secondary	none	none	After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_pa_6	BIO_14523085_pa_10	BIO_14523085_pa_6_10
BIO	14523085	pa	7	8	observation	observation	info-required	support	secondary	secondary	forw	info-required	These changes differed from changes seen in tissue lysates from the same animals.	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	BIO_14523085_pa_7	BIO_14523085_pa_8	BIO_14523085_pa_7_8
BIO	14523085	pa	7	9	observation	result	info-required	support	secondary	secondary	none	none	These changes differed from changes seen in tissue lysates from the same animals.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_pa_7	BIO_14523085_pa_9	BIO_14523085_pa_7_9
BIO	14523085	pa	7	10	observation	conclusion	info-required	support	secondary	secondary	none	none	These changes differed from changes seen in tissue lysates from the same animals.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_pa_7	BIO_14523085_pa_10	BIO_14523085_pa_7_10
BIO	14523085	pa	8	9	observation	result	support	support	secondary	secondary	forw	support	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_pa_8	BIO_14523085_pa_9	BIO_14523085_pa_8_9
BIO	14523085	pa	8	10	observation	conclusion	support	support	secondary	secondary	none	none	By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_pa_8	BIO_14523085_pa_10	BIO_14523085_pa_8_10
BIO	14523085	pa	9	10	result	conclusion	support	support	secondary	secondary	forw	support	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	BIO_14523085_pa_9	BIO_14523085_pa_10	BIO_14523085_pa_9_10
BIO	14523085	pa	10	9	conclusion	result	support	support	secondary	secondary	back	support	This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.	This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta.	BIO_14523085_pa_10	BIO_14523085_pa_9	BIO_14523085_pa_9_10
BIO	14663338	pa	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	BIO_14663338_pa_1	BIO_14663338_pa_2	BIO_14663338_pa_1_2
BIO	14663338	pa	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	BIO_14663338_pa_1	BIO_14663338_pa_3	BIO_14663338_pa_1_3
BIO	14663338	pa	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	BIO_14663338_pa_1	BIO_14663338_pa_4	BIO_14663338_pa_1_4
BIO	14663338	pa	1	5	motivation_background	proposal_implementation	info-required	sequence	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	BIO_14663338_pa_1	BIO_14663338_pa_5	BIO_14663338_pa_1_5
BIO	14663338	pa	1	6	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	BIO_14663338_pa_1	BIO_14663338_pa_6	BIO_14663338_pa_1_6
BIO	14663338	pa	1	7	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	BIO_14663338_pa_1	BIO_14663338_pa_7	BIO_14663338_pa_1_7
BIO	14663338	pa	1	8	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_pa_1	BIO_14663338_pa_8	BIO_14663338_pa_1_8
BIO	14663338	pa	1	9	motivation_background	observation	info-required	support	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_pa_1	BIO_14663338_pa_9	BIO_14663338_pa_1_9
BIO	14663338	pa	1	10	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Matrix metalloproteinase-9 (MMP-9) activity increases in the brain during the first day after focal ischemia and might be involved in the pathogenesis of tissue damage.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_pa_1	BIO_14663338_pa_10	BIO_14663338_pa_1_10
BIO	14663338	pa	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	BIO_14663338_pa_2	BIO_14663338_pa_3	BIO_14663338_pa_2_3
BIO	14663338	pa	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	BIO_14663338_pa_2	BIO_14663338_pa_4	BIO_14663338_pa_2_4
BIO	14663338	pa	2	5	motivation_background	proposal_implementation	support	sequence	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	BIO_14663338_pa_2	BIO_14663338_pa_5	BIO_14663338_pa_2_5
BIO	14663338	pa	2	6	motivation_background	observation	support	info-required	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	BIO_14663338_pa_2	BIO_14663338_pa_6	BIO_14663338_pa_2_6
BIO	14663338	pa	2	7	motivation_background	observation	support	info-required	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	BIO_14663338_pa_2	BIO_14663338_pa_7	BIO_14663338_pa_2_7
BIO	14663338	pa	2	8	motivation_background	observation	support	info-required	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_pa_2	BIO_14663338_pa_8	BIO_14663338_pa_2_8
BIO	14663338	pa	2	9	motivation_background	observation	support	support	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_pa_2	BIO_14663338_pa_9	BIO_14663338_pa_2_9
BIO	14663338	pa	2	10	motivation_background	conclusion	support	support	secondary	secondary	none	none	We previously showed MMP-9 in the extracellular space of brain parenchyma along with neutrophil recruitment after ischemia.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_pa_2	BIO_14663338_pa_10	BIO_14663338_pa_2_10
BIO	14663338	pa	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	BIO_14663338_pa_3	BIO_14663338_pa_4	BIO_14663338_pa_3_4
BIO	14663338	pa	3	5	proposal	proposal_implementation	none	sequence	main	secondary	none	none	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	BIO_14663338_pa_3	BIO_14663338_pa_5	BIO_14663338_pa_3_5
BIO	14663338	pa	3	6	proposal	observation	none	info-required	main	secondary	none	none	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	BIO_14663338_pa_3	BIO_14663338_pa_6	BIO_14663338_pa_3_6
BIO	14663338	pa	3	7	proposal	observation	none	info-required	main	secondary	none	none	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	BIO_14663338_pa_3	BIO_14663338_pa_7	BIO_14663338_pa_3_7
BIO	14663338	pa	3	8	proposal	observation	none	info-required	main	secondary	none	none	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_pa_3	BIO_14663338_pa_8	BIO_14663338_pa_3_8
BIO	14663338	pa	3	9	proposal	observation	none	support	main	secondary	none	none	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_pa_3	BIO_14663338_pa_9	BIO_14663338_pa_3_9
BIO	14663338	pa	3	10	proposal	conclusion	none	support	main	secondary	back	support	In the present study, we tested whether neutrophils were a direct source of enhanced MMP-9 in the ischemic brain.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_pa_3	BIO_14663338_pa_10	BIO_14663338_pa_3_10
BIO	14663338	pa	4	5	proposal_implementation	proposal_implementation	elaboration	sequence	secondary	secondary	back	sequence	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	BIO_14663338_pa_4	BIO_14663338_pa_5	BIO_14663338_pa_4_5
BIO	14663338	pa	4	6	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	BIO_14663338_pa_4	BIO_14663338_pa_6	BIO_14663338_pa_4_6
BIO	14663338	pa	4	7	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	BIO_14663338_pa_4	BIO_14663338_pa_7	BIO_14663338_pa_4_7
BIO	14663338	pa	4	8	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_pa_4	BIO_14663338_pa_8	BIO_14663338_pa_4_8
BIO	14663338	pa	4	9	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_pa_4	BIO_14663338_pa_9	BIO_14663338_pa_4_9
BIO	14663338	pa	4	10	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Neutrophil infiltration was prevented either by injecting an antibody against ICAM-1, which abrogates neutrophil adhesion to the endothelial vessel wall, or by inducing neutropenia.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_pa_4	BIO_14663338_pa_10	BIO_14663338_pa_4_10
BIO	14663338	pa	5	6	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	BIO_14663338_pa_5	BIO_14663338_pa_6	BIO_14663338_pa_5_6
BIO	14663338	pa	5	7	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	BIO_14663338_pa_5	BIO_14663338_pa_7	BIO_14663338_pa_5_7
BIO	14663338	pa	5	8	proposal_implementation	observation	sequence	info-required	secondary	secondary	none	none	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_pa_5	BIO_14663338_pa_8	BIO_14663338_pa_5_8
BIO	14663338	pa	5	9	proposal_implementation	observation	sequence	support	secondary	secondary	none	none	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_pa_5	BIO_14663338_pa_9	BIO_14663338_pa_5_9
BIO	14663338	pa	5	10	proposal_implementation	conclusion	sequence	support	secondary	secondary	none	none	One-hour intraluminal middle cerebral artery occlusion with reperfusion was induced, and studies were performed at 24 hours.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_pa_5	BIO_14663338_pa_10	BIO_14663338_pa_5_10
BIO	14663338	pa	6	7	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	BIO_14663338_pa_6	BIO_14663338_pa_7	BIO_14663338_pa_6_7
BIO	14663338	pa	6	8	observation	observation	info-required	info-required	secondary	secondary	none	none	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_pa_6	BIO_14663338_pa_8	BIO_14663338_pa_6_8
BIO	14663338	pa	6	9	observation	observation	info-required	support	secondary	secondary	none	none	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_pa_6	BIO_14663338_pa_9	BIO_14663338_pa_6_9
BIO	14663338	pa	6	10	observation	conclusion	info-required	support	secondary	secondary	none	none	Circulating neutrophils expressed 95-kDa MMP-9 and dimers, and infiltrated neutrophils stained positive for MMP-9.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_pa_6	BIO_14663338_pa_10	BIO_14663338_pa_6_10
BIO	14663338	pa	7	8	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	BIO_14663338_pa_7	BIO_14663338_pa_8	BIO_14663338_pa_7_8
BIO	14663338	pa	7	9	observation	observation	info-required	support	secondary	secondary	none	none	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_pa_7	BIO_14663338_pa_9	BIO_14663338_pa_7_9
BIO	14663338	pa	7	10	observation	conclusion	info-required	support	secondary	secondary	none	none	The expression of MMP-9 (mainly 95-kDa proform and dimers and, to a lesser extent, 88-kDa form) increased in brain after ischemia/reperfusion.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_pa_7	BIO_14663338_pa_10	BIO_14663338_pa_7_10
BIO	14663338	pa	8	9	observation	observation	info-required	support	secondary	secondary	forw	info-required	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_pa_8	BIO_14663338_pa_9	BIO_14663338_pa_8_9
BIO	14663338	pa	8	10	observation	conclusion	info-required	support	secondary	secondary	none	none	Treatments preventing neutrophil infiltration failed to preclude the ischemia-induced increase in 88-kDa MMP-9 form and gelatinase activity in neurons and blood vessels.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_pa_8	BIO_14663338_pa_10	BIO_14663338_pa_8_10
BIO	14663338	pa	9	10	observation	conclusion	support	support	secondary	secondary	forw	support	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	BIO_14663338_pa_9	BIO_14663338_pa_10	BIO_14663338_pa_9_10
BIO	14663338	pa	10	9	conclusion	observation	support	support	secondary	secondary	back	support	We conclude that neutrophil infiltration highly contributes to enhanced MMP-9 in the ischemic brain by releasing MMP-9 proform, which might participate in the tissular inflammatory reaction.	However, these treatments prevented the major increase in 95-kDa MMP-9 form and dimers.	BIO_14663338_pa_10	BIO_14663338_pa_9	BIO_14663338_pa_9_10
BIO	15094511	pa	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	The 70 kDa heat shock protein (Hsp70) is synthesized in response to a variety of stresses, including ischemia, and is thought to act as a molecular chaperone to prevent protein denaturation and facilitate protein folding.	Matrix metalloproteinases (MMPs), a family of serine proteases, are also upregulated by ischemia and are thought to promote cell death and tissue injury.	BIO_15094511_pa_1	BIO_15094511_pa_2	BIO_15094511_pa_1_2
BIO	15094511	pa	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	The 70 kDa heat shock protein (Hsp70) is synthesized in response to a variety of stresses, including ischemia, and is thought to act as a molecular chaperone to prevent protein denaturation and facilitate protein folding.	We examined the influence of Hsp70 on expression and activity of MMPs.	BIO_15094511_pa_1	BIO_15094511_pa_3	BIO_15094511_pa_1_3
BIO	15094511	pa	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	The 70 kDa heat shock protein (Hsp70) is synthesized in response to a variety of stresses, including ischemia, and is thought to act as a molecular chaperone to prevent protein denaturation and facilitate protein folding.	Astrocyte cultures were prepared from neonatal mice and transfected with retroviral vectors containing hsp70 or lacZ or mock infected, then exposed to oxygen-glucose deprivation followed by reperfusion.	BIO_15094511_pa_1	BIO_15094511_pa_4	BIO_15094511_pa_1_4
BIO	15094511	pa	1	5	motivation_background	result_means	info-required	support	secondary	secondary	none	none	The 70 kDa heat shock protein (Hsp70) is synthesized in response to a variety of stresses, including ischemia, and is thought to act as a molecular chaperone to prevent protein denaturation and facilitate protein folding.	Zymograms and Western blots showed that Hsp70 over-expression suppressed MMP-2 and MMP-9.	BIO_15094511_pa_1	BIO_15094511_pa_5	BIO_15094511_pa_1_5
BIO	15094511	pa	1	6	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	The 70 kDa heat shock protein (Hsp70) is synthesized in response to a variety of stresses, including ischemia, and is thought to act as a molecular chaperone to prevent protein denaturation and facilitate protein folding.	These findings suggest that Hsp70 may protect by regulating MMPs.	BIO_15094511_pa_1	BIO_15094511_pa_6	BIO_15094511_pa_1_6
BIO	15094511	pa	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	Matrix metalloproteinases (MMPs), a family of serine proteases, are also upregulated by ischemia and are thought to promote cell death and tissue injury.	We examined the influence of Hsp70 on expression and activity of MMPs.	BIO_15094511_pa_2	BIO_15094511_pa_3	BIO_15094511_pa_2_3
BIO	15094511	pa	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	Matrix metalloproteinases (MMPs), a family of serine proteases, are also upregulated by ischemia and are thought to promote cell death and tissue injury.	Astrocyte cultures were prepared from neonatal mice and transfected with retroviral vectors containing hsp70 or lacZ or mock infected, then exposed to oxygen-glucose deprivation followed by reperfusion.	BIO_15094511_pa_2	BIO_15094511_pa_4	BIO_15094511_pa_2_4
BIO	15094511	pa	2	5	motivation_background	result_means	support	support	secondary	secondary	none	none	Matrix metalloproteinases (MMPs), a family of serine proteases, are also upregulated by ischemia and are thought to promote cell death and tissue injury.	Zymograms and Western blots showed that Hsp70 over-expression suppressed MMP-2 and MMP-9.	BIO_15094511_pa_2	BIO_15094511_pa_5	BIO_15094511_pa_2_5
BIO	15094511	pa	2	6	motivation_background	conclusion	support	support	secondary	secondary	none	none	Matrix metalloproteinases (MMPs), a family of serine proteases, are also upregulated by ischemia and are thought to promote cell death and tissue injury.	These findings suggest that Hsp70 may protect by regulating MMPs.	BIO_15094511_pa_2	BIO_15094511_pa_6	BIO_15094511_pa_2_6
BIO	15094511	pa	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	We examined the influence of Hsp70 on expression and activity of MMPs.	Astrocyte cultures were prepared from neonatal mice and transfected with retroviral vectors containing hsp70 or lacZ or mock infected, then exposed to oxygen-glucose deprivation followed by reperfusion.	BIO_15094511_pa_3	BIO_15094511_pa_4	BIO_15094511_pa_3_4
BIO	15094511	pa	3	5	proposal	result_means	none	support	main	secondary	none	none	We examined the influence of Hsp70 on expression and activity of MMPs.	Zymograms and Western blots showed that Hsp70 over-expression suppressed MMP-2 and MMP-9.	BIO_15094511_pa_3	BIO_15094511_pa_5	BIO_15094511_pa_3_5
BIO	15094511	pa	3	6	proposal	conclusion	none	support	main	secondary	back	support	We examined the influence of Hsp70 on expression and activity of MMPs.	These findings suggest that Hsp70 may protect by regulating MMPs.	BIO_15094511_pa_3	BIO_15094511_pa_6	BIO_15094511_pa_3_6
BIO	15094511	pa	4	5	proposal_implementation	result_means	elaboration	support	secondary	secondary	none	none	Astrocyte cultures were prepared from neonatal mice and transfected with retroviral vectors containing hsp70 or lacZ or mock infected, then exposed to oxygen-glucose deprivation followed by reperfusion.	Zymograms and Western blots showed that Hsp70 over-expression suppressed MMP-2 and MMP-9.	BIO_15094511_pa_4	BIO_15094511_pa_5	BIO_15094511_pa_4_5
BIO	15094511	pa	4	6	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Astrocyte cultures were prepared from neonatal mice and transfected with retroviral vectors containing hsp70 or lacZ or mock infected, then exposed to oxygen-glucose deprivation followed by reperfusion.	These findings suggest that Hsp70 may protect by regulating MMPs.	BIO_15094511_pa_4	BIO_15094511_pa_6	BIO_15094511_pa_4_6
BIO	15094511	pa	5	6	result_means	conclusion	support	support	secondary	secondary	forw	support	Zymograms and Western blots showed that Hsp70 over-expression suppressed MMP-2 and MMP-9.	These findings suggest that Hsp70 may protect by regulating MMPs.	BIO_15094511_pa_5	BIO_15094511_pa_6	BIO_15094511_pa_5_6
BIO	15094511	pa	6	5	conclusion	result_means	support	support	secondary	secondary	back	support	These findings suggest that Hsp70 may protect by regulating MMPs.	Zymograms and Western blots showed that Hsp70 over-expression suppressed MMP-2 and MMP-9.	BIO_15094511_pa_6	BIO_15094511_pa_5	BIO_15094511_pa_5_6
BIO	15319009	pa	1	2	motivation_background	motivation_background	info-required	support	secondary	secondary	forw	info-required	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	BIO_15319009_pa_1	BIO_15319009_pa_2	BIO_15319009_pa_1_2
BIO	15319009	pa	1	3	motivation_background	proposal	info-required	none	secondary	main	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	BIO_15319009_pa_1	BIO_15319009_pa_3	BIO_15319009_pa_1_3
BIO	15319009	pa	1	4	motivation_background	proposal_implementation	info-required	elaboration	secondary	secondary	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	BIO_15319009_pa_1	BIO_15319009_pa_4	BIO_15319009_pa_1_4
BIO	15319009	pa	1	5	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	BIO_15319009_pa_1	BIO_15319009_pa_5	BIO_15319009_pa_1_5
BIO	15319009	pa	1	6	motivation_background	observation	info-required	info-required	secondary	secondary	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	BIO_15319009_pa_1	BIO_15319009_pa_6	BIO_15319009_pa_1_6
BIO	15319009	pa	1	7	motivation_background	observation	info-required	support	secondary	secondary	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	BIO_15319009_pa_1	BIO_15319009_pa_7	BIO_15319009_pa_1_7
BIO	15319009	pa	1	8	motivation_background	result	info-required	support	secondary	secondary	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_pa_1	BIO_15319009_pa_8	BIO_15319009_pa_1_8
BIO	15319009	pa	1	9	motivation_background	conclusion	info-required	support	secondary	secondary	none	none	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent.	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_pa_1	BIO_15319009_pa_9	BIO_15319009_pa_1_9
BIO	15319009	pa	2	3	motivation_background	proposal	support	none	secondary	main	forw	support	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	BIO_15319009_pa_2	BIO_15319009_pa_3	BIO_15319009_pa_2_3
BIO	15319009	pa	2	4	motivation_background	proposal_implementation	support	elaboration	secondary	secondary	none	none	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	BIO_15319009_pa_2	BIO_15319009_pa_4	BIO_15319009_pa_2_4
BIO	15319009	pa	2	5	motivation_background	observation	support	info-required	secondary	secondary	none	none	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	BIO_15319009_pa_2	BIO_15319009_pa_5	BIO_15319009_pa_2_5
BIO	15319009	pa	2	6	motivation_background	observation	support	info-required	secondary	secondary	none	none	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	BIO_15319009_pa_2	BIO_15319009_pa_6	BIO_15319009_pa_2_6
BIO	15319009	pa	2	7	motivation_background	observation	support	support	secondary	secondary	none	none	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	BIO_15319009_pa_2	BIO_15319009_pa_7	BIO_15319009_pa_2_7
BIO	15319009	pa	2	8	motivation_background	result	support	support	secondary	secondary	none	none	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_pa_2	BIO_15319009_pa_8	BIO_15319009_pa_2_8
BIO	15319009	pa	2	9	motivation_background	conclusion	support	support	secondary	secondary	none	none	So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury.	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_pa_2	BIO_15319009_pa_9	BIO_15319009_pa_2_9
BIO	15319009	pa	3	4	proposal	proposal_implementation	none	elaboration	main	secondary	back	elaboration	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	BIO_15319009_pa_3	BIO_15319009_pa_4	BIO_15319009_pa_3_4
BIO	15319009	pa	3	5	proposal	observation	none	info-required	main	secondary	none	none	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	BIO_15319009_pa_3	BIO_15319009_pa_5	BIO_15319009_pa_3_5
BIO	15319009	pa	3	6	proposal	observation	none	info-required	main	secondary	none	none	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	BIO_15319009_pa_3	BIO_15319009_pa_6	BIO_15319009_pa_3_6
BIO	15319009	pa	3	7	proposal	observation	none	support	main	secondary	none	none	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	BIO_15319009_pa_3	BIO_15319009_pa_7	BIO_15319009_pa_3_7
BIO	15319009	pa	3	8	proposal	result	none	support	main	secondary	none	none	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_pa_3	BIO_15319009_pa_8	BIO_15319009_pa_3_8
BIO	15319009	pa	3	9	proposal	conclusion	none	support	main	secondary	back	support	To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices.	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_pa_3	BIO_15319009_pa_9	BIO_15319009_pa_3_9
BIO	15319009	pa	4	5	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	BIO_15319009_pa_4	BIO_15319009_pa_5	BIO_15319009_pa_4_5
BIO	15319009	pa	4	6	proposal_implementation	observation	elaboration	info-required	secondary	secondary	none	none	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	BIO_15319009_pa_4	BIO_15319009_pa_6	BIO_15319009_pa_4_6
BIO	15319009	pa	4	7	proposal_implementation	observation	elaboration	support	secondary	secondary	none	none	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	BIO_15319009_pa_4	BIO_15319009_pa_7	BIO_15319009_pa_4_7
BIO	15319009	pa	4	8	proposal_implementation	result	elaboration	support	secondary	secondary	none	none	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_pa_4	BIO_15319009_pa_8	BIO_15319009_pa_4_8
BIO	15319009	pa	4	9	proposal_implementation	conclusion	elaboration	support	secondary	secondary	none	none	Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 microJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI).	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_pa_4	BIO_15319009_pa_9	BIO_15319009_pa_4_9
BIO	15319009	pa	5	6	observation	observation	info-required	info-required	secondary	secondary	forw	info-required	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	BIO_15319009_pa_5	BIO_15319009_pa_6	BIO_15319009_pa_5_6
BIO	15319009	pa	5	7	observation	observation	info-required	support	secondary	secondary	none	none	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	BIO_15319009_pa_5	BIO_15319009_pa_7	BIO_15319009_pa_5_7
BIO	15319009	pa	5	8	observation	result	info-required	support	secondary	secondary	none	none	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_pa_5	BIO_15319009_pa_8	BIO_15319009_pa_5_8
BIO	15319009	pa	5	9	observation	conclusion	info-required	support	secondary	secondary	none	none	In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury).	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_pa_5	BIO_15319009_pa_9	BIO_15319009_pa_5_9
BIO	15319009	pa	6	7	observation	observation	info-required	support	secondary	secondary	forw	info-required	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	BIO_15319009_pa_6	BIO_15319009_pa_7	BIO_15319009_pa_6_7
BIO	15319009	pa	6	8	observation	result	info-required	support	secondary	secondary	none	none	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_pa_6	BIO_15319009_pa_8	BIO_15319009_pa_6_8
BIO	15319009	pa	6	9	observation	conclusion	info-required	support	secondary	secondary	none	none	Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 microM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later.	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_pa_6	BIO_15319009_pa_9	BIO_15319009_pa_6_9
BIO	15319009	pa	7	8	observation	result	support	support	secondary	secondary	forw	support	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_pa_7	BIO_15319009_pa_8	BIO_15319009_pa_7_8
BIO	15319009	pa	7	9	observation	conclusion	support	support	secondary	secondary	none	none	At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%).	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_pa_7	BIO_15319009_pa_9	BIO_15319009_pa_7_9
BIO	15319009	pa	8	9	result	conclusion	support	support	secondary	secondary	forw	support	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	BIO_15319009_pa_8	BIO_15319009_pa_9	BIO_15319009_pa_8_9
BIO	15319009	pa	9	8	conclusion	result	support	support	secondary	secondary	back	support	This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage.	BIO_15319009_pa_9	BIO_15319009_pa_8	BIO_15319009_pa_8_9
